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Abstract 
Peripheral nerve injuries represent one of the leading causes of disability 
globally; due to limitations of current therapies, there is a clear clinical need for 
a novel peripheral nerve graft . Decellularised porcine peripheral nerves may 
represent a suitable material; however, they would require terminal sterilisation 
prior to use.  
The main aim of this study was to identify a sterilisation method which minimally 
impacted upon decellularised nerve extracellular matrix (ECM) structure, 
biochemical composition, biomechanical properties and biocompatibility. 
Peracetic acid (PAA) solution 0.1 % (v/v) caused disruption to the structure of 
the endoneurium and reductions in the intensity of antibody labelling for 
basement membrane components, particularly collagen IV (with increased 
severity after a 12 month storage period). Supercritical carbon dioxide (SCCO2) 
treatment (with an additive solution containing 13.5 - 18.5 % [v/v] PAA and 4.5 - 
6 % [v/v] H2O2) under standard conditions induced similar effects to the 
histioarchitecture and significant alterations to tensile mechanical properties; 
processing of the tissue whilst submerged in phosphate-buffered saline 
appeared to protect against such effects. 
Treatment with gamma radiation (25 – 28 kGy) and E Beam (33 – 37 kGy) 
mediated retention of the decellularised nerve ECM structure, and changes to 
the localisation and intensity of labelling for basement membrane components 
were minimal compared with those observed following treatment with PAA 
solution or SCCO2 under standard conditions. However, gamma radiation 
caused the stiffness of the nerves to increase.  
Contact culture experiments did not yield evidence of cytotoxicity following any 
of the sterilisation methods; furthermore, the sterilised nerves did not induce 
any significant changes in the secretion of key cytokines by a murine 
macrophage cell line.  
These data indicate that E Beam could be an optimal sterilisation method for 
use with the decellularised nerves, notwithstanding preliminary results indicating 
that SCCO2 processing under submerged conditions may enable superior 
basement membrane preservation.  
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1 Introduction 
1.1 General Introduction 
Peripheral nervous system injuries are associated with a high socioeconomic 
burden [11]. The annual cost of surgery and primary care for peripheral nerve 
injuries is approximately $7 billion in the USA; in the UK, the annual cost of 
treating of peripheral nerve injuries to the hand alone increased threefold 
between 1990 and 2000 to a figure in excess of £100 million [12]. Indirect costs, 
as a result of lost working hours, have been estimated as being up to sixfold 
greater than the direct treatment-related costs [13]. Peripheral nerve injuries are 
a major cause of chronic morbidity; using current repair methods, the duration 
of time between injury and restoration of function may be seven years [14, 15]. 
Full rehabilitation may never be achieved, negatively impacting the personal 
and professional activities of patients, and consequently their quality of life, over 
an extended period of time.  
Peripheral nerve injuries typically follow a different pattern to those in some 
other tissue types, being more commonly the result of acute traumatic injury 
than chronic diseases related to processes of ageing and regeneration.  The 
relatively young age of the patient demographic and the poor inherent 
regenerative capacity of the tissue mean that surgical interventions and the 
implantation of graft material are often required for the repair of all but the 
smallest defects [16]. 
Current therapies include the use of autografts and synthetic nerve guidance 
conduits. However, each method presents significant limitations when 
considering application across defects of varied size and location.  
Processes mediating the removal of whole cells and other potentially 
immunogenic materials have been developed for use with allogeneic and 
xenogeneic materials [17]. Such “decellularisation” processes may enable these 
materials to be implanted and support regeneration in much the same manner 
as a conventional autograft or allografts. 
Decellularised tissues have numerous advantages over conventional graft 
materials including minimal immunogenicity, the ability to supply large quantities 
- 20 - 
of graft material and the provision of an extracellular matrix scaffold with similar 
biomechanical, structural and biochemical properties to native tissue.  
Previous research has led to the development of a decellularisation process for 
porcine peripheral nerves, which has shown initial promise as a material for 
supporting the growth of infiltrating Schwann cells and neurons [18]. Given 
these results, and the clear clinical need for novel peripheral nerve grafts, these 
decellularised nerves may represent a promising alternative material for use in 
the repair of peripheral nerve defects.  
Xenogeneic tissues may harbour a pathogenic bioburden which could pose a 
serious infection risk to patients following implantation [19]. Therefore, in order 
for decellularised porcine nerves to be considered as a potential graft material, 
a suitable terminal sterilisation method must be identified. Such a method 
should enable international standards for bioburden reduction to be met whilst 
minimally affecting scaffold properties. The identification of such a method could 
enable further progression of decellularised nerve grafts towards clinical use. 
1.2 Anatomy of the peripheral nervous system 
The peripheral nervous system consists of individual nerves facilitating the 
passage of neural cell structures, known as axons, to the end target innervated 
organ/tissue [20]. Axons are extensions of neurons originating from cell bodies 
located close to the regions of the central nervous system (e.g. in dorsal root 
ganglia) [21]. Neurons function either to mediate the communication of sensory 
information (sensory/afferent nerve fibre) or facilitate control of a specific 
function through effectors (motor/efferent nerve fibre). The distribution of such 
sensors and effectors requires the network of the peripheral nervous system to 
be present throughout the body, up to and including the extremities of the limbs 
(Figure 1-1). 
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Figure 1-1 Peripheral nervous system 
Overview of the major components of the peripheral nervous system in the 
human anatomy. The central nervous system (brain and spinal cord) is also 
shown. Adapted from original image (Wikimedia commons       ).      
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1.2.1 Cells of the peripheral nervous system 
1.2.1.1 Neurons 
Neurons are the primary functional cell type of the peripheral nervous system, 
responsible for conducting sensory or function-activating (e.g. muscular 
contraction, hormone release) information in the form of electrical impulses [23]. 
Neurons consist of a cell body located within regions of the central nervous 
system (e.g. spinal cord), from which the long, thin axons project. The 
dimensions of peripheral axons vary greatly; the length of axons may be 
between 1 – 100 cm (or greater), and diameter can vary from 1 – 20 m [24]. 
Electrical impulses initiated at the cell body propagate along axons by 
directional depolarisation of the plasma membrane. This is caused by a 
transmembrane influx of sodium ions,  temporarily creating a positive 
membrane potential. This membrane potential “propagates” along the axon by 
the sequential opening of sodium channels stimulated by a local change in 
voltage becoming greater than the typical resting level (from approximately - 60 
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millivolts (mV) to approximately – 30 mV). Repolarisation is mediated by the 
release of potassium ions from the cell, allowing potassium-sodium exchange 
pumps to remove sodium from the cell and restore the original polarity.  
1.2.1.2 Schwann cells 
Schwann cells are a glial cell type present on/near the surface of axons, the 
primary function of which is to coat axons with multiple layers of plasma 
membrane containing a lipid-rich substance known as myelin [25]. This process 
is referred to as myelination. Myelin is a highly effective insulator due to a high 
lipid content, and therefore prohibits effective transmembrane ion exchange of 
the axon outside of regularly spaced myelin-free sites known as Nodes of 
Ranvier. Distance between nodes (internode distance) is dictated by the length 
of individual myelinating Schwann cells, and may vary from around 0.2 – 2 mm 
[26]. The large variance in internode length is thought to be due to factors such 
as the length and diameter of the nerve in question, growth and ageing [27]. 
Myelination maintains the speed of conductivity during propagating action 
potentials, due to the fact that full length depolarisation requires the opening of 
fewer ion channels and therefore can occur at a greater rate.  
1.2.1.3 Accessory cells of the peripheral nervous system 
 Perineurial cells are a type of glial cell found within the perineurium and are 
epithelial-like in their characteristics, with a flattened squamous morphology 
[28]. Perineurial cells are thought to  modulate mechanical stresses and enable 
homeostasis of the intraperineurial environment via the formation of intercellular 
tight junctions [29]. Perineurial cells are found attached to the concentric basal 
lamina layers of the perineurium.  
Exterior to the basement membrane the endoneurium is populated by cells 
exhibiting fibroblastic properties, whose primary function is the production of 
extracellular matrix (ECM) components [30]. These cells may also have roles in 
regulating processes associated with the degradation of the nerve following 
injury (e.g. the infiltration and response of the immune system). 
A population of resident macrophages exists within peripheral nerves [31]. 
Resident neural macrophages are particularly important in the early phase 
response to injury in peripheral nerve, mediating clearance of cellular and 
matrix debris resulting from the injury and stimulating the de-differentiation of 
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Schwann cells. Resident neural macrophages act synergistically with Schwann 
cells to recruit non-resident macrophages (as well as ) from the circulation, 
through the secretion of cytokines including interleukins (IL)-1, IL-6 and tumour 
necrosis factor (TNF)- [32].  
The recruitment of a large population of activated macrophages ensures rapid 
clearance through phagocytosis of the debris resulting from myelin and axonal 
fragmentation [33]. Following the recruitment of immune cells (primarily 
macrophages) from circulation, the secretion of IL-10 is upregulated; this limits 
the duration of the pro-inflammatory response and so enables the process of 
tissue regeneration to begin (section 1.6) [34, 35]. The level of cytokine 
secretion and the specific cytokines secreted can have a profound impact upon 
the host response to an implanted graft material (e.g. decellularised tissue) [36, 
37]. Investigation of the host response, in an in vitro and/or in vivo setting, is 
therefore a vital step in determining the likely biocompatibility of such materials. 
1.2.2 Macroscopic structure of peripheral nerves  
Peripheral nerves have a common macroscopic structure, there are three 
distinct regions: the endoneurium, the perineurium and the epineurium (Figure 
1-2). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-2 Structure and anatomy of peripheral nerve. 
Details of peripheral nerve anatomy, including A) Depiction of peripheral 
nerve showing the concentric layering of the major ECM structures of the 
epineurium, perineurium and endoneurium, as well as other features 
including the vasculature (vasa nervorum) and in situ Schwann cells and 
axons; B) Cross sectional image of human peripheral nerve transected 
during surgical repair. Individual fascicle indicated by dashed circle. Adapted 
from Grinsell et al (2014) [2], Ray and Mackinnon (2010) [10]. 
B A 
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1.2.2.1 Epineurium 
The outermost layer of the nerve containing all endoneurial and perineurial 
structures, is the epineurium. The epineurium is a sheath-like structure 
composed primarily of type I and III collagens, and can be divided arbitrarily into 
the interfascicular epineurium and the outer epineurial sheath of the nerve [38]. 
There is a gradual rather than delineated transition between the two epineurial 
regions. In addition to collagenous ECM, adipose tissue is also present in the 
epineurium, located primarily within the interfascicular region [39]. The adipose 
tissue within the epineurium may have a crucial role in the regulation of lipid 
metabolism by Schwann cells located within the endoneurium. 
The epineurium defines the nerve from the external environment, insulates it 
and facilitates the passage of the vasa nervorum [40]. The major vessels of the 
vasa nervorum are located in the epineurium, and branch to form the minor 
blood vessels which facilitate blood supply to the interior tissues of the nerve. 
The epineurium is a major contributor to the mechanical strength of the 
peripheral nerve tissue as a whole, a function aided by its high type I collagen 
content [8].  
1.2.2.2 Perineurium 
The perineurium is located superior to the endoneurium, containing groups of 
endoneurial tubes known collectively as a bundle or fascicle (Figure 1-2). The 
perineurium is a concentrically-layered lamellar matrix structure composed 
primarily of type I and II collagens . Each layer of the perineurium also contains 
a basal lamina (or basement membrane), which provides attachment sites for 
the perineurial cells. The primary components of the perinerurial basal lamina 
are type IV collagen, fibronectin, laminin, and heparan sulphate [41]. The 
interior structure of peripheral nerves is made up of multiple perineurial tubes 
connected by a highly-collagenous ECM-region known as the interstitial matrix 
(or internal epineurium) [42]. 
The function of the perineurium can be considered to be twofold; the provision 
of mechanical strength and the regulation and maintenance of the 
intrafascicular microenvironment [4]. The perineurium provides site-specific 
mechanical support and protection to the axons and Schwann cells contained 
within the endoneurial bundles, aiding in the prevention of injury through 
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Figure 1-3  Diagram of peripheral nerve tight junctions relative to 
histoarchitecture 
The different levels of peripheral nerve ECM structure are shown, with the 
epineurium surrounding individual fascicles. The layered lamellar structure of 
the perineurium is depicted, and inferior to the the network of tubules which form 
the distinctive structure of the endoneurium.  At each level, the types of 
intercellular tight junction enabling homeostasis of the perinaurial and 
endoneurial microenvironments are shown. Cl = claudin, ZO = zonula 
occludens, Occl = occludin. Adapted from Peltonen et al (2013) [4]. 
mechanisms such as excessive compression. In addition to this, the 
perineurium also contributes significantly, along with the epineurium, to the 
determination of the tissue-scale biomechanical properties of peripheral nerve 
[43]. 
The perineurium is a crucial structure for the homeostatic regulation of the 
intrafascicular environment (including the regulation of pressure and 
concentration of soluble molecules and ions), and therefore ultimately the 
microenvironment of axons and Schwann cells within individual endoneurial 
tubules [44]. The perineurium provides a highly effective diffusion barrier, with 
transport regulated by intercellular tight junctions composed of proteins 
including as occludins and claudins (Figure 1-3) [4]. Passage of molecules and 
ions across the perineurium is thought to be mediated by specific trans-
membrane transport proteins (e.g. glucose is transported via Glucose 
transporter-1) and vesicular transit [4].  
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1.2.2.3 Endoneurium 
The endoneurium is an ECM structure with a honeycomb-like cross section, 
contained within each fascicle interior to the perineurium.  Individual myelinated 
axons (or multiple axons if unmyelinated), together with Schwann cells and 
other fibroblastic-type cells, are contained within the tube-like structures of the 
endoneurium. The majority of the endoneurium is made up of type I and II 
collagens [45]. Individual endoneurial tubules contain basal lamina with a 
composition similar to that found in the perineurium, made up of molecules 
including heparan sulphate, laminin, fibronectin and collagen IV [46].  
The endoneurial basal lamina within each tubule provides directional 
chemotrophic guidance and also facilitates Schwann cell adherence, growth 
and migration. The endoneurial basal lamina is therefore crucial to successful 
growth, regeneration and myelination of axons (described in section 1.2.1.2)  
[47, 48].  The larger vessels of the peripheral nerve vascular network , the vasa 
nevorum, do not directly access the endoneurium [40]. Instead, a fine capillary 
network permits individual axons access to the circulation. 
1.3 Biochemical composition of peripheral nerve extracellular 
matrix 
The peripheral nerve ECM is made up of numerous different biomolecules, the 
most abundant of which is type I collagen [49]. Other peripheral nerve ECM 
components include type II, III, IV and V collagens, glycosaminoglycans 
(GAGs), elastin, laminin, fibronectin and chondroitin sulphate proteoglycans 
(CSPGs) [50]. The interaction of cells (e.g. neurons, Schwann cells and immune 
cells such as macrophages) with peripheral nerve ECM components may 
influence tissue regeneration following injury, by the promotion or inhibition of 
processes such as cell growth and migration, the secretion of additional ECM 
components and remodelling of the ECM.  
1.3.1 Collagens 
Collagens represent the majority of the biomolecules making up peripheral 
nerve ECM (approximately 90 %) [49]. Collagens are key structural components 
of nerve ECM histoarchitecture, including the nerve–specific structures; the 
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epineurium, perineurium and endoneurium [51]. Collagen is a trimeric molecule, 
the main functional domain of which is the alpha chain [52]. The combination of 
alpha chain sub-types determines the overall type of the collagen molecule.   
In vivo, fibrillar collagen molecules are assembled in a hierarchical order of 
increasing size as microfibrils, fibrils and fibres [53]. The tri-helix three-
dimensional structure of fibrillar collagen molecules (of which types I, III and V 
are examples present in the peripheral nerve) within the ECM are crucial for 
mechanical strength, and therefore important for the support and protection of 
axons [54].  
Type IV collagen is a highly glycosylated network-forming collagen located 
mainly in the basal lamina of the endoneurium. Due to the structural differences 
compared with other collagen subtypes at the level of individual molecules, 
such as retention of a C4 domain at the C-terminus and the lack of the regular 
glycine residue every third amino acid, type IV collagen molecules do not 
assemble in a parallel, hierarchical fibrillar pattern [55]. Instead,  type IV 
collagen molecules assemble to form ß-sheets; these are crucial to the function 
of basement membranes, and in the nerve provide binding sites for the key 
moieties (e.g. laminins) which in turn enable the cellular processes of Schwann 
cells and neurons [56].  
1.3.2 Elastin 
Elastin is known to be present in low concentrations within the peripheral nerve 
ECM, in each of the epineurium, perineurium and endoneurium [57]. Bundles of 
elastin fibrils are thought to be most concentrated in the perineurium, as well as 
the lumen of blood vessels in the vasa nervorum. It is thought that elastin 
predominantly contributes to the initial biomechanical properties (at low strain 
levels) of peripheral nerve tissue [58].  
1.3.3 Laminins 
Laminins are ECM proteins made up of three subunits (α,β,γ), with around 45 
differing isoforms possible [50].  Laminins are a crucial component of the basal 
lamina (both endoneurial and perineurial), with extensive functions related to 
cell adhesion, growth and migration [47]. Laminins have been linked to an 
important role in the promotion of axonal regeneration within endoneurial tubes 
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following injury; however, exact functions differ by sub-type. Laminins are most 
frequently bound by integrins, which mediate both cell adhesion and the 
transduction of signals from contact with different ligands [59]. A comparison 
study showed that the addition of laminin to the surface of a poly-3-
hydroxybutyrate scaffold produced the biggest increase in Schwann cell growth 
and proliferation compared with type I collagen or fibronectin [60]. The 
importance of differing laminin subtypes to different functions within the nerve 
have also been examined. In lama4 -/- gene knockout mice, Schwann cell 
function was impaired to a greater degree following a sciatic nerve crush injury 
compared with wild type animals; for example, the myelin sheath in mutant 
animals was approximately 15% thinner, and myelination was not consistent 
between axons and across the length of individual axons [61]. In contrast, 
axonal growth did not appear to be affected by the mutation. These results 
suggested that Schwan cell function is influenced by interaction with laminin-8, 
which contains the laminin-α4 chain, whereas axons interact with the basement 
membrane through binding to laminin-2. These results were corroborated by a 
concurrent in vitro study, which demonstrated that increased growth of 
Schwann cells when incubated with a substrate of laminin-2 compared with 
laminin-8; the opposite was found to be true for neurons. 
1.3.4 Fibronectin 
Fibronectin, a key component of the basal lamina, is synthesised in nerves by 
Schwann cells in vivo [50]. Fibronectin is a glycoprotein that enables binding of 
cell surface proteins such as integrins [60]. When included as a supplementary 
material within a nerve guidance conduit, fibronectin has been shown to 
stimulate Schwann cell growth and migration. Fibronectin is predominantly 
located in the endoneurium and perineurium. Fibronectin is associated with 
axonal regeneration and myelination; for example, the addition of fibronectin to 
an alginate-based hydrogel conduit improved Schwann cell viability and 
enabled association with neurons, ultimately leading to improved neuronal 
regeneration in a rat sciatic nerve defect model [62].  
1.3.5 GAGs 
GAGs are polysaccharide molecules forming conjugates with proteins to give an 
overall unit known as a proteoglycan [63]. GAGs may be sulphated (e.g. 
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heparan sulphate) or non-sulphated (hyaluronic acid). Sulphated GAGs confer a 
range of functions, which can be broadly subdivided into modulation of cellular 
processes (e.g. heparin sulphates, chondroitin sulphates) and maintenance of 
tissue hydration (keratan sulphates, chondroitin sulphates) [64]. Non-sulphated 
GAGs, which (unlike sulphated GAGs) are only linked to proteins in a non-
covalent manner, primarily function to aid in shock absorption (e.g. in 
articulating joints, where high concentrations of hyaluronic acid are found in the 
articular cartilage coating the joint surface). GAGs are known to be present in 
the ECM of peripheral nerve, with hyaluronic acid being the most abundant [58]. 
However, the specific function of GAGs within peripheral nerve is poorly 
characterised [65].  
Chondroitin sulphate proteoglycans (CSPGs) are a sub-type associated with the 
Schwann cell basal lamina in the peripheral nerve [50]. CPSGs are upregulated 
following injury to the nerve and are known to be inhibitory to the process of 
Schwann cell attachment and axonal regeneration [66]. This is thought to be 
due to CSPGs binding to laminins in the basement membrane, inhibiting the 
chemotrophic effect these molecules can exert upon Schwann cells and 
neurons [67]. The magnitude of this effect is compounded by the increase in 
concentration of CSPGs within the endoneurium following damage, providing a 
potential barrier to sprouting neurons and therefore restoration of function [68]. 
It is thought that these CSPGs are subsequently degraded, permitting the 
extension of axons and the growth and migration of Schwann cells [69, 70]. 
Because of this, some nerve grafts (e.g. the Avance® decellularised human 
nerve graft) derived from native peripheral nerve ECM have been treated with 
the enzyme chondroitinase to eliminate CSPGs. This may serve to improve 
function, though to date insufficient evidence exits to conclusively demonstrate 
the clinical benefit of such treatment [69, 71]. In addition, it is highly likely that 
that the categorisation of CPSGs as only inhibitory to processes of 
neuroregeneration is an oversimplification. Rather, it is increasingly thought that 
CSPGs may have important regulatory functions during neuroregeneration. A 
previous study utilised transmission electron microscopy to provide evidence 
that CSPGs may influence the direction and phenotype (e.g. growth cone 
morphology, cell attachment molecule expression) of extending axons during 
regeneration [72]. 
- 30 - 
1.4 Biomechanical properties of peripheral nerves 
Unlike tissues such as bone, tendon and ligament, the primary function of 
peripheral nerve tissue is not primarily related to an ability to bear mechanical 
load. Instead, the mechanical functions of peripheral nerve ECM primarily relate 
to the protection of the axonal cell bodies travelling within the tissue [73].  The 
epineurium and perineurium are the ECM structures thought to be primarily 
responsible for the mechanical properties of peripheral nerve, whilst the 
endoneurium is thought to have mainly non-mechanical functions (e.g. axonal 
guidance, the provision of Schwann cell attachment sites). The perineurium, 
formed from a highly organised, layered lamellar structure of aligned collagen 
fibrils, surrounds each fascicle and is thought to be the most important 
contributor to the tensile mechanical properties of peripheral nerve [74]. 
Peripheral nerves must be able to maintain structure and functional properties 
when subjected to differing forces. As well as tensile stress, peripheral nerves 
may also experience compressive and shear stresses [8]. Articulating joints and 
muscular tension and relaxation may alter the dimensions of the connective 
tissue channel through which the nerve travels, subjecting the nerve to an 
increase in compressive stress [73]. Such changes in the magnitude and type of 
stress experienced at differing locations are reflected by the local structure of 
the perineurium [75]. Regions of the nerve at sites likely to generate higher 
levels of tensile and compressive stress (e.g. nerve junctions, nerves close to 
articulating joints) have a greater number of perineurial layers than areas of 
nerve fibre found in regions associated with lesser mechanical stress. 
The level of strain (and therefore stress) a peripheral nerve is subjected to may 
also be influenced by the movement of the nerve within its connective tissue 
sheath; a gliding motion known as excursion [76]. Excursion of the nerve may 
decrease the overall tensile strain the nerve experiences, but result in an 
increase in shear stress due to friction between the exterior of the peripheral 
nerve and the connective tissue it resides within. 
The length and distribution of peripheral nerves result in a wide variation in the 
localised mechanical forces experienced by the tissue [8]. Peripheral nerve 
tissue must therefore exhibit sufficient extensibility and elasticity to avoid 
compromising axonal function during movement, whilst also providing protection 
- 31 - 
from compression and shear forces. The biomechanical properties of peripheral 
nerves are known to vary with changes in parameters such as the diameter, 
location, fascicle number and function (sensory/motor etc.) of the nerve [77]. 
Such localised heterogeneity of properties is particularly crucial when the nerve 
is present in spaces close to articulating joints, for example within the arm 
where the median, radial and ulnar nerves travel close to the elbow joint 
between the humerus and the radius and ulnar. For example, sections of nerve 
located close to articulating joints may exhibit higher levels of compliance than 
those in regions experiencing less frequent and lower levels of localised strain.  
A 2006 study by Topp and Boyd utilised cadaveric human limbs to facilitate 
measurement of the strain experienced by peripheral nerves during movement 
[8]. When the limbs were positioned at different degrees of joint flexion, strains 
of approximately 5 - 11 % were applied to the nerve trunk (Figure 1-4) . At 
specific locations, for example where the ulnar nerve passes through the elbow, 
strain levels of up to 30 % were observed. 
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Figure 1-4 Variation in peripheral nerve strain during articulating joint 
flexion  
Variation of localised strain experienced by the median (continuous line) and 
ulnar (dashed line) nerves during extension of A) the elbow and B) the wrist. 
Adapted from Topp and Boyd (2006) [8]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mechanical properties of a tissue are commonly expressed as a curve of 
stress against strain (Figure 1-5). The mechanical characteristics of collagenous 
tissues are generally well characterised, particularly for tissues where the 
primary function is directly related to such properties. For example, the 
functions of soft musculoskeletal tissues (e.g. tendon, and ligament, such as the 
maintenance of stability within articulating joints whilst simultaneously facilitating 
complex movement patterns), are highly dependent on specific mechanical 
properties, and as a result these properties have been the subject of numerous 
studies [78]. In contrast, the mechanical functions of peripheral nerve tissue are 
considered secondary are primarily related to the protection of the key effector 
cells (especially axons and neurons) from mechanical injury; therefore, these 
properties are comparatively less studied. However, in common with other soft 
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tissues, the mechanical properties of peripheral nerve are primarily thought to 
be mediated by the fibrillar collagens (e.g. collagen I) which represent the 
majority of the ECM. Therefore, the limited data which do exist regarding 
peripheral nerve biomechanics can reasonably be compared to data from other 
such tissues when attempting to understand the underlying processes which 
determine these properties.  
Indeed, a comparison of stress-strain curves for three soft collagenous tissues, 
tendon, diaphragm, and peripheral nerve, indicates that the basic 
characteristics are similar (Figure 1-5) [74, 79, 80]. The stress-strain curves for 
all three tissues (peripheral nerve, tendon and diaphragm) exhibit a toe region, 
a linear region and a defined point of rupture. The toe region is seen at low 
levels of strain; this region is characterised by comparatively low rates of 
increase in stress versus strain (i.e. the relationship between the two is non-
linear in this region of the stress-strain curve). Studies investigating the 
mechanical properties of tendon and peripheral nerve have attributed this to the 
uncrimping of higher order collagen structure; this has been further 
corroborated through the use of biophysical analytical techniques [81-83]. For 
example, a 2018 synchotron x-ray diffraction study of the human ligament; 
based on observed changes in individual collagen fibre and fibril-level strain and 
stress when the ligaments were subjected to differing strain rates, the authors 
concluded that the characteristic regions of the stress-strain curve pertaining to 
collagenous tissues are primarily determined both by the higher order structure 
and proteoglycan sidechains forming bridges between tropocollagen molecules 
(Figure 1-6) [79, 84]. In the toe region the relationship between stress and strain 
is primarily determined by unfolding of the collagen crimp, loss of molecular-
level “kinks” and recruitment of individual collagen molecules, whereas the 
linear region is predominantly defined by extension of the collagen fibres 
(mediated both by extension of the triple helices and sliding of the individual 
tropocollagen molecules past each other), and to a lesser extent isolated 
instances of fibril rupture. An x-ray diffraction study of rat sciatic nerves during 
tensile loading revealed differential levels of contribution to the bearing of 
mechanical load between the different tissue components, with collagen fibril 
strain correlating linearly with load in the linear region of the tissue-level stress-
strain curve [81]. At the point of failure (rupture), the proteoglycan bridges are 
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Figure 1-5 Example stress- strain curves for collagenous soft tissues 
Example stress-strain curves for (A) human tendon, (B) human diaphragm, and 
(C) rat sciatic nerve. Adapted from (A) Trumbull et al (2016), (B) Paur et al 
(2016), and (C) Borschel et al (2003) [74, 79, 80]. 
 
Microscopic failure and sliding of individual 
tropocollagen molecules 
 
Straightening of fibres (loss of crimp) 
debonded from the tropocollagen molecules, causing widespread (macroscopic) 
loss of fibril integrity (Figure 1-5A and Figure 1-6).  
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Figure 1-6 Multilevel changes in collagen tissue structures underlying 
different regions of the characteristic stress-strain curve 
Structural changes which act as prmary determinants underlying the stress-
strain characteristics of collagenous soft tissues, including changes in collagen 
fibre and fibril structure, and intermolecular GAG bridges between individual 
tropocollagen units. The different changes correspond to tissue in the (A) 
resting state, (B) toe region, (C) linear region and (D) point of rupture (and to a 
lesser extent the linear region)Adapted from Karunaratne et al (2018) [84]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The difference in the shape of the stress-strain curve (and therefore the 
differences in the underlying mechanical properties) between tissues and 
polymeric materials are likely due to three main factors. Biological tissues (such 
as peripheral nerve) generally exhibit a heterogeneity of structure and 
composition, with different constituent ECM components and structures 
contributing to the overall mechanical properties of the tissue (even though 
fibrillary collagens are often the most important contributing component) [50, 
81]. Further, in contrast to synthetic polymeric materials, biological tissues 
contain a significant fluid component (interstitial fluid) [85]. The flow of this fluid 
within the tissue is known to affect the tensile mechanical properties of soft 
tissues, particularly at lower levels of strain as the fluid is forced out of the 
tissue; this is primarily due to a relative decrease in cross-sectional area as the 
level of strain is increased. In the context of peripheral nerve, the fluid 
component within the tissue therefore has the potential to influence the toe 
region of the curve in particular. Finally, as detailed above, the unique and 
complex multilevel structure of collagen proteins (at the level of fibres, fibrils, 
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and interactions between individual tropocollagen units) is fundamentally 
different to that of polymers, and produces a unique and characteristic stress-
strain curve [52, 53]. Because of these three factors, the typical stress-strain 
curve exhibited by polymers is therefore quite different (for example, the toe 
region is absent), and is instead primarily reliant on differences in intermolecular 
branching and chain length and is not governed by the same structural changes 
[86].  
However, these differences also present potential disadvantages when 
conducting in vitro mechanical testing of tissues. Whereas the effect of 
environmental factors on the mechanical properties of polymers have been well 
characterised, a tissue sample which has been excised, possibly stored, and 
then subjected to mechanical testing under non-native like conditions is unlikely 
to exhibit exactly the same mechanical behaviour as it would in situ [85]. For 
example, in an in vivo situation a peripheral nerve is likely under a low level of 
mechanical tensile strain (compared with the same material when not physically 
attached at two defined points [i.e. after excision]) at resting state [73, 87, 88]; 
therefore, unless this exact level of strain (and changing patterns of strain 
application, which may influence the repeatability of stress-strain values taken 
from collagenous soft tissues and can be simulated through cyclic 
preconditioning) can be measured and replicated prior to the initiation of testing, 
measured tensile testing data may not completely reflect the “true” tensile 
properties fo the tissue in situ (e.g. the measured toe region may be extended 
slightly due to the additional strain required to achieve the transition to the linear 
region) [89]. In addition, the exact proportion of fluid within the tissue in an in 
vitro situation is unlikely to be the same as when the tissue is within it’s native 
homeostatic environment; as fluid flow is thought to contribute to the 
mechanical properties of soft tissue, change in the relative fluid proportion 
within the tissue may therefore also alter the measured mechanical properties 
of the tissue relative to the in vivo situation [90].  
Cross-referencing of the likely conditions (e.g. strain levels) experienced once 
the tissue graft is in situ (Figure 1-4) with the baseline mechanical properties of 
native tissue (Figure 1-5) can enable informed consideration of the potential 
impact of changes to tissue mechanical properties on the function of a tissue 
(including the function of resident cells within the tissue). Given the 
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physiologically relevant levels of strain experienced by peripheral nerve tissue, 
approximately 0 - 30 % (Figure 1-4), changes to tissue mechanical properties 
influencing the toe region and the initial part of the linear region of the stress-
strain curve have the greatest potential to influence axonal function (Figure 1-5). 
For example, a decrease in the level of strain at which the linear elastic region 
is entered, or alteration to the gradient of the linear slope, and therefore to the 
Young’s Modulus (also known as the Modulus of Elasticity), would likely cause 
an increase in the local levels of stress experienced by axons. 
Levels of strain and/or stress in excess of physiological parameters can have a 
multitude of effects upon cells within the peripheral nerve tissue, particularly if 
the tissue is subjected to such conditions over extended periods of time [91]. 
Possible effects include changes to the vessel diameter of the vasa nervorum 
and therefore a decreased supply of blood to cells within the nerve, and a 
decrease in the number of successfully activated action potentials and 
compound action potentials (due to multiple causative factors including an 
increase in distance between Nodes of Ranvier, increased Schwann cell death 
and a decrease in the number axons travelling within the nerve) [92, 93].  
1.5 Clinical background to peripheral nerve injury 
Peripheral nerve injuries occur within the population at a frequency of 
approximately 1 in 1000, with approximately 300,000 new injuries incurred 
annually in the European Union alone [94]. According to the World Health 
Organisation, the global incidence rate is thought to vary between 2.25 and 6 
million new cases per year [95].  Approximately half of clinically diagnosed 
peripheral nerve injuries require surgical repair by grafting [96].  
The affected demographic are relatively young, with the mean age of incidence 
being approximately 27 [97]. This may be due to the greater levels of physical 
activity (associated with work, sports etc.), as well as (in some locations) 
increased likelihood of injury as a result of excessive consumption of alcohol 
within this demographic and a consequently increased risk of traumatic injury 
[97]. By contrast, a 2015 study by Bekelis et al found that older patients are 
more susceptible to incurring peripheral nerve injury as a result of a simple fall, 
with 39 being the mean age of incidence for this type of injury [98].  
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Peripheral nerve injuries result in significant disability, significantly affecting 
quality of life due to effects such as decreased ability to work and engage in 
leisure pursuits [2]. A 2015 study reviewed quality of life following compressive 
peripheral nerve injuries to the upper limb [99]. The review found that the 
outlook for perceived quality of life is highly dependent on the severity and, in 
particular, the location of a given injury, with more proximal injuries linked to a 
relatively poor quality of life. For example, a study of 158 patients suffering from 
upper limb peripheral nerve injuries found that injuries to the brachial plexus a 
significantly higher score on the DASH matrix (Disabilities of the Arm, Shoulder 
and Hand; brachial plexus) compared with those to more distal branches such 
as the ulnar nerve [100].   
Patients suffering from longer-lasting physical symptoms as a result of 
peripheral nerve injury, for example chronic pain and loss of function, were 
found to have an increased incidence of additional psychosocial comorbidities 
such as depression and anxiety [100].  
The loss of working days and the cost of care and rehabilitation associated with 
peripheral nerve injuries results in the induction of a significant economic 
burden. As an example, the cost of surgery and primary care alone resulting 
from peripheral nerve injury in the USA is approximately $7 billion. The total 
cost would be much higher when loss of productivity and the cost of social care 
during the recovery period are added to this figure.  
Peripheral nerve damage is typically the result of traumatic injury, through 
mechanisms such as crushing (compression), laceration and excessive tension 
(traction) [101]. Injury to the nerves can be the result of (relatively) chronic or 
acute damage; an often cited example of chronic damage is “Saturday night 
palsy” (AKA radial nerve palsy), caused by radial nerve compression (often 
following after heavy alcohol consumption) incurred following an unusual 
sleeping position and consequent excess local pressure being exerted for long 
periods of time on the radial nerve [102]. 
Nerves in the limbs (e.g. the brachial or peroneal nerves) are particularly 
vulnerable to injuries [97]. The leading cause of peripheral nerve injuries in 
civilian populations is vehicle accidents; other common causes include bullet 
wounds, glass fragment/blade-induced laceration, injuries associated with 
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sports, blunt trauma and accidents during surgical procedures [11, 103]. 
Peripheral nerve injuries are associated with industries requiring physical 
activity in higher risk environments, examples of such being the agricultural, 
forestry and construction sectors [97].   
Peripheral nerve injuries are commonly characterised according to one of two 
accepted grading systems, Seddon’s Classification and Sunderland’s 
Classification (Table 1-1) [16]. The first two categories of both classification 
systems describe injuries in which a degree neuronal function is lost without 
significant disruption or physical damage to the ECM structure. Sunderland’s 
injury grades III, IV and V describe differing extents of damage resulting from  
severe compression, traction or laceration of the nerve, according to the depth 
to which the ECM has been damaged and the extent of the injury (Figure 1-6). 
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Table 1-1 Grades of Nerve injury according to the classification systems 
of Seddon and Sunderland [16, 104] 
 
 
Sunderland’s/ 
Seddons’ 
Type and severity of injury 
Prognosis for 
recovery 
I / Neurapraxia 
Some localised demyelination 
and associated temporary loss 
of conduction. Axons intact. 
Surgery generally 
not required 
II / Axonotmesis 
Demyelination combined with 
some disruption of axons. 
ECM remains intact. 
Slower than Grade 
I, but surgery not 
generally required. 
III / Axonotmesis 
Disruption of axons and the 
endoneurium, leading to 
significant, prolonged loss of 
conductivity. 
Surgical intervention 
may be required, 
according to the 
extent of disruption. 
IV / Axonotmesis 
Disruption to axons, 
endoneurium and perineurium. 
No recovery without surgery, 
slow recovery following 
surgery. 
Surgical intervention 
required. Recovery 
very limited with no 
intervention. 
V / Neurotmesis 
Total severance of nerve-
axons, endoneurium, 
perineurium and epineurium all 
disrupted. Most likely grade to 
require graft material for repair. 
No prospect for 
recovery of function 
without surgical 
intervention. 
VI / Elements of 
more than one 
category 
A mixed injury which may 
require intervention according 
to the type and severity. 
Presents elements of more 
than one grade of injury. 
Surgical intervention 
generally required, 
with varying extent. 
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Figure 1-7 Visual representations of traumatic peripheral nerve injury 
classifications according to Sunderland’s and Seddon’s scales 
Adapted from Tsao et al, 2006 [105]. 
1.6 Pathophysiology of peripheral nerve injury 
The timescale of recovery and degree of functional restoration following 
peripheral nerve injury is dependent on the type and extent of damage which 
has been incurred [103]. Sunderland type I injuries recover without surgical 
intervention, as remyelination occurs independently with time (the axon itself 
does not suffer significant damage). Higher grades of injury, where the axon is 
damaged or severed, have longer and more complex processes of 
regeneration.  
Axons which have been severely damaged (typically from Sunderland’s Grade 
II upwards; Figure 1-6) undergo a process known as Wallerian Degeneration 
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[105, 106]. The segment of the axon distal to the site of injury begins to 
degenerate within 48 - 72 hours of occurrence. The first stage of Wallerian 
Degeneration is cytoskeletal destruction mediated by the protease calpain. 
Calpain activation is mediated by the increased intracellular calcium 
concentration. The increase in intracellular calcium is driven by a cessation of 
nuclear intron maturase 2 (Nmat2) signalling, which promotes cell survival 
through the regulation of transmembrane calcium exchange [70]. Nmat2 is 
produced in the neuronal cell body, and therefore is no longer able to reach the 
severed, distal portion of the axon following injury. The decreased local 
concentration of Nmat2 and associated breakdown products leads to the dis-
regulation of calcium signalling and rapid opening of calcium channels post-
injury [107]. After a short delay (latent period), rapid degradation of the distal 
axon is initiated. This axonal degeneration is a result of a combination of 
factors, which include further protease activity degrading remaining cytoskeletal 
components, fragmentation of the axon, and increased membrane permeability. 
The remainder of the intracellular components are destroyed in the period 
immediately following cytoskeletal degradation and fragmentation (Figure 1-8). 
Axonal degradation is followed by fragmentation of the myelin sheath, thought 
to be mediated by polymerisation of actin at key locations (e.g. the Schmid-
Lanterman clefts) and subsequent elimination of E-cadherin [108]. Schwann 
cells de-differentiate and proliferate, whilst pro-inflammatory cytokine signalling 
(e.g. IL-1, TNF-) signalling from both the Schwann cells and activated 
resident tissue macrophages leads to the recruitment and activation of 
monocytes from the systemic circulation. Fragmented myelin and cellular debris 
from the degraded distal portion of the neuron is removed through phagocytosis 
or selective autophagy, mainly by Schwann cells and macrophages [109].  
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The proximal stump of the axon retracts following injury, but does not undergo 
Wallerian Degeneration; instead, regenerative processes begin to occur (Figure 
1-9). Schwann cells dedifferentiate and proliferate, then begin to secrete (and 
stimulate the secretion of) cell-signalling molecules such as nerve growth factor 
(NGF), leukemia inhibitory factor (LIF), brain-derived neurotrophic factor 
(BDNF) and fibroblast growth factor (FGF) [48]. These molecules act to promote 
processes associated with neuroregeneration, such as the formation of a 
proximal neuronal growth cone and the secretion of chemotrophic factors by 
Schwann cells to enhance directional guidance of the regenerating axon [110]. 
The expression of signalling molecules and receptors associated with inhibition 
of neuroregeneration processes is downregulated simultaneously as expression 
of receptors associated with the promotion of neuroregeneration is upregulated. 
The secretion of key ECM components, such as that of the basal lamina 
components fibronectin and laminin by Schwann cells, is upregulated following 
injury [111]. This process provides material for the fabrication of new ECM 
structures which provide guidance and further chemotrophic stimulation to 
regenerating axons. 
1 2 
3 4 
Figure 1-8 The process of Wallerian Degeneration illustrated 
through fluorescent imaging of neurons in mice expressing 
yellow fluorescent protein (pseudo-coloured green) 
The difference between proximal sections of nerve following crush (1) 
and severance (3) compared to distal sections (2 following crushing, 4 
following severance) can clearly be seen. Fragmentation of the neurons 
is much more evident in the distal sections.  Severance of the nerve also 
appears to induce a more severe degenerative response in comparison 
to crushing. Adapted from Beirowski et al (2005) [5].  
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Intracellular signalling through pathways such as the mitogen-activated protein 
kinase pathway leads to the formation of “sprouts” at the proximal stump of the 
affected axon, each with an associated “growth cone” (a bulbous formation with 
multiple extending processes [filopodia], the structure of which is primarily 
maintained by the cytoskeletal component actin) which mediates interaction 
with the surrounding ECM environment and is the primary site of growth and 
elongation [112]. Neuronal sprouts extend distally from the proximal stump, with 
the purpose of reconnecting with the target innervated organ/tissue and 
restoring downstream function. Factors influencing the rate and success of 
downstream target reinnervation include the size of the defect, the proportion of 
the axonal population severed, the distance from the target organ and the 
proportion of conserved/remodelled endoneurial tubules available for physical 
guidance [106]. Greater distance between the injury site and end target is 
associated with a lesser chance of full functional recovery due to the 
degradation of distal components, increased distance from cells secreting 
chemotrophic factors and the increased length of axonal regeneration required. 
Without the influence of environmental factors (e.g. appropriate physical and 
chemotrophic guidance), the direction of growth is random in nature [113]. 
These random growth patterns may lead to the formation of a benign tumour 
known as a neuroma and these are characterised by hyperexcitable axonal 
sprouts that can cause chronic neuropathic pain in affected patients [7]. 
Surgical intervention is often required to reduce the likelihood of neuroma 
formation and provide an optimal environment to support the reinnervation of 
downstream targets.  
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1.7 Strategies for the repair of peripheral nerve defects 
Strategies for the repair of peripheral nerve injuries vary according to the size of 
the defect and the functional importance of the nerve [114]. Currently, the vast 
majority of repairs are carried out using long-established surgical techniques of 
coaptation and autografting [115]. However, the limitations of such therapies 
Figure 1-9 Possible outcomes after peripheral nerve injury 
Processes underlying degradation and regeneration of a peripheral nerve within 
three months of incurring an injury of Grade II or higher according to 
Sunderland’s classification scale. Processes depicted are (1) injury), (2) 
Wallerian Degeneration, (3) Initial regeneration, (4) successful reinnervation 
and (5) neuroma formation. Adapted from Arslatunali et al (2014) [103].   
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(particularly over defects of a larger size, including longer length and in nerves 
of a greater diameter and fascicle number) mean that functional restoration 
following injury, and consequently patient quality of life, is often severely 
compromised. Therefore, there is a clear need for an alternative in the form of 
therapeutic medical devices [116]. In order to become widely adopted, the 
efficacy and safety of these medical devices must be established and a 
comparison to current therapies must be determined. Furthermore, the ability of 
new therapies to provide further advantages, for example in areas such as ease 
of sourcing and supply, must be demonstrated to strengthen a case for 
widespread clinical adoption. 
1.7.1 Coaptation 
Coaptation is defined as repair of peripheral nerve defects by microsurgical 
suturing of the epineurium at the severed ends of the nerve, sometimes with 
dissection of surrounding connective tissue to facilitate the repair [117]. 
Coaptation is extremely effective for restoring function over nerve gap injuries of 
a lower length (approximately < 8 mm). In some cases direct fascicle to fascicle 
matching may be possible [118]. Coaptation also avoids the multiple surgical 
procedures and associated donor site morbidities which are required for 
allograft procedures.  
It has been extensively documented that coaptation repairs placing a strain of 
greater than 10 % on the surrounding nerve tissue and subsequent increase in 
tension placed upon the axons residing within the nerve can impair 
regeneration, [119] decreasing both the speed and size of propagating action 
potentials [120]. A tension-free repair is the ideal surgical intervention, however 
larger nerve gaps require additional material to form a graft “bridging” the gap 
between the proximal and distal nerve endings. 
1.7.2 Autografts 
The current gold standard treatment for nerve defects too large to be repaired 
by coaptation is the autograft [121]. Donor tissue is taken from a nerve 
considered to be of lesser functional importance, such as the sural nerve 
(Figure 1-10 [122]), and implanted within the defect. The ECM structure of the 
tissue acts as a scaffold, with the endoneurium in particular providing guidance 
and support to regenerating axons. 
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One of the most important limitations of autografting is the induction of donor 
site morbidity and associated loss of function in the affected nerve (e.g. loss of 
sensory function on the outside of the foot in the case of the sural nerve) [50]. In 
addition, complete repair of larger defects may not be possible due to the 
limited length and diametric range of the available donor tissue; it is not possible 
to sacrifice a large amount of autologous peripheral nerve tissue without 
comprising function elsewhere. This is especially true during the repair of 
defects within a larger diameter nerve and it is not practical for a “like-for-like” 
match to be obtained. In such situations, it is possible to “cable” several 
sections of smaller diameter nerve using suture material to create a  graft 
structure with the appropriate dimensions [123]. Significant anatomical variation 
can also exist between the donor nerve and the site of grafting (e.g. fascicle 
size and number, epineurial thickness etc.) [114]. This can compromise 
functional restoration, increasing the likelihood of permanent loss of function. 
Autografts have also been linked to the occasional formation of neuromas 
(benign but abnormal growth of nerve tissue) over longer time periods [119]. 
 
 
 
 
 
 
 
 
 
 
 
 
     [122] 
Figure 1-10 Anatomical location of the sural nerve 
Depiction of the peripheral nerve anatomy surrounding the ankle joint, including 
the location of the sural nerve. Adapted from Citak et al (2007) [111].  
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1.7.3 Nerve Guidance Conduits 
The use of nerve guidance conduits (NGCs) may be needed for nerve gaps 
which are too large to repair by coaptation [10]. NGCs are tubular structures 
which are implanted by suturing and give directional guidance to regenerating 
axons and aid in the maintenance of a pro-regenerative microenvironment (by 
ensuring localisation of cell signalling molecules is retained).  Directional cell-
scale guidance is often improved by the inclusion of surface patterning, 
striations or fibres within the NGC, arranged in a linear fashion, or by producing 
the conduit material in a single sheet and rolling it to create internal layers [124]. 
NGCs have been fabricated from a range of materials, both natural (e.g. 
collagen) and synthetic (e.g. Polyglycolic acid ( PGA), Poly (lactic-co-glycolic 
acid) (PGLA), Polycaprolactone (PCL) [125].  
Several NGCs have been fully translated and are currently in clinical use 
including Neurotube® (PGA; Synovis) and Axoguard™ (Porcine subintestinal 
mucosa; Axogen Inc) [126]. NGCs can be highly effective when used to 
facilitate repair over smaller defects. For example, a study using the 
NeuroGen® (Integra LifeSciences) conduit (composed of type I collagen) 
demonstrated restoration of function after 12 months in patients with digital 
nerve gaps of 6 - 18 mm; the majority of  patients scoring “good” or “excellent” 
in sensibility testing (a subjective test measuring restoration of nerve function 
through the ability to difference in the ability to discriminate between two distinct 
points of contact in a defined zone on the skin; this was assessed using the 
established static and moving two point method) [127]. Various strategies have 
been investigated in an attempt to extend the length of defect over which 
successful reinnervation is possible, including 3D structures inside the conduit 
(e.g. striations, “honeycomb” tubular structures mimicking the structure of the 
native endoneurium, fibres travelling in a linear direction within the conduit), the 
incorporation of growth factors (e.g. NGF, transforming growth factor-β) and 
seeding of the conduit with “support cells” e.g. Schwann cells (Figure 1-11) 
[128].  
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Despite advances in NGC structure and the incorporation of growth factors/cells 
within the conudits, the key limitation of NGCs remains that the degree of 
functional restoration is curtailed when the size of a given defect exceeds a 
critical value, due to difficulty in supporting the growth of axons  [7]. The critical 
value has often been defined as a length, generally given as 3 cm. However, it 
is thought the volume of the defect space may be a more important measure 
[10]. This effect is illustrated diagrammatically below (Figure 1-12). 
Figure 1-11 NGC modifications to improve directional growth 
Examples of modifications to NGC structure/supporting biological components 
to maximise the capacity to support neuroregeneration. Adapted from Hudson 
et al (2000) [118]. 
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The limitations described may be due the lack of neurotrophic cues and nerve-
specific ECM architecture [7]. This insufficient physical directional guidance 
combined with an unfavourable chemical microenvironment for effective 
stimulation of regeneration means axons are unlikely to re-innervate distal 
portions of nerve [7]. The inability of nerve conduits to support repair over larger 
defects has been observed in case studies [7]. One such study examine the 
implantation of a type I collagen conduit (NeuraGen) into a 7 x 20 mm defect in 
the median nerve. After a 4 year period the graft was investigated surgically in 
an attempt to identify the cause of persistent pain. A large neuroma had formed 
within the conduit, with no evidence of reinnervation across the defect and, 
consequently, no restoration of function. Histological examination revealed a 
disorganised structure, consistent with random growth of neuronal sprouts 
without sufficient directional guidance. Similar results (neuroma formation and 
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Figure 1-12  Size limitations of nerve guidance conduits 
Diagram showing diametric constraints when considering the use of a nerve 
guidance conduit. In the example given here,  the radius (and therefore diameter) 
of the nerve to be repaired is doubled, the maximum length for effective conduit 
repair is reduced by a factor of 4. Figure adapted from Moore et al (2009) [7].  
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lack of functional restoration) were observed in other larger nerve defects 
repaired with conduits composed of PGA and type I collagen (GEM neurotube 
and NeuraGen, respectively). Functional restoration was only achieved in 
patients who elected to have autologous graft surgery, with the inherent 
disadvantage of having to sacrifice additional peripheral nerve tissue and the 
associated donor site morbidities which are incurred because of this.  
1.7.4 Decellularised Nerve Grafts 
Whilst unprocessed allogeneic and xenogeneic materials can provide an ECM 
structure to act as a scaffold for tissue regeneration in a similar fashion to an 
autograft, the potential immunogenicity presents a significant disadvantage [37]. 
In allogeneic cellular tissues, cells, nucleic acids and some ECM components 
all present antigens which may be recognised as foreign by the innate and 
specific immune system resulting in a catastrophic inflammatory cascade and 
ultimately graft rejection [129]. Xenogeneic cellular tissue present similar issues, 
in addition to further specific antignes such as Gal(1,3)Gal in porcine tissue. 
Decades of research have led to the development of numerous methods for the 
removal of cells and nucleic acids from tissue, referred to under the umbrella 
term of decellularisation [17]. Decellularisation significantly reduces the 
possibility of an adverse host immune response to the graft, and therefore 
maximises the chance of successful graft integration and subsequently the 
restoration of function [130]. Numerous methods have been developed to 
achieve decellularisation of tissues; these include (but are not limited to) the use 
of chemicals including detergent, weak acids/bases and hypo-/hypertonic buffer 
solutions, and physical methods such as repetitive freeze-thaw, sonication, 
pressure and agitation [17]. Physical and chemical methods have been used 
across different tissues in combination and isolation; different tissue types often 
require radically different decellularisation protocols.  
Decellularisation should remove immunogenic material from a tissue in order to 
minimise the potential for an adverse immunological response [131]. Whilst 
there are no officially defined parameters for such a reduction, previous 
proposals have included the requirement for a total of less than 50 ng of double 
stranded DNA (more than 200 base pairs in length), and no nuclear material 
visible when tissue is stained with haematoxylin and eosin (H & E). Incomplete 
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decellularisation results in residual cellular component debris (e.g. nucleic 
acids, cytosolic components, phospholipid membrane fragments), collectively 
referred to as damage-associated molecular patterns (DAMPs) [132, 133]. The 
immune response to decellularised tissues may be more favourable to graft 
integration and eventual functional restoration compared with an untreated 
cellular graft [36, 37, 132, 134]. The exact nature of the immune response to a 
decellularised tissue graft is likely to vary in response to a range of factors. 
Given the likely importance of such a response to the process of graft 
integration and functional restoration, it should be considered and investigated 
when developing a novel tissue graft.  
A suitable decellularisation process for peripheral nerves would allow retention 
of the ECM histioarchitecture (with endoneurial structure considered to be 
particularly important) and biochemical composition, providing guidance, 
mechanical support and chemical stimulation to regenerating axons [135-137]. 
Previous work on the decellularisation of human peripheral nerves led to the 
development of a clinical product licensed for use in the USA, the Avance® 
nerve graft. This has shown promising results (around 75-100 % of patients 
recovering function depending on the size of the defect and the type of nerve) in 
the functional regeneration of nerve tissue, and has been successfully applied 
over a much greater range of defect size than NGCs (up to 7 cm in length). A 
functional model of a defect in the sciatic nerve of rats showed that in the nerve 
defect sizes studied (14 and 28 mm), acellular nerves produced through the 
Avance® process facilitated the growth of a 20 fold greater population of 
myelinated axons in comparison to a synthetic NGC [138].  
The use of xenogeneic tissue as a source material presents potentially 
significant advantages over human tissue in terms of a consistent supply of high 
quality tissue [58]. To take advantage of these factors, a collaborative research 
partnership was formed between the University of Leeds and the University of 
Sheffield to develop an optimised decellularisation process for use with porcine 
peripheral nerves [18]. The nerves appear to retain similar structural, 
biochemical and biomechanical properties to native porcine nerves, and initial in 
vitro and in vivo evidence suggests the decellularised nerves support the 
attachment and growth of rat Schwann cells and neurons [18, 139]. Further 
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translational research is required for these nerves to progress towards a clinical 
product. 
1.8 Need for effective sterilisation of decellularised grafts 
Medical devices (including processed allografts and xenografts) may be 
contaminated with pathogenic organisms, increasing the risk of foreign-body 
related infections (FBRIs) [140]. FBRIs are extremely varied in both severity and 
distribution, and are most commonly introduced during surgical procedures. 
Surgical staff, equipment and the patients themselves represent possible 
sources of infection. However, ineffective sterilisation procedures can also lead 
to pathogens being present on a medical device prior to surgery, providing a 
potentially significant route of infection [141].  
Decellularised scaffolds of allogeneic or xenogeneic origin may contain 
infectious pathogenic organisms either sourced from the donor or introduced 
during harvesting and tissue processing [142]. The risk of infection is an 
important potential cause of severe adverse effects following tissue 
transplantation procedures [143]. Screening donors/tissue sources prior to 
harvesting can reduce this risk. However, complete assurance can only be 
provided by an effective terminal sterilisation procedure. 
Estimates for the mortality rate amongst individuals contracting FBRIs vary from 
10 - 80 %, determined by factors including distribution of the infection and the 
specific pathogen present [144]. The identification of a suitable sterilisation 
method for a given decellularised ECM scaffold is therefore a crucial step in the 
translational process towards producing a medical device suitable for use in a 
clinical environment [145]. A terminal sterilisation step, meaning one which can 
be applied after packaging and thereby eliminate the risk of contamination post-
sterilisation, effective across a broad range of pathogenic species must 
therefore be developed [146].  
1.8.1 Accepted standards of sterility for medical devices 
The efficacy of a sterilisation procedure is commonly defined by the ability to 
achieve the accepted sterility assurance level (SAL) for medical devices of 10-6, 
defined in the international standard ISO 14937 [147].  The attainment of this 
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Figure 1-13    Diagram demonstrating the measurement of D-value 
reduction time  
D-value is defined as a the time/dose for a log reduction in a given population of 
microorganisms (e.g. bacterial spores, bacteria, viruses, fungi) when exposed to 
a defined sterilisation process.  
value means that less than 1 in 1,000,000 devices sterilised by a given method 
within a defined set of parameters will contain a surviving viable microorganism 
[148].  
The D-value of population reduction, also known as the decimal reduction 
value, is another measure of sterilisation efficacy [149]. The D-value can be 
defined as the time taken for a given dosage of a sterilisation method to achieve 
a pre-determined reduction in a population of microorganisms, typically a D-
log10 (D10, 90 %) reduction in the overall population (Figure 1-13). D-values vary 
considerably between pathogens for a particular sterilisation method, due in 
part to differing susceptibilities to specific methods of killing. Establishing D10 
values for specific sterilisation methods requires the use of standard indicator 
organisms, for which the relative resistance to different killing mechanisms is 
well characterised [150]. Standard indicator organisms are highly resistant to 
most killing (sterilisation) methods, and so represent a “worst case” scenario; 
commonly used examples include endospores of Bacillus pumilis and Bacillus 
atrophaeus [151].  
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1.8.2 Common pathogens associated with tissue grafts 
Tissue grafts may be contaminated with pathogenic organisms from a variety of 
different sources [152]. Pathogens may be resident within the tissue (though 
screening of source tissue for known bacteria and viruses reduces this 
possibility) or acquired from the environment during processing. To mitigate 
against the possibility of introducing an FBRI, it is therefore crucial that terminal 
sterilisation methods are effective across a diverse population of pathogens.  
1.8.2.1 Bacteria 
Bacteria are prokaryotic unicellular organisms, with a cell wall composed 
primarily of peptidoglycan located exterior to the membrane [153]. Bacteria can 
be divided into two classes, Gram-negative and Gram-positive [154]. Gram-
positive bacteria have a thicker layer of peptidoglycan within the cell wall than 
Gram-negative species, whilst the cell wall of Gram-negative bacteria is more 
permeable to the transport of ions and molecules due to the presence of protein 
channels known as porins [155].  
A population of bacteria may form a three-dimensional polysaccharide matrix 
known as a biofilm to create a perfect niche for cell survival and proliferation; 
they are also associated with residual endotoxins within medical devices [156]. 
Biofilms can increase the difficulty of accessing and eliminating the bacterial 
cells within, and represent one reason why dose levels of a sterilisation 
treatment proven to achieve the standard of SAL 10-6 (or equivalent) are often 
exceeded in common practice [141]. 
Antibiotic compounds are unsuitable for use in the sterilisation of tissue 
scaffolds, due to a lack of efficacy against other classes of pathogens such as 
viruses and the recent emergence of resistant strains of several bacteria 
common to clinical environments (e.g. methicillin-resistant Staphylococcus 
aureus; MRSA) [157]. 
1.8.2.2 Bacterial endospores 
Some bacteria (predominantly Gram-Positive e.g. Bacillus subitilis, Clostridium 
difficile) have the ability to adopt a dormant phenotype known as a spore when 
subjected to environmental challenges (e.g. lack of sufficient nutrients) [9]. 
Sporulation can facilitate survival of the population until the environment 
- 56 - 
Figure 1-14  Structure of a bacterial endospore 
The core region is depicted, containing important components (e.g. nucleic 
acids) required for germination and transition to cellular form. The coats, 
membranes and exosporium all protect the core and restrict access of potential 
sources of damage (e.g. ionising radiation, alkylating agents). Adapted from 
Setlow (2006 [9]). 
 
becomes favourable, at which point the endospore can reactivate itself to 
the vegetative (cellular) state.  
Bacterial spores are significantly more resistant to external stresses (e.g. 
radiation) than vegetative cells, and therefore generally require administration of 
a greater dosage of a given sterilisation treatment to achieve the equivalent 
reduction in population [158]. Spores have layers of protective extracellular 
proteins and polysaccharides surrounding the cellular components in the core; 
for example, the exosporium is a spore coat consisting primarily of components 
including peptidoglycan and dipicolinic acid [159] (Figure 1-14). 
 
 
 
 
 
 
 
  
 
 
 
 
These external protective layers can prevent the access of chemical agents to 
the core, and contain enzymes aiding this function (e.g. superoxide dismutase 
for the prevention of oxidant action). Pigments within these layers may 
absorb/block a proportion of ionising radiation [160]. Other mechanisms protect 
spores against the indirect effects of radiation. Spores have a decreased water 
content in comparison to the cellular form of the organisms, and therefore a 
decreased chance of hydroxyl radical formation. Spores also contain small acid-
soluble spore proteins (SASPs), which appear to have a protective effect 
against oxidative damage both from radiation-generated radicals and chemical 
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agents [161]. SASPs change the shape and structure of DNA helices upon 
binding, a process which has been strongly implicated in protection against 
direct radiation damage to DNA.   
The ability of bacteria to survive extreme conditions when in the form of 
endospores means that the efficacy of sterilisation methods against spores is a 
key factor in the choice of specific method and dosage to be used. 
1.8.2.3 Viruses 
Viruses are non-cellular organisms, which may exist as single or double 
stranded RNA or DNA [23]. The nucleic acid components are contained within a 
protein capsid, and this may be surrounded by a lipid membrane known as an 
envelope. Viruses function through infiltrating host cells and utilising the 
intracellular machinery to replicate nucleic acids, synthesise components of the 
capsid and envelope and ensure the release of replicated viral particles. Viruses 
are referred to as obligate intracellular parasites, lacking the molecular 
machinery to carry out these processes independently.   
The specific population of pathogens present within a tissue graft of allogeneic 
or xenogeneic origin may differ significantly from those present on a medical 
device fabricated from synthetic materials, such as an artificial joint [162]. Of 
particular concern in grafts originating from porcine tissue are porcine 
endogenous retroviruses, which are (unlike most human endogenous 
retroviruses) capable of host infection [163].Tissue allograft sterilisation 
procedures should consider both the possibility of environmental contamination 
(as is applicable to all medical device manufacture), in addition to pre-existing 
pathogenic populations already residing within the tissue. The necessity of 
donor screening when using human tissue was reinforced by documented 
cases of HIV transmission through bone allografts [164].  Regardless of the 
efficacy of such screening programmes, sterilisation processes for tissue-based 
grafts should be able to produce a reduction in viral population of a similar level 
to other microbial populations (i.e. in line with the accepted benchmark of SAL 
10-6).  
1.8.2.4 Fungi 
Fungi are eukaryotic organisms which may take either unicellular or multicellular 
forms [165]. In the context of infections associated with tissue allografts, 
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multicellular fungi are largely irrelevant. Unicellular ungi have been identified as 
responsible for approximately 38 % of infections related to tissue allografts, with 
organisms such as Candida albicans and Aspergillus niger commonly 
implicated [166].  
Fungi are susceptible to killing via DNA damage by radiation or chemical 
agents; however, the D10 value varies considerably and some fungi are 
significantly more resistant to killing than a majority of bacterial species [152]. 
1.8.2.5 Prions 
Prions were only formally proposed as a class of infectious agents as recently 
as 1967 [167]. Prions are thought to possess no nucleic acids but are able to 
replicate via influencing protein folding within cells. Prions are obligate parasites 
implicated in diseases including Creuzfeld-Jakob Disease [168] and 
Gerstmann-Straussler-Scheinker Syndrome [169].  An American study of 
infections acquired over a three year period as a result of tissue transplants 
found one case of potential infection with a prion [166]. The possibility of 
infection means they cannot be discounted when considering the sterilisation of 
tissue-based scaffolds. 
1.8.3 Tissue sterilisation methods 
Sterilisation of devices for medical use can be carried out through a number of 
methods, which can be broadly subdivided according to mechanism of action 
into heat-based methods, ionising radiations and chemical methods [170]. While 
some materials, such as stainless steel surgical equipment, may be able to 
withstand rigorous sterilisation methods such as autoclaving, tissue grafts are 
much more susceptible to degradation and function-altering damage. The 
proteinaceous components of the ECM may be damaged by heat (for example, 
the denaturation temperature of collagen is approximately 66 °C), direct 
interaction with radiation, and interaction with free radicals or alkylating agents 
[171-173]. As such, selection of a suitable sterilisation method  for use with a 
decellularised tissue which is sufficiently robust to ensure a sterilising action 
throughout the graft material, can achieve the accepted sterility benchmark of 
SAL 10-6 whilst retaining the key biological and biomechanical properties of the 
graft represents a complex challenge.  
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1.5.3.1. Peracetic Acid 
Treatment with peracetic acid (PAA) solution has been used as a sterilisation 
method across diverse tissue types including dermis [174], anterior cruciate 
ligament [175] and (most commonly) bone [176].  
In solution PAA exists in equilibrium with derivative compounds, acetic acid and 
hydrogen peroxide (H2O2) [177] (Figure 1-14). The mode of killing of PAA is 
thought to be related to a high level of oxidative activity [178], inducing the 
denaturation of intracellular and membrane-associated proteins, and critical 
disruption of the cellular membrane [179]. PAA is eliminated from the scaffold 
as non-toxic breakdown products including H2O, O2 and CO2.  This presents an 
advantage over some other chemical methods such as ethylene oxide 
treatment [180]. 
 
 
Other advantages to the use of PAA include good efficacy against a broad 
spectrum of pathogenic organisms [181], relatively low cost and requirements 
for additional equipment, the relatively short duration of the procedure and the 
fact that it can be carried out at room temperature, eliminating the risk of heat-
induced degradation of the ECM proteins.  
However, grafts treated with PAA require an aseptic transfer process following 
treatment to place the tissue within the final packaging . This introduces the 
possibility that the tissue could be contaminated with a pathogen post-
processing, and necessitates the use of additional equipment (e.g. controlled 
environments such as clean rooms). As such, PAA treatment cannot be 
considered to be a truly “terminal” sterilisation method.  
O
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Figure 1-15   Diagram of equilibrium for PAA in solution 
PAA exists in equilibrium with acetic acid and H2O2 when in solution [165].  
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1.8.3.1 Ethylene Oxide 
Ethylene oxide has been extensively used in the sterilisation of surgical 
equipment, joint replacement components and some tissue allografts such as 
bone [182].  Ethylene oxide is a highly reactive epoxide gas which causes the 
addition of adducts to nucleic acids and some amino acids (e.g. cysteine, 
histidine, valine) through alkylation, altering the metabolic processes of 
microorganisms and preventing reproduction. Ethylene oxide also has the ability 
to diffuse effectively through scaffolds enabling it to be a highly penetrative 
method of sterilisation [183]. When used with medical devices constructed from 
robust materials (e.g. stainless steel), ethylene oxide treatment may be 
conducted at temperatures ranging between 100 - 140 °C. Whilst such 
conditions would normally prohibit the use of a sterilisation method with 
temperature-sensitive materials such as collagenous tissue grafts, the sterilising 
activity of ethylene oxide has been validated against a range of pathogens 
(including bacterial spores such as Bacillus atrophaeus and viruses such as 
HIV-1) in human musculoskeletal grafts at relatively low temperatures 
(approximately 30 - 40 °C for 14 hours) [184-186].  In terms of historical clinical 
use with tissue scaffolds, ethylene oxide treatment has primarily been applied to 
bone allografts [187].  
Ethylene oxide treatment of scaffolds leads to the deposition of residues of both 
ethylene oxide and associated derivative compounds [188]. Common 
derivatives include ethylene chlorohydrin and ethylene glycol, which are formed 
as a result of reactions with chloride ions and water respectively [189]. 
Accepted levels of ethylene oxide and derivative by-products in medical devices 
are defined by the international standard ISO 10993-7 [189].  
Both ethylene oxide and associated derivative by-products have been linked to 
the induction of acute toxic effects, as well as causing longer term morbidities 
(including a possible increased cancer risk as a result of the carcinogenic 
properties of ethylene oxide) [190]. A 3 year follow-up study of 109 patients who 
received a freeze-dried, ethylene oxide-treated bone-patella tendon-bone 
allograft noted that 6.4% experienced a chronic intraarticular inflammatory 
response, which resolved upon removal of the graft [191]. Although increased 
cancer risk has not been linked to ethylene oxide-treated tissue grafts, exposure 
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to ethylene oxide in the workplace has been associated with an increased 
incidence of mortality as a result of cancer (particularly haematological and 
lymphatic malignancies), and as such this risk cannot be ruled out on the basis 
of current evidence [192]. In order to minimise the formation of toxic derivatives, 
decellularised scaffolds can be lyophilised to reduce the amount of potential 
reactants present [193]. Lyophilisation may also aid penetration of ethylene 
oxide into the scaffold, increasing sterilisation efficacy. Due to the inherent toxic 
properties of ethylene oxide, an effective aeration procedure is required 
following completion of the sterilisation process to ensure elimination of residual 
ethylene oxide and any derivative compounds (e.g. ethylene chlorohydrin and 
ethylene glycol)  [194]. The use of gas permeable packaging allows ethylene 
oxide treatment to be used as a true terminal sterilisation step [146]. 
1.8.3.2 Gamma Radiation 
Gamma irradiation has long been used for sterilisation of food, medical devices 
and surgical equipment [195], as well as for the direct radiotherapy treatment of 
tumours [196]. Gamma radiation is an ionising radiation, typically sourced from 
neutron-beam generated synthetic radioisotopes such as Cobalt-60 (Co60). The 
decay of such isotopes leads to the emission of high-energy photons known as 
gamma rays.  
Control of the dosage is both of critical importance and difficult to achieve, as 
the rate of photon emission from the isotope cannot be artificially altered. 
Altering the length of exposure time, distance from source and configuration of 
source (e.g. quantity of Co60) are the most effective methods to dictate dose 
control [197]. The standard accepted dosage for medical device sterilisation is 
determined by ISO 11137 [198], which specifies the application of 25 kilograys 
(kGy) to achieve the SAL of 10-6. Sterilisation by gamma irradiation is slow 
relative to some other methods (e.g. E-Beam) [199]. However, gamma radiation 
can penetrate materials to a greater depth than other forms of radiation 
treatment i.e. E-beam and so may be more suitable for the sterilisation of larger 
tissue grafts. 
Gamma rays induce changes to nucleic acids through effects such as double 
and single strand breaks, crosslinking of nucleic acids and proteins and 
oxidative damage of component bases [200]. Direct damage to DNA occurs due 
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to direct energy transfer from photons to nucleic acid chains. Hydroxyl radicals 
formed by the interaction of gamma radiation and water molecules can cause 
indirect damage to nucleic acids, which accounts for approximately 90 % of total 
lesions. Inactivation/death of microorganisms can be caused when DNA repair 
mechanisms are unable to repair the quantity of lesions formed, or when 
aberrational repair leads to the presence of mutations at critical points within the 
nucleic acid sequence [201].  
The susceptibility of pathogenic organisms to radiation varies; cellular 
organisms and spores are more susceptible than viruses, possibly due to the 
water content within the cell [202, 203]. Data from previous studies indicate that 
a higher dosage of approximately 30 kGy is required to achieve sufficient 
inactivation of some viruses, such as HIV [204-206]. Water content is an 
environmental factor which significantly affects the ability of ionising radiation to 
induce DNA strand breaks through hydroxyl radical production. However, this 
effect can be counteracted if compounds with “radical scavenging” properties 
are present (e.g. ascorbic acid & ethanol) [207]. These compounds have been 
shown to be radioprotective to bacterial and fungal cells, an effect which 
increases linearly with increased scavenger concentration.  
1.8.3.3 Electron Beam (E beam) 
E beam sterilisation utilises an electron accelerator to produce beams of 
electrons equivalent to between 0.3 and 12 megaelectronvolts (MeV) [208]. The 
principal advantage of E Beam compared with alternative sources of ionising 
radiation (e.g. Co60) allows greater control of dose intensity possible through 
manipulating the output of the electron accelerator [194]. Historically, E beam 
has been used much less frequently than gamma radiation for the purpose of 
medical device sterilisation, and as such little clinical data is available. The 
effects of E beam on tissue grafts have been investigated in a laboratory 
setting, primarily with musculoskeletal tissues (e.g. rabbit tendon, human patella 
tendon-bone) [209, 210].  
The required dosage for sterilisation is determined by ISO-11137 [198] and 
ISO/ASTM-51649 [211]. Similarly to gamma radiation, the minimum applied 
dose has generally been considered as 25 kGy (with a beam strength of 10 
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MeV) [209]. However, higher doses (over 30 kGy) may be required to eliminate 
more resistant pathogens such as parvovirus or HIV [204].  
A major disadvantage of E beam is a lack of penetrance in comparison to 
gamma radiation; historically, this means has limited the range of medical 
devices suitable for E beam treatment [212]. However, recent evidence 
suggests this may be dependent on the energy of the beam applied. A 10 MeV 
beam may penetrate tissue to a depth of around 6 cm, which would enable the 
use of E beam for the sterilisation of all sizes of peripheral nerve [213].  
1.8.3.4 Supercritical Carbon Dioxide 
Supercritical carbon dioxide (SCCO2) is a supercritical fluid, also known as a 
dense phase gas [3]. This state is formed by maintaining CO2 above critical 
values of temperature and pressure, 304.25 Kelvin (K) and 7.58 megapascals 
(MPa) respectively (Figure 1-16). Supercritical fluids exhibit properties similar to 
both gases (e.g. excellent diffusibility) and liquids (e.g. solvent-like properties) 
[175]. Recent research has examined the potential use of SCCO2 for the 
purpose of tissue sterilisation, due to the potential reduced induction of adverse 
effects upon soft tissue grafts when other sterilising agents are applied (see 
1.8.4) [214].  
SCCO2 can achieve a high level of penetration scaffolds due to its diffusibility, 
viscous properties and ability to be compressed. SCCO2 operates at relatively 
low temperatures and pressures and presents low toxicity potential in 
comparison to some other methods such as ethylene oxide. SCCO2 can also be 
rapidly and effectively eliminated from a scaffold by decreasing the pressure 
causing transition to a gaseous state and allowing elimination by aeration.  
The diffusibility of SCCO2 is thought to enable it to pass through plasma 
membranes and accumulate at high concentrations within cells [3], leading to 
cell death through the production of carbonic acid which lowers the intracellular 
pH, disrupting metabolic processes and the transport of substances (e.g. ions) 
across the membrane. 
SCCO2 is less effective as a sterilising agent against organisms with no 
membrane/an additional defensive structure such as a cell well; for example, 
viruses and bacterial spores. This has prevented validation and standardisation 
as achieving the required SAL of 10-6. Adding small volumes of additional 
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Figure 1-16 Diagram showing phases of CO2 within different parameters of 
temperature and pressure 
Certain substances can be maintained in a supercritical fluid state when 
subjected to given conditions of temperature and atmospheric pressure. The 
“critical point” at which this transformation occurs can be achieved in CO2 using 
relatively moderate conditions, minimising the potential for adverse effects on 
tissue. Image adapted from White et al (2006)[3].  
 
 
agents, primarily oxidising agents such as PAA and H2O2, may allow a SAL of 
10-6 to be achieved [215]. There would theoretically be a reduced likelihood of 
adverse effects on the tissue, due to the fact that such additives are included at 
significantly lower concentrations than when employed as stand-alone 
treatments.  A study by Qiu et al in 2009 found that a combination treatment of 
SCCO2 and 0.1 % (v/v) PAA solution led to the successful achievement of SAL 
10-6 for indicator organisms of bacterial spores (Bacillus atrophaeus) and 
viruses (encephalomyocarditis) in a time of approximately 30 minutes [216]. The 
authors postulated that the highly diffusive properties of SCCO2 may help to 
increase the penetration of the PAA into the scaffold and therefore allow it to act 
upon a greater proportion of the bioburden present. 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.8.3.5 H2O2 (in isolation or combination with Copper (II) Chloride) 
H2O2 is extensively used in isolation as an industrial sterilant [217].  H2O2 
sterilisation is applied across a wide variety of fields including water purification, 
food chain sterilisation processes and the treatment of surgical equipment and 
medical devices. Whilst the precise mechanism of action is unclear, the biocidal 
properties of H2O2 are believed to be due to a highly oxidative nature and an 
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ability to lyse structures such as bacterial cells and spores [218]. The free 
radicals derived from H2O2, particularly hydroxyl radicals, can cause extensive 
oxidative damage to nucleic acids (through the formation of single base 
substitutions and crosslinking DNA lesions), proteins and lipid components of 
cell membranes. 
The elimination of H2O2 is straightforward, due to its degradation over time into 
water molecules [219]. Any adverse effects induced by treatment of an ECM 
scaffold with H2O2 (e.g. changes to mechanical properties, microstructural 
alterations) would likely to be the result of the hydroxyl radicals generated [220]. 
Previous work has found that at an effective dosage (3 % [v/v]) there was no 
significant alteration to the trabecular structures of a demineralised bone ECM 
scaffold [221].  
The formation of free radicals can be catalysed by the presence of transition 
metals [141]. This has been demonstrated by work showing that cells with a 
greater intracellular iron concentration require the presence of a significantly 
lower H2O2 concentration to be reduced to a specified percentage of the original 
population size [142].  
Recent work within the NHS Blood and Transplant Tissue and Eye services 
(NHSBT TE) has indicated promise in the use of a solution of copper (II) 
chloride and H2O2 as a novel sterilisation treatment [222]. Both compounds 
independently have biocidal properties; however, use in combination requires 
lower concentrations of each and potentially reduce the extent to which 
changes to scaffold properties are induced.  
The addition of copper (II) chloride leads to the presence of (cupric) copper ions 
within the solution. Copper is a transition metal, meaning it can mediate the 
formation of hydroxyl radicals from H2O2 through Fenton chemistry [223]. 
Copper ions are known to bind to the DNA base pairing Guanine-Cytosine (G-
C); this would mean that radicals formed will be in close proximity to nucleic 
acid strands and therefore are more likely to induce lesions.  
A combination treatment regime of copper (II) chloride and H2O2 therefore 
provides both a potential source of hydroxyl radicals and a potent catalytic 
agent which would be likely to locate itself in a favourable region for the 
induction of nucleic acid lesions [222].  
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1.8.4 Overview of the adverse effects of sterilisation methods on 
ECM scaffolds 
In addition to effectively reducing the bioburden a sterilisation method should 
minimally affect the properties, and therefore efficacy, of the device being 
sterilised [170].  This is especially critical for susceptible materials such as 
ECM-based scaffolds. 
It is well documented that sterilisation processes can significantly alter the 
histoarchitecture (including cell-scale architecture) and mechanical properties of 
ECM-based scaffolds (e.g. ultimate tensile/compressive strength, Young’s 
Modulus) and therefore the capacity to support recellularisation [224] [173]. The 
use of different sterilisation techniques, and any observed effects resulting from 
the application of such methods, have been studied in both cellular and 
decellularised tissue grafts; however, these studies have focussed on a limited 
range of tissue types.  
Sterilisation techniques requiring the application of high temperatures, such as 
dry heat, steam or pasteurisation, are clearly inappropriate for use in the 
treatment of scaffolds derived from ECM. The exposure of ECM-based products 
to temperatures approaching and in excess of 65 °C would result in extensive 
denaturation of the pretentious components of the scaffold and consequently a 
critical loss of function [141].  
Radiation-based sterilisation methods, such as gamma irradiation and E beam, 
can have pronounced effects on the structure of collagen chains [225]. 
Disrupted ultrastructural features were observed when decellularised murine 
tracheas and porcine heart valves treated with gamma radiation (10 and 25 kGy 
respectively) were examined by transmission electron microscopy, 
predominantly manifesting as a loss of organisation in the collagen fibres [226, 
227]. Gouk et al (2008) used scanning electron microscopy and haematoxylin 
and eosin staining to highlight significant alterations to the histoarchitecture of 
lyophilised Alloderm®, a decellularised human dermis which is currently in 
clinical use, following gamma radiation (12 kGy; Figure 1-17) [6]. While the 
porosity of the scaffold appeared to have increased following irradiation, which 
may aid in cellular infiltration post-implantation, the finer details of the ECM 
structure were lost. These changes compromised the mechanical properties of 
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the scaffold, causing a decrease in ultimate tensile strength compared with non-
sterilised Alloderm®. Gamma irradiation also increased the susceptibility of the 
tissue to digestion with proteolytic enzymes (trypsin, pepsin and proteinase K). 
Gamma irradiation of Alloderm did not appear to negatively impact upon the 
growth of seeded human fibroblasts over 21 days compared with a non-
irradiated control, and, when examined with Masson’s Trichrome staining, 
collagenous ECM appeared to be remodelled and deposited by the fibroblasts 
in greater quantities on the gamma-irradiated scaffolds. This corresponds with 
the increase in susceptibility to enzymatic digestion; together, these 
observations may be indicative of chain scission within the ECM, due to the fact 
that the gamma irradiation was carried out under dry conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
If tissue is irradiated in a wet state, alterations to the collagen chains are 
primarily mediated by interaction with hydroxyl radicals generated through 
radiolysis of water molecules, leading to the formation of cross-links between 
collagen chains (Figure 1-18) [228]. This can affect the mechanical properties of 
a tissue; for example, radiation-mediated crosslinking has been associated with 
increased ultimate strength but also increased stiffness in decellularised tissues 
such as porcine heart valve (gamma-irradiated at 1 - 100 Gy)  [229]. In contrast, 
Figure 1-17 Haematoxylin and Eosin-stained samples of AlloDerm™ 
decellularised dermis  
Freeze-dried decellularised dermis and 2) freeze-dried decellularised dermis 
treated with gamma irradiation at 12 kGy. Alterations are evident following 
irradiation, with increased porosity and apparent loss of the finer ECM 
structures. Adapted from Gouk et al (2008) [6]. 
 
1 2 
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when tissue is irradiated in a dry state (e.g. if the tissue has been lyophilised) 
the predominant mechanism of action is direct breakage (or scission) of the 
polypeptide chains. This can lead to a decrease in all mechanical parameters, 
and produce an altered histoarchitectural structure as described above. E beam 
treatment also causes the production of free radicals which interact directly with 
collagens in the tissue, and may affect structural and biomechanical properties 
[230]. However, if the dose is applied in a consecutive series of lower doses of 
radiation (e.g. the original dose is applied in 10 equal doses, 2.5 kGy if using 
the industry standard 25 kGy) then the magnitude of such effects may be 
reduced [231]. This process is known as fractionation, and can also be applied 
(less easily) to gamma radiation [232]. Treatment of allograft tendon with 10 
doses of 3.4 kGy as opposed to 1 dose of 34 kGy retains effective reduction of 
the populations of key indicator organisms in allograft tendon, whilst significantly 
reducing biomechanical changes [213].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dry state  Wet state  
Figure 1-18 Comparison of the effects of irradiation on collagen fibrils 
under dry and wet conditions 
Representation of structural changes to collagen after irradiation in dry or wet 
state. In dry state irradiation, chain scission is the dominant phenomenon and 
leads to fragmented collagen chains and degradation to higher order structures. 
In contrast, Irradiation in a wet state induces the formation of crosslinks 
between the collagen chains (and therefore maintenance of higher order 
structure). Adapted from Aquino (2012) [1]. 
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Kajbafzadeh et al (2013) demonstrated this phenomenon in decellularised ovine 
livers treated with gamma radiation (30 kGy) [233]. Livers irradiated in a “wet” 
state retained an ultimate tensile strength and elastic modulus close to that of 
native tissue, whereas livers which were lyophilised prior to irradiation were 
found to have incurred decreases in these parameters of approximately 30 and 
50 % respectively. ECM-based scaffolds should therefore be irradiated in a wet 
state, as the changes caused by dry state irradiation are likely to result in an 
unsuitable graft material.  
Following 12 weeks in vivo, the tensile mechanical properties of ovine musculus 
flexor digitorum superficialis tendons treated with E Beam (34 kGy), including 
the maximum load at failure and stiffness, were found to have decreased in 
comparison to a non-irradiated control allograft [234]. However, increased 
tissue remodelling, cellular activity and vascularisation were also observed, 
suggesting that over a longer time span the E Beam-treated samples may 
exhibit better integration into the injury site and therefore superior functionality 
as a graft material.  
The induction of alterations to ECM scaffold properties is not unique to 
radiation-based sterilisation methods. Commonly used chemical sterilants (e.g. 
oxidising agents such as PAA, alkylating agents such as ethylene oxide) may 
also significantly interact with and alter the protein components of ECM-based 
scaffolds [235].  
PAA treatment has been shown to induce alterations to the structure and 
biomechanical properties of some ECM-based scaffolds, which may be related 
to an increase in scaffold porosity [236]. Sterilisation of decellularised human 
patellar tendons with 0.1 % (v/v) PAA appeared to maintain the integrity of 
individual tissue structures, whilst causing a notable increase in the 
looseness/porosity of the overall tissue histoarchitecture [237]. Some alterations 
to the basement membrane component collagen type IV have been observed in 
decellularised tissues including porcine mitral valves, porcine pulmonary valves, 
human aorta and porcine bladder, where each tissue was treated with 0.1 % 
(v/v) PAA as a terminal sterilisation step [238-241]. The exact nature of these 
changes and the associated implications for cell attachment (and therefore 
tissue regeneration) remain unclear. Matuska et al (2014) found that sterilisation 
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with either ethylene oxide or PAA (in 4 % ethanol) caused an approximate 80 % 
reduction in the compressive modulus of temporomandibular disks [179]. 
Furthermore, structural disruption was observed to the ultrastructure of sample 
treated with ethylene oxide, and a reduction in seeded cell viability compared to 
PAA-treated or gamma irradiated samples. 
There is limited knowledge regarding the effects of SCCO2 treatment on ECM 
structure and composition, due to its relatively recent development as a 
sterilisation method [19]. However, the inclusion of oxidising agents (e.g. PAA, 
H2O2) as components of an additive solution (to aid in the reduction of 
viral/bacterial spore populations) raises the possibility of adverse alterations 
being induced to ECM structure, as well as damage to components of the 
basement membrane (in particular collagen IV) [242]. Decellularised porcine 
aortic valves treated with SCCO2 combined with a small volume of additive 
solution (containing 13.5–18.5 % PAA and 4.5– 6 % H2O2 [v/v]) did not appear 
to sustain damage to the ECM structure upon histological and SEM-based 
examination [19]. Treatment of decellularised rat lungs with a similar process 
appeared to mediate superior retention of ECM structure and key components 
for cell attachment (e.g. laminin) compared with lungs treated with 0.1 % (v/v) 
PAA  solution in 4 % (v/v) ethanol [243]. However, an approximate threefold 
increase in the Young’s Modulus of the decellularised lungs compared with non-
sterilised decellularised lungs was recorded at a strain of 30 %; the authors 
postulated crosslinking of collagens due to the elevated pressures 
(approximantely 1400 – 1500 pounds per suare inch [PSI]) associated with 
processing, or dehydration of the tissue during processing, as possible 
mechanisms underlying this change. When the (limited) published data are 
taken together, these initial results suggest that SCCO2 processing may be a 
promising method for achieving effective sterilisation of tissue whilst inducing 
minimal adverse effects to the ECM relatively to methods such as irradiation or 
ethylene oxide treatment, and that the use of a small volume of additive solution 
may limit the occurrence of alterations to basement membrane components 
which have been described when agents such as PAA are used in isolation.  
Ethylene oxide treatment of tissue grafts can also result in the induction of an 
adverse host immune response following implantation. In vitro studies have 
provided contrasting data regarding the cellular response to ethylene oxide 
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residuals. Lyophilised human bone containing 2.61 µg/g  of ethylene oxide 
reduced the growth of fibroblasts by 22 % compared with non-treated samples 
[244]. However, a 2001 study found that ethylene oxide sterilisation of human 
bone did not alter the secretion of pro-inflammatory cytokines by human 
peripheral blood monocytes compared with a non-sterilised control [245].  
Despite these data, 6.4 % of a patient cohort who underwent implantation of a 
bone-tendon-bone allograft ACL replacement developed a chronic, intraarticular 
inflammatory reaction which necessitated the removal of the graft; the cellular 
populations were found to be predominantly lymphocytic in nature [191]. The 
authors concluded that the presence of an ethylene oxide breakdown product, 
ethylene chlorohydrin, within the grafts was the likely cause of the observed 
immune response. Concerns such as these, alongside worries that 
lyophilisation may negatively impact mechanical properties, underlie the relative 
lack of use of ethylene oxide (compared with gamma radiation) amongst tissue 
banks [173, 182, 188, 191, 192]. The working concentration of chemical 
sterilisation agents, the length of time for which a scaffold is exposed and the 
implementation of an appropriate elimination strategy post-treatment are critical 
determinant parameters when minimising potential alterations to scaffold 
properties.  
Relatively little is known about the potential effects of copper (II) chloride on the 
properties of ECM-based scaffolds, and therefore this should be considered 
carefully [246]. High intracellular concentrations of copper are known to be 
cytotoxic (due to intracellular redox reactions) [247], and therefore effective 
removal of residual copper (II) chloride would be essential to ensure the 
prevention of adverse effects on tissue integration or cellular ingrowth 
capabilities of the graft [248, 249]. Furthermore, copper is known to induce 
neurodegenerative symptoms in patients suffering disorders such as Wilson’s 
disease; here, a mutated form of the ATP7B gene prevents removal of copper 
from the brain, resulting in neurodegeneration and associated symptoms such 
as parkinsonism and ataxia. While the effect of copper toxicity is less well 
defined in the PNS than the CNS, this evidence of neurotoxicity indicates that 
treatment of materials with copper compounds should be carried with caution, 
and full elimination of the reagent should be ensured, if the material functions to 
support neurons. A further potential disadvantage of this sterilisation method 
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would be the requirement for an additional aseptic transfer procedure before 
final packaging (similar to PAA), increasing the risk of contamination.  
The need for the identification of an effective terminal sterilisation process for 
decellularised porcine peripheral nerves is clear, due to the source of the tissue 
and the intended application. However, it has been well documented that 
sterilisation can negatively impact the functional properties of an ECM-derived 
scaffold; these include (but are not limited to) biocompatibility (including 
immunogenicity), biomechanical properties, biochemical composition, and 
histoarchitecture (including retention of ECM structures and components). Due 
to the possible implications of changes to such properties, the sterilisation 
method chosen for use with a novel tissue scaffold must be evaluated carefully.  
To date, the majority of the literature regarding the sterilisation of tissue 
scaffolds focusses on the use of historically commonly applied methods 
(particularly gamma radiation) with musculoskeletal and dermal allografts. 
Evidence is particularly lacking regarding the effects of sterilisation methods 
upon tissues containing delicate ECM structures which are thought to be critical 
to effective function. The endoneurium in peripheral nerve is an example of 
such a structure; maintenance of the intricate “honeycomb” structure and the 
integrity of the basement membrane (e.g. retention of key components such as 
type IV collagen and laminin) is thought to be key to stimulating and supporting 
neuroregeneration and functional restoration. The material properties of the 
nerves must be retained to ensure the axons are protected from excessive 
mechanical forces which may impair growth and function. Furthermore, given its 
importance in determining the success or otherwise of graft integration following 
implantation, the effect of sterilisation on the immune response to decellularised 
tissue grafts has not been widely investigated. A range of potentially suitable 
sterilisation methods, established and/or more novel, should be identified and 
the effects on sterilised decellularised nerves should be compared with baseline 
data from tissue which has not undergone a terminal sterilisation procedure. 
The identification of a suitable method preserving the key functional properties 
of the decellularised nerves is essential to enabling clinical translation of the 
device; retaining such properties would provide an optimal material for 
supporting the growth of key cell types including neurons and Schwann cells, 
and the promotion of functional restoration.  
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1.9 Hypothesis and aims 
Project hypothesis 
A terminal sterilisation process, novel or established, can be used to treat 
decellularised porcine peripheral nerves without compromising biological and/or 
physical properties. 
Project aims 
1. To optimise and validate the previously developed decellularisation 
process for porcine peripheral nerves; 
2. To characterise the biochemical, biomechanical and biological properties 
of decellularised porcine peripheral nerves; 
3. To identify candidate sterilisation methods with the potential for use with 
decellularised porcine nerves, and characterise the effects of sterilisation 
on the structural and biochemical properties of sterilised decellularised 
porcine nerves.  
4. To characterise the material properties of  decellularised porcine 
peripheral nerves treated with identified candidate sterilisation methods. 
5. To determine the effect of candidate sterilisation methods on the 
biocompatibility and immunogenicity of decellularised porcine peripheral 
nerves. 
6. To determine the effects of storage on the properties of sterilised 
decellularised porcine peripheral nerves. 
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2 General Methods 
 
This chapter details the general methods used during the course of this study. 
Specific methods are described in the relevant chapter. 
2.1 Chemicals and reagents 
For details of chemicals and reagents used in this study, see Appendix A, Table 
1. 
2.2 Equipment 
For details of equipment used in this study, see Appendix A, Table 2. 
2.3 Glass/plasticware 
For details of glass/plasticware used in this study, see Appendix A, Table 3. 
2.4 Consumables 
For details of consumables used in this study, see Appendix A, Table 4. 
2.5 Antibodies 
For details of antibodies used in this study, see Appendix A, Table 5. 
2.6 Determination of pH 
A Jenway 3020 pH meter was used to determine the pH of solutions. The pH 
meter was used in conjunction with a temperature probe to allow for variance 
caused by temperature change. Buffer solutions of pH 4, 7 and 10 were utilised 
to calibrate the pH meter prior to use. If required, solutions of 1 M hydrochloric 
acid and 1M sodium hydroxide were used to adjust the pH, added in a drop wise 
fashion with constant stirring. 
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2.7 Light microscopy 
A Zeiss Axio Imager M2 microscope was used for Köhler, circularly polarised and 
fluorescent microscopy. An HPX 120 illuminator was used in conjunction with a 
DAPI filter (450 - 465 nm) for fluorescent imaging. Images were captured using 
an attached Zeiss Axiocam MRc5.  
Zeiss Zen Pro software was used to control the microscope and camera, and 
process the images captured. An Olympus IX51 Inverted microscope (fitted with 
an Olympus XC-50 camera) was used for phase contrast microscopy. Cell B 
software was used to capture images. 
2.8 Sterilisation of equipment/reagents and solutions 
Dissection equipment was sterilised in a hot air oven (190 °C for four hours). 
Solutions (and equipment deemed unsuitable for sterilisation by dry heat) were 
sterilised in an autoclave. Items were subject to a temperature of 121 °C and 
pressure of 15 PSI for 20 minutes. 
2.9 Dissection of porcine peripheral nerve plexus 
Porcine hind legs were obtained from a local abattoir (J. C. Penny, Rawdon, 
Leeds, United Kingdom) within 24 hours of slaughter. The skin was removed, and 
the major nerve plexus (consisting of the sciatic, tibial and peroneal nerves) of 
the leg was then extracted by blunt dissection. The plexus was separated into the 
individual constituent nerves and the superficial connective tissue was removed. 
The nerves were washed at room temperature (with gentle agitation) in 
phosphate buffered saline (PBS) for 30 minutes (pH 7.2 -7.4). The nerves were 
stored for up to six months at - 70 °C prior to use. 
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Figure 2-1 Dissection of porcine nerve architecture  
Images showing (A) the nerve architecture partially dissected from porcine hind 
leg and (B) the dissected major nerve architecture. Different levels of 
anatomical hierarchy can be identified. Most superior is (1) the sciatic nerve, 
running down to its bifurcation into the branches of (2) the common peroneal 
nerve and (3) the tibial nerve. The most inferior branch which can be observed 
is (4) the sural nerve. 
 
 
 
 
 
 
 
 
 
  
 
   
   
 
 
 
 
 
2.10  Decellularisation of porcine peripheral nerves 
2.10.1 Preparation of solutions for decellularisation 
2.10.1.1 Phosphate Buffered Saline (PBS) 
Ten PBS tablets were dissolved in 1 L of distilled water using a magnetic stirrer 
bar. The pH of the solution was adjusted to 7.2 - 7.4 using 6 M sodium 
hydroxide (NaOH) or 6 M hydrochloric acid (HCl). 
2.10.1.2 Disinfection solution 
Stock solutions of the antibiotics vancomycin hydrochloride, gentamicin sulphate 
and polymyxin B were added to 100 ml of PBS and mixed using a magnetic stirrer 
bar (required concentrations and volumes given in Table 2-1). The pH of the 
solution was adjusted to 7.2 - 7.4 using 6 M NaOH or 6 M HCl, and the solution 
made up to 1 L with sterile PBS. 
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Table 2-1 Reagent concentrations for antibiotic wash solution 
Working concentrations, stock concentrations and required volumes of stock 
solution of antibiotics for 2 L of disinfection solution. 
 
2.10.1.3 EDTA solution (200 mM EDTA) 
EDTA solution was produced by dissolving 74.4 g EDTA in 900 ml of distilled 
water using a magnetic stirrer bar. The pH of the solution was adjusted to 7.2 - 
7.4 by the addition of 6 M NaOH or 6 M HCl, and the solution was made up to a 
final volume of one litre using distilled water. 
2.10.1.4 Hypotonic buffer solution (10 mM tris, 2.7 mM EDTA, 10 
KIU.ml-1 aprotinin) 
Hypotonic buffer solution was produced by dissolving 1.21 g trizma base and 1 g 
EDTA in 900 ml of distilled water using a magnetic stirrer bar. The pH of the 
solution was adjusted to 8.0 - 8.2 by the addition of 6 M NaOH or 6 M HCl, and 
the solution was made up to a final volume of one litre using distilled water. 
Aprotinin (10,000 KIU.ml-1) was added immediately before use; 1 ml was added 
per litre of solution. 
2.10.1.5 Hypotonic buffer solution containing 0.1 % (w/v) SDS (10 mM 
tris, 2.7 mM EDTA, 10 KIU.ml-1 aprotinin) 
Sodium dodecyl sulphate (SDS; 10 %; w/v; 10 ml) was added aseptically to 990 
ml hypotonic buffer solution (produced as described in section 3.2.1.1.4), to give 
a working concentration of 0.1 % (w/v). Aprotinin (10,000 KIU.ml-1) was added 
immediately before use; 1 ml was added per litre of solution. The solution was 
mixed by inversion and used immediately. 
2.10.1.6 PBS-EDTA solution (2.7 mM EDTA, 10 KIU.ml-1 aprotinin) 
PBS-EDTA solution was produced by dissolving ten Oxoid PBS tablets and 1 g 
EDTA in 900 ml of distilled water using a magnetic stirrer bar. The pH of the 
Antibiotic Working 
Concentration 
Stock 
concentration 
Volume 
of stock  
Vancomycin hydrochloride 0.05 mg.ml-1 10 mg.ml-1 5 ml 
Gentamicin sulphate 0.5 mg.ml-1 100 mg.ml-1 5 ml 
Polymyxin B 0.2 mg.ml-1 50 mg.ml-1 4 ml 
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solution was adjusted to 7.2 - 7.4 using 6 M NaOH or 6 M HCl, and the solution 
was made up to a final volume of one litre using distilled water. Aprotinin (10,000 
KIU.ml-1) was added immediately before use; 1 ml was added per litre of solution. 
2.10.1.7 Nuclease solution (50 mM tris, 1 mM MgCl2.6H2O, 1 U.ml-1 
Benzonase) 
Nuclease buffer solution was produced by dissolving 6.1 g trizma base and 0.203 
g magnesium chloride in 100 ml of distilled water using a magnetic stirrer bar. 
The pH of the solution was adjusted to 7.5 - 7.7 using 6 M NaOH or 6 M HCl, and 
the solution was made up to a final volume of one litre using distilled water.  
Benzonase stock solution (4 µl, stock concentration 250 U.µl-1) was added to the 
solution immediately prior to use, and mixed gently by inversion. 
2.10.1.8 Hypertonic buffer solution (50 mM tris, 1.5 M sodium 
chloride) 
Hypertonic buffer solution was produced by dissolving 87.66 g sodium chloride 
and 6.06 g tris in 900 ml of distilled water, using a magnetic stirrer bar. The pH of 
the solution was adjusted to 7.5 - 7.7 using 6 M NaOH or 6 M HCl, and the solution 
was made up to a final volume of one litre using distilled water. 
2.10.2 Decellularisation process 
The method detailed here illustrates the final iteration of the deceullarisation 
process, resulting from several rounds of optimisation. With the exception of 
Chapter 3, which describes the optimisation process, the decellularised tissue 
used for the work described here was produced according to this method. With 
the exception of the initial dissection and antibiotic wash steps, all changes of 
solution were carried out under aseptic conditions in a laminar flow cabinet.  
Dissected porcine peripheral nerves (sciatic [Chapter 3 only], tibial and peroneal) 
were thawed and cut into segments approximately 1.5 - 3 cm in length. All washes 
(with the exception of the Benzonase step) were with agitation, at a speed of 110 
rpm. Nerve segments were washed for 30 minutes in an antibiotic cocktail (0.05 
mg.ml-1 vancomycin hydrochloride; 0.5 mg.ml-1 gentamycin sulphate; 0.2 mg.ml-
1 polymyxin B) at 37 °C. Each segment was washed using in 200 mM EDTA (pH 
7.2 - 7.4) at 4 °C for 24 hours. Nerve segments were subject to washes in a 
hypotonic buffer (10 mM Tris-HCL; 2.7 mM EDTA; 10 KIU.ml-1 aprotinin; pH 8.0 
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- 8.2) and hypotonic buffer with the addition of SDS at a concentration of 0.1 % 
(w/v) for 24 hours each at 42 °C. The nerve segments were then subjected to 
three 30 minute washes in PBS, and incubated in PBS for 16 hours at 42 °C. 
Each segment was washed using PBS-EDTA solution (2.7 mM EDTA; 10 KIU.ml-
1 aprotinin; pH 7.2 - 7.5) for 48 - 72 hours at 4 °C, before being incubated in a 
buffer solution (50 mM Tris; 1 mM MgCl2; pH 7.5 - 7.7) containing Benzonase (1 
U.ml-1) at 37 °C for two periods of three hours with agitation (50 rpm). Nerve 
segments were then washed in PBS for 16 hours, then washed in hypertonic 
buffer (50 mM Tris; 1.5 M NaCl; pH 7.5 - 7.7) for 24 hours (both at 42 °C). A series 
of three washes in PBS at 42 °C were then carried out for 30 minutes each. 
Decellularised nerve segments were stored in PBS at 4 °C for up to three months.  
2.10.3 Sterilisation of decellularised nerves 
A range of sterilisation methods were applied to the decellularised nerve 
segments during the course of this work; the specific methods and conditions 
used are described here.  
2.10.3.1 PAA 
2.10.3.1.1  Solution 
2.8 ml of 36 – 40 % (v/v) PAA was added to 800 ml of distilled water and mixed 
using a magnetic stirrer bar. The pH of the solution was adjusted to 7.2 with 
12M HCl, and the volume was adjusted to one litre through the addition of 
distilled water. The solution was used within one hour of preparation. 
2.10.3.1.2  Method 
Groups of decellularised nerve segments (n = 30) were incubated in 0.1 % (v/v) 
PAA solution (pH 7.2 - 7.5) at room temperature for three hours at room 
temperature with agitation (110 rpm). Each nerve segment was subsequently 
washed three times in PBS (pH 7.4) at 42 °C for 30 minutes each. 
2.10.3.2 Gamma radiation 
Groups of decellularised nerve segments (n = 30) were suspended individually 
in 3 ml PBS (pH 7.4) within polystyrene bijou tubes. The decellularised nerves 
were gamma irradiated at a dose level of 25 kGy (range 25 - 28 kGy) (Dalton 
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Nuclear Institute, University of Manchester). The internal temperature of the 
irradiation chamber did not exceed 35 °C. 
2.10.3.3 E Beam 
Groups of decellularised nerve segments (n = 30) were suspended individually 
in 3 ml PBS (pH 7.4) within polystyrene bijou tubes and treated with an E Beam 
(Synergy Health, STERIS). The administered dose level was approximately 33 - 
37 kGy. 
2.10.3.4 SCCO2  
Decellularised nerve segments (n = 30) were packaged individually in 
polystyrene tubes and placed in the Nova2200 SCCO2 reaction chamber 
(NovaSterilis Inc, NY, USA). NovaKill™ proprietary additive (4 ml; 13.5 - 18.5 % 
[v/v] PAA and 4.5 - 6 % [v/v] H2O2) was added to a cellulose pad within the 
chamber and 25 ml of water was sprayed into the vessel. CO2 was injected into 
the chamber to reach a set pressure of 1,436 PSI and the temperature was held 
at 35 °C.  These conditions were maintained for three hours before the CO2 was 
released from the chamber. Sterile PBS (pH 7.4) was then added to the tubes 
aseptically prior to shipping. 
2.10.3.5 Positive control 
2.10.3.5.1 Solution 
NaOH (40 g) was added to 250 ml of distilled water, and mixed using a 
magnetic stirrer bar until dissolved.  
2.10.3.5.2 Method 
Groups of decellularised nerve segments (n = 3) were incubated in 100 ml of 
1 M NaOH at room temperature for 12 hours; the nerve segments were 
subsequently washed three times in PBS for one hour each. Samples were 
stored in PBS (pH 7.4) at 4 °C. 
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2.11  Histology 
2.11.1 Fixation and processing of native and decellularised 
tissue samples 
Tissue samples for histology were trimmed to 9 - 10 mm using a scalpel and 
placed inside a histology cassette. All samples were fixed and processed using 
a Leica TP1020 processor using a predetermined protocol (Table 2-2). 
 
 
 
2.11.2 Microtomy 
Paraffin wax embedded samples were sectioned using a Leica RM2255 
microtome at a thickness of 5 μm. The sections were floated onto glass slides. 
The temperature of the water bath was held at 30 °C as opposed to the 
conventional 56 °C, due to an observed loss of tissue integrity at higher 
temperatures. Slides were dried overnight at room temperature. 
Table 2-2 Tissue processing protocol  
List of reagents and incubation times used during the fixation and wax 
embedding of porcine peripheral nerve segments. 
Station  Solution  
 
Duration (hours) 
1 10 % (w/v) neutral buffered formalin 1 
2 70 % (v/v) alcohol 1 
3 90 % (v/v) alcohol 1 
4 100 % (v/v) alcohol 0.5 
5 100 % (v/v) alcohol 1 
6 100 % (v/v) alcohol 1 
7 100 % (v/v) alcohol 1 
8 Xylene; 100 % (v/v) 1 
9 Xylene; 100 % (v/v) 1 
10 Xylene; 100 % (v/v) 1 
11 Molten wax 1 
12 Molten wax 1 
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2.11.3 Dewaxing and rehydration 
Samples were immersed in two changes of xylene for ten minutes each for 
dewaxing and rehydrated by three successive washes in 100 % (v/v) ethanol and 
a single wash in 70 % (v/v) ethanol (three, two, two and two minutes in length 
respectively), and immersion for three minutes in running water. 
2.11.4 Dehydration and mounting 
Sections were immersed in 70 % (v/v) ethanol (five seconds), before successive 
immersions in 100 % (v/v) ethanol for periods of two minutes each. Sections were 
then immersed twice in xylene for ten minutes each, and mounted using 
Distyrene Plasticiser Xylene (DPX) mountant. All sections were allowed to air dry 
overnight in a fume cabinet. 
2.11.5 Haematoxylin and eosin staining 
Dewaxed rehydrated sections were immersed in Mayer’s haematoxylin for one 
minute and rinsed in tap water until running clear. Sections were then immersed 
consecutively in Scott’s tap water and eosin for three minutes each. Sections 
were dehydrated, mounted and visualised using Köhler illumination. 
2.11.6 DAPI staining 
Sections were stained with DAPI (4’,6-diamino-2-phenylinole) to reveal the 
presence and distribution of double stranded DNA. DAPI working solution 
(concentration 0.1 μg.ml-1) was made up immediately prior to use by addition of 
20 μl DAPI dye to 200 ml PBS. Dewaxed, rehydrated sections were immersed in 
DAPI working solution for ten minutes in darkness. The sections were 
subsequently washed three times in PBS in darkness, then mounted using DAKO 
fluorescent mounting medium. The slides were allowed to dry at room 
temperature overnight in darkness, and stored at 4 °C prior to imaging. Sections 
were viewed and imaged using a DAPI filter and fluorescent illumination.  
2.11.7 Sirius red and Miller’s Elastin 
2.11.7.1 Solutions 
5  % (w/v) potassium permanganate: 15 g of potassium permanganate was 
added to 300 ml of distilled water and mixed using a magnetic stirrer bar. The 
solution was filtered before use.  
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1 % (w/v) oxalic acid: 1 g of oxalic acid was added to 100 ml of distilled water 
and mixed using a magnetic stirrer bar. The solution was used immediately.   
Weigerts haematoxylin: Equal volumes of solution A and solution B were mixed 
by gentle agitation and used immediately.  
1% acid alcohol (1% concentrated Hydrochloric Acid in 70% Ethanol): 5ml of 
concentrated HCl was added to 495 ml of 70 % (v/v) ethanol.  
0.1 % (w/v) Sirius red: 0.1 g Sirius red was added to 100 ml of aqueous 
saturated picric acid solution and mixed using a magnetic stirrer bar. The 
solution was filtered before use. 
2.11.7.2 Methods 
Tissue sections were stained for the presence of collagen and elastin using Sirius 
red and Miller’s stain. Dewaxed, rehydrated sections were immersed in 5 % (w/v) 
potassium permanganate for five minutes and washed in distilled water. Tissue 
sections were then immersed in 1 % (w/v) oxalic acid for two minutes and washed 
in distilled water for two separate periods of one and four minutes respectively. 
Sections were immersed sequentially for periods of one minute in 70 % (v/v) and 
95 % (v/v) ethanol, and then subjected to treatment with Miller’s stain for one 
hour. Each section was rinsed in 95 % (v/v) ethanol until running clear, then in 70 
% (v/v) ethanol for one minute and running tap water for two minutes. Sections 
were stained in Weigert’s haematoxylin for ten minutes, then washed in water 
and 1 % (v/v) acid alcohol for one minute each, and rinsed in distilled water for 
30 seconds. Sections were immersed in 0.1 % (w/v) picrosirius red for one hour, 
before excess stain was removed by rinsing with distilled water. Sections were 
dried by blotting, dehydrated and mounted. Sections were visualised using both 
Köhler and circularly polarised illumination. 
2.11.8 Immunohistochemistry  
Immunohistochemistry was used to locate the presence of specific ECM 
components  in sections of porcine peripheral nerves.  
2.11.8.1 Solutions 
PBS: PBS was made up as described in 2.10.1.1. 
H2O2 solution (3 %; v/v): 20 ml of H2O2 solution (30 %; v/v) was added to 180 ml 
of PBS. The solution was mixed gently and used immediately. 
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10x TBS: 24 g of Trizma base and 88 g of NaCl were dissolved in 700 ml of 
distilled water, and mixed using a magnetic stirrer bar. The pH of the solution was 
adjusted to 7.6 with 12 M HCl, and the volume was adjusted to one litre through 
the addition of distilled water.  
1x TBS (20 mM Tris, 150 mM NaCl): 100 ml of 10x TBS was added to 900 ml of 
distilled water, and mixed using a magnetic stirrer bar. 
TBS containing 0.05 % (w/v) Tween 20 (TBS-T): 500 µl of Tween 20 was added 
to one litre of TBS and mixed using a magnetic stirrer bar. The pH of the solution 
was adjusted to 7.6 using 6 M NaOH or 6 M HCl. 
BSA solution (5 %; w/v BSA): 2.5 g bovine serum albumin was dissolved in 50 ml 
PBS using a magnetic stirrer bar. The solution was passed through a 0.2 µm filter 
into a sterile collection container in a class II cabinet. 
Antibody diluent (TBS, 0.1 % (w/v) BSA, 0.1 % (w/v) sodium azide): 6 ml sodium 
azide (1%) , 300 µl 5 % (w/v) bovine serum albumin and 40 ml TBS were mixed 
together using a magnetic stirrer bar. The pH of the solution was adjusted to 7.6 
using 6 M NaOH or 6 M HCl, and the volume made up to 60 ml with TBS.  
Scott’s tap water substitute (1x): 50 ml of Scott’s tap water 10x solution was 
added to 450 ml of distilled water.  
2.11.8.2 Horseradish peroxidase (HRP) Method 
Sections of porcine liver were included as a positive control, negative (diluent) 
and isotype controls were also carried out. Reagents from the Ultravision One 
immunohistochemistry kit were used for immunohistochemistry. Dewaxed, 
rehydrated sections were subjected to antigen retrieval by incubation in 
proteinase K solution (DAKO) for 20 minutes at room temperature. Each section 
was immersed in 3 % (v/v) hydrogen peroxide in PBS for ten minutes, and rinsed 
under running tap water for three minutes. The sections were then washed twice 
using Tris-buffered saline (TBS; pH 7.6) with gentle agitation for ten minutes. 
Each section was drawn around using an ImmEdge hydrophobic marker pen. 
Sections were blocked by application of 25 μl of endogenous enzyme block and 
incubated at room temperature for ten minutes. Sections were subjected to two 
further washes of ten minutes each in TBS with gentle agitation. Sections were 
incubated in primary antibody (diluted to working concentration using antibody 
diluent (TBS, 0.1 %; w/v BSA, 0.1 %; w/v sodium azide; pH 7.6) for 60 minutes 
at room temperature.  Each section was washed twice using Tris-buffered saline 
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containing 0.05 % (w/v) Tween 20 (TBST) with gentle agitation, followed by two 
additional ten minutes washes in TBS. HRP polymer was then added and the 
sections incubated for 30 minutes in the dark. Each section was washed using 
two ten minute washes in each of TBST and TBS respectively. Substrate DAB 
chromagen was added in aliquots of 25 - 50 μl per section, and the sections were 
incubated for ten minutes at room temperature. The sections were each washed 
four times in distilled water, then incubated in haematoxylin for ten seconds. 
Sections were rinsed in tap water until excess stain was removed, and immersed 
in Scott’s tap water for ten minutes. Each section was rinsed in tap water for three 
minutes, dehydrated and mounted. Sections were visualised using Köhler 
illumination. 
2.11.8.3 Immunofluorescent Method 
Initial processing (including antigen retrieval and incubation with the primary 
antibody) were conducted as described in section 2.11.8.2. Fluorescent 
secondary antibodies, diluted to an appropriate concentration in antibody diluent, 
were added to each section. Sections were then incubated in a humidified 
chamber in conditions of darkness for 30 minutes at room temperature. Each 
section was washed for two ten minute periods in each of TBST and TBS 
respectively, all under conditions of darkness. The sections were incubated in 
DAPI working solution for one minute. Each section was rinsed in PBS three 
times in darkness, and mounted using fluorescent mounting medium. Sections 
were visualised and imaged using a DAPI filter and fluorescent illumination. 
2.12  Cytotoxicity testing 
2.12.1 Cell culture media 
Baby hamster kidney (BHK) cells were cultured in Glasgows Modified Eagles 
Medium (GMEM), containing 5 % (v/v) foetal bovine serum (FBS), 10 % (v/v) 
tryptone phosphate broth (TPB), 100 μg.ml-1 penicillin-streptomycin and 2 mM L-
glutamine. 
L929 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM), 
containing 10 % (v/v) FBS, 100 μg.ml-1 penicillin-streptomycin and 2 mM L-
glutamine. 
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2.12.2 Resurrection and culture cells from cryostorage 
Vials of cells were removed from cryostorage in liquid nitrogen. The cell pellets 
were thawed rapidly in a water bath at 37 °C and transferred in a class II 
environment to individual sterile universal tubes. Culture media (10 ml) was 
added drop wise to each universal, before centrifugation at 150 x g for ten 
minutes. The supernatant was discarded, the cells resuspended in 5 ml of specific 
culture medium and transferred into a T75 flask. The cells were incubated at 37 
°C in an atmosphere of 8 % (v/v) CO2 in air. The culture medium was changed 
24 hours after revival, then every 48 - 72 hours. Cells were passaged once they 
were observed to be 80 % confluent. 
2.12.3 Cell passaging 
Upon reaching 80 % confluence, the medium was aspirated from the culture flask, 
and the cell layer washed twice in PBS (without magnesium or calcium). The PBS 
was discarded and 3 ml trypsin/EDTA was added, and the flask incubated for five 
minutes at 37 °C with 8 % (v/v) CO2 in air. The cells were carefully dislodged by 
tapping and 10 ml of culture medium was added. The total volume present in the 
flask was transferred to a universal tube and centrifuged at 150 g for ten minutes. 
The supernatant was discarded, and the cells suspended in 1 ml of medium. The 
cells were counted and viability determined with Trypan blue. Cell suspension 
and Trypan Blue (20 µl each) were mixed, and 10 µl was added to a 
haemocytometer. The number of viable cells per grid was then determined, and 
the total number of cells ml-1 calculated using the equation below: 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠. 𝑚𝐿−1 =  
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠
𝑛
 𝑥 104 𝑥 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 
The cell suspension was then diluted as appropriate and seeded to a T 75 flask 
and incubated at 37 °C in an atmosphere of 8 % (v/v) CO2 in air. 
2.12.4 Contact cytotoxicity assay 
This assay was carried out using two distinct cell types ( BHK and L929 cells). 
Triplicate samples of decellularised peripheral nerve (5 mm2) were dissected, 
placed in to individual wells of a six well plate and secured using Steri-Strips. A 
positive control was provided by the addition of a droplet of cyanoacrylate to a 
separate culture well on each plate. A Steri-Strip was added to another well, to 
act as a negative control. Each well was seeded with cells a density of 5 x 106 
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cells in 2 ml of media. The plates were incubated at 37 °C, in an atmosphere of 
8 % (v/v) CO2 in air, for hours. After 48 hours in culture, the cells in each well 
were observed using phase contrast microscopy and images captured digitally.  
Any changes in cell morphology were noted. The medium was aspirated from 
each well, and the plates washed twice in PBS (without calcium or magnesium) 
and the cell layer fixed for ten minutes using 10 % (v/v) Neutral Buffered Formalin 
(NBF). After the NBF was removed, Giemsa stain was added to each well and 
the plates were incubated for a further five minutes. The plates were washed in 
gently running tap water. Stained cell sheets were viewed using Köhler 
illumination and images captured digitally. 
2.13  Uniaxial tensile testing 
Samples of peripheral nerve from each test group were subject to uniaxial tensile 
testing to failure using an Instron 3365 machine equipped with a 5 kN load cell. 
Segments of peripheral nerve were cut to approximately 30 mm in length, and 
the width and thickness of each determined using callipers and a thickness 
gauge. The nerve segments were mounted in indented grips, using a baseplate 
to ensure a gauge length of 10 mm was maintained (Figure 2-2). Paper towel was 
used to prevent slippage of the tissue during testing. The grips were then 
attached to the Instron housing in a tension free manner and subject to a single 
ramp-to-failure tensile test, at a strain-rate of 10 mm.minute-1. The maximum load 
each sample sustained was recorded and used (in conjunction with the measured 
cross sectional area) to calculate the ultimate tensile strength, and the gradient 
of the slope in the linear region of the stress-strain curve was used to define the 
Young’s Modulus (Figure 2-3). If the tissue sample was observed to slip within 
the grip (s) or fail at the grip, the data from the sample was considered void.  
It was not possible to shape the nerves into standard sizes for testing, due to 
the heterogeneity of nerve ECM structure and the differing contributions of the 
structures in nerve ECM to mechanical properties. Therefore, a method to 
measure the dimensions of the nerve samples without resizing was developed. 
However, due to the inherent inaccuracies which these restrictions could 
introduce to the calculation of cross-sectional area, maximum load and stiffness 
were also considered during the course of this study, as measures of 
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B A 
Figure 2-2 Uniaxial tensile testing of peripheral nerves. 
Images show (A) peripheral nerve segment in the process of mounting onto 
tensile grips (mounted on baseplate) and (B) peripheral nerve sample at point 
of failure during tensile test. 
 
mechanical properties which could be determined independent of the physical 
dimensions of the tissue.  
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Figure 2-3  Formulas used to calculate mechanical properties of 
peripheral nerve segments. 
The formulas displayed were used to calculate stress, strain, Young’s Modulus 
and stiffness of the peripheral nerves. 
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2.14  Biochemical characterisation 
2.14.1 Lyophilisation 
The wet weight of peripheral nerve samples was determined by triplicate 
measurements. Samples were transferred to a freeze dryer (Savant ModulyoD) 
and lyophilised under constant conditions of -50 °C and 0.15 – 0.2 mbar. 
Repeated measurements of sample weight were taken at 48 hours, and at 24 
hour intervals thereafter until a constant weight was achieved.  The dry weight 
of all samples was determined to allow accurate calculation of biochemical 
constituents. 
2.14.2 Acid hydrolysis 
Samples of nerve were lyophilised, diced and placed in vented glass test tubes. 
A volume of 5 ml of 6 M HCl was added to each tube, and the samples were 
transferred to a benchtop autoclave to conditions of 121 °C and 15 PSI for four 
hours. Samples were neutralised by the addition of NaOH at varying 
concentrations. 
𝐹 = 𝑓𝑜𝑟𝑐𝑒 𝑎𝑝𝑝𝑙𝑖𝑒𝑑 
𝐴 = 𝑐𝑟𝑜𝑠𝑠 𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑟𝑒𝑎 
𝐿 = 𝑠𝑎𝑚𝑝𝑙𝑒 𝑙𝑒𝑛𝑔𝑡ℎ 
∆𝐿 = 𝑐ℎ𝑎𝑛𝑔𝑒 𝑖𝑛 𝑙𝑒𝑛𝑔𝑡ℎ 
𝐸 = 𝑌𝑜𝑢𝑛𝑔′𝑠 𝑀𝑜𝑑𝑢𝑙𝑢𝑠 
𝑘 = 𝑠𝑡𝑖𝑓𝑓𝑛𝑒𝑠𝑠 
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2.14.3 Quantification of hydroxyproline content  
In vertebrates, the amino acid hydroxyproline is mainly found in collagen 
(though it is also present in elastin). It occurs at a known frequency in the 
amnino acid sequence of collagen, and therefore the quantification of 
hydroxyproline within a tissue sample can be used to produce an accurate 
estimate of collagen content. Quantification was achieved by a colourimetric 
assay based on the method of Edward’s and O’Brien (1980)[250]. Pyrroles 
formed by oxidation of hydroxyproline react with p-dimethylaminobenzaldehyde 
to produce a red chromophore which can be measured spectrophotometrically. 
2.14.3.1 Solutions 
Assay Buffer: Assay buffer was made up by dissolving 13.3 g citric acid, 32 g 
sodium acetate hydrate, and 9.1 g sodium hydroxide in 3.2 ml glacial acetic acid 
and 80 ml propan-1-ol using a magnetic stirrer bar. The solution was then made 
up to 300 ml using distilled water. The pH was adjusted to 6.0 - 6.5 using 6 M 
NaOH or 6 M HCl. 
Chloramine T: This solution was made up for immediate use. 1.41 g of 
chloramine T was dissolved in 100 ml distilled water using a magnetic stirrer 
bar. 
Ehrlich’s reagent: This solution was made up for immediate use. 7.5 g p-
dimethylaminobenzaldehyde was added to 30 ml propan-1-ol and 13.4 ml 60 % 
(v/v) perchloric acid. A volume of 6.6 ml distilled water was added and the 
solution was mixed with a magnetic stirrer bar. 
2.14.3.2 Assay method 
Samples of nerve were lyophilized to give a dry weight of approximately 20 mg, 
and hydrolysed in 5 ml of 6 M HCl (as described in 2.14.1 and 2.14.2 
respectively).  
Solutions of known concentrations of trans-4-hydroxy-L-proline (0, 2, 4, 6, 8, 10, 
15, 20, 25 and 30 μg.ml-1) were made up, to be used as the basis of a standard 
curve. Test solutions were diluted at a ratio of 1:20 in assay buffer. 
Aliquots (50 μl) of each known standard/sample was added in triplicate to a 
clear flat-bottomed 96 well plate. Chloramine T solution (100 μl) was added to 
each well, and the plate was subjected to gentle agitation for five minutes. 
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Ehrlich’s reagent (100 μl) was added to each well, and the plate was incubated 
at 60 °C in an orbital incubator shaker (no agitation) for 45 minutes. 
Measurements of optical density were taken for each well containing a standard 
and sample, at a wavelength of 570 nm.  
A curve of absorbance against concentration was plotted for the known 
standards, and used as a standard curve. The absorbance values for test 
samples were used to generate interpolated hydroxyproline concentrations. 
These values were then used in conjunction with the values of tissue mass and 
dilution factor to calculate the hydroxyproline content of the tissue samples. 
2.14.4 Estimation of collagen content from hydroxyproline 
content 
The collagen content of the tissue samples was estimated by extrapolation from 
the calculated hydroxyproline content. Values produced by Goll et al (1963) are 
widely used to estimate collagen content, based on the ratio of hydroxyproline 
residues to other amino acids in the primary structure of collagen [251]. The 
calculated hydroxyproline content of each sample was multiplied by the given 
factor of 7.52 to give an accurate estimate of collagen content [252]. 
2.14.5 Quantification of denatured collagen content 
Denatured collagen content was determined by a colourimetric assay of 
solubilised enzyme digestion products.  This was enabled by enzymatic 
digestion with α-chymotrypsin, which selectively digests denatured collagen 
molecules. 
2.14.5.1 Solutions 
α-chymotrypsin digest buffer: 1.21 g Trizma base and 0.15 g calcium chloride 
were dissolved in 100 ml of distilled water using a magnetic stirrer bar. The pH 
of the solution was adjusted to 7.8 using 6 M NaOH or 6 M HCl.   
α-chymotrypsin working solution: Lyophilised α-chymotrypsin was dissolved in 
the digest buffer using a magnetic stirrer bar, to give a working concentration of 
5 mg.ml-1. 
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2.14.5.2 Assay Method 
Samples of nerve were diced and lyophilised (as described in 2.14.1) to give a 
dry weight of approximately 20 - 30 mg. α-chymotrypsin working solution (5 ml) 
was added to each sample, and the samples were incubated in a water bath for 
24 hours at 30 °C. The digested samples were centrifuged at 600 g for ten 
minutes, and the supernatant (4 ml) was transferred to a sterile glass tube. HCl 
(4 ml; 6 M) was added to each tube, and the samples were hydrolysed and 
neutralised as described in section 2.14.2.  
The neutralised samples were then subjected to colourimetric assay with P-
dimethylaminobenaldehyde as described in section 2.14.3.2 and the denatured 
collagen content estimated as described in section 2.14.4. 
2.14.6 Quantification of GAG content  
Sulphated GAG concentration in tissue samples can be calculated from 
solubilised enzymatic digestion products. A colourimetric assay was used, 
based on the method described by Farndale et al (1982) [253]. The assay 
reaction is based upon the metachromasy which is induced when 1,9-
dimethylmethylene (dimethylene blue, DMB) interacts with GAGs under acidic 
conditions. 
2.14.6.1 Solutions 
Papain digest buffer: 0.788 g L-cysteine hydrochloride and 1.8612 g disodium 
EDTA were disosolved in 1 L of distilled water using a magnetic stirrer bar. The 
pH of the solution was adjusted to 6.0 using 6 M NaOH or 6 M HCl.  
Papain working solution: Lyophilised papain was dissolved in the digest buffer 
to give a working concentration of 800 kU.ml-1. 
0.1 M sodium di-hydrogen orthophosphate: 3.45 g sodium di-hydrogen 
orthophosphate was dissolved in 250 ml distilled water using a magnetic stirrer 
bar. 
0.1 M di-sodium hydrogen orthophosphate: 3.55 g di-sodium hydrogen 
orthophosphate was dissolved in 250 ml distilled water using a magnetic stirrer 
bar. 
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Assay buffer: 137 ml of 0.1 M sodium di-hydrogen orthophosphate and 63 ml of 
0.1 M d-sodium hydrogen orthophosphate were mixed using a magnetic stirrer 
bar. The pH of the solution was adjusted to 6.8 using 6 M NaOH or 6 M HCl. 
DMB Dye solution: 16 mg of DMB was dissolved in 5 ml ethanol and 2 ml formic 
acid using a magnetic stirrer bar. 2 g of sodium formate was added, and distilled 
water was added to give a total volume of 1 L. The pH of the solution was 
adjusted to 3 by the addition of formic acid. 
2.14.6.2 Assay Method 
Samples of nerve were lyophilised (as described in section 2.14.1) to give a dry 
weight of approximately 50 mg. Papain working solution (5 ml) was added to 
each sample. The samples were incubated at 60 °C in an orbital incubator 
shaker for 36 hours. 
Solutions of known concentrations of chondroitin sulphate B (0, 3.125, 6.25, 
12.5, 25, 50, 100, 150, 200 μg.ml-1) were made up in assay buffer, to be used 
as the basis of a standard curve. Test solutions were assayed neat. Each 
known standard/sample was added in triplicate 40 μl aliquots to a clear flat-
bottomed 96 well plate. DMB dye solution (250 μl) was added to each well, and 
the plate was subject to gentle agitation for two minutes. Measurements of 
optical density at a wavelength of 525 nm were taken for each well, using a 
spectrophotometer.  
A standard curve of absorbance against concentration was plotted for the 
known standards. GAG concentrations  were interpolated using the standard 
curves from average absorbance values.  The final GAG concentration was 
calculated by factoring in tissue mass and any dilution factor. 
2.14.7 Quantification of fat content 
A colourimetric assay for the quantification of fat in tissue was carried out, 
based on a protocol developed by Stern and Shapiro (1953)[254]. The assay 
relies on a reaction between hydroxylamine and esters of fatty acids in solution. 
The hydroxamic acids formed by this reaction can be quantified by comparison 
of optical density following reaction with iron (III) chloride.  
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2.14.7.1 Solutions 
Hydroxylamine hydrochloride (2 M): 1.39 g hydroxylamine hydrochloride was 
added to 10 ml of distilled water and mixed by inversion. 
Iron (III) chloride in trichloroacetic acid: 500 mg iron (III) chloride and 3.75 g 
trichloroacetic acid were added to 5 ml distilled water and mixed by inversion. 
2.14.7.2 Assay Method 
Samples of nerve were lyophilised (as described in 2.14.1) to give a dry weight 
of approximately 30 mg. The samples were immersed in 600 μl of ethanol and 
incubated at 42 °C for 4 hours with agitation. Porcine lard was dissolved in 600 
μl of ethanol to give a range of standards of known concentrations (0, 39, 78, 
156, 312.5, 625, 1250, 2500 μg.ml-1). Hydroxylamine hydrochloride and 3.5 M 
NaOH (100 μl each) were added to each standard/sample. The standards and 
samples were incubated for 20 minutes at room temperature, before 100 μl 
each of 4 m HCL and iron (III) chloride were added. Aliquots of each standard 
or sample (250 μl) were added in triplicate to a clear, flat-bottomed 96 well 
plate. Measurements of optical density at a wavelength of 540 nm were taken 
for each well, using a spectrophotometer. A curve of absorbance against 
concentration was plotted for the known standards, and used as a standard 
curve. The absorbance values for test samples were used to generate 
interpolated fat concentrations. These values were then used in conjunction 
with the values of tissue mass and dilution factor to calculate the fat content of 
the tissue samples. 
2.15  Statistical analysis 
Means were compared using the statistical analysis software GraphPad Prism 
7. Confidence limits at 95 % (α = 0.05) were calculated with a minimum of n=3 
using the equation shown (Figure 2-4). The distribution of the data was 
determined using a Shapiro-Wilk test. If the data were found to follow Gaussian 
distribution, the difference between two means was determined using a 
student’s t-test, and three (or more) means by one-way analysis of variance 
(ANOVA; if one independent variable) or two-way ANOVA (if two independent 
variables). If the data were not found to follow Gaussian distribution, the 
- 96 - 
difference between two means was determined using a Mann-U Whitney test, 
and three (or more) means by Kruskal-Wallis. The location of significant 
differences was determined by Tukey’s Honestly Significant Difference test 
(parametric data) or Dunn’s test (non-parametric data). The minimum significant 
difference (MSD) between two means was defined as p = 0.05. Data was 
displayed as ± 95 % confidence limits. Linear regression analyses of standard 
curves, via calculation of the coefficient of determination (r2), was used to 
determine the strength of a liner relationship between x and y (with 0 = no 
relationship and 1 = perfect relationship) and therefore the accuracy of 
interpolating unknown values via such a regression. 
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𝑛 = 𝑠𝑎𝑚𝑝𝑙𝑒 𝑠𝑖𝑧𝑒 
𝑀 = 𝑚𝑒𝑎𝑛 
𝑆𝑇 𝑑𝑒𝑣 = 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 
𝑆𝐸 = 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑒𝑟𝑟𝑜𝑟 
𝑡 = 𝑐𝑟𝑖𝑡𝑖𝑐𝑎𝑙 𝑣𝑎𝑙𝑢𝑒 
𝑀𝑆𝑤 = 𝑀𝑒𝑎𝑛 𝑠𝑞𝑢𝑎𝑟𝑒 𝑤𝑖𝑑𝑡ℎ 
𝑀𝑆𝐷 =  𝑀𝑖𝑛𝑖𝑚𝑢𝑚 𝑠𝑖𝑔𝑛𝑖𝑓𝑖𝑐𝑎𝑛𝑡 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 
𝑄 =  𝑐𝑟𝑖𝑡𝑖𝑐𝑎𝑙 𝑣𝑎𝑙𝑢𝑒𝛼 =  𝑝 =  0.05 
𝑘 =  𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑔𝑟𝑜𝑢𝑝𝑠 
𝑣 =  𝑑𝑒𝑔𝑟𝑒𝑒𝑠 𝑜𝑓 𝑓𝑟𝑒𝑒𝑑𝑜𝑚 (𝑛 –  1) 
Figure 2-4 Selected equations applied for statistical calculations  
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3 Decellularisation and characterisation of porcine peripheral 
nerves 
3.1 Introduction 
3.1.1 Decellularised tissues in regenerative medicine 
Decellularised tissues have great potential for use as scaffolds in tissue 
engineering applications. A major advantage of the use of decellularised tissues 
in comparison to synthetic graft materials is the inherent similarity to native 
tissue. The retention of the ECM microarchitecture, biomechanical properties, 
biochemical composition and chemotrophic cues ensures a native-like 
microenvironment [255]. A native-like ECM microenvironment can promote 
cellular infiltration and the retention of tissue-specific phenotypic characteristics 
[17]. The environmental niche provided by decellularised tissue can also induce 
the expression of such characteristics in undifferentiated stem cells; this has 
been demonstrated in adipose-derived stem cells and bone marrow-derived 
stem cells seeded to segments of decellularised adipose and tendon 
respectively [256, 257]. The provision of an optimal environment for the 
promotion of cell infiltration, growth and function is key to facilitating tissue 
regeneration.  
Decellularisation protocols typically mediate the removal of cells and nucleic 
acids from the tissue, and may be tailored to remove other unwanted ECM 
components or cellular debris (e.g. the xenoantigen alpha-1,3-galactose) which 
may stimulate an adverse immune response [36]. It can be hypothesised that 
the removal of these major sources of foreign antigens from the tissue 
maximises the chance of successful graft integration and restoration of function 
[130]. 
The widely used criteria for the removal of immunogenic material are based 
upon data presented by Crapo et al (2011) [131]. The guidelines proposed 
include a total of less than 50 ng of double stranded DNA (dsDNA) per mg of 
tissue (dry weight), no fragments of DNA greater than 200 base pairs in length, 
and no nuclei visible when tissue is stained with haematoxylin and eosin (H & 
E). These criteria are based upon evidence suggesting that the extent of the 
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host immune response can be directly linked to the concentration of DNA 
present in a scaffold [258]. Although the presence of residual DNA in 
decellularised tissues is associated with an adverse immune response, in 
isolation DNA is only thought to induce some localised calcification [259]. 
Gilbert et al (2012) found quantifiable levels of DNA in eight commercially 
available ECM-based scaffolds [260]. Histological examination of scaffolds 
derived from porcine intestinal submucosa and porcine urinary bladder 
basement membrane and mucosa also revealed visible nuclear remnants and 
whole nuclei.  Individual studies into each scaffold showed good clinical 
efficacy, indicating that the degree of host response induced by such materials 
is not sufficient to negatively affect function of the scaffold. Instead, it is thought 
that the proposed relationship between the measured DNA content and host 
response to decellularised material is primarily due to the relative levels of other 
cellular debris [134]. If DNA is retained following decellularisation, it is highly 
likely that other debris such as membrane phospholipids (together with 
associated integral proteins/glycoproteins) are also retained [260]. Membrane 
fragments, cytoplasmic proteins and other cellular debris represent a source of 
important foreign antigens (e.g. alpha 1,3-galactose, major histocompatibility 
complex I) [261]. It may be beneficial, depending on the tissue type and donor 
source, to demonstrate the elimination of specific antigens during the 
development of a novel decellularisation process (e.g. alpha 1,3-galactose in 
porcine aortic valves) [262]. The criteria presented by Crapo et al therefore 
represent a guideline rather than a required standard for decellularisation, and 
parameters such as percentage DNA reduction are instead used as predictive 
indicators of the likely host response [263].  
3.1.2 Methods of decellularisation 
Since decellularisation was first proposed as a potential method for producing 
alternative graft materials, research has focused on the identification of an 
optimal method for the lysis and removal of cells and other immunogenic 
material. Such decellularisation techniques can be classified into the distinct 
sub-categories of physical, chemical and enzymatic methods. It is common for 
decellularisation protocols to utilise a number of techniques in combination to 
maximise the removal of immunogenic material whilst minimising alterations to 
the properties of the scaffold. 
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3.1.2.1 Chemical methods 
3.1.2.1.1 Detergents 
Detergents are surfactants, with a hydrophilic head region and a hydrophobic 
tail. Detergents are powerful agents of decellularisation, able to integrate within 
the phospholipid bi-layer of the cell membrane [264]. This process eventually 
induces the formation of micelles and ultimately leads to cell lysis.  Detergents 
are also able to mediate the detachment of nucleic acids from ECM proteins 
following cell lysis, reducing the potential immunogenicity of the scaffold. The 
concentration of detergent used is key to enabling these beneficial effects 
without causing significant disruption to the biochemical composition, structure 
and material properties of the ECM [265]. Ferng et al (2017) demonstrated that 
the use of SDS at a concentration of 3 % (v/v) to decellularise porcine hearts 
resulted in no measurable decrease in Young’s Modulus [266]. However, the 
use of SDS at concentrations of 5 % and 10 % caused reductions in Young’s 
Modulus of approximately  20 % and 90 % respectively; reductions of such a 
magnitude would have negative implications for the functionality of the tissue. 
Scanning electron microscopy was used by Oliveira et al (2013) to demonstrate 
superior retention of ECM structures murine small intestine was decellularised 
with Triton-X at a concentration of 0.1 % (v/v) as opposed to 0.3 % or 0.6 % 
[267].  
Detergents can be classified according into three categories:  ionic, non-ionic 
and zwitterionic.  
Ionic detergents are those in which the head group is either positively or 
negatively charged (cationic or anionic respectively). They are effective 
decellularisation agents, acting by disrupting non-covalent protein-protein, 
protein-lipid and lipid-lipid interactions [268]. However, the concentration of 
detergent used is proportional to the level of disruption/damage to, and/or 
denaturation of, ECM proteins. For example, SDS is an anionic detergent which 
is highly effective at disrupting membranes and facilitating the removal of both 
phospholipid and protein components, but is also known to significantly reduce 
the collagen and GAG content of decellularised scaffolds if used at high 
concentrations or for extended periods of time [269]. Protein denaturation is 
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mediated through single molecules of SDS binding to hydrophobic regions of a 
protein between alpha helices [270]. This provides a “nucleation site” enabling 
further SDS molecules to bind, a process which leads to micelle formation, the 
disruption of non-covalent linkages and unfolding of the tertiary structure. The 
ability of SDS to unfold higher-order protein structures, enabling denaturation of 
cellular proteins and ECM components, is further evidenced by its application in 
a range of protein identification assays [271]. One example is SDS 
polyacrylamide gel electrophoresis (SDS-PAGE), in which SDS is used to 
solubilise and unfold proteins and thereby enable identification according to 
size. 
Non-ionic detergents, such as Triton X-100, have no overall charge at the head 
region (which is therefore hydrophilic) [272]. Non-ionic detergents do not disrupt 
protein-protein interactions, and therefore induce lower levels of denaturation 
relative to ionic detergents. However, studies comparing decellularisation 
protocols for rat aortic valves and porcine carotid arteries indicated that 
treatment with Triton X-100, even at relatively high concentrations (e.g. 5 – 10 
%), is inferior in terms of nuclei and DNA removal compared to treatment with 
SDS [273, 274]. A combination treatment of 0.05 % trypsin and 5 % Triton X-
100 was able to sufficiently eliminate nuclei in the rat aortic valves, but lead to 
widespread disruption of the ECM ultrastructure. Dense tissues such as bone, 
cartilage, blood vessel and kidney may be able to withstand more robust SDS-
based protocols than more delicate tissues such as cornea, and may require 
such protocols due to the increased difficulty of cell and nucleic acid removal 
[17]. The use of concentration Triton X-100 may be more appropriate for more 
delicate tissues such as cornea [275]. 
Zwitterionic detergents have a net neutral charge, effectively disrupt protein-
protein interactions and exhibit properties of both ionic and non-ionic detergents 
[265]. They are less potent as agents of decellularisation in relative terms, and 
are mainly employed in thinner/ more delicate tissues where the use of ionic or 
non-ionic detergents may cause significant disruption to the ECM integrity [276, 
277]. The most commonly used zwitterionic detergent in decellularisation 
processes is 3-[(3-Cholamidopropyl)dimethylammonio]-1- 
propanesulfonate (CHAPS). CHAPS has been used to successfully 
decellularise lung tissue from several species including rat, pig and human, 
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whilst preserving ECM structures and mechanical properties better than SDS  
[277, 278]. However, Ferng et al (2017) showed that intact nuclei were still 
present in porcine heart tissue after treatment with CHAPS, indicating 
incomplete decellularisation [266].     
Failure to sufficiently eliminate detergents from tissue can lead to post-
production degradation of the ECM, and cytotoxic effects following implantation 
[279].   
3.1.2.1.2 Buffer solutions 
Hypotonic and hypertonic buffer solutions are commonly used in 
decellularisation protocols to alter osmotic pressure [17]. Whilst treatment with 
such buffer solutions in isolation is typically sufficient to cause cell lysis, they 
are commonly used in combination with other decellularisation agents (e.g. 
detergents) to increase efficacy and ensure the removal of cellular debris. 
Hypertonic buffer solutions are also employed for their ability to dissociate any 
DNA-protein complexes remaining within the tissue [280].  
3.1.2.1.3 Other chemical agents 
Low concentrations of PAA have been successfully used to decellularise tissues 
such as subintestinal mucosa and bladder through oxidation of membrane 
components and denaturation of intracellular nucleic acids. However, mass 
spectrometric data from murine lungs treated with PAA suggested that 
denaturation/degradation of major ECM components including collagens type I, 
IV and VI and laminin had occurred, the most likely mechanism for which is 
oxidative damage [242]. Syed et al were able to successfully decellularise 
porcine small intestinal submucosa using a 12 hour incubation in 0.1 % (v/v) 
PAA, but the treatment induced significant increases in Young’s Modulus and 
yield stress, and a significant decrease in the failure strain, compared to 
untreated tissue [281]. PAA can also be used in conjunction with other reagents 
to aid in decellularisation; Rosario et al (2008) found that treatment of porcine 
bladder with 0.1 % (v/v) SDS followed by 0.1 % (v/v) PAA enabled the 
production of a fully decellularised matrix with no apparent adverse effects to 
the mechanical properties, structure or the attachment and growth of primary 
stromal cells [282].  
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Compounds capable of chelating metal ions (in particular 
ethylenediaminetetraacetic acid (EDTA)) are commonly used in 
decellularisation processes (in combination with other reagents e.g. detergents) 
[283]. Chelating agents enable the disruption of interactions between cell 
adhesion molecules and the ECM by chelating ions (e.g. Mg2+, Ca+) necessary 
for adhesions through key cell attachment molecules such as integrins [284]. 
The process of decellularisation carries an inherent risk of scaffold damage due 
to the activity of proteolytic lysosomal enzymes, which are released upon cell 
lysis [17, 285, 286]. The chelation of metal ions inhibits the activity the activity of 
matrix metalloproteases (MMP’s), thereby limiting enzymatic damage to the 
matrix following cell lysis [287]. For similar reasons the small polypeptide 
aprotinin is often added to solutions of decellularisation agents in order to 
competitively inhibit serine proteases, preventing degradation of the ECM [288]. 
3.1.2.2 Enzymatic methods  
The primary advantage of the use of enzymes in decellularisation is the 
specificity of their site of action, and they are therefore most commonly 
employed to mediate highly targeted destruction and/or removal of undesirable 
tissue components [17]. Nucleases are commonly used to degrade nucleic 
acids, which often remain following cell lysis by chemical or physical methods. 
Endonucleases (such as Benzonase) are considered to be superior for this 
function as they are able to cleave nucleotide sequences from within, in 
comparison to exonucleases which systemically remove nucleotides from the 
ends [289]. 
Proteases, such as trypsin, have been considered for use as the sole agent of 
decellularisation [17]. However, the relatively high enzyme concentration and 
long incubation time required to mediate a full cell removal will also typically 
cause a significant reduction in the concentrations of ECM components such as 
collagen and elastin, and lead to a major alteration in the mechanical properties 
of the scaffold in particular [290, 291]. Treatment with a lower concentration of 
trypsin has been successfully employed as an initial decellularisation step, to 
mediate detachment of cells and better diffusion of reagents in tissues with 
relatively dense ECM [292]. The addition of tryspin treatment to decellularisation 
protocols based on treatment with other reagents such as EDTA, SDS or Triton 
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X-100 led to more complete decellularisation in harder tissues such as human 
auricular cartilage, porcine trachea and porcine articular cartilage [293].  
3.1.2.3  Physical methods 
The repetitive application of freeze-thaw cycles in solution is an effective 
mechanism of cell lysis and mediates increased tissue porosity, enabling better 
diffusion of reagents [294]. Freeze-thaw can be carried out by snap freezing 
tissue in liquid nitrogen (to minimise the formation of large ice crystals) or by 
controlled rate freezing to minus 20 °C, followed by a controlled thawing 
process [295]. Whilst freeze-thaw has been successfully applied in the 
decellularisation of tissues such as cartilage, liver and lung, ice crystal formation 
may induce adverse alterations to the microarchitecture and mechanical 
properties of the resulting scaffolds [296]. The suitability of freeze-thaw is 
therefore highly dependent upon the degree to which such alterations may 
affect the capacity of a given decellularised tissue to effectively support 
regeneration. Tissues for which the main function is mechanical in nature (e.g. 
cartilage, tendon) are thought to be able to best withstand this process [17].  
Physical methods are typically used as an element of a decellularisation 
process rather than in isolation. Similarly to the application of freeze-thaw, 
processes such as agitation and sonication are commonly employed to increase 
the rate of diffusion of chemical/enzymatic agents through the tissue and to aid 
the passage of cellular debris out of the tissue [17]. The intensity of such 
processes must be adjusted according to tissue type, as excessive agitation 
speed/sonication frequency can lead to disruption of the ECM microarchitecture 
(with potentially negative implications for cell infiltration and migration). For 
example, a study by Montoya and McFetridge (2009) found that rotary agitation 
at 100 rpm gave a two-fold greater yield of soluble hydroxyproline in 
comparison to a convective flow technique when decellularising human 
umbilical veins [297]. This indicated that a greater degradation of the key 
structural ECM component collagen was induced by the rotary agitation, and 
that better preservation of the collagenous ECM could be achieved through the 
application of the convective flow method. 
- 104 - 
3.1.3 Application of Leeds decellularisation process to porcine 
peripheral nerves 
A collaborative partnership between the University of Leeds and the University 
of Sheffield resulted in the development of a decellularisation process for use 
with porcine peripheral nerves [58]. The key reagents are EDTA, SDS, 
hypotonic buffer solution, hypertonic buffer solution and Benzonase (Table 3-1). 
This process was adapted from the patented Leeds decellularisation protocol 
[298], which has been adapted for use with a multitude of tissue types including 
dermis, heart valve, amnion, meniscus, tendon and cartilage [299-304]. 
Table 3-1 Decellularisation process for porcine peripheral nerves, prior to 
optimisation 
 
Each of the decellularisation steps is shown, in chronological order. For details 
of the solutions used, refer to section 2.10.1. 
Step Time (hours) Temperature 
(°C) Freeze 24 - 80
Thaw 
 
Haw 
1 37 
Dissection of fascia/fat 2 N/A 
Antibiotic wash solution 0.5 
 
37 
200 mM EDTA solution 24 4 
Hypotonic buffer 24 42 
0.1 % (w/v) SDS in hypotonic 
buffer 
24 42 
Hypotonic buffer 24 42 
PBS-EDTA 48-56 4 
Hypotonic buffer 24 42 
PBS 24 42 
Benzonase (x 2) 3 37 
PBS (x 3) 0.5 42 
Benzonase (x 2) 3 42 
PBS (x3) 0.5 42 
Hypertonic buffer 24 42 
PBS 48-56 4 
Storage (PBS) 6 weeks 4 
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3.2 Aims and Objectives 
 
3.2.1 Aim:  
The aim of the work detailed in this chapter was to optimise and validate a 
previously developed decellularisation process for porcine peripheral nerves, 
reducing the time required for processing whilst maintaining the efficacy in 
terms of cell removal and preserving the structure of regions key for axonal 
function (e.g. the endoneurium). 
 
3.2.2 Objectives: 
i. To determine the effect of varying the number of cycles of 0.1 % (w/v) SDS 
treatment on decellularised nerve histoarchitecture and the efficacy of 
decellularisation, through staining with H&E. 
ii. To determine the effect of different agitation speeds on decellularised nerve 
histoarchitecture and the efficacy of decellularisation, through staining with 
H&E.  
iii. To validate the successful elimination of cells and DNA from different nerve 
branches (sciatic, tibial and peroneal) following optimisation of the 
decellularisation process, through staining with H&E and DAPI respectively. 
iv. To confirm that the major structures of the peripheral nerve histoarchitecture 
were preserved following decellularisation, through staining with H&E. 
v. To confirm that the optimised decellularisation process sufficiently reduced 
the DNA content of peripheral nerves. 
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3.3 Methods and Experimental approach 
For details of the generic decellularisation protocol which was used in this 
study, see section 2.10. This work package had the objective of optimising a 
previously developed decellularisation protocol. The desired protocol would 
minimise structural damage to the histoarchitecture of the nerves (particularly 
the endoneurium), whilst ensuring that the nerves met widely accepted criteria 
defining successfully decellularised tissue.  
In order to minimise damage induced as a result of the protocol and reduce the 
duration of the decellularisation process from 14 days to 10 days, two hypotonic 
buffer steps were removed from the protocol (together with the corresponding 
PBS wash steps). The decellularisation protocol was then further optimised to 
ensure effective cell and nucleic acid removal while enabling structural 
retention. 
3.3.1 Optimisation of decellularisation process 
Three principal factors potentially affecting the efficacy of decellularisation were 
identified. Two of these represented possible causes of structural disruption to 
the peripheral nerve ECM, these being the use of the detergent SDS and the 
speed of the orbital shakers used to agitate the nerves in solution. 
In addition, the anatomical differences between the differing nerve branches 
used meant it was necessary to determine the efficacy of the decellularisation 
process in each.  
This process is outlined in Figure 3-1. 
3.3.1.1 Number of SDS incubation cycles 
The generic Leeds decellularisation protocol stipulates the incubation of tissues 
in a hypotonic buffer solution containing SDS at a concentration of 0.1 % (w/v); 
however, the optimal length and number of such incubations varies widely 
between tissues. Therefore, two separate groups of nerves were subject to 
decellularisation processes inclusive of either one or two cycles of incubation in 
hypotonic buffer containing SDS. The results were analysed histologically by 
staining with H & E and DAPI. 
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3.3.1.2 Agitation speed 
The optimal agitation speed varies between tissue types, as harder/more dense 
tissues may require greater agitation speed to ensure complete permeation of 
reagents, whilst such speeds may result in adverse changes to the structure of 
softer tissues. As peripheral nerve is a relatively delicate tissue it was thought 
that a lower speed may be appropriate. To confirm this, two groups were 
subject to identical decellularisation processes, but during each step were 
agitated either at 240 rpm or 120 rpm. The results were analysed histologically 
by staining with H & E and DAPI. 
3.3.1.3 Differing branches of the porcine nerve plexus 
Due to the previously observed morphological differences between nerve 
branches in the porcine leg, the efficacy of the decellularisation process may 
vary depending on the origin of a particular nerve segment. Therefore, 
segments of the sciatic, tibial and peroneal nerves were subject to the optimised 
decellularisation process, and the results analysed histologically by staining with 
H & E and DAPI. 
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3.3.1.4 Histological analysis of tissue treated with optimised 
decellularisation process 
Nerves treated with the final optimised decellularisation process were subjected 
to histological analysis. H & E staining was used to analyse the degree of cell 
Final optimised 
decellularisation protocol 
Tibial nerve 
H & E and DAPI 
Sciatic nerve 
Decellularisation Protocol: 
Agitation 120 rpm 
 
H & E and DAPI 
Decellularisation protocol:       
2 SDS cycles 
Decellularisation protocol:      
1 SDS cycle 
Peroneal nerve 
H & E and DAPI 
DNA quantification 
Decellularisation Protocol: 
Agitation 240 rpm 
 
Figure 3-1  Schematic of the experimental approach taken during 
optimisation of the decellularisation protocol  
This was carried out in three separate stages, independently varying the 
incubation time in 0.1 % (w/v) SDS, the speed of agitation and the specific 
nerve branch used respectively. Histological examination was used as the 
primary means of evaluating the effects of each change on the efficacy of cell 
removal and the preservation of ECM morphology.  
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removal and the preservation of matrix structures. DAPI staining was used to 
determine whether DNA (and/or nuclei) was removed. 
3.3.1.5 DNA isolation and quantification 
Quantification of wet and dry weight DNA content was used as a method of 
validating the efficacy of the optimised decellularisation process. Samples of 
native (25 - 50 mg; n = 6) and decellularised (100 - 250 mg; n = 6) peripheral 
nerve tissue were diced using a scalpel and placed into sterile Eppendorf tubes 
in preparation for DNA isolation using the DNeasy kit (Qiagen). Samples of 
native and decellularised nerves for dry weight quantification (n = 6) were 
lyophilised to a constant weight. Buffer ATL (360 μL) and proteinase K (40 μL) 
were added to each sample, mixed and incubated for three hours at 56 °C. 
Each sample was vortexed every 30 minutes. Samples were subject to 15 
seconds of vortexing before 400 μL Buffer AL and 400 μL ethanol (100 %; v/v) 
were added to each, mixing by vortex after each addition. An aliquot of each 
sample (600 μL) was added to a DNeasy spin column and centrifuged at 6000 x 
g for one minute. The flow-through was discarded. This step was repeated until 
all of the original solution had been filtered by the spin column. The spin 
columns were transferred to fresh collection tubes, and 500 μL Buffer AW1 was 
added. The spin columns were centrifuged at 6000 x g for one minute and the 
collection tube was discarded. The spin columns were transferred to fresh 
collection tubes and 500 μL Buffer AW2 was added, before centrifugation at 
16,000 x g for five minutes. The spin columns were placed in sterile 1.5 ml 
microfuge tubes, and 200 μL Buffer AE was added to the membrane at the base 
of the columns. The columns were incubated at room temperature for one 
minute and then centrifuged at 6000 x g for one minute. The eluted DNA 
contained was stored at - 20 °C until quantification. Total DNA in each isolated 
sample (2 μL aliquots) was quantified by measuring absorbance at 260 nm in 
triplicate with a Nanodrop 1000 spectrophotometer; Buffer AE was used as a 
blank. The DNA content of samples was calculated by interpolating the sample 
values against a standard curve of absorbance vs calf thymus DNA, and 
normalising the resulting values according to the sample mass.  
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3.4 Results 
3.4.1 Variation of SDS cycles 
Early attempts to decellularise porcine peripheral nerves resulted in alterations 
to the histoarchitecture. It may be hypothesised that SDS is at least partially 
responsible for this effect. Accordingly the number of cycles of SDS treatment 
used was varied between one and two cycles. 
H & E staining showed that treatment of nerves with a decellularisation protocol 
incorporating two cycles of 0.1 % (w/v) SDS led to severe disruption to the 
major ECM structures of the nerve, including the epineurium, perineurium and 
especially to the endoneurium (Figure 3-2). Nerves treated with one cycle of 
SDS appeared to better retain these structures. 
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Figure 3-2     Representative images of sections stained with haematoxylin 
and eosin/DAPI 
Sections of native (A and B) and sections of decellularised nerve following 
treatment with protocols incorporating (C and D) one SDS cycle and (E and F) 
two SDS cycles (both with agitation at 240 rpm), stained with (A, C and E) 
haematoxylin and eosin and (B, D and F) DAPI.  ECM regions marked as EN 
(endoneurium), PE (perineurium) and EPI (epineurium). Images were acquired 
under Köhler illumination using a x10 objective. Scale bars = 100 µm. 
EPI 
  
A 
EN 
PE 
EPI 
EN 
B 
F E 
D C 
PE 
  
EN 
PE 
EPI 
100 µm 
100 µm 
100 µm 
100 µm 
100 µm 
100 µm 
- 112 - 
3.4.2 Variation of agitation speed  
It was proposed that the mechanical forces experienced by the nerves during 
agitation could be causing alterations to ECM histoarchitecture, particularly in 
the endoneurium. Therefore, two further groups of nerves were treated with a 
decellularisation protocol incorporating one cycle of SDS; in one group, the 
agitation speed was reduced from 240 rpm (as used previously) to 120 rpm. 
Both protocols appeared to successfully mediate the removal of cells from the 
tissue, whilst reducing the agitation to 120 rpm appeared to enable better 
retention of ECM histoarchitecture (Figure 3-3). 
 
 
 
 
 
 
 
 
 
 
 F 
- 113 - 
 
 
 
 
 
 
 
 
 
 
A 
C D 
B 
Figure 3-3     Representative images of sections stained with haematoxylin 
and eosin/DAPI 
Sections of native nerve (A and B) and sections of decellularised nerve 
following treatment with decellularisation protocols incorporating one SDS cycle 
with agitation at 240 rpm  (C and D) and 120 rpm (E and F). Sections stained 
with haematoxylin and eosin (A, C and E) and DAPI (B, D and F). Images were 
acquired under Köhler illumination using a x10 objective. Scale bars = 100 µm. 
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3.4.3 Comparison of decellularisation efficacy in sciatic, peroneal 
and tibial 
The degree to which cell nuclei were successfully removed from tissue was 
observed to vary between individual samples following decellularisation. It was 
thought that this may be due to the thicker sciatic nerve requiring a more 
vigorous decellularisation process than the branches which are derived from it, 
the common peroneal and tibial nerves.  
Segments of each nerve were therefore subject to decellularisation by the 
previously established protocol (one SDS cycle, agitation at 120 rpm), and 
sections taken and analysed histologically.  
DAPI staining showed the presence of DNA in the endoneurium of sections of 
sciatic nerve, whereas no obvious staining was visible in sections of the 
peroneal and tibial nerves (Figure 3-4). Similarly, there were visible cell nuclei in 
sections of sciatic nerve stained with H & E, but none in either the sciatic nerve 
or tibial nerve. As a consequence of this, and the ECM structural damage likely 
to be induced by a more vigorous decellularisation protocol, the sciatic nerve 
was no longer included in the study. 
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Figure 3-4   Representative images of sections stained with haematoxylin 
and eosin/DAPI 
Sections of native peroneal nerve (A and B), and sections of sciatic (C and D), 
tibial (E and F) and peroneal (G and H) nerve following treatment with a 
decellularisation protocol incorporating one SDS cycle and agitation at 120 rpm. 
Sections stained with haematoxylin and eosin (A, C, E and G) and DAPI (B, D, 
F and H). Images were acquired under Brightfield illumination using a x10 
objective. Scale bars = 100 µm. 
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3.4.4 Final optimised decellularisation protocol  
The optimisation process detailed above yielded a shortened decellularisation 
protocol for use with peroneal and tibial porcine peripheral nerves (Table 3-2). 
Table 3-2 Final optimised decellularisation protocol for porcine peripheral 
nerves 
 
Each of the decellularisation steps is shown, in chronological order. For details 
of the solutions used, refer to section 2.10.1. 
 
 
 
Step Time (hours) Temperature (°C) 
Freeze 24 - 80 
Thaw 
 
Haw 
1 37 
Dissection of fascia/fat 2 N/A 
Antibiotic wash solution 0.5 
 
37 
200 mM EDTA solution 24 4 
Hypotonic buffer 24 42 
0.1 % (w/v) SDS in hypotonic buffer 24 42 
PBS (x 3) 0.5 42 
PBS 24 42 
PBS-EDTA 48-56  4 
PBS (x 3) 0.5  42 
Benzonase (x 2) 3 37 
PBS  24 42 
Hypertonic buffer 24 42 
PBS (x 3) 0.5  42 
PBS 24 42 
Storage (PBS) 6 weeks 4 
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3.4.5 Histological evaluation of decellularisation efficacy and ECM 
histoarchitecture retention by comparison with native porcine 
peripheral nerves  
H & E staining of native porcine peripheral nerve sections revealed the structure 
of the peripheral nerve ECM (Figure 3-5). An external layer of thick dense 
epineurium was evident, whilst deeper into the tissue the structure of the 
epineurium was less organised and appeared to contain globular fatty regions 
(Arrow, Figure 3-5 C). The dense ring-like structures of the perineurium 
surrounding each individual fascicle were evident. Both H & E and DAPI stained 
sections showed a dense cellular population within the perineurium, particularly 
in comparison to the epineurial tissue exterior to it. Each fascicle contained a 
honeycomb-like structure of endoneurial tubes. Haematoxylin staining revealed 
the presence of cells (morphologically Schwann cells) within the individual 
endoneurial tubes. 
The major ECM structures of the decellularised peripheral nerves 
(decellularisation protocol incorporating one SDS cycle, with agitation at 120 
rpm) appeared similar to that of native nerves following the application of the 
decellularisation protocol, with some slight disruption to the endoneurium of the 
decellularised tissue being the only obvious difference. H & E and DAPI staining 
of native tissue showed a relatively dense cell population within the 
endoneurium, consistent with the function of the endoneurium in providing an 
environment for neurons and Schwann cells to attach. Other regions which 
appeared to have a notable cellular population included the perineurium and the 
blood vessels travelling within the epineurium (the vasa nervorum). In contrast, 
the looser collagenous tissue of the epineurium appeared to contain a relatively 
sparsely distributed cellular population. Sections taken from samples of 
decellularised tissue showed no visible cell nuclei/nucleic acids. 
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Figure 3-5    Representative images of sections stained with haematoxylin 
and eosin/DAPI 
Sections of native (A and C) and decellularised (B and D) porcine peripheral nerves 
stained using DAPI (A and B) and haematoxylin and eosin (C and D). Arrow indicates 
suspected fatty globular tissue within the epineurium. Images were acquired under 
Köhler illumination using a x10 objective. Scale bars = 100 µm.  
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3.4.6 DNA content of native and decellularised porcine peripheral 
nerves 
Isolation of total DNA from both wet and lyophilised tissue samples was used to 
determine the completeness and reproducibility of the decellularisation process. 
The wet-weight DNA content of native porcine peripheral nerves was found to 
be 63.01 (+/- 17.25) ng.mg-1, whereas the DNA content of decellularised nerves 
was 13.64 (+/- 6.54) ng.mg-1, representing a reduction of 79 %; Figure 3-6). The 
DNA content of lyophilised native nerves was 169.42 (+/- 29.26) ng.mg-1, 
whereas freeze-dried decellularised nerves had a DNA content of 14.93 (+/- 
6.34) ng.mg-1, representing a reduction of 91 % (w/w; Figure 3-6). 
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Figure 3-6    DNA content of native and decellularised porcine peripheral 
nerves 
(A) Standard curve of DNA concentration against absorbance at 260 nm and (B) 
DNA content of wet-weight and lyophilised native and decellularised nerves. Data  
shown as mean (n=6) +/- 95 % confidence interval. Statistical analysis was by 
Student’s T-test, * denotes groups which are significantly different. 
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3.5 Discussion 
Low concentration SDS, in combination with hypotonic and hypertonic buffers 
and nuclease enzymes, was utilised to decellularise porcine peripheral nerves. 
The number of cycles in SDS and the speed of agitation were varied during an 
optimisation process. The decellularisation protocol developed includes a PAA 
incubation as a disinfection / sterilisation step, however due to previously 
observed adverse effects this was not applied here [175, 240]. The ability to 
remove cells was evaluated histologically in different peripheral nerve branches. 
Cell removal in the finalised protocol was confirmed using histological staining 
and DNA quantification. 
Histological analysis indicated that in comparison to native tissue the nerve 
ECM structure was broadly retained following decellularisation. However, 
alterations to the histoarchitecture were observed in the endoneurium. In 
particular, the structure of individual tubules appeared to be less defined. The 
implications of this structural change for the ability of the graft to support 
neuroregeneration remain unclear. Alteration of the structure of the ECM (e.g. 
disorganisation, increased density (loss of porosity), loss of components) has 
been shown to negatively impact upon the ability of cells to infiltrate tissue and 
compromise biomechanical properties in a diverse range of decellularised 
tissues, including tendon, heart, liver and lung [305-308]. The primary function 
of the endoneurium is the provision of an optimal microenvironment for the 
Schwann cells and axons residing within it. Infiltration of regenerating axons 
and proliferating Schwann cells is key to the successful repair of peripheral 
nerves; one of the key advantages of the use of autografts or decellularised 
allografts over NGCs is the provision of a microscale architecture which can 
stimulate and guide this process [116]. Therefore, any alterations affecting the 
structure of the scaffold or key cell attachment motifs would potentially 
negatively impact on the efficacy of the graft [111]. Treating biological ECM-
based scaffolds with ionic detergents such as SDS at higher concentrations is 
known to affect histoarchitecture and biomechanical properties. This occurs 
primarily through the disruption of non-covalent linkages and the denaturation of 
ECM proteins such as collagens, altering their tertiary conformational structure 
[309]. A study of porcine aortic heart valves found a significant reduction in 
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thermal stability and extensive disruption to collagen structures following 
treatment with 1 % (w/v) SDS, indicating that the use of SDS at this 
concentration is damaging to the scaffold. The collagenous ECM is critical to 
facilitating the function of the axons travelling within the nerve, maintaining an 
optimal microenvironment and protecting them from mechanical stress. Other 
commonly used detergents in decellularisation processes include the non-ionic 
Triton X-100, the key functional reagent in the production of the Avance® nerve 
graft. Histology shows changes to the structure of the endoneurial tubes in the 
Avance® graft similar to those seen here [310]. SDS has been chosen over 
Triton X-100 in this study due to superior efficacy in the removal of nuclei from 
tissue (following cell lysis). In addition, SDS has previously been shown to 
induce significantly less alteration to the mechanical properties of soft tissues 
than Triton X-100 [311].  
Whilst the gross morphology of the decellularised nerve ECM appeared to be 
preserved following agitation at the higher speed of 240 rpm, the fine structure 
of the endoneurium appeared to be damaged. Because high agitation forces 
may have a damaging effect on soft tissue scaffolds, agitation is typically used 
to enhance the perfusion of solutions through tissues rather than as a primary 
mechanism of decellularisation [312].   
The microanatomy of the porcine nerve plexus varies significantly between the 
separate major branches, in both porcine and human tissue [58, 313]. The 
peroneal and tibial nerves represent distal branches of the sciatic nerve, and as 
such are of a lesser diameter.  A 2012 study by Gustafson et al found that the 
average diameter of the human tibial and peroneal nerves was 23 % and 49 % 
less than that of the sciatic nerve, respectively [313]. Additionally, the ECM 
making up the outer epineurium of the sciatic nerve is extensive, and surrounds 
the “true” epineurium of the individual bunches of fascicles which give rise to the 
peroneal and tibial nerves. This additional connective tissue can alternatively be 
defined as a distinct region of the ECM, the “paraneurium” [314].  Due to the 
highly collagenous, sheath-like nature of this structure, it may inhibit the 
diffusion of reagents into the tissue. This has been identified as a possible 
cause of failure in the application of local nerve block, necessitating the use of 
ultrasound guidance to ensure full block of the descending fascicles; with regard 
to decellularisation, this could prevent effective cell lysis being achieved in the 
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deeper regions of the tissue. In addition, there is a greater proportion of 
fascicular tissue relative to outer epineurium / “paraneurium” in the peroneal 
and tibial nerves than in the sciatic nerve. An decellularised graft produced from 
these nerves would therefore contain a greater proportion of tissue capable of 
supporting and guiding infiltrating axons and neurons.  
During this study, decellularised nerve segments were produced from porcine 
peripheral nerves. The only decellularised nerve graft currently commercially 
available (limited to USA) is the Avance® nerve graft, produced from cadaveric 
human peripheral nerves [138]. The case for the use of porcine peripheral 
nerves as an alternative source of graft material is supported by a number of 
considerations. Xenogeneic tissue (derived from the food supply chain) can be 
more easily sourced in greater quantities than cadaveric human tissue, 
increasing the possible production rate (and potentially the overall availability) of 
decellularised grafts [315]. The tissue is taken from relatively young animals 
(approximately 6 months for porcine tissue), eliminating the risk of inferior 
quality tissue being used for the production of grafts (due to the typically older, 
in relative terms, human donor population) [316]. Furthermore, the tissue is 
sourced from an inbred strain (Large White Pig), ensuring maximal consistency 
in terms of the tissue used as the starting material prior to decellularisation. The 
use of xenogeneic tissue could also reduce the cost of graft production by 
eliminating the ethical regulatory framework and increased complexity of 
processing and storing tissue which is required when using human tissue.      
In order to be approved for clinical use, decellularised tissue scaffolds must 
pose no increased risk of harm to the patient in comparison to current therapies, 
whilst providing a measurable clinical benefit. Minimising the potential for the 
induction of an adverse host immune response is particularly important for 
scaffolds derived from xenogeneic tissue, and the post-processing DNA content 
of a scaffold is one quantitative measure which is commonly used in this context 
[317]. Fragments of double-stranded DNA sourced from lysed cells in 
processed tissue grafts, malignant cells or intracellular pathogens are 
recognised following phagocytosis by intracellular sensor proteins including toll-
like receptor 9 (TLR-9), absent in melanoma 2 (AIM2) and gamma-interferon-
inducible-protein 16 (IFI16) [318]. These sensor proteins reside within in the 
cytosol and/or endosome membranes of innate immune system monocytes 
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such as macrophages and dendritic cells. Binding of dsDNA by sensor proteins 
leads to downstream stimulation of signalling pathways via mediators including 
myeloid differentiation adaptor protein 8 (MyD8), the apoptosis-associated 
Speck-like Protein Containing a Card-caspase 1 complex (ASC-Casp1) and 
stimulator of interferon genes (STING) [319]. A pro-inflammatory response is 
initiated in response to activation of these pathways, characterised by the 
induction of type 1 phenotype in activated macrophages and increased 
secretion of immunomodulatory cytokines such as IFN-, IL-1 and IL-6.   
Previously, a threshold value of less than 50 ng double stranded DNA per mg 
(dry weight) of tissue was commonly referenced as the accepted upper limit for 
a decellularised tissue [17]. Other studies have used different metrics for the 
determination of sufficient DNA removal; for example, a reduction of greater 
than 90 % (w/w) of the original native DNA content was specified in a study 
attempting to decellularised small diameter sections of vasculature [320]. Many 
decellularised tissue products which are currently successfully used in clinical 
settings (e.g. OasisTM and RestoreTM, both derived from porcine small intestine 
submucosa) have been found to contain trace amounts of DNA [260]. Based on 
these findings, the degree to which these small quantities  of DNA may induce 
an adverse response is likely to be negligible. The two cycles of treatment with 
Benzonase employed during the decellularisation process here appeared to 
ensure both of the thresholds defined above were achieved, and therefore 
decellularisation of the porcine nerves can be considered to have been 
sufficient.  
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4 Characterisation of the structure, cytocompatiblity, 
mechanical and biochemical properties of decellularised 
porcine peripheral nerves  
4.1 Introduction 
Physical and chemical methods of decellularising tissues are known to disrupt 
the structure and composition of the ECM. Changes are possible from the level 
of whole tissue histoarchitecture down to the ultrastructural alterations and the 
degradation/removal of ECM components.  
The key functional reagent in the optimised decellularisation protocol for porcine 
peripheral nerves, SDS, is an ionic detergent which can disrupt the 
conformation of and/or denature ECM proteins. The protocol also includes 
physical processing methods including a freeze-thaw cycle and agitation, both 
of which may induce structural disruption to the ECM. 
Basement membrane components in the endoneurium and perineurium, 
including collagen IV, laminin and fibronectin, are thought to be key to enabling 
the attachment of perineurial cells, Schwann cells and neurons [42, 321]. 
Therefore retention of such components in a decellularised nerve graft is likely 
to aid cell infiltration and, ultimately, the reinnervation of downstream target 
sites. Preserving the higher order structure of collagen I molecules, which make 
up approximately 90 % (w/w) of peripheral nerve ECM, is crucial to maintaining 
the major ECM structures (the epineurium, perineurium and endoneurium) 
which provide physical guidance and support to infiltrating cells and determine 
the mechanical properties of the tissue [38, 73, 82].  
Efficacy of the porcine peripheral nerve decellularisation protocol has been 
established in terms of cell and nucleic acid removal. Characterisation of the 
collagenous histoarchitecture, distribution of basement membrane components, 
mechanical properties and biochemical composition of the nerves before and 
after decellularisation would enable the retention of properties considered key to 
graft function to be assessed. 
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4.2 Aims and Objectives 
4.2.1 Aim 
The aim of this chapter was to characterise the properties of native and 
decellularised porcine peripheral nerves, to provide a baseline dataset for the 
determination of the effects of sterilisation treatments on decellularised porcine 
peripheral nerves. 
4.2.2 Objectives 
i. To determine the effect of decellularisation on the distribution and 
structure of collagens, elastin and specific basement membrane proteins 
within peripheral nerve ECM, through staining with Sirius Red and Miller’s 
Elastin and antibody labelling. 
ii. To determine the biocompatibility of the decellularised nerves, through 
contact culture using two distinct cell types. 
iii. To determine the effects of decellularisation on the mechanical properties 
of peripheral nerves, through slow strain rate to failure uniaxial tensile 
testing. 
iv. To determine the effects of decellularisation on the biochemical 
composition of peripheral nerves, through quantification of collagen, 
denatured collagen, GAGs and fat. 
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4.3 Materials and Methods 
4.3.1 Histological analysis 
Processing and sectioning of tissue was carried out as described in section 
2.11. Staining of sections with Sirius Red & Miller’s Stain was carried out as 
described in 2.11.7. 
4.3.2 Antibody labelling for collagen IV, laminin and fibronectin  
Processing and sectioning of tissue was carried out as described in section 
2.11. Labelling of sections with specific antibodies for collagen IV, laminin and 
fibronectin was carried out as described in section 2.11.8. 
4.3.3 Contact cytotoxicity assay of sterilised nerves 
Decellularised nerves were subject to contact cytotoxicity testing, as described 
in section 2.12.  
4.3.4 Uniaxial tensile testing 
Samples of decellularised nerve were subject to uniaxial tensile testing, as 
described in section 2.13. 
4.3.5 Quantification of collagen content 
The amount of collagen in the decellularised nerves was quantified as 
described in section 2.14.  
4.3.6 Quantification of denatured collagen content 
The amount of denatured collagen in the decellularised nerves was quantified 
as described in section 2.14.5.  
4.3.7 Quantification of fat content 
The amount of fat in the decellularised nerves was quantified as described in 
section 2.14.7.  
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4.4  Results 
4.4.1 Sirius Red and Millers Elastin 
Sirius Red/Miller’s staining was used to define the distribution of collagen and 
elastin with the ECM of native and decellularised nerves (Figure 4-1).  Sirius red 
staining of porcine peripheral nerve sections showed collagen was present in all 
three major structures of the ECM. Collagen was highly ordered in the 
perineurium enveloping each fascicle, and the layered lamellar structure 
previously described was evident. Sirius red-stained sections showed a greater 
intensity of staining in these regions when viewed under polarised light, whilst 
much less intense staining was evident in the endoneurial tubes. Outside of the 
blood vessels, bundles of elastin fibres were not evident within any of the major 
structures of the ECM. 
The major collagen structures of the ECM were evident in sections stained with 
Sirius red following decellularisation, however collagen structures appeared to be 
slightly more disorganised and less tightly packed than in native tissue. When 
viewed under polarised light collagen present in the perineurium appeared to 
have a highly organised structure, whereas in the epineurium the collagen 
appears to be less organised, but consist of larger fibrils. The staining of the 
perineurium and epineurium also appears to be less intense following 
decellularisation, possibly indicating damage to or loss of collagen within the 
ECM. Miller’s Elastin stained sections showed the majority of elastin to be present 
in the lumen of vessels of the vasa nevorum (indicated with arrows in Figure 4-1 
A, C and E); the distribution and intensity of staining for elastin did not appear to 
be altered following decellularisation.  
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Figure 4-1  Representative images of sections of decellularised nerve 
stained with Sirius red / Miller’s elastin stain 
Images of native (A - D) and decellularised (E - H) porcine peripheral nerve under 
(A, C, E, G) Köhler or (B, D, F, H) circularly polarised illumination. The greatest 
concentration of elastin is in the lumen of blood vessels of the vasa nevorum 
(indicated by arrows). Images were acquired using a x10 objective, scale bars =  
100 µm. 
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4.4.2 Immunohistochemical labelling of collagen IV 
Sections of native and decellularised peripheral nerve were labelled with 
monoclonal antibodies against collagen IV. Collagen IV was present in the 
fascicular structures, the perineurium and the endoneurium (Figure 4-2 C). 
Staining was particularly intense in the perineurium (black arrows, Figure 4-2 C 
and D). Labelling intensity was reduced following decellularisation. In the 
epineurium, labelling was mainly limited to the vasa nervorum. Intense labelling 
was seen in the smooth muscle and luminal regions of the positive control, 
porcine femoral artery. No positive labelling was observed in the negative 
control.  
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Figure 4-2 Representative images of sections labelled with monoclonal 
antibodies against collagen IV 
Images of (A) porcine femoral artery positive control, (B) native porcine peripheral 
nerve isotype control, (C) native porcine peripheral nerve and (D) decellularised 
porcine peripheral nerve, immunohistochemically labelled for the presence of 
collagen IV. Arrows indicate intense collagen IV staining in the perineurium. 
Images were acquired under Köhler illumination using a x10 objective. Scale bars 
=  100 µm. 
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4.4.3 Immunohistochemical labelling of laminin 
Sections of native and decellularised peripheral nerve were labelled with 
specific antibodies to demonstrate the presence of laminin. Labelling revealed 
the presence of laminin in the perineurium and endoneurium of native and 
decellularised porcine peripheral nerves (Figure 4-3). The signal appeared to be 
slightly reduced, but increased in area in the decellularised nerves. The signal 
remained localised within the perineurium and endoneurium. Specific labelling 
was observed in the lumenal and smooth muscle regions of the positive control, 
porcine femoral artery, whilst no labelling was seen in the negative control. 
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Figure 4-3 Representative images of sections labelled with a monoclonal 
antibody against laminin and counterstained with haematoxylin 
Images of (A) porcine femoral artery positive control, (B) native porcine 
peripheral nerve isotype control, (C) native porcine peripheral nerve and (D) 
decellularised porcine peripheral nerve. Laminin was predominantly found in the 
endoneurium and perineurium, indicated by black arrows. Images were acquired 
under Köhler illumination using a x10 objective. Scale bars =  100 µm. 
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4.4.4 Immunofluorescent labelling of fibronectin 
Sections of native and decellularised peripheral nerve were labelled with specific 
primary and fluorescently-tagged secondary antibodies, to demonstrate the 
presence of laminin. Fibronectin was found to be most prevalent in the 
perineurium, whilst less intense labelling was evident in the endoneurium (Figure 
4-4). Intense labelling for fibronectin was seen throughout the porcine femoral 
artery positive control. DAPI staining for nuclei but not antibody labelling was 
observed in the negative control. 
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Figure 4-4 Representative images of sections labelled with a monoclonal 
antibody against fibronectin and counterstained with DAPI  
Images show (A) porcine femoral artery positive control, (B) native porcine 
peripheral nerve negative control, (C) native porcine peripheral nerve and (D) 
decellularised porcine peripheral nerve. Fibronectin labelling was intense in the 
lamellar structured perineurium, indicated by white arrows. Images were acquired 
using a x10 objective. Scale bars =  100 µm. 
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4.4.5 Contact cytotoxicity of decellularised nerves  
The in vitro biocompatibility of decellularised porcine peripheral nerves was 
assessed by contact culture studies using two distinct cell lines, BHK and L929. 
Cyanoacrylate contact adhesive was used as a positive control and a 
commercially available surgical closure strip (Steri-Strip) as a negative control. 
Cells incubated with the positive control were sparsely distributed and displayed 
a rounded morphology indicative of cell death (Figure 4-5 A & B). 
Cells incubated with the negative control and test samples (segments of 
decellularised porcine peripheral nerve) appeared to grow up to and in contact 
with the samples. The cells appeared to display normal morphological 
characteristics. L929 cells displayed an elongated morphology and less dense 
population, whilst BHK cells displayed a rounded morphology and denser 
population. 
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Figure 4-5  Representative images of Giemsa-stained BHK and L929 cells 
cultured for 48 hours with decellularised porcine peripheral nerves   
Images show (A) BHK cells cultured with cyanoacrylate positive control, (B) L929 
cells cultured with cyanoacrylate positive control, (C) BHK cells cultured with 
Steri-Strip negative control, (D) L929 cells cultured with Steri-strip negative 
control, (E) BHK cells cultured with a segment of decellularised porcine peripheral 
nerve and (F) L929 cells cultured with a segment of decellularised porcine 
peripheral nerve. Images were acquired under Brightfield illumination using a x10 
objective. Scale bars = 100 µm. 
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4.4.6 Uniaxial Tensile Testing  
Samples of native and decellularised porcine peripheral nerves were subject to 
uniaxial tensile testing. The UTS of decellularised nerves was found to be 10.37 
(+/- 1.16) MPa, whereas that of native tissue was found to be 11.82 (+/- 2.29) 
MPa (Figure 4-6A). The Young’s Modulus of native porcine peripheral nerve 
was found to be 27.33 (+/- 4.56) MPa, whereas the Young’s Modulus of 
decellularised peripheral nerves was 25.73 (+/- 7.30) MPa (Figure 4-6 B). 
Statistical analysis by a student’s T-test revealed no significant differences 
between the mechanical properties of native and decellularised nerves. 
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Figure 4-6   Ultimate Tensile Strength and Young’s Modulus of native and 
decellularised porcine peripheral nerve  
(A) Ultimate Tensile Strength and (B) Young’s Modulus of native and 
decellularised porcine peripheral nerves. Data shown as mean (n = 6) +/- 95 % 
confidence interval, n = 6. Statistical analysis was by student’s T-test. * denotes 
groups which are significantly different. 
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The maximum load at failure sustained by native nerves was 53.13 N (+/- 
15.15), whereas for decellularised nerves it was 59.69 N (+/- 29.84) (Figure 
4-7A). The stiffness of native nerves was 15.39 N.mm-1 (+/- 3.42), whereas for 
decellularised nerves it was 14.92 (+/- 6.02) N.mm-1 (Figure 4-7B). No 
significant differences were found between the values.  
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Figure 4-7   Maximum load at failure and stiffness of native and 
decellularised porcine peripheral nerves  
(A) Maximum load at failure and (B) Stiffness of native and decellularised porcine 
peripheral nerves. Data shown as mean (n = 6) +/- 95 % confidence interval, n = 
6. Statistical analysis was by student’s T-test. * denotes groups which are 
significantly different. 
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Figure 4-8 Energy to break values for native and decellularised porcine 
peripheral nerves  
Energy to break values for native and decellularised porcine peripheral nerves. 
Data shown as mean (n = 6) +/- 95 % confidence interval, n = 6. Statistical 
analysis was by student’s T-test. * denotes groups which are significantly 
different. 
Energy to break values were 8.08 MJ/m3 for native peripheral nerves and 7.31 
MJ/m3 for decellularised peripheral nerves. No significant differences were 
identified between the values. 
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R2 = 0.9985 
4.4.7 Quantification of peripheral nerve collagen content 
The hydroxyproline content of native porcine peripheral nerve was 28.98 (+/- 
5.03) µg.mg-1, significantly less than decellularised porcine peripheral nerve 
which had a hydroxyproline content of 39.29 (+/- 5.80) µg.mg-1 (p < 0.05) 
(Figure 4-9). These values were then used to estimate collagen content by 
using the previously determined conversion factor (7.52) [252]. The collagen 
content of native porcine peripheral nerve was therefore estimated to be 217.92 
(+/- 37.79) µg.mg-1, numerically lower than decellularised porcine peripheral 
nerve which had a collagen content of 295.50 (+/- 43.64) µg.mg-1 (p < 0.05) . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-9    Collagen content of native and decellularised porcine 
peripheral nerves 
(A) standard curve of hydroxyproline content against absorbance at 570 nm and 
(B) estimated collagen content of native and decellularised porcine peripheral 
nerves. Data shown as mean (n = 6) +/- 95 % confidence interval. Statistical 
analysis was by student’s T-test. * denotes significant difference compared to 
native samples. 
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4.4.8 Quantification of denatured collagen content 
The denatured collagen content of native and decellularised nerves was 
determined by digestion of samples with α-chymotrypsin enzyme. Acid 
hydrolysis was then carried out on the digested samples, and the 
hydroxyproline content was determined. The hydroxyproline content of the 
digested collagen fraction was 0.71 (+/- 0.04) µg.mg-1 and 0.97 (+/- 0.004) 
µg.mg-1 for native and decellularised nerves respectively. These values were 
used to calculate the denatured collagen content using a previously described 
conversion factor (7.52) [252]. No significant difference was found between the 
denatured collagen content of native and decellularised nerves, which were 
determined to be 5.32 (+/- 2.26) and 7.32 (+/- 2.62) µg.mg-1 respectively (Figure 
4-10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-10 Denatured collagen content of native and decellularised 
porcine peripheral nerves 
Estimated denatured collagen content of native and decellularised porcine 
peripheral nerves. Data shown as mean (n = 6) +/- 95 % confidence interval. 
Statistical analysis was by student’s T-test. * denotes groups which are 
significantly different. 
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Figure 4-11 GAG content of native and decellularised porcine peripheral 
nerves 
(A) Standard curve of absorbance at 525 nm against GAG content and (B) GAG 
content of native and decellularised porcine peripheral nerves. Data shown as 
mean (n = 6) +/- 95 % confidence interval. Statistical analysis was by student’s 
T-test. * denotes groups which are significantly different. 
 
R2 = 0.9866 
4.4.9 Quantification of GAG content 
Native and decellularised nerves were digested with papain enzyme. The GAG 
content of the digest was then quantified using a colourimetric assay utilising 1,9-
dimethylmethylene blue as an indicator. Native and decellularised peripheral 
nerves were found to have a GAG content of 11.03 (+/- 10.81) and 13.19 (+/- 
12.54) µg.mg-1 respectively (Figure 4-11). Statistical analysis by students T-test 
indicated there was no significant difference between the groups. 
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R2 = 0.9969 
4.4.10 Quantification of fat content  
The fat content of native and decellularised nerves was determined by subjecting 
tissue samples to an extraction process in a known volume of ethanol. The fat 
concentration of the extracts was then quantified and used to calculate the fat 
content of the nerves. Native and decellularised nerves were found to have a fat 
content of 471 (+/- 131) and 511 (+/- 116) µg.mg-1 respectively (Figure 4-11). 
Statistical analysis by students T-test indicated there was no significant difference 
between the groups. 
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Figure 4-12 Fat content of native and decellularised porcine peripheral 
nerves 
Chart shows fat content of native and decellularised porcine peripheral nerves. 
Data shown as mean (n = 6) +/- 95 % confidence interval. Statistical analysis was 
by Mann-U Whitney test. * denotes groups which are significantly different. 
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4.5 Discussion 
The histoarchitecture, biochemical composition and material properties of the 
porcine peripheral nerves were generally well preserved following 
decellularisation. The decellularised nerves appeared to be biocompatible, with 
no apparent cytotoxicity evident during contact culture with two distinct cell 
types.  
The structure of the epineurium appeared to be slightly “looser” following 
decellularisation. Degradation of the histoarchitecture during decellularisation 
may be caused by mechanical, chemical or enzymatic treatments, either in 
isolation or combination [17]. Depending on the compatibility of a tissue with 
different treatments and the role of tissue structure in facilitating function and/or 
recellularisation, a degree of structural disruption may be acceptable to ensure 
full decellularisation. Azhim et al (2013) observed an increase in the porosity 
and collagen fibre “looseness” of porcine aorta ECM following decellularisation 
with SDS at a concentration of 2 % (v/v) compared to 0.1 % (v/v) [322]. The use 
of sonication at 1750 Hz, in place of reciprocal shaking at 30 rpm, caused much 
higher levels of structural disruption during decellularisation with 2 % (v/v) SDS 
solution. However, H & E staining revealed the presence of whole nuclei in 
samples treated with reciprocal shaking, and a 3-fold greater DNA content than 
in sonicated samples.  
Koch et al (2013) decellularised porcine ureters using 1 % (v/v) SDS and 
lyophilised the resulting scaffold, increasing the porosity of the ECM but 
retaining the gross morphological features [323]. The structural changes did not 
impede cell infiltration during subcutaneous implantation in a Wistar rat model. 
After 30 days, cells were observed growing throughout the scaffold from the 
exterior to the lumen. In contrast cell growth in decellularised ureters with a 
tighter “native-like” structure, induced through the use of cross-linking agents 
(including genipin and 1-ethyl-(3-dimethylaminopropyl)carbodiimide 
hydrochloride), was limited to the outer region. The structural disruption did not 
appear to result in any changes to the mechanical properties of the nerves 
following decellularisation. 
Some structural disruption and increase in ECM porosity may therefore be 
beneficial in decellularised grafts. During decellularisation, increased structural 
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looseness or porosity may enable increased solution access and egress from 
the tissue, thereby ensuring maximal removal of cellular material [324]. 
Following implantation, increased porosity and looseness may enable faster cell 
infiltration and graft integration. The histoarchitectural disruption observed in the 
present study was primarily limited to the epineurium. As the structure of 
individual endoneurial tubules did not appear to be significantly altered, these 
changes are unlikely to have serious implications for the ability of the 
decellularised nerves to facilitate the attachment and growth of Schwann cells 
and regenerating axons.  
Increased disruption to the collagenous ECM may also explain the observed 
reductions in basement membrane component antibody labelling after 
decellularisation. This was particularly evident in the perineurium. The tightly 
packed lamellar basement membrane layers of the native perineurium were 
evident when labelled for key components such as laminin and collagen IV, but 
were less distinct following decellularisation [58]. Given the larger-scale 
structural alterations seen in the (primarily collagenous) epineurium, and the 
fact that basement membrane labelling remained localised, it is likely that 
disruption to underlying constituent collagen I networks (rather than the 
basement membrane) was the primary causative factor. Scanning electron 
microscopy imaging of a porcine urinary bladder ECM scaffold revealed the 
induction of structural disruption within the collagen fibre network following 
treatment with 0.1 % (v/v) SDS [325]. SDS-treatment of porcine urinary bladder 
ECM also led to reductions in collagen IV and laminin antibody labelling 
intensity [269]. Human urothelial cells cultured on the SDS-treated urinary 
bladder ECM displayed abnormal morphological characteristics and reduced 
growth compared to an untreated control.  
Similar changes to the basement membrane have been seen in porcine 
pulmonary heart valves, porcine dermis, and human pulmonary and aortic 
valves decellularised using variations of the patented Leeds protocol (the 
common key reagents being 0.1 % SDS, hypotonic and hypertonic buffer 
solutions, Benzonase) [240, 326, 327]. The observed reduction in antibody 
labelling intensity for laminin and collagen IV did not seem to affect cell ingrowth 
to the decellularised human aortic valve ECM during subcutaneous implantation 
in C3H mice, which was higher than in the cellular tissue control. Laminin and 
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collagen IV facilitate the attachment of Schwann cells and axons in the 
endoneurium and perineurial cells in the perineurium [47, 56, 328]. Whilst the 
cell ingrowth in human aortic valves decellularised using a similar protocol is 
encouraging, the extent to which the observed changes to the basement 
membrane would negatively affect the infiltration of site-specific cells (thereby 
slowing and/or impeding the process of neuroregeneration following scaffold 
implantation) remains unclear.  
The levels of collagen and denatured collagen did not appear to change 
following decellularisation, indicating minimal loss of the collagenous ECM. This 
is consistent with data from other tissue types decellularised with SDS including 
porcine superflexor tendon, porcine anterior cruciate ligament, and human 
aortic and pulmonary valves [327, 329, 330]. The native and decellularised 
nerves contained a high proportion of fat, making up approximately 50 % of the 
dry mass. The majority of fatty tissue in native peripheral nerve is located in the 
epineurium, commonly referred to as interfascicular adipose tissue [331]. The 
distribution of interfascicular adipose tissue is variable; as with the collagenous 
components of the epineurium, interfascicular adipose tissue is present in 
greater relative quantities in larger, multifascicular nerve branches such as the 
sciatic nerve [104]. The main function of interfascicular adipose tissue is thought 
to be the protection of fascicles from compressive mechanical forces [332]. The 
nerve branches used in the present study, the peroneal and the tibial, descend 
from the sciatic nerve and are relatively large and multifascicular compared to 
more distal branches (e.g. the sural nerve) [58]. Therefore, the relatively high 
proportion of fat seen here in the native and decellularised nerves is to be 
expected. This is consistent with the large areas of suspected globular adipose 
tissue observed in sections stained with H & E, which are likely to be important 
for the maintenance of tissue histoarchitecture in the decellularised nerves.  
The distribution and quantity of GAGs in peripheral nerve is not well 
characterised. Data from the present study indicates that that the GAG content 
of porcine peripheral nerve ECM is highly variable, and is relatively low 
compared to other tissues such as articular cartilage [304]. Decellularised 
porcine peripheral nerves with a slightly higher GAG content were able to 
support the growth of site-specific cells in an in vivo rat model [139]. In light of 
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this, the low measured GAG content of decellularised nerves seen in the 
present study is not of concern in terms of potential axonal growth inhibition.  
The structural and biological properties of the porcine peripheral nerves were 
well conserved following decellularisation. The identification of a robust terminal 
sterilisation process which induces the minimum possible additional changes to 
these properties is crucial to facilitating translation of the decellularised nerves 
towards use as a clinical product.  
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5 The effects of sterilisation on the ECM structure, 
composition and basement membrane integrity of 
decellularised nerves 
5.1 Introduction 
There is a requirement for the terminal sterilisation of medical devices intended 
for in vivo implantation or use (e.g. artificial joint replacements, surgical 
equipment); this includes decellularised xenogeneic scaffolds [333, 334]. 
Sterilisation methods which may be suitable for use with decellularised porcine 
peripheral nerves include treatment with PAA solution, gamma radiation, E 
Beam, supercritical CO2, and ethylene oxide [19, 179, 209].  
The potential for sterilisation methods to disrupt the structure and biochemical 
composition of the ECM in decellularised tissue grafts has been widely 
documented (section 1.8.4) [6, 170, 242, 243, 335]. Furthermore, data in the 
literature indicate that the extent and severity of such disruption varies 
according to the specific method (and conditions) used and the individual tissue 
type being treated. 
For example, sterilisation with ionising radiations, such as gamma radiation and 
E Beam, has been shown to induce extensive structural disruption to the ECM 
when carried out under dry conditions but not if the tissue is hydrated (a 
hydrated state being taken as tissue graft which has not undergone an artificial 
process to remove water from the ECM) [336]. Modulation of the total dose 
applied (usually quantified in kGy), the dose rate (kGy/h), and the use of dose 
fractionation, can all influence the extent of disruption to the ECM [1]. 
Treatment of decellularised tissue grafts with PAA solution has been associated 
with disruption to the structure and composition of the ECM (especially the 
basement membrane) in tissues including porcine heart valve, porcine arteries 
and decellularised porcine dermis [240, 243, 326, 337]. These effects vary 
according to the concentration of PAA solution and total treatment time [173, 
179]. A study in which the same decellularisation process was applied to both 
porcine and human dermis found that antibody labelling for collagen IV was lost 
in the porcine dermis treated with 0.1% (v/v) PAA, but retained in the human 
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dermis for which the PAA sterilisation step was omitted [326]. There is limited 
knowledge regarding the effects of supercritical CO2 treatment on ECM 
structure and composition, due to its relatively recent development as a 
sterilisation method [19]. However, the inclusion of oxidising agents (e.g. PAA, 
H2O2) as additives to aid in viral/spore killing raises the possibility of associated 
effects to ECM components being induced.  
Prior to treatment with ethylene oxide, decellularised tissue grafts must be 
dehydrated to enable full diffusion of the gas [193]. This is typically achieved 
through lyophilisation; however, the ice crystals which form during this process 
have been shown to induce structural disruption in decellularised soft tissues 
such as porcine arteries and bovine pericardium [338, 339]. In contrast, hard 
tissues may be able to better withstand lyophilisation (without negative effects 
to structural or mechanical properties); historically, lyophilisation followed by 
ethylene oxide treatment has been widely applied to human bone allografts in 
tissue banking [187]. Because nerve is a soft tissue with delicate ECM 
structures (particularly in the endoneurium), and therefore likely to be 
susceptible to ice crystal-induced ECM damage, the use of alternative 
dehydration techniques (e.g. desiccation) should be considered. It is also 
important to demonstrate that the dehydrated tissue can be fully rehydrated 
without compromising functional properties (e.g. structural and material 
properties) after processing but prior to implantation, to ensure usability in a 
clinical situation.   
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5.2 Aims and objectives 
The aim of the work described in this chapter was to characterise the effects of 
sterilisation methods (PAA solution, gamma radiation, E Beam and supercritical 
CO2 treatment) on the structure and composition of decellularised nerve ECM. 
Alterations were identified by comparison with the baseline dataset described in 
Chapter 4. 
 
Objectives 
i. To determine the effects of methods for dehydrating tissue on 
decellularised nerve ECM, through staining of histological sections with H 
& E. 
ii. To determine the effects of sterilisation on decellularised nerve ECM 
structure through staining of histological sections with H & E and Sirius 
Red with Miller’s Elastin. 
iii. To determine the effects of sterilisation on the distribution of collagen 
type IV, laminin and fibronectin within the ECM structure through 
antibody labelling of histological sections. 
iv. To determine the effects of sterilisation on the biochemical composition 
of decellularised nerves, through quantification of collagen and 
denatured collagen. 
v. To determine the effects of a novel submerged supercritical CO2 
treatment on the retention of basement membrane integrity in 
decellularised nerves. 
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5.3  Materials and Methods 
5.3.1 Decellularisation of porcine peripheral nerves 
Porcine peripheral nerves were dissected, divided into segments of 
approximately 3 cm in length and decellularised (n = 30 segments per group) 
using the optimised process as described in section 2.10. Removal of cells and 
preservation of ECM was assessed using staining with H & E and DAPI and 
through quantification of DNA content, as described in sections 2.11 and 
3.3.1.5. 
5.3.2 Optimisation of dehydration process for ethylene oxide 
treatment 
Decellularised nerves (n = 5 per group) were dehydrated using two different 
processes. 
One group of decellularised nerves were frozen to -80 °C, placed in bijous, 
transferred to a freeze dryer (Savant ModulyoD) and lyophilised at a 
temperature of -50 °C and a pressure of 0.15 – 0.2 mbar.  
A second group of decellularised nerves were placed in bijous and transferred 
to a glass desiccator with 500 g of silica beads (Figure 5-1).  
 
 
 
  
 
 
 
 
 
 
Figure 5-1 Desiccator used to dehydrate decellularised nerves 
The interface between the two halves of the dessicator was sealed with 
petroleum jelly, to ensure an effective seal was maintained as fully as possible.  
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Each decellularised nerve segment was weighed once every 24 hours. The 
dehydration processes were continued until a constant mass was maintained 
for at least 48 hours. Following dehydration 4 ml of PBS was added to each 
tube. The dehydrated nerves were incubated in the PBS at 4 °C for up to seven 
days to allow complete rehydration of the tissue. The results were analysed 
histologically.  
A group of decellularised nerves were frozen once and thawed, as a control for 
the effects of ice crystal formation during lyophilisation.  
The effects were determined by histological staining (H & E). 
5.3.3 Sterilisation of decellularised nerves 
Groups of decellularised nerves were treated using the following sterilisation 
methods: PAA (n = 30), gamma radiation, E-beam (n = 30) and supercritical 
CO2 (n = 30 for main group; n = 6 for a preliminary study of a novel submerged 
SCCO2 processing method). The specific conditions used are described in 
section 2.10.3. The effects of each sterilisation method on the ECM were 
determined by histological staining (n = 6 per group), antibody labelling (n = 6 
per group) and quantification of collagen and denatured collagen content (n = 6 
per group). Sodium hydroxide-treated nerves (produced as described in section 
2.10.3.5) (n = 3) were used as a positive control. 
5.3.3.1 Novel supercritical CO2 sterilisation method for the processing of 
tissue under submerged conditions 
Decellularised nerves (n = 6) were subjected to a novel supercritical CO2 
process. The conditions (temperature, pressure, cycle length) within the 
reaction chamber were maintained as described in section 2.10.3.4, but the 
individual nerve segments were submerged in 3 ml of PBS (pH 7.4) during the 
treatment cycle. This eliminated the requirement for aseptic addition of sterile 
PBS following processing. The effects of this process were determined by 
histological staining (n = 6) and antibody labeling (n = 6). 
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5.3.4 Histological staining 
Formalin-fixed paraffin-embedded sections of decellularised nerves sterilised 
using different methods were stained using H & E and Sirius Red & Miller’s 
Stain.  For each treatment group, sections were taken from segments 
originating from the peroneal and tibial nerves (n = 3 from each). All sections 
were viewed microscopically and compared to non-sterilised samples and 
nerves treated using 1 M NaOH.  Any differences were noted. 
Processing and sectioning of tissue was carried out as described in sections 
2.11.1 and 2.11.2. Staining of sections with H & E and Sirius Red & Miller’s 
Stain was carried out as described in sections 2.11.5 and 2.11.7. 
5.3.5 Antibody labelling  
Processing and sectioning of tissue was carried out as described in sections 
2.11.1 and 2.11.2. Labelling of sections with specific antibodies for collagen IV, 
laminin and fibronectin was carried out as described in section 2.11.8. 
5.3.6 Quantification of collagen and denatured collagen content 
The amount of collagen and denatured collagen in the sterilised nerve 
segments (n = 6 for each group in each assay) was quantified as described in 
section 2.14.  
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5.4 Results 
5.4.1 Histological characterisation of the effects of different 
dehydration protocols on decellularised nerves 
Dehydration of decellularised tissues is key to enabling the effective application 
of gaseous sterilisation treatments such as ethylene oxide. H & E staining was 
used as an initial assessment of the effects of different dehydration protocols 
upon decellularised nerve histoarchitecture (Figure 5-2). 
In isolation, one cycle of freeze-thaw did not result in any gross structural 
changes in the ECM of decellularised nerves (Figure 5-2 A & B). However, 
extensive structural disruption was observed when decellularised nerves were 
frozen and subsequently lyophilised (Figure 5-2 C & D). Disruption to the 
histioarchitecture was particularly evident in the endoneurium, with the original 
structure of packed, well-defined tubules almost completely lost. Areas of 
structural disruption were also seen in the epineurium surrounding the fascicles, 
with the fascicles appearing to be more detached from the surrounding ECM. 
All ECM structures were well-conserved when decellularised nerves were 
desiccated at room temperature (Figure 5-2 E). However, the structures 
appeared to be more compact following desiccation and rehydration (Figure 5-2 
F, G & H). The original gross histological characteristics of the decellularised 
nerves, with a loose network of collagenous structures in the epineurium and a 
defined tighter region of perineurium surrounding each fascicle, did not appear 
to be restored after incubation in PBS over time points up to six days; this 
indicated that full rehydration of the tissue was not achieved. 
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Figure 5-2 Representative images of sections stained with H & E (previous 
page) 
H & E-stained sections of (A and B) decellularised nerves frozen to - 80 °C and 
thawed in PBS, (C and D) decellularised nerves frozen to – 80 °C and 
lyophilised for 72 hours, before being rehydrated in PBS for 7 days, and 
decellularised nerves desiccated for 72 hours before being rehydrated in PBS 
for (E) 0 days, (F) 2 days, (G) 4 days and (H) 6 days. Arrows indicate areas of 
structural disruption. Images were acquired using Köhler illumination and a x10 
objective, scale bars = 100 µm. 
 
- 156 - 
5.4.2 Histological analysis of changes to ECM structure. 
H & E staining was used to assess the effects of sterilisation treatments upon 
decellularised nerve histoarchitecture, including the key ECM structures of the 
epineurium, perineurium and endoneurium (Figure 5-3). Some disruption to 
both the overall integrity of the endoneurium within each fascicle, as well as the 
structure of individual tubules, was evident in decellularised nerves treated with 
PAA and supercritical CO2. However, none of the sterilisation treatments 
caused obvious damage to the structures making up the perineurium and 
epineurium. By contrast, considerable structural changes were observed in the 
epineurium and perineurium of samples in the positive control group, 
decellularised nerve denatured through treatment with NaOH. All major ECM 
structures appeared well conserved following treatment with both gamma 
radiation and E Beam. 
Increased spacing was observed between the perineurium and endoneurium in 
Figure 5-3 A and Figure 5-3 F. This is likely representive of artefacts introduced 
during sectioning. 
Sirius Red/Miller’s Elastin stain was used to define the distribution and structure 
of collagen and elastin (Figure 5-4). As observed following H & E staining, 
structural disruption was most evident in the endoneurium of decellularised 
nerves treated with PAA and supercritical CO2 when compared to non-sterilised 
samples. No differences in collagen fibre organisation were evident when 
sections were viewed under polarised light. The collagen making up the walls of 
the individual endoneurial tubules appeared to be less dense/thick than in the 
perineurium and epineurium; however, no differences were discernible between 
samples in this regard. 
  
 
 
  
 
 
- 157 - 
Figure 5-3 Representative images of sterilised decellularised nerve 
sections stained with H & E 
H & E-stained sections of decellularised nerve treated with (A) no sterilisation 
process, (B) NaOH (positive control), (C) PAA, (D) gamma radiation, (E) E 
Beam and (F) supercritical CO2. There was some evidence of disruption to 
decellularised nerves treated PAA and supercritical CO2, predominantly located 
in the endoneurium (EN). Arrows indicate areas of structural disruption. Images 
were acquired using Köhler illumination and a x10 objective, scale bars = 100 
µm. 
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Figure 5-4  Representative images of decellularised sterilised nerve 
sections stained with Sirius Red/Miller’s Elastin (previous page) 
Sirius Red/Miller’s-stained decellularised nerve treated with (A and B) no 
sterilisation process, (C and D) PAA, (E and F) gamma radiation, (G and H) E 
Beam and (I and J) supercritical CO2. Some evidence of structural changes 
were evident, particularly to the endoneurium (indicated by arrows). Images 
were acquired under Köhler illumination (A, C, E, G, I) and Polarised light 
conditions (B, D, F, H, J) and using a x10 objective, scale bars = 100 µm. 
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5.4.3 Immunohistochemical labelling of collagen IV 
Sections of decellularised nerves from each sterilisation group were labelled 
with a monoclonal antibody against collagen type IV to identify if each 
sterilisation method affected the distribution of collagen IV (Figure 5-5). 
Specificity of labelling was confirmed through the inclusion of a native porcine 
artery positive control (Figure 5-5 G). As expected, in non-sterilised nerves 
collagen IV labelling was predominantly located in the endoneurium and 
perineurium (Figure 5-5 A); positive labelling appeared to retained in these 
regions in decellularised nerves treated with gamma radiation and E Beam 
(Figure 5-5 C, D). The intensity of labelling in irradiated samples was slightly 
reduced compared with non-sterilised decellularised nerve Figure 5-5 C & D) 
No positive labelling for collagen IV was seen in decellularised nerves treated 
with PAA or supercritical CO2 (Figure 5-5 B & E, respectively). 
 
 
 
 
 
 
 
 
 
 
Figure 5-5  Representative images of decellularised sterilised nerve 
sections labelled with monoclonal antibodies against collagen IV (next 
page) 
Collagen IV-labelled decellularised nerves treated with (A) no sterilisation 
process, (B) PAA, (C) gamma radiation, (D) E Beam and (E) supercritical CO2. 
An isotype control (F) and a porcine artery positive control (G) were included. 
The endoneurium (EN) is labelled for reference. Arrows indicate the basement 
membrane region of the perineurium (PE). Images were acquired using Köhler 
illumination and a x10 objective, scale bars = 100 µm. 
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Figure 5-6 Representative image of of decellularised nerve sections 
labelled with monoclonal antibodies against laminin (next page) 
Laminin-labelled decellularised nerves treated with (A) no sterilisation process, 
(B) PAA, (C) gamma radiation, (D) E Beam and (E) supercritical CO2, 
immunohistochemically labelled for the presence of laminin. An isotype control 
(F) and a porcine artery positive control (G) were included. Images were 
acquired under Köhler illumination and a x10 objective, scale bars = 100 µm. 
 
5.4.4 Immunohistochemical labelling of laminin 
Sections of decellularised nerves from each sterilisation group were labelled 
with a monoclonal antibody against laminin to identify if each sterilisation 
method affected the distribution of laminin within the ECM (Figure 5-6). The 
specificity of labelling for laminin was confirmed using a native porcine artery 
positive control (Figure 5-6 G).  
Strong labelling was observed in decellularised nerves treated with PAA, 
gamma radiation and E Beam (Figure 5-6 B, C and D); as in non-sterilised 
nerves Figure 5-6 A), laminin labelling was primarily confined to the perineurium 
and endoneurium. This suggested that laminin was retained in the basement 
membrane following these treatments.  
However, labelling was much reduced in intensity following treatment with 
supercritical CO2 (Figure 5-6 E). The localisation of the labelling was also less 
defined, with weak labelling appearing to be widely distributed throughout the 
tissue rather than limited to the endoneurium and perineurium. 
Increased spacing was observed between the perineurium and endoneurium in 
Figure 5-6 D and Figure 5-6 F. This is likely representive of an artefact 
introduced during sectioning. 
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Figure 5-7 Representative images of decellularised sterilised nerve 
sections labelled with a monoclonal antibody against fibronectin and 
counterstained with DAPI (next page) 
Fibronectin-labelled decellularised nerves treated with (A) no sterilisation 
process, (B) PAA, (C) gamma radiation, (D) E Beam and (E) supercritical CO2, 
immunofluorescently labelled for the presence of fibronectin. An isotype control 
(F) and a porcine artery positive control (G) were included. Fibronectin labelling 
intensity was well conserved in nerves treated with PAA, gamma radiation and 
E Beam. Labelling was predominantly localised to the perineurium. The 
intensity of labelling appeared to be reduced after treatment of decellularised 
nerves with supercritical CO2. The endoneurium (EN) and perineurium (PE, 
arrow) are labelled on the first image for reference. Images were acquired at a 
wavelength of 488 nm using a x10 objective, scale bars = 100 µm. 
5.4.5 Immunofluorescent labelling of fibronectin 
Sections of decellularised nerves from each sterilisation group were labelled 
with a monoclonal antibody against fibronectin to identify if each sterilisation 
method affected the distribution of fibronectin within the ECM.  The primary 
monoclonal antibody was visualised using a fluorescently-tagged secondary 
antibody. A native porcine artery positive control was included to confirm 
specificity of labelling (Figure 5-7 G).  
Some degree of labelling for fibronectin appeared to be retained following each 
of the sterilisation treatments (Figure 5-7). The distribution and intensity of 
fibronectin labelling in nerves treated with PAA, gamma radiation and E Beam 
(Figure 5-7 B, C and D, respectively) was similar to that observed in non-
sterilised nerves (Figure Figure 5-7 A). Fibronectin labelling was intense in the 
perineurium, but weaker and less consistent in the endoneurium.  
The distribution of fibronectin appeared to be altered in decellularised nerves 
treated with supercritical CO2 when compared to non-sterilised samples (Figure 
5-7E). Fibronectin labelling was reduced in intensity in the perineurium and 
appeared to be almost completely absent in the endoneurium. 
Increased spacing was observed between the perineurium and endoneurium in 
Figure 5-7 F. This is likely representive of an artefact introduced during 
sectioning. 
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5.4.6 Quantification of collagen and denatured collagen content 
In order to quantify the collagen and denatured collagen content, tissues were 
assayed for hydroxyproline content with or without prior α-chymotrypsin digest. 
The assay protocol produced a linear relationship between absorbance at 570 
nm and hydroxyproline concentration (Figure 5-8). 
No significant differences were found between the collagen content or 
denatured collagen content of decellularised nerves in any of the treatment 
groups (Figure 5-9). The exception to this was the NaOH positive control group, 
which had a significantly increased denatured collagen content in comparison to 
all other treatment groups. 
 
Figure 5-8 Standard curve for the interpolation of hydroxyproline content 
Relationship between absorbance at 570 nm and trans-4-hydroxy- L-proline 
concentration (n = 3), used for the interpolation of hydroxyproline content from 
hydrolysed and neutralised samples. Samples were either tissue segments or α-
chymotrypsin digest supernatants.  
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Figure 5-9 Collagen and denatured collagen content of native, 
decellularised and sterilised porcine peripheral nerves 
(A) Collagen content and (B) denatured collagen content of native peripheral 
nerves, decellularised peripheral nerves from all treatment groups. Data shown 
as mean +/- 95 % confidence interval, n = 6. Statistical analysis was by (A) one-
way ANOVA or (B) Kurskal-Wallis. * denotes groups which are significantly 
different (p<0.05).  
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5.4.7 Comparison of basement membrane composition in 
decellularised nerves treated with standard and submerged 
supercritical CO2 processes 
Decellularised nerves were treated with supercritical CO2 under two different 
conditions, 1) in air (section 2.10.3.4) or 2) submerged in PBS (section 5.3.3.1). 
Sections of decellularised nerves from both treatment groups were labelled with 
monoclonal antibodies against collagen IV, laminin and fibronectin to establish 
the distribution of each component throughout the ECM following sterilisation 
(Figure 5-10). 
Collagen IV distribution patterns were retained when decellularised nerves were 
treated with supercritical CO2 under submerged conditions (compared with non-
sterilised decellularised nerves, verified through comparison with a native 
porcine artery positive control; Figure 5-5 G), with collagen IV appearing highly 
localised to the endoneurium and perineurium; however, positive labelling for 
collagen IV was completely absent in samples treated under the standard 
conditions (Figure 5-10 A & B). 
Laminin labelling was reduced in intensity (compared with non-sterilised 
decellularised nerve [Figure 5-10A]; specificity confirmed through comparison 
with native porcine artery positive control [Figure 5-6 G]) and seemed to be 
diffuse throughout the tissue (rather than primarily located in the basement 
membrane regions of the endoneurium and perineurium) in decellularised 
nerves treated under the standard conditions (Figure 5-10 C). In decellularised 
nerves treated under submerged conditions, the intensity and localisation of 
staining appeared to be close to that seen in the untreated (non-sterilised) 
decellularised nerves (Figure 5-10 D). A reduction in the intensity of fluorescent 
labelling for fibronectin was observed in decellularised nerves treated under the 
standard protocol (Figure 5-10 E) compared with non-sterilised decellularised 
nerves, where positive labelling for fibronectin was evident in the basement 
membrane regions of the perineurium and endonerium (Figure 5-7 A; specificity 
was confirmed by labelling of a native porcine artery positive control [Figure 5-7 
G]). Coverage was incomplete, even in the perineurial region. In contrast, 
fibronectin seemed to be retained throughout the perineurium of decellularised 
nerves treated under the submerged process, with some weaker labelling also 
present in the endoneurium (Figure 5-F). 
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Figure 5-10 Images of sections of decellularised nerves labelled with 
monoclonal antibodies against collagen IV, laminin and fibronectin 
Collagen IV, laminin and fibronectin-labelled decellularised nerves treated with 
(A, C and E) the standard published supercritical CO2 protocol and (B, D and F) 
the submerged supercritical CO2 protocol, immunohistochemically labelled for 
the presence of (A and B) collagen IV, (C and D) laminin and (E and F) 
fibronectin. Images of collagen IV and laminin were acquired using Köhler 
illumination, and images of fibronectin were acquired at a wavelength of 488 
nm, using a x10 objective. Scale bars = 100 µm. 
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5.5 Discussion  
Through staining with H & E and Sirius Red/Miller’s, the sterilisation treatments 
used in this study were shown not to cause extensive damage to the 
histoarchitecture of the decellularised nerves; quantitative biochemical assays 
revealed no alterations to the collagen/denatured collagen content. Antibody 
labelling revealed some changes to the intensity and distribution of collagen IV 
in the endoneurium and perineurium of nerves treated with PAA or supercritical 
CO2 (standard process); similar changes were seen when supercritical CO2-
treated nerves were labelled for laminin and fibronectin. 
The only decellularised nerve graft currently in clinical use, the Avance® nerve 
graft, is sterilised using gamma radiation [137]. While little information is given 
in the literature about the specific conditions used during irradiation, the nerves 
appeared to retain positive antibody labelling for laminin following irradiation 
and did not appear to sustain any obvious structural alterations to the ECM 
when examined histologically [340]. The published data do not distinguish 
between the effects of decellularisation and the effects of sterilisation, and it is 
possible that, given the possible alterations which may occur following gamma 
irradiation of a tissue graft (e.g. the potential for the induction of chain 
scission/crosslinking of collagens within the ECM), another sterilisation method 
may be more suitable for use with decellularised peripheral nerve tissue [1, 172, 
341]. A decision was made during the present study to consider the use of 
several different sterilisation methods (both well established and relatively 
novel, for use with the decellularised porcine nerves), and to extensively 
characterise the effects of such methods upon a range of key biological and 
physical parameters identified as potentially affecting the ability of the grafts to 
support cell growth and migration and facilitate maximal functional restoration.  
For a decellularised tissue graft to be effectively sterilised through ethylene 
oxide treatment, it must first be dehydrated to enable full diffusion of the gas 
through the ECM [342]. The formation of ice crystals during the process of 
lypohilisation may induce structural disruption in decellularised tissue grafts, 
with soft tissues such as artery being more susceptible than harder tissues such 
as bone (which is widely used in surgical procedures) [338, 343]. However, a 
single freeze-thaw cycle has been successfully employed (with no histological 
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evidence of resulting structural degradation) as a first step in the 
decellularisation process for tissues such as porcine nerves (including in the 
current study) and arteries, to “open” the ECM structure and enable better 
penetration and egress of decellularisation reagents and associated cellular 
debris [18, 344]. While the process of freezing in isolation did not appear to 
damage the histoarchitecture of decellularised nerves, extensive structural 
disruption was evident following rehydration of lyophilised nerves. The loss of 
structural integrity was evident at all levels of the ECM including the 
endoneurium, perineurium and epineurium. Such changes are likely to inhibit 
the mechanical support and physical guidance of regenerating axons, and so it 
is unlikely nerves treated in this manner would be suitable for use as a graft 
material. 
The process of lyophilisation is mediated through subjecting a given material 
dissolved in water/containing water (e.g. active biologics in solution, 
decellularised tissue grafts) to specific environmental conditions of low 
temperature and pressure in order to induce sublimation (i.e. the change in 
state of frozen water directly to vapour) [338, 345]. The application of this 
process to biological materials is widely practised, as the controlled conditions 
and low temperatures generally enable superior preservation of functional 
properties compared with other drying processes (e.g. heat-mediated; biological 
materials are liable to degradation if exposed to excessive heat and/or 
conditions which may enable facilitate microbial growth and thereby enzymatic 
digestion) [323, 346]. Because of these advantages, lyophilisation is widely 
used as a preservation method for biological materials in the food and 
pharmaceutical industries. As materials must be frozen prior to (and during) 
lyophilisation, the possible consequences of ice crystal evolution within the 
tissue should be considered. The thermodynamics of ice crystal formation 
favours the formation of irregular structures under slower and variable rates of 
freezing [345]. In the present study, the freezing process alone did not appear 
to affect the histoarchitecture of the decellularised nerves; therefore, 
temperature variation within the freeze dryer may have been responsible. In a 
study of decellularised porcine arteries, initial controlled rate freezing to -40 °C 
(the rate of which was increased using a pre-cooled shelf) followed by an 
increase in temperature to 0 °C induced minimal structural disruption compared 
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to controlled rate freezing to -10 °C [338]. Rapid cooling followed by 
maintenance of a stable temperature promotes the formation of ice crystals with 
a more uniform and stable structure, decreasing the likelihood of structural 
disruption. The freeze dryer used during the present study did not allow for 
controlled-rate freezing or precise control of internal temperature, and as a 
result irregular ice crystal structures are likely to have formed and likely induced 
the observed structural disruption.  
In contrast to the lyophilised nerves, structural disruption was minimal after the 
desiccation of decellularised nerves, likely because the chamber was 
maintained at room temperature throughout the process. However, the ECM 
structure appeared to remain “tight” and did not fully rehydrate after incubation 
in PBS, even after a duration of seven days. A possible explanation for this 
finding is the relatively high proportion of fat in the decellularised nerves, as 
demonstrated in section 4.4.10. Meyer et al (2013) examined the rate and 
extent of rehydration in different dehydrated porcine tissues including fat, 
muscle, lung, cartilage and tendon [347]. Fat was the only tissue not to 
significantly increase in mass after 60 minutes of rehydration, remaining at 
approximately 80 % of the original mass. The hydrophobicity of fat was 
postulated as the most likely reason for this effect, and it is probable that the 
fatty tissue in the decellularised nerves inhibits full rehydration in a similar 
manner. Due the role of fat in protecting axons from compressive mechanical 
forces in the decellularised nerves and the potential impact of removal agents 
on the ECM, extraction of fat from the tissue using ethanol or acetone could 
negatively impact upon the ability of the decellularised nerves to support 
neuroregeneration [348]. Ethylene oxide treatment requires prior dehydration of 
tissue-based scaffolds, to allow access of the gas throughout the ECM and 
enable egress (through aeration) of residual toxic breakdown products 
remaining within the ECM post-processing [184, 185, 342]. Such toxic 
breakdown products are thought to be retained in higher quantities in fatty 
tissue; a 35% increase in fibroblast growth was observed when the cells were 
incubated with lyophilised, ethylene oxide-treated human femoral bone chips 
which were defatted prior to processing versus those which were not defatted 
[244]. Until suitable dehydration and rehydration processes for decellularised 
nerves can be identified, and concerns surrounding the fat content of the nerves 
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and the resultant potential for the retention of toxic by-products have been 
addressed, ethylene oxide treatment cannot be considered for use as a 
sterilisation method with the decellularised nerves.  
Some evidence of structural disruption was seen in decellularised nerves 
treated with 0.1 % (v/v) PAA solution, which was primarily characterised by a 
loss of definition in the tubular structures of the endoneurium. Structural 
disruption has been demonstrated in other decellularised soft tissues treated 
with PAA, including murine lung and porcine small intestine submucosa [173, 
242]. In the present study disruption was almost exclusively located in the 
endoneurium, with no obvious alterations to the perineurium or epineurium. 
Existing evidence is inconclusive as to whether retention of endoneurial tubule 
structure is required for a graft to facilitate reinnervation; this is due to the 
potential for restriction of axonal growth direction resulting in forced rerouting 
and the potential for compromised functional recovery resulting from this [349]. 
Some misdirection of regenerating axons was observed in a simple model of rat 
sciatic nerve laceration, repaired through coaptation and measured through 
electromyography. However, kinematic analysis of movement patterns did not 
reveal any negative implications for functional recovery resulting from this 
(compared to untreated control animals).  Macrophages and Schwann cells 
mediate some remodelling of the endoneurial tubules through the release of 
MMPs and secretion of new ECM components, which could correct the minor 
structural disruption seen here in PAA-treated nerves [350]. 
A 2018 study compared axonal reinnervation of distal pathways following repair 
of a rat sciatic defect with either a chitosan/PGLA guidance conduit or an 
autograft [135]. The conduit facilitated superior improvements in motor function 
and directional accuracy of axonal growth in a 3 mm defect but not in a 6 mm 
defect. It is recognised that in larger defects regenerating axons benefit from 
aligned physical and chemotrophic cues to stimulate and guide growth [7]. 
ECM-based grafts, including autografts and cellular or decellularised allografts 
and xenografts, fulfil both of these requirements with intact endoneurial tubules 
composed of key cell attachment molecules including collagen IV, laminin and 
fibronectin [18].  
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In vitro studies have shown that synthetic guidance conduits with a linear, 
aligned topography (whether in the form of striations on the inner surface of the 
conduit, channels or a mesh of aligned fibres) are able to promote more 
directed neurite growth across greater distances than those with a simple 
topography [351]. Preliminary in vivo results indicated that the implantation of a 
multichannel PLGA nerve conduit into a rat sciatic defect model corresponded 
with a downstream muscle composition being closer to that found in native 
control tissue animals (a higher proportion of type I to type II muscle fibres) after 
12 week in situ [352]. In animals where the defect was repaired with a single 
lumen PGLA conduit, the ratio was closer to 1:1. The authors suggested that 
this was indicative of a more organised growth of axons across the defect, 
leading to a higher rate of functional reinnervation at the effector site (distal to 
the defect). However, the small sample sizes used in this study meant that no 
differences were detected across other functional parameters including direction 
of axon growth and the amplitude of compound muscle action potentials, and, 
when examined histologically; furthermore, both conduits were found to support 
the growth of significantly fewer myelinated axons across the defect site 
compared with an autograft repair. Given the relative importance of physical 
and chemotrophic guidance, it is unlikely that a significantly disrupted 
endoneurium (such as that observed in decellularised nerves treated with PAA) 
would facilitate axonal regeneration across large defects. Decellularised nerves 
sterilised with gamma radiation, E Beam and supercritical CO2 appeared to 
retain the fine “honeycomb” structure of the endoneurial tubules and are 
therefore likely to provide physical guidance for regenerating axons in a similar 
manner to an autograft, the current gold standard therapy in defects considered 
too large for repair by coaptation [115].  
Cell attachment motifs in the basement membrane are crucial for the 
attachment, growth and function of cells including Schwann cells, neurons and 
perineurial cells [42]. In the peripheral nerve, laminin and fibronectin are thought 
to be the main mediators of interaction between key cell types (axons and 
Schwann cells) and the ECM [50]. The relative importance of differing subtypes 
of such components should also be considered; for example, laminin-8 is 
thought to primarily promote Schwann cell growth and function (e.g. 
myelination), whereas laminin-2 is associated with axonal growth. These 
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interactions have been demonstrated in vitro and in an in vivo murine gene 
knockout model [61]. In the present study, reductions in the intensity of antibody 
labelling for basement membrane components (in particular collagen IV) were 
seen in decellularised nerves treated with PAA and supercritical CO2. A loss of 
positive staining for collagen IV following PAA treatment has been 
demonstrated in decellularised porcine mitral valves and porcine & human 
decellularised arteries. [239]. Collagen IV provides a scaffold for the attachment 
of other basement membrane components such as laminin, fibronectin, 
nidogen, and perlecan [353]. It is unlikely that the collagen IV has been fully 
denatured or degraded in decellularised nerves treated with PAA solution, due 
to the preservation of positive labelling for laminin and fibronectin and the fact 
that collagen IV forms a scaffold structure in the basement membrane onto 
which these components are bound [60, 328]. Instead, changes to the 
conformation and/or surface chemistry of the collagen IV molecule may have 
altered the specific target epitope of the CIV-22 antibody and thereby reduced 
the incidence of high affinity binding events. 
It is likely that a similar chemical mechanism is responsible for the changes 
seen in decellularised nerves treated with supercritical CO2, where laminin and 
fibronectin labelling intensities were also diminished. Supercritical CO2 is 
thought to diffuse through the membrane/wall of bacterial cells/endospores, and 
thereafter dissolve within the cytoplasm. This would increase levels of carbonic 
acid, and thereby lower the intracellular pH to cytotoxic levels [215, 216]. 
However, such a mechanism would not be effective against non-cellular 
pathogens. Therefore the incorporation of the NovaKill additive solution, 
containing the oxidising agents PAA and H2O2, is necessary for effective 
elimination of viral bioburden during supercritical CO2 processing [216].  
The effects of oxidising agents such as PAA and H2O2 on ECM proteins at a 
molecular level, and the resultant implications for cell binding, have not been 
fully elucidated. Finnegan et al (2010) showed that oxidising agents react with a 
range of amino acids in solution including glycine, cysteine, methionine, lysine, 
histidine and tryptophan, leading to degradation and the formation of oxidation 
products [180]. PAA was noticeably more potent than H2O2, which required a 
higher ratio of oxidative agent to amino acid for the reaction to occur. The 
primary mechanisms for the alteration of amino acids are thought to be 
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dependent on the side chain type; for example, aliphatic amino acids are 
susceptible to hydrogen abstraction whereas aromatic amino acids undergo 
hydrogen addition [354]. Fourier transform infrared spectroscopy (FTIR) 
analysis of decellularised temporomandibular discs revealed changes in surface 
chemistry as a result of treatment with 0.2 % (v/v) PAA solution in 4 % (v/v) 
ethanol [179]. The predominant site of damage was aliphatic side chains; it was 
postulated that this would not adversely affect cell attachment due to the non-
aliphatic composition of the common cell attachment motif RGD (arginine-
glycine-aspartic acid). This theory was supported by the results of an in vitro cell 
seeding experiment conducted during the same study. When seeded with 
human umbilical cord Wharton's Jelly matrix cells, decellularised 
temporomandibular discs treated with the PAA-ethanol solution supported an 
approximately fivefold greater surface area of cell coverage compared to those 
sterilised with either gamma radiation (dry state) or ethylene oxide. These data 
suggest that the changes to basement membrane components induced through 
treatment with oxidising agents may not impede cell attachment.  
A study into the ability of oxidising agents to degrade proteins found that bovine 
serum albumin (BSA) was fully degraded by PAA solution [180]. H2O2 in a 
vapourised form mediated full degradation of BSA, whereas H2O2 in solution did 
not. These findings are consistent with the different redox potentials of each 
reagent, at 1.81 volts (V) compared to 1.76 V for PAA and H2O2 respectively 
[355, 356]. PAA is also known to disrupt disulphide bonds, which are crucial to 
the maintenance of tertiary and quaternary structure (and therefore the 
conformation) of collagen IV [357-359].  
Mass spectrometric analysis of decellularised murine lungs revealed a 
significant increase in residual ECM components following PAA treatment but 
not after gamma radiation [242]. The relative increase was largest for sub-
chains associated with collagen types I, IV and VI, laminin, and fibronectin. The 
increased level of “free” ECM components was attributed to the solubilisation of 
the ECM components during PAA treatment, which could provide an 
explanation for the non-specific distribution of laminin seen in sample treated 
with supercritical CO2 under standard (non-submerged) conditions.   
Histological examination of impacted human allograft bone chips sterilised with 
SCCO2 in the absence of an additive solution and implanted as part of an ACL 
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repair procedure found evidence of “creeping” integration into the surrounding 
cancellous bone, with a marked improvement in tissue remodelling and 
organisation in biopsies taken 10 months versus those taken at 7 months [360]. 
This provides the first evidence of the effective use of SCCO2-treated tissue in a 
clinical setting; however, evidence suggests to that addition of supplementary 
agents (e.g. oxidising agents) is likely necessary to achieve a sufficient 
reduction in viral and/or bacterial spore populations to meet the criteria of SAL 
10-6, and so the effects of SCCO2 sterilisation in combination with such agents 
must be considered here [215].  
These effects of oxidising agents (especially PAA) including the solubilisation of 
ECM components, the induction of changes to the conformation of proteins, and 
alterations to the chemistry of amino acid side chains, have the potential to 
affect the availability and function of cell attachment motifs and 
chemoattractants within the basement membrane of decellularised nerves, and 
therefore could negatively impact on cell ingrowth and neuroregeneration.    
The increased severity of basement membrane degradation in decellularised 
nerves treated with the standard SCCO2 process (i.e., with the tissue segments 
directly exposed to the SCCO2 and NovaKill reagent rather than being 
submerged in a PBS solution during processing) compared to those treated with 
the 0.1% (v/v) PAA solution may be due to higher local concentrations of 
oxidising agents. The NovaKill reagent contains PAA at a concentration of 
13.5 – 18.5 % (v/v) and H2O2 at 4.5 – 6 % (v/v). As the decellularised nerves 
were not submerged in buffer solution (e.g. PBS) during the SCCO2 treatment 
cycle under standard conditions, it is possible that the concentration of PAA in 
direct contact with the ECM components was significantly higher than the 0.1 % 
(v/v) in the PAA treatment solution. The documented effects of oxidising agents 
on proteins and the similarities in labelling patterns between decellularised 
nerves treated with PAA solution and the SCCO2 process (under standard 
conditions) suggest oxidation of basement membrane components (and 
solubilisation following the aseptic addition of PBS) is the likely mechanism of 
damage in these non-submerged conditions.  
The retention of localised basement membrane labelling seen in decellularised 
nerves treated with supercritical CO2 while submerged in PBS provides further 
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evidence suggesting that the supercritical fluid is not responsible for the damage 
observed under standard processing conditions. A similar result was seen in 
decellularised rat lungs treated with a NovaKill™-based process [243]. In this 
study, which represents the only published work to examine similar parameters 
within a decellularised tissue graft, the tissue was not subjected to the 
proprietary submerged SCCO2 processing method; instead, the lungs were 
filled with a small volume of PBS to prevent collapse of the airways during 
processing. However, antibody labelling revealed preservation of laminin 
labelling after processing, indicating that a similar protective effect may have 
been provided by the PBS. The lungs were not labelled for collagen IV or 
fibronectin, and the only other study investiagitn the use of SCCO2 processing 
as a terminal sterilisation step for decellularised tissues (decellularised porcine 
aortic valves) did not investigate the retention of specific ECM components [19]. 
The protective effect of the PBS solution may be multifactorial, preventing the 
local concentration of oxidising agents from becoming too high and ensuring the 
elution of any residual reagents following the processing cycle. The retention 
and distribution of collagen IV, laminin and fibronectin following treatment with 
supercritical CO2 under submerged conditions was superior to all other 
sterilisation treatments. Comparison of the relative levels of active (i.e. non-
degraded) PAA and H2O2 and characterisation of oxidation products in the 
decellularised nerves treated with the standard and submerged supercritical 
processes would provide further evidence to support the proposed mechanism 
of degradation and the protective effect of PBS solution.  
The implications of the observed changes to the basement membrane for the 
support of neuroregeneration are not known. The importance of fibronectin and 
(especially) laminin for the growth and migration of Schwann cells and 
regenerating axons has been widely demonstrated [42]. Laminin and fibronectin 
act as chemoattractants for Schwann cells and facilitate direct binding of 
regenerating axons, while the expression of both molecules is upregulated in 
Schwann cells following injury [361]. Cell interaction with laminin and fibronectin 
appears to be dependent upon specific components or regions within these 
ligands: the 2, 4 and 1 laminin sub-chains (contained within the isoforms 
laminin 2 and laminin 8) and the “V region” of fibronectin are regarded as 
particularly important [42, 61]. The effects of the changes seen following PAA 
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and supercritical CO2 treatment therefore may be dependent on the extent and 
nature of oxidative damage. The reduction of specific labelling for fibronectin 
and the loss of localisation in labelling for laminin seen following treatment with 
the standard supercritical CO2 process implies a greater level of basement 
membrane degradation compared to PAA treatment. If the oxidising agents 
used in this study have caused changes to the localisation, surface chemistry 
and/or conformation of key binding sites then cellular interaction (and 
associated process such as Schwann cell growth, ECM remodelling, and axon 
attachment) may be impeded. Additionally, such alterations could cause the 
ECM components (or fragments thereof) to be recognised as DAMPs, leading 
to activation of the innate immune system and potentially compromising the 
integration of the graft [132, 133]. Conversely, if the specific target epitopes of 
the antibodies used to label fibronectin and laminin have been affected but the 
key cell attachment motifs have not, then the ability of the decellularised nerves 
to support site-specific cells and effectively promote neuroregeneration may not 
have been compromised.  
The role of collagen IV in neuroregeneration is less well characterised than for 
laminin or fibronectin. Beyond the primary function as a supporting scaffold for 
the other basement membrane components, in vitro studies with rat cells have 
indicated that collagen IV may have an additional role in cell interaction [321]. 
Axons interact with collagen IV through α1β1 integrin, while Schwann cells 
interact with collagen IV through the integrins α1β1 and α2β1 and the G-protein 
coupled receptor GPR126 [362-364]. Downstream signalling through adenosine 
3’-5’-cyclic monophosphate (cAMP) induces the Schwann cells to differentiate 
and adopt pro-myelinating characteristics; genetic knockout studies altering the 
conformation of GPR126 prevented the expression of myelin basic protein 
[365]. The degree of similarity between human and rat Schwann cells and 
associated myelination processes remains unclear, but specific interaction with 
collagen IV may well be of importance. Therefore, changes such as those seen 
after treatment with PAA solution and the standard supercritical CO2 process 
preventing antibody binding may also disrupt cell-matrix interactions such as 
that mediated by GPR126.  
Treatment with sterilisation methods incorporating oxidising agents (specifically 
0.1% (v/v) PAA in solution and supercritical CO2 processing incorporating an 
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additive solution containing low concentration PAA and H2O2) appeared to have 
induce some disruption to the structure of the endoneurial tubules in the 
decellularised nerves, as well as causing a loss of specific antibody labelling for 
basement membrane components associated with cell attachment (laminin, 
fibronectin). Conducting supercritical CO2 treatment under submerged 
conditions appeared to prevent such alterations, suggesting that the local 
concentration of oxidising agents in the tissue during and after treatment may 
be an important factor in determining the extent of oxidative damage incurred to 
ECM components. The results of the histological staining and antibody labelling 
detailed here suggest that treatment of the decellularised nerves with SCCO2 
under submerged conditions, gamma radiation, and E Beam mediate superior 
preservation of peripheral nerve histoarchitectural features and key cell 
attachment molecules compared with either PAA in solution or SCCO2 
processing under standard conditions, and therefore may present a superior 
material for the promotion and guidance axonal and Schwann cell growth and 
function when implanted into a defect site.   
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6 Physical properties of sterilised decellularised nerves 
6.1 Introduction 
The importance of retaining material properties for the function of decellularised 
grafts varies by tissue type. Peripheral nerves, unlike musculoskeletal tissues 
(such as cartilage, tendon, ligament and bone), do not primarily function to 
provide strength, structure and biomechanical stability [8]. The mechanical 
function of peripheral nerve ECM is to provide protection for cells residing within 
the tissue from external tensile and compressive forces. Unique challenges are 
posed by the length of axons and the potential induction of degenerative injury 
in the event of exposure to excessive mechanical forces. In particular, 
peripheral nerves must provide protection from such forces in regions close to 
articulating joints, where rapid and frequent changes to tensile and compressive 
stress may be encountered.  
Terminal sterilisation methods may alter the material properties of decellularised 
tissue grafts [179]. Ionising radiations, such as gamma radiation and E Beam, 
can induce crosslinking or chain scission in the structurally important collagen 
molecules which make up the majority of the ECM [1]. Treatment with oxidising 
agents such as PAA or H2O2 can cause oxidative degradation and solubilisation 
of ECM components [242]. Insufficient rehydration of dried decellularised 
tissues can lead to an increase in stiffness [339]. Changes to the mechanical 
properties of the decellularised nerves could impede the growth and function of 
axons; for example, collagen  [73, 366]. 
The structure of collagen within the ECM,  including the folding of individual 
tropocollagen units and interaction between separate units, is crucial to tissue 
structure and function [367]. The non-covalent  (e.g. hydrogen bonds, ionic 
bonds) and covalent (e.g. disulphide linkages, trivalent pyridinoline and pyrole 
crosslinks) bonds which contribute to the higher order structure of collagens are 
susceptible to disruption by decellularisation and sterilisation methods [145, 
368]. Disruption of inter and intra-molecular bonds in collagen can lead to full or 
partial unfolding of higher order structure, potentially affecting the mechanical 
properties and capacity to support cells of a decellularised tissue.  
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Differential scanning calorimetry (DSC) enables quantitative analysis of 
changes in protein bonding patterns [369]. DSC enables the denaturation 
temperature of collagen to be determined; this represents the temperature at 
which the higher order structure of the collagen molecule unfolds. A decrease in 
the denaturation temperature indicates non-covalent and/or covalent bonds 
have been disrupted and therefore less thermal energy is required to disrupt the 
remaining bonds. An increase in the denaturation temperature may indicate an 
increase in inter and/or intra-molecular crosslinking, such as that which may be 
induced by ionising radiation in the presence of water molecules.  
Disruption of inter and/or intra-molecular bonds may also be detected by 
differences in susceptibility to enzymatic digestion by collagenase A [370]. 
Samples of tissue are digested for a given time period, after which the 
hydroxyproline content of the digest solution is quantified and extrapolated to 
give digested collagen content. A greater proportion of digested collagen per 
tissue mass is likely to be indicative of disruption to inter and/or intra-molecular 
crosslinks enabling more rapid digestion.  
As the material properties of the decellularised nerves are likely to affect the 
growth and function of cells in vivo, quantification of changes following 
sterilisation is important to identify methods capable of preserving such 
properties.  
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6.2 Aims and Objectives 
 
6.2.1 Aims 
 
The aim of this chapter was to characterise the effects of sterilisation methods 
on the physical properties of decellularised nerves. 
 
6.2.2 Objectives 
 
i. To determine the effects of sterilisation on the mechanical properties of 
decellularised nerves through uniaxial tensile testing. 
ii. To determine the effects of desiccation on the mechanical properties of 
decellularised nerves through uniaxial tensile testing. 
iii. To determine the effect of sterilisation on the denaturation temperature of 
collagen in the ECM of decellularised nerves, though DSC. 
iv. To determine the effect of sterilisation on the collagenase susceptibility of 
decellularised nerves. 
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6.3 Materials and Methods 
6.3.1 Decellularisation and sterilisation 
Porcine peripheral nerves were dissected, decellularised and sterilised as 
described in sections 2.9 and 2.10.  
6.3.2 Production of controls representing crosslinking and 
denaturation of collagens in decellularised nerve 
Two control treatments were produced as extreme examples for the 
denaturation or crosslinking of collagens in the ECM. One group of 
decellularised nerves (n = 6) were denatured through treatment with NaOH, as 
described in section 2.10.3.5.  
A further group (n = 6) of decellularised nerves were incubated in 10 % (v/v) 
NBF for 120 hours. The samples were washed three times in PBS for one hour 
each time, before a further PBS wash overnight.  
Samples from both control groups were stored in PBS at 4 °C until use.  
6.3.3 Uniaxial tensile testing 
Samples of native, decellularised, and decellularised nerves from each 
sterilisation treatment group (n = 6 per group) were subject to uniaxial tensile 
testing, as described in section 2.13. Briefly, samples of nerve were mounted 
onto an Instron 3365 machine using clamps and grips which were specifically 
designed for use with soft tissue. The samples of nerve were subjected to a 
single ramp-to-failure tensile test at a strain-rate of 10 mm.minute-1. The 
maximum load each sample sustained was used (in conjunction with the 
measured cross sectional area) to calculate the ultimate tensile strength, and 
the gradient of the slope in the linear region of the stress-strain curve was used 
to define the Young’s Modulus. Full details of how these values were calculated 
is given in section 2.13. 
As it was not possible to shape the nerves into standard sizes for testing, due to 
the heterogeneity of nerve ECM structure and the differing contributions of the 
structures in nerve ECM to mechanical properties. Therefore, a method to 
measure the dimensions of the nerve samples without resizing was developed. 
However, due to the inherent inaccuracies which these restrictions could 
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introduce to the calculation of cross-sectional area, maximum load and stiffness 
were also considered during the course of this study, as measures of 
mechanical properties which could be determined independent of the physical 
dimensions of the tissue.  
6.3.4 DSC analysis of sterilised nerves 
Samples of native, decellularised and sterilised decellularised nerves (n = 6 per 
group) were dissected to give individual segments of 2 – 5 mg (wet weight). 
Samples were then transferred to individual 1.5 ml eppendorfs containing 1 ml 
of PBS and shipped in an icepack-cooled container to the Department of 
Materials Science, University of Cambridge.  
The thermal stability of each sample was determined using a Q2000 differential 
scanning calorimeter. Samples were hermetically sealed into aluminium 
containers. The temperature was increased at a constant rate of 4 °C.min-1, 
from 15 - 130 °C. Heat flow through each sample was measured and 
normalised against the mass of the sample to give a value defined in Watts per 
gram (W/g). The denaturation temperature was taken as the point of maximum 
heat flow through the sample. 
6.3.5 Collagenase susceptibility assay 
The collagenase susceptibility of the nerves (native, non-sterilised 
decellularised, and treated with either PAA, gamma radiation, E Beam, SCCO2 
or NaOH; n = 6 per group) was determined by a colourimetric assay of 
solubilised enzyme digestion products.  This was enabled by enzymatic 
digestion with collagenase A. 
6.3.5.1 Solutions 
Collagenase A digest buffer 
6.055 g Tris-HCl and 3.7 g calcium chloride were dissolved in 900 ml of distilled 
water using a magnetic stirrer bar. The pH of the solution was adjusted to 8 
using 6 M NaOH or 6 M HCl.   
Collagenase A working solution 
Lyophilised Collagenase A was dissolved in the digest buffer (pre-warmed to 37 
°C) using a magnetic stirrer bar, to give a working concentration of 1 mg.ml-1. 
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6.3.5.2 Assay Method 
Samples of nerve were lyophilised (as described in 2.14.1) in a sterile 1.5 ml 
eppendorf to give a dry weight of approximately 10 – 20 mg. Collagenase A 
working solution (600 µl) was added to each sample, and the samples were 
incubated in a water bath for three hours at 37 °C. The digested samples were 
centrifuged at 15,500 x g for ten minutes, and 25 µl of supernatant was 
transferred to a fresh sterile screw top 2 ml Eppendorf complete with O-ring 
seal. HCl (12 M; 25 µl) was added to each tube. Each tube was then sealed 
autoclaved (121 °C, 18 PSI) for one hour to enable hydrolysis.  
After hydrolysis, 450 µl of chloramine T (see section 2.14.3.1) was added to 
each tube. The tubes were transferred to a water bath and incubated at 65 °C 
for 20 minutes. 500 µl of Ehrlichs solution (see 2.14.3.1) was added to each 
tube, after which the samples were transferred back to the water bath for a 
further 20 minute incubation at 65 °C. 200 µl aliquots of each sample were 
added in triplicate to a 96 well plate, together with known standards. 
Measurements of optical density were taken for each well containing a standard 
and sample, at a wavelength of 570 nm.  
A curve of absorbance against concentration was plotted for the known 
standards, and used as a standard curve. The absorbance values for test 
samples were used to generate interpolated hydroxyproline concentrations. 
These values were then used in conjunction with the values of tissue mass and 
dilution factor to calculate the hydroxyproline content of the tissue samples. The 
total mass of digested collagen was then calculated using a conversion factor of 
7.52,  as described in 2.14.4. 
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6.4 Results 
6.4.1 Uniaxial tensile testing of sterilised nerves 
Six samples from each different treatment group were subject to uniaxial tensile 
testing. The data from each sample was plotted as a stress-strain curve, to 
enable analysis of the effects of the sterilisation treatments on the mechanical 
properties of decellularised nerves (Figure 6-1).  
The UTS of decellularised nerves treated with PAA (7.63 +/- 2.28 MPa) was 
significantly reduced in comparison to native peripheral nerves (11.82 +/- 1.16 
MPa), but not untreated decellularised nerves (10.37 +/- 2.29 MPa; Figure 6-2 
A). The UTS of decellularised nerves treated with SCCO2 (14.91 +/- 4.78 MPa) 
was increased in comparison to untreated decellularised nerves (10.37 +/- 2.29 
MPa) and decellularised nerves treated with PAA, gamma, E Beam (7.63 +/- 
2.28 MPa, 10.52 +/- 1.51 MPa, and 10.74 +/- 2.75 MPa, respectively).  
The maximum load of decellularised nerves treated with SCCO2 (113.3 +/- 29.2 
N) was increased compared to native peripheral nerves (53.13 +/- 15.5 N), 
untreated decellularised nerves (59.69 +/- 29.84 N) and decellularised nerves 
treated with PAA and gamma radiation (62.53 +/- 12.88 N and 69.23 +/- 20.75 
N; Figure 6-2 B). 
The Young’s Modulus of decellularised nerves treated with SCCO2 was 
increased compared to native and untreated decellularised nerves and those 
treated with PAA and E Beam (Figure 6-3 A). The Young’s Modulus of 
decellularised nerves treated with gamma radiation was greater than that of 
decellularised nerves treated with PAA. 
The stiffness of decellularised nerves treated with SCCO2 (45.77 +/- 14.29 MPa) 
was greater than that of native peripheral nerves (27.33 +/- 4.56 MPa), 
untreated decellularised nerves (25.73 +/- 7.295 MPa) and decellularised 
nerves treated with PAA or E Beam (17.68 +/- 3.58 MPa and 24.73 +/- 6.94 
MPa, respectively; Figure 6-3 B). The stiffness of decellularised nerves treated 
with gamma radiation (24.37 +/- 7.55 N/mm-1) was greater than that of native 
peripheral nerves (15.39 +/- 3.42 N/mm-1), untreated decellularised nerves 
(14.12 +/- 6.02 N/mm-1) and decellularised nerves treated with PAA (15.2 +/- 
2.99 N/mm-1). 
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UTS 
Young’s  
Modulus 
No differences were seen between native nerves, non-sterilise decellularised 
nerves or decellularised nerves treated with any of the candidate sterilisation 
methods in terms of energy to break (Figure 6-4). 
NaOH-treated decellularised nerves displayed consistently degraded 
mechanical properties compared with all other treatment groups; by 
comparison, NBF-treated decellularised nerves only showed significant 
differences compared with SCCO2 in terms of UTS and Young’s Modulus, as 
well as compared with E Beam-treated, PAA-treated, non-sterilised and native 
nerves in terms of stiffness and nerves from all groups except those treated with 
gamma radiation, E Beam or SCCO2 in terms of energy to break values. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-1 Stress-strain curve for a sample of native peripheral nerve 
Stress-strain curve produced from combining load-extension data with the 
measured cross-sectional area and a known gauge length. Labels indicate the 
peak value for stress (UTS) and the region of linear extension from which the 
Young’s modulus is defined.  
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Figure 6-2 UTS and Maximum Load of native, decellularised and sterilised 
peripheral nerves 
(A) UTS and (B) Maximum Load of peripheral nerves from all treatment groups. 
Data shown as mean +/- 95 % confidence interval, n = 6. Statistical analysis 
was by (A) one-way ANOVA or (B) Kruskall-Wallis. * denotes groups which are 
significantly different (p<0.05).  
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Figure 6-3 Young’s Modulus and Stiffness of native, decellularised and 
sterilised peripheral nerves 
(A) Young’s Modulus and (B) Stiffness of peripheral nerves from all treatment 
groups. Data shown as mean +/- 95 % confidence interval, n = 6. Statistical 
analysis was by (A) Kruskal-Wallis or (B) one-way ANOVA. * denotes groups 
which are significantly different (p<0.05).  
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Figure 6-4 Energy to break values for native, decellularised and sterilised 
peripheral nerves 
(A) Young’s Modulus and (B) Stiffness of peripheral nerves from all treatment 
groups. Data shown as mean +/- 95 % confidence interval, n = 6. Statistical 
analysis was by one-way ANOVA. * denotes groups which are significantly 
different (p<0.05).  
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6.4.2 Uniaxial tensile testing of desiccated nerves 
Samples of desiccated decellularised nerves were rehydrated and subjected to 
uniaxial tensile testing to determine the effects of desiccation on the material 
properties of decellularised nerves. As desiccation represents a potential 
preparation method for a sterilisation method (ethylene oxide treatment) rather 
than a sterilisation method in it’s own right, the desiccated decellularised nerves 
were analysed separately to the groups of sterilised nerves. Extra groups of 
native and decellularised nerves were also tested and included in the analysis.  
The UTS of desiccated decellularised nerves, at 16.28 (+/- 6.49) MPa, was 
significantly higher than native nerves but not untreated decellularised nerves at 
11.35 (+/- 2.03) MPa and 9.84 (+/- 2.79) MPa respectively (Figure 6-5 A).  
The Young’s Modulus of desiccated decellularised nerves, at 48.11 (+/- 26.7) 
MPa, was significantly higher than both native and untreated decellularised 
nerves at 29.97 (+/- 5.46) MPa and 23.09 (+/- 6.45) MPa respectively (Figure 
6-6 A).  
The values for maximum load at failure, stiffness, and energy to break for 
desiccated decellularised nerves were not significantly different from either 
native or decellularised nerves (Figure 6-5 B, Figure 6-6 B, and Figure 6-7).  
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Figure 6-5 UTS and Maximum Load of native, decellularised and 
desiccated peripheral nerves 
(A) UTS and (B) Max Load of native, decellularised and desiccated peripheral 
nerves. Data shown as mean +/- 95 % confidence interval, n = 6. Statistical 
analysis was by one-way ANOVA. * denotes groups which are significantly 
different (p<0.05).  
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Figure 6-6 Young’s Modulus and Stiffness of native, decellularised and 
desiccated peripheral nerves 
(A) Young’s Modulus and (B) Stiffness of native, decellularised and desiccated 
peripheral nerves. Data shown as mean +/- 95 % confidence interval, n = 6. 
Statistical analysis was by one-way ANOVA. * denotes groups which are 
significantly different (p<0.05).  
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Figure 6-7 Energy to break values for native, decellularised and 
desiccated peripheral nerves 
Energy to break values for native, decellularised and desiccated peripheral 
nerves. Data shown as mean +/- 95 % confidence interval, n = 6. Statistical 
analysis was by one-way ANOVA. * denotes groups which are significantly 
different (p<0.05).  
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6.4.3 DSC analysis of native, decellularised and sterilised nerves 
The denaturation temperatures of samples for each group were quantified by 
measuring heat flow (W/g) in a differential scanning calorimeter (Figure 6-8). 
Mean denaturation temperatures in nerves from each of the treatment groups 
were found to be significantly different to most or all of the other groups (Figure 
6-9). The denaturation temperatures of untreated decellularised nerves at 65 
(+/- 0.65) and PAA-treated nerves at 64.29 (+/- 0.26) °C were not significantly 
different from that of native nerves at 65 (+/- 0.4) °C. The denaturation 
temperatures of PAA-treated and SCCO2-treated nerves were not significantly 
different from each other, at 64.29 (+/- 0.26) °C and 64.2 (+/- 0.35) °C 
respectively. The denaturation temperatures of gamma irradiated and E Beam-
treated nerves were approximately 5 – 6 °C lower than the other groups but 
were not significantly different from each other, at 58.98 (+/- 0.22) °C and 58.53 
(+/- 0.23) °C respectively. The NaOH-treated control had a denaturation 
temperature of 44.96 (+/- 1.29) °C, approximately 20 °C lower than untreated 
decellularised nerve. The NBF-treated control had a denaturation temperature 
of 88.46 (+/- 0.17) °C, approximately 23 °C higher than untreated decellularised 
nerve. 
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Figure 6-8 Example of thermogram from native porcine peripheral nerve 
Data output from Q2000 differential scanning calorimeter, showing heat flow 
through a sample of native porcine peripheral nerve. Two peaks in heat flow are 
seen, with denaturation temperature taken as the point of greatest heat flow at 
64 °C. 
Temperature (°C) 
Heat 
Flow 
(W/g) 
°C 
°C 
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Figure 6-9 Denaturation temperatures of native, decellularised and 
sterilised porcine peripheral nerves 
Denaturation temperatures of peripheral nerves from all treatment groups. Data 
shown as mean +/- 95 % confidence interval, n = 6. Statistical analysis was by 
one-way ANOVA. * denotes groups which are significantly different (p<0.05).  
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6.4.4 Determination of collagenase susceptibility in native, 
decellularised and sterilised nerves 
The susceptibility of nerves to digestion by collagenase A did not significantly 
change following either decellularisation or treatment of the decellularised 
nerves with gamma radiation or E Beam (Figure 6-10). Decellularised nerves 
treated with PAA were significantly more susceptible to digestion, with the 
collagen digested as proportion of overall tissue mass at 269.7 (+/- 41.7) g.mg-
1 compared to 180.7 (+/- 21.25) g.mg-1 and 190.7 (+/- 17.85) g.mg-1 for native 
nerves and untreated decellularised nerves respectively.  Significantly more 
collagen was digested in decellularised nerves treated with SCCO2 compared to 
native nerves, but not untreated decellularised nerves, at 248.5 (+/- 34.75) 
g.mg-1. Collagenase susceptibility in gamma irradiated, PAA-treated and 
SCCO2-treated nerves was not significantly different from the NaOH-treated 
positive control. 
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Figure 6-10 Collagenase susceptibility of native, decellularised and 
sterilised porcine peripheral nerves 
(A) Standard curve for interpolation of digest samples and (B) the mass of 
collagen digested by collagenase A from peripheral nerves in all treatment 
groups. Data shown as mean +/- 95 % confidence interval, n = 6. Statistical 
analysis was by one-way ANOVA. * denotes groups which are significantly 
different (p<0.05).  
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6.5 Discussion 
The sterilisation treatment methods used in the present study induced changes 
to the material properties of the decellularised nerves. These changes were 
particularly evident in terms of collagen molecular and structural integrity, but 
less pronounced at the level of whole tissue biomechanics.  
The UTS of decellularised nerves were altered following treatment with PAA. A 
possible explanation for this may have been the slightly increased levels of 
structural disruption which were observed histologically (see Chapter 5). 
However, the structure of peripheral nerve ECM is heterogenous, with a large 
degree of variation between different regions. The layered lamellar structure of 
the perineurium, composed of aligned and highly organised collagen fibrils, 
surrounds each fascicle and is thought to be the primary contributor to the 
tensile mechanical properties of peripheral nerve [74]. Structural disruption in 
decellularised nerves treated with PAA was limited to the epineurium and 
endoneurium. The epineurium is composed of loosely organised adipose tissue 
and collagenous ECM, and is primarily thought to modulate compressive stress 
and enable movement of the nerve within the connective tissue sheath 
(excursion) [43]. The endoneurium, composed of a fine honeycomb structure of 
collagens and basement membrane components including fibronectin and 
laminin, provides guidance and attachment sites for Schwann cells and 
neurons.  
As the structural disruption observed following PAA treatment was limited to the 
epineruium and endoneurium, it is unlikely to have contributed to the reduced 
tensile strength. Instead, the increased spacing/looseness in the epineurium 
may have led to an overall increase in cross sectional area, thereby altering the 
material properties of the nerve as a whole without altering the mechanical 
properties of the perineurium surrounding each fascicle. Evidence for this is 
provided by the fact that while PAA-treated nerves had a reduced UTS (which is 
dependent on cross-sectional area) compared to native nerves, there was no 
difference in the maximum load at failure. Considering the retention of overall 
load-bearing capacity, the distribution of the structural disruption and the 
uneven contribution of the different ECM structures to the mechanical properties 
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of peripheral nerves, it is unlikely that the reduction in UTS would affect the 
efficacy of the decellularised tissue in vivo. 
Treatment with SCCO2  caused increases in all mechanical parameters 
compared to untreated decellularised nerves. Previous studies into the effect of 
SCCO2 treatment on the biomechanical properties of decellularised tissue grafts 
have yielded mixed results. SCCO2  treatment  did not appear to affect strength 
or Young’s modulus in studies of decellularised human and rabbit cortical bone; 
however, as bone is a mineralised hard tissue these effects may not be directly 
comparable to peripheral nerve [371, 372]. However, SCCO2  treatment caused 
an approximate increase of 135 % in the Young’s modulus of decellularised rat 
lung matrices and an approximate 15 % increase in the Young’s modulus of a 
synthetic collagen scaffold crosslinked with EDC [214, 243]. The mechanism 
underlying these changes and those observed in the present study is currently 
unknown. Balestrini et al suggested that the high pressure in the SCCO2  
reaction chamber could have mediated the formation of crosslinks between 
and/or within collagen molecules in the decellularised lung ECM [243].  
Dehydration of the decellularised nerves would be a necessary step prior to 
sterilisation with ethylene oxide, enabling diffusion of the ethylene oxide into the 
tissue, reducing the potential for the formation the toxic breakdown products 
ethylene glycol and ethylene chlorohydrin, and enabling the removal of the 
ethylene oxide (and any associated breakdown products) from the tissue 
through an aeration process [194]. Due to the structural damage to the 
endoneurium observed when decellularised nerves subject to lyophilisation 
(section 5.4.1), desiccation was considered as an alternative method of 
dehydration. However, desiccation increased the Young’s modulus of the 
decellularised nerves. Histological analysis indicated that the decellularised 
nerves were not fully rehydrated after desiccation. Increases in Young’s 
modulus as a result of dehydration have been demonstrated both on a whole 
tissue and a molecular scale, through uniaxial mechanical testing of tissues 
including  human skin and  bovine cornea, and measurement of individual 
collagen fibrils using atomic force microscopy [54, 373, 374]. Inter and 
intramolecular hydrogen bond-mediated “water bridges” form between pairs of 
amino acids, including hydroxyproline and glycine, during the synthesis and 
folding of the individual collagen molecules and higher order structures [375]. 
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The results of a computational simulation study evaluating the molecular 
dynamics of collagen-like peptides before and after dehydration indicated that 
the removal of water molecules (and therefore the water bridges) significantly 
increased hydrogen bonding between pairs of amino acids as well as the 
structural rigidity of the molecules [376]. The study also found that the increase 
in rigidity mediated by the hydrogen bonds was unlikely to be reversed by the 
reintroduction of water molecules (i.e. the water molecules would be unable to 
disrupt the hydrogen bonds). This implies that while water molecules may be 
able to re-infiltrate inter and intramolecular spaces of dehydrated collagen 
molecules, the increase in stiffness mediated by the formation of hydrogen 
bonds in place of water bridges may not be reversible. Experimental data 
supporting this hypothesis have been gathered using Raman spectroscopy 
analysis of collagen I and DSC analysis of cross-linked and partially dehydrated 
rat tail tendon [171, 377]. The formation of the intramolecular hydrogen bonds 
and increased structural “tightness” mediated by dehydration within the 
individual alpha helices has been further evidenced by measurement of the 
intermolecular overlap, or D-period, within collagen fibrils [378]. An atomic force 
microscopy study of scleral collagen I indicated that the D-period decreased 
from 64 nm in hydrated collagen to 21 nm in dehydrated collagen, as well as a 
decrease in lateral spacing between tropocollagen units [379]. Similarly, a study 
of collagen I in decellularised bovine dermis using synchotron-based small 
angle X-ray scattering revealed a significant decrease in fibril width and 
intermolecular spacing following dehydration. These mechanisms may partially 
explain the findings of the 2013 study by Meyer et al, which demonstrated that 
collagenous porcine tissues (especially adipose tissue) do not fully rehydrate 
after dehydration [347]. The increase in Young’s modulus seen here may 
therefore be an irreversible consequence of dehydration. 
Whilst an increase in UTS or maximum load at failure is unlikely to be of 
concern in a peripheral nerve graft, changes to the Young’s Modulus and 
stiffness may have a negative effect on axonal function [8]. The elastic 
properties of peripheral nerve ECM modulate the tensile stress experienced by 
axons carried within the endoneurium. This function is particularly important in 
regions of nerves travelling close to articulating joints; for example, levels of 
strain in the ulnar and median nerves of the human arm can change by up to 
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approximately 35 % during elbow and wrist joint flexion and extension. Axons 
interact with (and bind to) basement membrane ECM components in the 
endoneurium through integrins, such as the 71 receptor for laminin and the 
51 receptor for fibronectin [380]. Changes in strain to the nerve ECM are 
therefore directly transduced to the axons contained within the endoneurium 
[381].  
Given that the perineurium primarily determines the mechanical properties of 
peripheral nerve, the increase in stiffness but not Young’s modulus seen in 
gamma irradiated nerves is likely to be due to changes (e.g. increased 
intermolecular crosslinking) being localised to the perineurium. In the nerve as a 
whole the epineurium, a heterogeneous structure composed of of adipose and 
collagenous tissue which is a comparatively minor contributor to tensile 
mechanical strength, makes up the majority of the cross sectional area of 
peripheral nerve [104]. It is likely that if individual fascicles (made up of a 
perineurial sheath surrounding the endoneurium) were dissected away from the 
epineurium in the gamma irradiated nerves and subject to uniaxial tensile 
testing, the Young’s Modulus would be altered in addition to the stiffness. 
An increase in the Young’s Modulus (and/or stiffness) of the decellularised 
nerve graft, such as that seen following SCCO2  treatment, desiccation and 
gamma radiation, could lead to axonal bodies experiencing increased tensile 
stress in the regions immediately proximal and distal to the graft-tissue 
interface. Graft material with an increased Young’s Modulus would not deform 
to the same extent as native tissue under a given load; therefore, the 
surrounding nerve tissue would be required to deform further during the peak 
strain levels induced by joint flexion to compensate. Elevated local levels of 
strain would increase the probability of tensile stress exceeding normal 
physiological levels. The severity of this effect would likely be dictated by the 
size and location of the defect. The greater the proportion (in terms of length) of 
a given nerve replaced with an inherently stiffer graft material, the greater the 
change in peak strain levels within the distal and proximal tissue.   
High levels of tensile stress in axons can lead to increased local expression of 
transmembrane voltage-gated sodium channels, which mediate the conduction 
of action potentials along the length of the axon through localised membrane 
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depolarisation [382]. The effects of increased ion channel expression are 
compounded by changes in distribution; normally restricted to specific sites, 
most commonly the Nodes of Ranvier between myelinated regions, excessive 
tensile stress induces sodium channel insertion over wider regions of the axonal 
cell membrane, thereby potentially impeding the conduction speed of action 
potentials.  
Multiple in vivo studies have shown that blood flow in the network of vessels 
local to the peripheral nerve, the vasa nervorum, can be impeded by excessive 
levels of tensile strain. A tensile strain of 16 % in the sciatic nerve of a New 
Zealand white rabbit resulted in a 49 % reduction in blood flow [383]. A strain of 
8 % to a rat sciatic nerve was found to induce a 50 % reduction in blood flow, 
increasing to an 80 % reduction under strain levels of 15 % [384]. 
Excessive tensile stress can also negatively impact upon Schwann cells, 
inducing either cell death or a decrease in the expression of myelin-associated 
adhesion molecules and regulatory genes including neuregulin 1, neural cell 
adhesion molecule, Krox20 and Sox10, and therefore resulting in localised 
(segmental) demyelination of axons [385, 386].  
The speed of signal transduction in peripheral nerve axons is dependent on the 
concept of saltatory conduction, where membrane depolarisation propagates 
between the Nodes of Ranvier (length 1 – 2 m) which separate the longer 
regions of membrane insulated with myelin (length 766 – 1739 m) [387]. 
Decreased blood flow within the nerve, loss of the insulating myelin coating the 
axon and increased sodium channel expression over wider areas of the axonal 
membrane would likely slow and/or impede the conduction of action potentials, 
as membrane depolarisation no longer propagates between relatively small and 
well-spaced regions [388]. In vivo studies have demonstrated this effect. 
Driscoll et al demonstrated that a tensile strain of 16 % to the sciatic nerve of 
New Zealand white rabbits induced a 34 % decrease in nerve conduction 
velocity [383]. Given the documented negative impact of increased strain on 
nerve function, and the fact that a stiffer graft material is likely to result in locally 
elevated strain, it is therefore desirable for a terminally sterilised graft material 
to retain elastic properties similar to native nerves. 
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Changes to the denaturation temperature of collagen in the decellularised 
nerves appeared to be directly linked to the type of sterilisation method used. 
Decellularisation and sterilisation can affect inter and intramolecular structure 
and interactions of collagen in the ECM. Higher order structure and organisation 
of collagen molecules, including α-helices and the fibrillar organisation of 
tropocollagen units in collagen type I, and β-sheets in collagen type IV, is 
determined by a range of covalent and non-covalent bonds between amino acid 
side chains including hydrogen bonds, pyridinoline crosslinks, ionic bonds and 
dipole-dipole interactions [389].  
Decellularisation appeared to have no detectable effect on denaturation 
temperature, inferring that treatment with decellularisation reagents such as 
SDS induced minimal disruption to the structural integrity of collagen in the 
nerves. Sterilised decellularised nerves could be separated into two separate 
groups based on type of sterilisation method, defined by statistically similar 
changes in denaturation temperature; the ionising radiations (gamma radiation 
and E Beam) and methods utilising oxidising agents (PAA and SCCO2).  
Treatment with both gamma radiation (25 kGy) and E Beam (34 kGy) appeared 
to cause an approximate 6 °C drop in the denaturation temperature, indicative 
of some level of denaturation within collagen structures in the decellularised 
nerves. Similar results have been seen in decellularised porcine superflexor 
tendons. Tendons treated with 0.1 % (v/v) PAA, gamma radiation (30 kGy) and 
E Beam (34 kGy) were found to have denaturation temperatures of 66.2 °C, 
58.3 °C and 58.2 °C respectively [336]. As in the present study, the tissue was 
in a hydrated (wet) state during irradiation.  
It is accepted that ionising radiation can induce both chain scission (direct 
interaction) and crosslinking (indirect interaction) in collagen molecules [172, 
390]. While crosslinking is thought to be the predominant mechanism in the 
presence of water molecule-generated free radicals, chain scission still occurs. 
The process of native crosslink formation is induced enzymatically by lysyl 
oxidase during collagen maturation [391]. Due to the specificity of native 
crosslinks to the amino acids lysine and hydroxylysine, the occurrence and 
contribution to structural stability of such crosslinks is governed by the 
distribution of these amino acids within the primary structure. Radiation-induced 
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crosslinks, formed due to interactions with the hydroxyl radicals produced by 
radiolysis of water molecules, are likely to be more randomly distributed as no 
specific enzyme action is required to mediate their formation [1].  
Chain scission is thought to be primarily an intramolecular process, disrupting 
covalent peptide bonds within the primary collagen structure [228]. Hydroxyl 
radicals are also thought to disrupt hydrogen bonds, further accounting for the 
reduction in denaturation temperature observed in this study. It has been 
postulated that the formation of additional crosslinks during irradiation primarily 
affects higher levels of structure, such as between individual tropocollagen units 
[152]. Chain scission could therefore cause the α helix structure of collagen 
(including types I and III) to be destabilised and mean that less thermal energy 
is required to initiate denaturation and uncoiling, without compromising tensile 
mechanical properties which are primarily mediated through higher order 
structures determined by intermolecular interactions.  
The findings presented here corroborate previous studies indicating that 
superior preservation of collagen molecular integrity is achieved when 
collagenous tissues are irradiated in a wet state, inducing synergistic chain 
scission and crosslinking, rather a dry state favouring the predomination of 
chain scission through direct interaction of radiation with collagen molecules 
[392]. A previous study examined the effects of lyophilisation prior to gamma 
irradiation (28.6 kGy) on decellularised human dermis. After rehydration and 
DSC analysis, the induced decrease in denaturation temperature was 
measured as approximately 20 °C [393]. This was accompanied by a 
deterioration in tensile mechanical properties, a decrease in histoarchitectural 
integrity, and a 75 % decrease in overall tissue mass, all of which correlate with 
widespread fragmentation of collagen structure through chain scission [6]. In 
contrast, a study of decellularised porcine superflexor tendons found that 
treatment with gamma radiation (30 kGy) and E Beam (34 kGy) induced only a 
6 °C decrease in denaturation temperature, and minimal alterations to 
histoarchitecture and mechanical properties [336]. Porcine toe extensor tendons 
which were gamma irradiated (25 kGy) in a frozen hydrated state retained 
native-like tensile mechanical properties, whereas the UTS and Young’s 
modulus of tendons irradiated (25 kGY) after lyophilisation decreased by 
approximately 80 % and 50 % respectively [228]. While relatively limited data 
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exist towards the likely clinical efficacy of irradiated decellularised grafts, the 
efficacy and safety of allograft tissues sterilised with gamma radiation in a 
hydrated state has been demonstrated clinically in both soft and hard tissues 
(including amniotic membrane and bone) [394, 395].  
The denaturation temperature of decellularised nerves treated with 0.1 % PAA 
was not significantly different from that of SCCO2. This finding provides further 
evidence to suggest that a common mechanism of oxidative damage is causing 
alterations to ECM components in decellularised nerves treated with both 
methods. The NovaKill™ additive solution used during SCCO2  contains the 
oxidising agents PAA and H2O2. A study of decellularised porcine aortic valves 
found that sterilisation with either PAA solution or SCCO2 with the NovaKill™ 
additive solution both induced 4 °C increase in denaturation temperature from 
native tissue. Although SCCO2 treatment appeared to cause a slight reduction 
in the denaturation temperature of decellularised nerves, the reduction was less 
than 1 °C. The small reduction in denaturation temperature induced by PAA 
treatment was not significantly significant. Therefore, despite the potential 
changes to ECM component surface chemistry observed in sections 5.4.3, 5.4.4 
and 5.4.5, both methods appear to have minimal effect on structurally integral 
inter or intramolecular collagen bonding.   
A smaller peak in heat flow was observed in all samples between a temperature 
range of approximately  25 – 35 °C. While it is possible that a partially 
denatured protein structure could produce such a peak, a more likely 
explanation is melting of adipose tissue within the peripheral nerve. A 
quantitative biochemical assay, detailed in section 4.4.10, showed that fat 
makes up approximately 50 % of peripheral nerve dry mass. Previous studies 
into the thermal properties of adipose tissue yielded a similar peak in heat flow 
within this temperature range. DSC analysis revealed a peak heat flow of 
approximately 28 °C for bovine adipose tissue [396]. A DSC study of porcine 
adipose tissue from different anatomical locations revealed differences in the 
temperature of peak heat flow [397]. Peak heat flow was 31.1 °C in 
subcutaneous adipose tissue, 32.6 °C in intermuscular adipose tissue and 32.9 
°C in kidney leaf adipose tissue. In contrast, the measured denaturation 
temperature for native porcine skin, which like peripheral nerve has an ECM 
primarily composed of collagen I, is 66.8 °C [398]. In all of the samples (except 
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NaOH and NBF controls) measured here the greatest peak in heat flow was 
observed between 55 - 66 °C, indicating that the primary causative factor was 
uncoiling of the collagen I α helix.  
Changes to the susceptibility of ECM-based grafts to digestion with collagenase 
enzymes can give further indication of molecular level changes to structure and 
bonding. A study of different decellularised porcine dermis grafts revealed the 
effects of different processing techniques on collagenase susceptibility [399]. 
Permacol®, composed of decellularised porcine dermis crosslinked with 
hexamethylene diisocyanate, had a higher collagenase resistance than the non-
crosslinked Strattice®. The authors of the study hypothesised that both 
crosslinking and physical “spacing” within the matrix could influence the extent 
of matrix digestion by collagenase over a given timeframe. In the present study, 
treatment with the ionising radiations gamma radiation and E Beam enabled 
retention of “native-like” collagenase susceptibility, whereas PAA and SCCO2-
treated decellularised nerves were both more susceptible to collagenase 
digestion. Despite the likely scission of peptide bonds within the primary 
structure of collagen in irradiated samples, which was implied by the decrease 
in denaturation temperature, increased intermolecular crosslinking appears to 
have a protective effect with regard to digestion by collagenase enzyme. In 
contrast, the oxidative modifications (including possible partial solubilisation) to 
ECM components which are likely to have occurred during treatment with PAA 
and the NovaKill™ SCCO2  additive solution may have increased access of the 
collagenase enzyme to specific binding sites and thereby increased 
susceptibility to digestion [242]. The collagenase used in this assay, 
Collagenase A, specifically cleaves the peptide bond between glycine and 
amino acid “X” in the primary sequence proline-X-glycine-proline, which is 
common in collagens but occurs infrequently in other proteins [400]. Increased 
looseness was seen histologically in the epineurium of decellularised nerves 
treated with PAA, and to a lesser extent samples treated with the standard 
SCCO2  process. It is possible that such histoarchitectural changes may also 
have increased collagenase digestion, enabling the enzyme to access to a 
greater proportion of the ECM.  
Susceptibility to collagenase digestion is likely to influence tissue remodelling 
and retention of histoarchitectural structure in vivo. Little difference was 
- 210 - 
observed in regeneration (including parameters such as cell infiltration and 
fibrous encapsulation) of a porcine abdominal wall defect over 12 months when 
Permacol® was compared to Strattice®, despite the difference in collagenase 
susceptibility [401]. The main differentiating factor was the rate of degradation 
and deposition of ECM components, which appeared to be twofold higher in the 
non-crosslinked Strattice® compared to the crosslinked Permacol®. This was 
especially notable in the early stages, one month post-implantation. The 
implications of these findings for function in vivo are unclear. It has been 
postulated that retention of the ECM histoarchitecture is favourable for the 
promotion of neuroregeneration by  peripheral nerve graft, providing physical 
and chemotrophic guidance to infiltrating Schwann cells and regenerating axons 
[18, 58]. A higher susceptibility to collagenase digestion implies that greater 
remodelling of the matrix may take place post-implantation.  
The optimal level of tissue remodelling depends on the tissue type. Faster 
remodelling, facilitated by a graft material with a greater susceptibility to 
enzymes such as collagenase, which may be favourable in some tissue types 
such as dermis [401]. The network of endoneurial tubules provided by 
autografts, the current gold standard therapy for the repair of large defects, is 
thought to be a key factor in their clinical efficacy [402]. Based on the measured 
growth rate of human peripheral nerve axons, a maximum of 1 mm/day, optimal 
guidance of regeneration across a defect of 30 mm would require a high level of 
endoneurial structural maintenance for at least 30 days post-implantation [403]. 
Therefore, in peripheral nerve regeneration the native-like resistance to 
collagenase digestion (mediating a slower ECM remodelling process) of 
decellularised nerves sterilised with gamma radiation or E Beam is likely to be 
preferable during the initial period of regeneration.  
Each sterilisation method appeared to affect at least one measured physical 
parameter of the decellularised nerves. Treatment with SCCO2 under standard 
conditions, or methods requiring dehydration of the tissue (e.g. ethylene oxide), 
induced multiple alterations and so may not be appropriate for use with 
decellularised porcine peripheral nerves. E Beam treatment appeared to 
mediate the best overall preservation of material properties and molecular 
collagen integrity.  
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7 Cytotoxicity and immunoreactivity of sterilised nerves 
7.1 Introduction 
The biocompatibility of a biomaterial (such as a decellularised tissue graft) can 
be evaluated at different levels, from the relatively simple measure of 
cytotoxicity through to the local and systemic response of the host immune 
system. Given that terminal sterilisation processes may induce alterations to the 
structural, biochemical and physical properties of decellularised tissues, the 
potential of such grafts to induce an adverse cellular response should be 
assessed prior to clinical use [37, 132]. For a number of reasons, in vitro assays 
are preferred for the initial assessment of the biological response to 
biomaterials before conducting in vivo implantation studies.  
During the initial development of a biomaterial, it is common practice to assess 
the toxicity to mammalian cells using recognised cytocompatibility assays [404]. 
While this this can be carried out in vivo, in vitro methods are more appropriate 
when considering an initial screening process. Although not truly representative 
of the in vivo response, the use of in vitro methods allows a high degree of 
control over experimental parameters and the simple outcome measures enable 
sensitive detection of any cytotoxic effects resulting from a biomaterial. Multiple 
cell types are used to ensure cytocompatibility across different tissue types. 
Conducting an initial cytotoxicity screen in vitro has the further advantage of 
reducing the need for animal experimentation in a given study, lessening 
suffering in accordance with the principles of the 3R’s (Replacement, Reduction 
and Refinement) [405]. 
ISO standard 10993-5 (2009) defines two distinct in vitro assays for assessing 
cytotoxicity compared with positive and negative controls [406]. The direct 
interaction of cells with a biomaterial is tested through the contact cytotoxicity 
assay. A sample of a given biomaterial is placed onto a cell monolayer; the 
growth and morphology of cells at the interface between the biomaterial and 
tissue culture plastic is observed. The extract cytotoxicity assay enables the 
evaluation of any soluble matter which may be released from the biomaterial 
following implantation. A sample of the biomaterial is incubated in a solvent 
(often cell culture media); aliquots are added to pre-seeded wells, which are 
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then incubated and observed for evidence of changes. Evidence of cytotoxicity 
during this initial screening process indicates that the biomaterial is likely to 
induce local and/or systemic toxicity in vivo.  
After establishing the basic cytocompatibility of a biomaterial, further aspects of 
biocompatibility should be considered prior to implantation in an in vivo system. 
The immunoreactivity of a biomaterial should be characterised, in terms of both 
the level and nature of the induced host immune response [407]. At the most 
basic level, the response of the innate and adaptive immune system impacts 
upon the potential integration or rejection of a biomaterial following implantation 
[36]. However, this does not fully describe the complexity of the host response, 
which is massively variable in terms of distribution within the body, contributory 
pathways and effect. Host immune cells can influence the graft integration 
process through debris clearance and wound repair following surgical 
implantation, stimulation of site-specific cells and immune cells towards a 
phenotypic change, secretion of chemoattractants and secretion of matrix 
metalloproteases to aid cell ingrowth and tissue remodelling.  
The host response to an ECM-derived biomaterial, such as a decellularised 
tissue graft, is complicated by the inherent variability in composition versus a 
comparatively uniform and inert material (such as a metal or ceramic hip 
replacement). The most important modulators of adverse host immune 
response in decellularised tissue grafts are residual cellular component debris 
including nucleic acids, cytosolic components and phospholipid membrane 
fragments; these are collectively referred to as damage-associated molecular 
patterns (DAMPs) [132, 133]. Untreated cellular tissue (e.g. murine heart 
allografts) and decellularised grafts (e.g. decellularised porcine lungs implanted 
into rhesus macaques) have been observed to elicit an adaptive T cell-driven 
response but also an innate immune response; however, the magnitude of any 
response is likely to be much reduced due to the inherently lower concentration 
of cellular components present in decellularised tissues [37, 408-410]. The 
immune response to decellularised tissues may therefore be more favourable to 
graft integration and eventual functional restoration compared with an untreated 
(cellular) allo/xenograft [36, 37, 132]. The magnitude and exact nature of the 
immune response to a decellularised tissue graft is likely to vary in response to 
a range of factors. Tissues may retain relatively high levels of DNA and cellular 
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debris after a given decellularisation process has been applied; for example, a 
2015 study examined the effects of this on the macrophage response to 
decellularised porcine-SIS in vivo [132]. The porcine-SIS was decellularised 
through treatment with PAA solution for either 0 (PBS wash only), 1 or 2 hours, 
which resulted in correspondent differences in the retention of intact nuclei and 
DNA fragments; histological analysis indicated that scaffolds treated with PBS 
only (i.e. not decellularised) or the 1 hour PAA protocol elicited a much greater 
innate inflammatory response compared with scaffolds treated with the 2 hour 
PAA protocol (which achieved the greatest relative reduction in DNA content), 
which showed the greatest level of ECM remodelling and integration to the 
surrounding tissue. Furthermore, some tissue types may have higher levels of 
resident immune cells and/or greater potential for the infiltration of circulating 
immune cells compared with others (e.g. immune access to the CNS is much 
more restricted than to other tissues such as dermis) [411, 412]. 
In both arms of the immune system, the nature of the response to an implanted 
tissue graft is driven by the polarisation of key mediating cells. In the adaptive 
immune system, CD4+ T helper cells are the initial effector cells [134]. T helper 
cells can adopt either a pro-inflammatory (Th1; characterised by the secretion of 
pro-inflammatory cytokines including IL-2, IFN-, TNF and TNF,) phenotype 
or anti-inflammatory (Th2; characterised by the secretion of anti-inflammatory 
cytokines such as IL-4, 5, 6 and 10) phenotype, in response to stimulation from 
antigen-presenting cells such as macrophages and dendritic cells [413, 414] 
Decellularised tissue grafts appear to induce a predominantly Th2-mediated 
response, as demonstrated following subcutaneous implantation of 
decellularised porcine SIS into mice [415, 416] [417]. Both IL-4 and IFN- were 
present in the graft after 7 days; however, IFN- expression was 100-fold lower 
than in animals implanted with a non-decellularised control tissue. Gross 
histological analysis of explanted decellularised SIS grafts revealed an initial 
inflammatory response characterised by the infiltration of monocytes, followed 
by extensive remodelling and integration of the ECM after 28 days in situ. In 
contrast, the non-decellularised control tissue consistently stimulated pro-
inflammatory processes for the duration of the study, including monocyte 
activation and giant cell formation, T cell infiltration, structural degeneration of 
the graft and the formation of a fibrotic capsule surrounding the graft. This 
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encapsulation and fibrosis is characteristic of chronic rejection. A similar 
response was seen when the decellularised SIS was implanted in humans, with 
no evidence of rejection or significant adverse events [418].  
The innate immune system is dominant in the acute response following 
implantation and strongly influences the nature of the chronic response, 
stimulating pathways favouring either ECM remodelling and integration or 
fibrosis and encapsulation [36]. Macrophages are the primary mediators of the 
innate response to tissue grafts. Similarly to CD4+ T cells, macrophages 
undergo activation and phenotypic polarisation in response to external stimuli; 
these stimuli vary in nature but in the case of tissue grafts they are generally 
interaction with DAMPs [133]. Pro/anti-inflammatory cytokines secreted by local 
cells (and already activated macrophages) can amplify the activation and 
polarisation of macrophages. Macrophages polarise towards two phenotypes: 
M1, characterised by the secretion of pro-inflammatory cytokines such as IL-1, 
IL-6, IL-12 and TNF, and M2, characterised by the secretion of the anti-
inflammatory cytokines IL-10 and TGF- [419]. Recent evidence suggests that 
changes in macrophage phenotype can be more accurately characterised as a 
spectrum rather than two distinct categories, with the amount and type of 
cytokines secreted being particularly variable in the classical M2 category [419]. 
Regardless of the classification system used, high levels of M1 type cytokines 
are associated with a pro-inflammatory microenvironment and increased 
likelihood of tissue graft rejection, especially upon stimulation of a CD4+ cells 
towards a Th1 phenotype and the induction of an associated chronic immune 
response [132].  
Beyond modulating the phenotype and distribution of cells, macrophages can 
also aid the integration of a graft through phagocytosis of wound-associated 
debris and the production of MMPs (including MMP1, 2, 7, 10 and 12) which 
enable the process of ECM remodelling to begin [420]. Conversely, chronic 
exposure to a pro-inflammatory microenvironment can cause macrophages to 
merge and form multi-nuclear “giant cells”, which are key mediators of the 
fibrotic capsule formation during graft rejection [421].  
An increasing body of literature supports the assertion that a strong 
macrophage response, briefly M1-dominated followed by predominantly M2 
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macrophages, is necessary for optimal remodelling and integration of 
decellularised tissue [37]. Elimination of macrophages in animal models, in an 
attempt to prevent an “adverse” M1 type response, results in inferior graft 
integration; this has been demonstrated though the study of implanted skeletal 
muscle, skin, and myocardium regeneration patterns in monocyte-
depleted/deficient murine models [422-424].  
Changes to the properties of decellularised tissue grafts induced as a result of 
specific production processes can modulate the magnitude and nature of the 
host immune response induced following implantation. Insufficient elimination of 
some decellularisation reagents, such as SDS, can lead to an adverse host 
response [425]. In a study evaluating immunostimulatory potential, excised rat 
abdominal wall segments were decellularised using 0.25 % (v/v) SDS solution. 
One group of wall segments were subject to a wash step with 0.5 mM CaCl2, 
resulting in the elimination of 98.4 % (w/w) of the residual SDS from the tissue. 
The decellularisation process for the second group of wall segments did not 
include this step, resulting in only  81.4 % (w/w) of the residual SDS being 
removed. The in vitro human macrophage response and in vivo performance of 
the scaffolds was then assessed. In vitro, secretion of TNF by macrophages 
was significantly increased in the high-SDS group compared to a non-
stimulated control, and expression of the pro-inflammatory marker chemokine 
receptor type 7 (CCR7) was significantly increased compared to the low-SDS 
group. PCR analysis of gene expression levels indicated that macrophages 
cultured with the low-SDS group (but not the high-SDS group) were polarised 
towards an M2-type expression profile. Implantation of grafts from the high-SDS 
group in a rat muscle defect model resulted in significantly higher expression of 
TNF and IL-1 compared to grafts from the low-SDS group. Gross histological 
analysis of explanted grafts from the low-SDS group revealed evidence of ECM 
remodelling, integration with the surrounding tissue and full infiltration of site-
appropriate myocytes. In comparison explanted grafts from the high-SDS group 
had a much reduced level of cell infiltration. Numerous giant multinuclear cells 
were observed surrounding the graft, together with the fibrotic capsule which is 
typically indicative of graft rejection. The response was further characterised by 
antibody labelling for the phenotypic cell surface markers, specifically CCR7 
(M1) and CD206 (M2). The ratio M1:M2 markers was significantly greater in the 
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high-SDS grafts, indicating a pro-inflammatory microenvironment induced as a 
result of increased local SDS concentrations.  
The immunomodulatory effects of different sterilisation methods for 
decellularised tissue grafts are not well characterised [37]. However, it is likely 
that sterilisation-associated effects such as crosslinking and chain scission of 
ECM components, the deposition of toxic residues and alterations to 
immunostimulatory antigens would affect how immune cells interact with the 
tissue. As the dynamics of macrophage phenotypic changes are the most 
important factor in determining the acute response to an implanted tissue (and 
heavily modulate the chronic response), they should be the initial focus of 
research.  
The development of an in vitro screening process could provide vital insight into 
macrophage phenotypic changes when seeded onto decellularised nerves 
sterilised with different methods; in addition, such data may also have wider 
applicability across other decellularised tissues.  
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7.2 Aims and Objectives 
 
Aim 
The aim of this study was to assess the cytocompatibility and immunoreactivity 
of the sterilised decellularised nerves in a controlled in vitro environment.  
 
Objectives 
i. To determine the cytotoxicity of the sterilised nerves through contact 
culture with two distinct cell types.  
ii. To optimise a cell viability assay, alamarBlue, for use with RAW 264.7 
cells. 
iii. To determine the efficacy of LPS in solution as a pro-inflammatory 
control.  
iv. To establish the sensitivity of enzyme-linked immunosorbent assays 
(ELISAs) for the detection of cytokines secreted by RAW 264.7 cells.  
v. To optimise a methodology for seeding RAW 264.7 cells onto segments 
of sterilised nerve. 
vi. To determine the effect of sterilisation on the viability and levels of 
cytokine secretion of RAW 264.7 cells seeded onto nerve segments over 
48 hours in culture. 
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7.3 Materials and Methods 
7.3.1 Contact cytotoxicity assay of sterilised decellularised nerves 
Sterilised decellularised nerves were subject to contact cytotoxicity testing, as 
described in section 2.12.  
7.3.2 Culture of RAW 264.7 cells and optimisation of alamarBlue 
assay  
RAW 264.7 cells are a murine macrophage cell line commonly used in 
preliminary in vitro assays to evaluate the immunostimulatory capacity of a 
given biomaterial.  
7.3.2.1 RAW 264.7 cell culture medium 
RAW 264.7 cells were cultured in Roswell Park Memorial Institute (RPMI)  
medium containing 10 % (v/v) FBS, 100 U.ml-1 penicillin-streptomycin and 2 mM 
L-glutamine (supplemented medium hereafter referred to as culture medium).  
7.3.2.2 Resurrection and culture of RAW 264.7 cells from cryostorage 
Vials containing RAW 264.7 cells were removed from cryostorage in liquid 
nitrogen. The vials were thawed rapidly in a water bath at 37 °C and the cell 
pellets were transferred to individual sterile universal tubes in a class II 
environment. Culture medium (10 ml) was added drop wise to each universal, 
before centrifugation at 150 x g for ten minutes. The supernatant was discarded 
and the cells re-suspended in 5 ml of culture medium and seeded into a T75 flask. 
The cells were incubated for 24 hours at 37 °C in an atmosphere of 5 % (v/v) CO2 
in air. The culture medium was replaced 24 hours after revival, then every 48 - 
72 hours. Cell growth was observed by light microscopy. 
7.3.2.3 Passaging of RAW 264.7 cells 
RAW 264.7 cells were passaged upon reaching a confluency of approximately 
80 %. The medium was aspirated from the culture flask and the cell layer washed 
twice in PBS (without magnesium or calcium). Fresh culture media (10 ml) was 
added and the cells were carefully dislodged using a cell scraper. The total 
volume present in the flask was then transferred to a universal tube and 
centrifuged at 150 x g for ten minutes. The supernatant was discarded, and the 
cells suspended in 1 ml of medium.  
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Cell suspension and Trypan Blue (20 µl each) were mixed, and 10 µl was added 
to a haemocytometer. The number of viable cells per grid was then determined, 
and the total number of cells.ml-1 was calculated using the equation detailed 
below. 
 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠. 𝑚𝑙−1 =  
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓𝑐ℎ𝑎𝑚𝑏𝑒𝑟𝑠
 𝑥 104 𝑥 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 
 
The cell suspension was then diluted as appropriate (to give a starting confluency 
of approximately 10 - 20 %), seeded to a T75 or T175 flask and incubated at 37 
°C in an atmosphere of 5 % (v/v) CO2 in air. 
7.3.2.4 Optimisation of alamarBlue assay for cell viability 
Viability and proliferation of RAW 264.7 cells was measured using the 
alamarBlue assay. The functional reagent in alamarBlue is 7-hydroxy-10-
oxidophenoxazin-10-ium-3-one (resazurin) [426, 427]. Resazurin is able to 
diffuse though phospholipid membranes, allowing monitoring of live cell viability 
in vitro. AlamarBlue acts an intermediate electron acceptor; upon accepting 
electrons, the oxidised form (resazurin) is reduced to resofurin. Within the cell 
this process is predominantly mediated by mitochondrial enzymes such as 
nicotimamide adenine dinucleotide phosphate (NADPH) and the cytochromes, 
but to a lesser extent also by cytoplasmic enzymes such as dihydrolipoamine 
dehydrogenase. Upon reduction the colour of the reagent changes from blue to 
pink. Reduction also causes the reagent to become fluorescent.  
Determining the relative percentage reduction of alamarBlue in wells 
containing cells compared to a medium and alamarBlue-only negative control 
enables quantification of cell viability and proliferation. Reduction of alamarBlue 
can be determined fluorescently or colorimetrically.  
The alamarBlue assay was carried out in six well plates. AlamarBlue regent 
was added to culture medium (2 ml/well) in a sterile universal to give a working 
concentration of 10 % (v/v). The medium was then added to the test and control 
wells, and incubated in conditions of darkness at 37 °C in an atmosphere of 5 % 
(v/v) CO2 in air. The length of the incubation period was optimised according to 
the approximate expected cell number (see below). Aliquots of medium were 
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then transferred in triplicate to a fresh 96 well plate and the absorbance of 
individual wells at 570 and 600 nm was measured using a spectrophotometer. 
The percentage reduction of the alamarBlue reagent was calculated using the 
equation detailed below (Equation 7-1). 
 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑟𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛 =
(𝐸𝑜𝑥𝑖600 𝑥 𝐴570) − (𝐸𝑜𝑥𝑖570 𝑥 𝐴600)
(𝐸𝑟𝑒𝑑570 𝑥 𝐶600) − (𝐸𝑟𝑒𝑑600 𝑥 𝐶570)
 𝑥 100 
 
𝐸 = 𝑚𝑜𝑙𝑎𝑟 𝑒𝑥𝑡𝑖𝑛𝑐𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 
𝐸𝑜𝑥𝑖570 =  𝐸 𝑜𝑓 𝑜𝑥𝑖𝑑𝑖𝑠𝑒𝑑 𝑎𝑙𝑎𝑚𝑎𝑟𝐵𝑙𝑢𝑒 𝑎𝑡 570 𝑛𝑚 = 80586 
𝐸𝑜𝑥𝑖600 = 𝐸 𝑜𝑓 𝑜𝑥𝑖𝑑𝑖𝑠𝑒𝑑 𝑎𝑙𝑎𝑚𝑎𝑟𝐵𝑙𝑢𝑒  𝑎𝑡 600 𝑛𝑚 = 117216 
𝐴570 = 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑡𝑒𝑠𝑡 𝑤𝑒𝑙𝑙𝑠 𝑎𝑡 570 𝑛𝑚 
𝐴600 =  𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑡𝑒𝑠𝑡 𝑤𝑒𝑙𝑙𝑠 𝑎𝑡 600 𝑛𝑚 
𝐸𝑟𝑒𝑑570 = 𝐸 𝑜𝑓 𝑟𝑒𝑑𝑢𝑐𝑒𝑑 𝑎𝑙𝑎𝑚𝑎𝑟𝐵𝑙𝑢𝑒 𝑎𝑡 570 𝑛𝑚 = 155677 
𝐸𝑟𝑒𝑑600 = 𝐸 𝑜𝑓 𝑟𝑒𝑑𝑢𝑐𝑒𝑑 𝑎𝑙𝑎𝑚𝑎𝑟𝐵𝑙𝑢𝑒 𝑎𝑡 600 𝑛𝑚 = 14652 
𝐶570 = 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑤𝑒𝑙𝑙𝑠 𝑎𝑡 570 𝑛𝑚 
𝐶600 = 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑤𝑒𝑙𝑙𝑠 𝑎𝑡 600 𝑛𝑚 
 
Equation 7-1 Equation used to calculate percentage reduction of 
alamarBlue reagent  
 
To enable determination of approximate seeding efficiency and cell proliferation, 
a standard curve of RAW 264.7 cell number against the percentage reduction of 
alamarBlue was required. Data in the literature predominantly refers to the 
use of the alamarBlue assay in 96 well plates. Therefore, the length of 
incubation time in alamarBlue was optimised according to cell number in 
individual wells of a six well plate containing 2 ml of culture medium. Serial 
dilutions of RAW 264.7 cell number were prepared to give a range of 0.0153 x 
106 – 1 x 106 cells/well. Cell suspension at each dilution was added in triplicate 
to the wells of six well plates. Separate groups were incubated for times of 3, 12 
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and 18 hours. The data was used to prepare standard curves of cell number 
against percentage reduction of the alamarBlue reagent. 
7.3.3 Determination of lipopolysaccharide efficacy as pro-
inflammatory control 
The bacterial endotoxin lipopolysaccharide (LPS) was used as a positive control 
agent to stimulate a pro-inflammatory response in RAW 264.7 cells. An 
experiment was devised to determine the effect of LPS stimulation on cell 
proliferation and cytokine secretion. Two separate medium solutions were 
prepared. For the test (positive control) groups, 200 mg.ml-1 LPS stock solution 
was diluted 1:1000 in culture medium to give a working concentration of 200 
ng.ml-1. The negative control consisted of culture medium without the addition of 
LPS.  
RAW 264.7 cells were passaged, counted and diluted in either in test or 
negative control culture medium. Cells from each group were seeded to two six 
well plates at a density of 2.5 x 105 cells/well and 1.25 x 105 cells/well 
respectively. The plates were incubated at 37 °C in an atmosphere of 5 % (v/v) 
CO2 in air for 24 hours. After 24 hours, the culture media was removed and 
transferred to individual sterile 2 ml eppendorfs corresponding to each well. The 
eppendorfs were centrifuged at 10000 x g for 10 minutes at 4 °C. The 
supernatants were transferred to fresh 2 ml eppendorfs and stored at -80  °C 
prior to quantification of IL-10 and TNF by ELISA. The effects of LPS 
stimulation on cell viability and proliferation were determined through the 
alamarBlue assay (Section 7.3.2.4).  
7.3.4 Enzyme-linked immunosorbent assay (ELISA) quantification of 
TNF, IL-10, IL-1β and IL-6 
The concentrations of the cytokines IL-10, TNF, IL-1β and IL-6 in medium 
supernatants were quantified by ELISA.  
7.3.4.1 Solutions 
Supplied kit solutions 
The ELISAs were carried out with READY-SET-GO kits from Invitrogen, 
according to the manufacturer’s instructions. Reagents were supplied as 
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concentrated stock solutions, which were diluted prior to use. Stock solutions of 
capture antibody were diluted in PBS. Stock solutions of detection antibody and 
avidin-horseradish peroxidase (avidin-HRP)  were diluted in ELISASPOT 
diluent. Lyophilised cytokine standard were rehydrated and diluted in distilled 
water. Test samples were diluted as necessary in distilled water. 
Tetramethylbenzidine (TMB) solution was supplied at working concentration.  
Wash Buffer 
TWEEN™-20 (1 ml) was added to 2 L of PBS to give a working concentration of 
0.05 % (v/v). 
Stop solution 
1 M Sulphuric acid (H2SO4) was used as a stop solution in the ELISA assays.  
7.3.4.2 Assay Method 
The same method was used for ELISA quantification of each cytokine in 
medium supernatants. Excess solution was removed between steps by blotting. 
All wash steps were carried out by the addition and aspiration of 300 μl/well of 
wash buffer. 
Capture antibody solution (100 μl/well) was added to the assay plates (96 well 
MaxiSorp™ plates), before being sealed with parafilm and incubated overnight 
at 4 °C to ensure coating of the wells. The solution was aspirated and the wells 
were washed three times. Wells were blocked with 200 μl/well of ELISASPOT 
diluent for one hour at room temperature. The ELISASPOT diluent was 
aspirated and the wells were washed once in wash buffer. Standards (3.9 – 
4000 pg.ml-1) and samples were added to the plates in duplicate 100 μl/well 
aliquots. ELISASPOT diluent was included as a negative control. The plates 
were incubated for two hours at room temperature. The contents of each well 
was aspirated and the wells were washed three times. Detection antibody 
solution (100 μl/well) was added and the plates were incubated for one hour at 
room temperature. The detection antibody solution was aspirated and the wells 
were washed three times. Avidin-HRP solution (100 μl/well) was added and the 
plates were incubated for one hour at room temperature. The avidin-HRP 
solution was aspirated and the wells were washed six times. TMB solution (100 
μl/well) was added and the plates were incubated for 15 minutes at room 
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temperature. Stop Solution (50 μl/well) was added, and the absorbance was 
read at 450 nm and 570 nm. Values read at 570 nm were subtracted from those 
at 450 nm, and a standard curve of cytokine concentration against adjusted 
absorbance was plotted to enable interpolation of unknown values.  
7.3.5 Optimisation of methodology for seeding RAW 264.7 cells to 
segments of decellularised nerve 
A method was developed for seeding RAW 264.7 cells onto decellularised 
nerve segments, to enable quantification of changes in proliferation and 
cytokine secretion according to the specific sterilisation method. The seeding 
process was optimised with non-sterilised decellularised nerve segments, 
produced under aseptic conditions.   
7.3.5.1 Seeding methodology 
Stainless steel seeding rings, with a chamber dimensions of approximately 10 x 
5 x 5 mm, were placed in individual wells of six well plates. Five ml of sterile 
water was added to the space between individual wells to humidify the local 
atmosphere within the plate and further limit media loss during seeding.  
Segments of decellularised nerve were resized using sterile dissection tools to 
give a uniform size of 5 x 10 mm, and transferred to individual seeding rings 
(Figure 7-2). The tissue segments and seeding chambers were washed with 
PBS (without magnesium or calcium). 
RAW 264.7 cells were passaged, counted and diluted in fresh medium to 
achieve a cell suspension of the required seeding density. Aliquots (200 μl) of 
cell suspension were transferred to each seeding ring, and incubated for a 
given time period. 
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Figure 7-2 Seeding setup used with nerve segments 
Pre-sized segments of decellularised nerve, sited within the wells of individual 
seeding rings prior to the addition of RAW 264.7 cell suspension. 
 
The length of the incubation period and the seeding density were optimised to 
ensure maximum seeding efficiency and subsequent cell viability. The 
appropriate incubation time in alamarBlue for RAW 264.7 cells seeded to 
decellularised nerve segments was determined following quantification of 
seeding efficiency and subsequent calculation of the cell number on each 
seeded segment. A linear regression was generated for each curve and the fit 
quantified through calculation of R-square.  
7.3.5.2 Optimisation of media retention and seeding protocol 
The use of agarose for the sealing of seeding rings within wells was identified 
as a method for the prevention of media loss and tissue dehydration. Agarose 
powder was added to distilled water (4 g in 100 ml) and heated in the 
microwave until dissolved to give a 4 % (w/v) solution. The solution was then 
autoclaved to ensure sterility. 
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Two sets of seeding rings (n = 12 per group) were placed in individual wells of 
separate six well plates. The edges of the wells in two plates were filled with 
approximately 2 ml/well of 4 % (w/v) agarose, which was then left to cool for 
approximately 30 minutes. Seeding rings within the other plate were left without 
agar sealing. Two groups each of decellularised nerve segments (n = 6 per 
group) were seeded with 1 x 106 RAW 264.7 cells per well. Individual plates 
were incubated for three hours at 37 °C in an atmosphere of 5 % (v/v) CO2 in 
air. Tissue segments (n = 6) from each group were then transferred to individual 
wells of fresh six well plates, and the alamarBlue assay (7.3.2.4) was used to 
determine the approximate seeding efficiency. The remaining tissue segments 
from each group (n = 6) were fixed, processed and sectioned as previously 
described (2.11). The sections were stained with H & E and analysed by light 
microscopy to determine differences in cell attachment patterns.  
7.3.6 Determining the effect of sterilisation on RAW 264.7 cell 
viability and cytokine secretion 
The immunostimulatory capacity of decellularised nerves treated with different 
sterilisation methods were analysed by seeding with RAW 264.7 cells.  
7.3.6.1 Sample preparation  
Seeding rings were placed in individual wells of six well plates (5 plates per 
group) and the edges sealed with 4 % (w/v) agarose as described above. 
Groups of decellularised nerve segments, sterilised with PAA, gamma radiation, 
E Beam or SCCO2 as previously described (section 2.10.3; n = 30 per treatment 
group) were resized in preparation for seeding. A further group of non-sterilised 
decellularised nerves (n = 30) were included, to be incubated with culture media 
containing 200 ng.ml-1 LPS as a positive control. There was considered to be a 
lack of a suitable true negative control; collagen gels do not offer a 
representative comparison to ECM tissue grafts due to differences in 
processing and source materials, whilst non-sterilised decellularised nerves 
present an unacceptable risk of introducing contaminating organisms (e.g. 
bacteria) to the culture media, which would both compromise cell viability assay 
results and potentially lead to changes in cytokine secretion. For these reasons, 
no negative control was included in the study. The segments were transferred 
to individual seeding rings.  
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7.3.6.2 Seeding, culture, data collection and analysis 
For each group, RAW 264.7 cells were passaged, counted and diluted in culture 
media to give a density of 5 x 106 cells/ml. Aliquots of cell suspension (200 μl) 
were transferred to each seeding ring, and the plates were incubated for three 
hours at 37 °C in an atmosphere of 5 % (v/v) CO2 in air. The tissue segments 
were then transferred to individual wells of new six well plates, and 2 ml of fresh 
culture media was added to each well. Each plate (n = 6 segments in each) was 
incubated for different time periods, with the end points defined as 0, 6, 12, 24 
and 48 hours.  Additional six well plates containing culture media-only (no tissue 
or cells) were included as a negative control for each timepoint.  
When each endpoint was reached, the media was removed from each well and 
supernatant obtained and stored as previously described (7.3.3). Fresh culture 
media (2 ml) containing 10 % (v/v) alamarBlue was added to each well and 
the plates were incubated for a further 12 hours.  
Cell viability (and therefore approximate relative cell number) was determined 
by the alamarBlue assay as previously described (7.3.2.4). The 
concentrations of IL-10, TNF, IL-1β and IL-6 in medium supernatants were 
quantified by ELISA (7.3.4) and normalised to cell number by reference to the 
alamarBlue estimated cell population (to give a value in pg.ml-1 per 1 x 106 
cells). 
7.3.7 Statistical analysis 
Differences between means in the timecourse experiments were determined 
using a two-way ANOVA. The location of significant differences was determined 
by Tukey’s Honestly Significant Difference test. The level of significance for the 
difference between two means was defined as p = 0.05. Data was displayed as 
+/- 95 % confidence limits.  
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7.4 Results 
7.4.1 Contact cytotoxicity assay of sterilised nerves 
The biocompatibility of decellularised nerves after different sterilisation 
treatments was assessed by contact culture studies with two distinct cell lines, 
BHK epithelial cells (Figure 7-3) and L929 fibroblasts (Figure 7-4). As previously 
described in section 2.12.4, cyanoacrylate contact adhesive was used as a 
positive control and a commercially available surgical closure strip (Steri-Strip) 
as a negative control. 
No evidence of cytotoxicity was observed in either cell line when cultured with 
nerves from each treatment group. Cells of both lines were observed to grow up 
to and in contact with the samples, maintaining a consistent morphology. 
The rounded appearance characteristic of the dead cells cultured in wells with 
the cyanoacrylate positive control was not observed in cells cultured with 
decellularised nerves from any of the treatment groups. 
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C D 
E F 
Figure 7-3  Representative images of Giemsa-stained BHK cells cultured 
for 48 hours with decellularised nerves 
Images show BHK cells cultured with decellularised nerve treated with (A) PAA, 
(B) gamma radiation, (C) E Beam, (D) SCCO2, (E) cyanoacrylate positive 
control and (F) Steri-Strip negative control. Tissue segments are indicated by 
arrows. Images were acquired under Brightfield illumination using a x10 
objective. Scale bars =  100 µm. 
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Figure 7-4 Representative images of Giemsa-stained L929 cells cultured 
for 48 hours with decellularised nerves 
Images show L929 cells cultured with decellularised nerve treated with (A) 
PAA, (B) gamma radiation, (C) E Beam, (D) SCCO2, (E) cyanoacrylate positive 
control and (F) Steri-Strip negative control. Tissue segments are indicated by 
arrows. Images were acquired under Brightfield illumination using a x10 
objective. Scale bars = 100 µm.  
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7.4.2 Optimisation of alamarBlue assay for use with Raw 264.7 
cells 
Serially-diluted populations of RAW 264.7 cells were incubated in alamarBlue 
for three different time periods. The range of the linear relationship between 
percentage alamarBlue reduction and cell number was assessed.  
A linear relationship between percentage alamarBlue reduction and cell 
number was apparent for cell numbers of up to 0.5 x 106, 0.125 x 106 and 
0.06125 x 106 after incubation periods of 3, 12 and 18 hours respectively, 
evidenced by the fit of linear regression between 0 and 0.125 x 106 cells (Figure 
7-5). Plateauing was observed above the linear range within each group, 
caused by a decreased relative gain in the percentage reduction of 
alamarBlue compared to the increase in cell number. 
Since low seeding efficiencies were expected in the later experiments with 
decellularised nerves, it was considered particularly important to identify the 
most suitable incubation period for populations up to 0.125 x 106 cells. 
An incubation time of up to 12 hours was found to produce the best fit for the 
interpolation of cell numbers up to 0.125 x 106 cells, with an R-square value of 
0.998 compared to 0.983 and 0.949 for incubation periods of three and 18 
hours respectively.  
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Figure 7-5 The effect of varying incubation time on the percentage 
alamarBlue reduction according to cell number 
Changes in percentage alamarBlue reduction across serially diluted cell 
populations from (A) 0 – 1 x 106 cells incubated over 3, 12 and 18 hours, and 0 
– 0.125 x 106 cells over incubation periods of (B) 3 hours, (C) 12 hours and (D) 
18 hours. The R-square value for each curve is displayed.  
 
C 
D 
R2 = 0.949 
R2 = 0.998 
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7.4.3 Efficacy of LPS as stimulator of pro-inflammatory response 
Two groups of RAW 264.7 cells were seeded to individual wells of a six well 
plate at 0.25 x 106 and 0.125 x 106 cells/well respectively. The effects of a 24 
hour incubation in media containing 200 ng.ml-1 LPS on cell proliferation were 
determined by interpolation of cell number from measured values for 
percentage alamarBlue reduction. The effect of LPS on TNF secretion was 
determined by ELISA quantification.  
Significantly fewer RAW 264.7 cells (p < 0.05) were detected after 24 hours 
culture in the presence of LPS compared to the negative control (Figure 7-6). In 
wells seeded with 0.25 x 106 cells, LPS stimulation caused a decrease in cell 
population to 0.225 (+/- 0.019) x 106 compared to an increase of 0.268 (+/- 
0.009) x 106 in the negative control. In wells seeded with 0.125 x 106 cells, LPS 
stimulation again caused a decrease (p < 0.05) in cell population to 0.099 (+/- 
0.039) x 106 compared to an increase of 0.137 (+/- 0.007) x 106 in the negative 
control.  
TNFα secretion (relative to cell number) was significantly increased in both 
LPS-stimulated populations compared to the negative control. In wells seeded 
with 0.25 x 106 cells, LPS stimulation induced a significant increase (p < 0.05) in 
TNFα secretion, at 3184 (+/- 544.5) pg.ml-1 per 106 cells compared to 22.97 (+/- 
11.79) pg.ml-1 per 106 cells in the negative control. In wells seeded with 0.125 x 
106 cells high levels of TNFa secretion were detected following LPS stimulation, 
at 4067 (+/- 1597)  pg.ml-1 per 106 cells, whereas very low levels were seen in 
the negative control (below the limit of accurate determination).   
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Figure 7-6 Effect of LPS on cell proliferation and TNF secretion at two 
different cell seeding densities 
The effects of 24 hours culture in medium containing 200 ng.ml-1 LPS on (A) 
RAW 264.7 cell number, interpolated from measured values of percentage 
alamarBlue reduction, and (B) TNF normalised to RAW 264.7 cell number.  
Data shown as mean +/- 95 % confidence interval, n = 6. Statistical analysis 
was by students t-test. * denotes groups which are significantly different 
(p<0.05). 
B 
A 
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7.4.4 Optimisation of methodology for seeding RAW 264.7 cells to 
segments of peripheral nerve 
The efficiency of seeding RAW 264.7 cells onto decellularised nerves with and 
without sealing of seeding rings with 4 % (w/v) agarose was determined by 
interpolation of cell number from measured values of percentage alamarBlue 
reduction. Tissue segments seeded in agarose-sealed rings appearing to have 
a higher surface cell density when histological sections were examined (Figure 
7-7). The alamarBlue® measured cell populations were 0.150 (+/- 0.086) x 106 
and 0.054 (+/- 0.046) x 106 (p<0.05) for decellularised nerve segments seeded 
in agarose-sealed or non-sealed rings respectively (Figure 7-8). The 
approximate seeding efficiencies, from an initial population of 1 x 106 cells, were 
therefore 15 % (+/- 8.6) % and 5.4 (+/- 4.6) % for agarose-sealed and non-
sealed rings respectively.   
A 
C 
B 
D 
Figure 7-7 Representative images of sections stained with H & E 
Images show decellularised nerves seeded with 1 x 106 RAW 264.7 cells in 
rings either (A and C) sealed with 4 % (w/v) agarose or (B and D) not sealed. 
Arrows indicate position of cells. Cell density appears to be greater on tissue 
segments from agarose-sealed rings. Images were acquired under Brightfield 
illumination using a x10 objective, scale bars = 50 µm. 
 
50 µm 50 µm 
50 µm 50 µm 
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Figure 7-8  Seeding efficiencies with and without agar sealing of seeding 
rings 
Number of cells on decellularised nerve segments seeded with 1 x 106 RAW 
264.7 cells in 200 μl of medium in stainless steel seeding rings, either sealed 
with  4 % (v/v) agar or left unsealed. Cell number was interpolated from 
measured values of percentage alamarBlue reduction. Data shown as mean 
+/- 95 % confidence interval, n = 6. Statistical analysis was by students T-test. * 
denotes groups which are significantly different (p<0.05). 
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7.4.5 Viability and cytokine expression in RAW 264.7 cells seeded 
onto segments of sterilised nerve 
RAW 264.7 cells were seeded onto segments of decellularised nerve sterilised 
with PAA, gamma radiation, E Beam or SCCO2. Non-sterilised decellularised 
nerves seeded with RAW 264.7 cells and incubated in medium containing 200 
ng.ml-1 LPS were used as a positive control. The effects on cell proliferation 
were determined by interpolation of cell number from measured values for 
percentage alamarBlue reduction. The effects of sterilisation on the secretion 
of TNF, IL-10, IL-1β and IL-6 were determined by ELISA quantification.  
7.4.5.1 Changes in cell population 
The number of cells on the seeded nerve segments appeared to increase 
between 0 – 24 hours on seeded PAA, gamma and SCCO2-treated nerves, 
before plateauing or decreasing slightly between 24 – 48 hours (Figure 7-9   
Changes in cell population on sterilised nerve segments over 48 hours in 
culture. Initial cell populations on E Beam-treated nerves and those stimulated 
with LPS were much lower than the other groups, at 0.04 – 0.05 x 106 cells 
compared to  0.08 – 0.15 x 106 cells. This difference was statistically significant 
(p < 0.05) and persisted throughout the course of the experiment. Cell 
populations in the E Beam and LPS  treatment groups remained relatively static 
for the initial 24 hour period, before rising towards 48 hours.  
7.4.5.2 Cytokine expression patterns 
The specific sterilisation treatment applied to decellularised nerve segments 
prior to seeding appeared to have some influence on the pattern of TNF, IL-
1β, IL-6 and IL-10 secretion by RAW 264.7 cells (Figure 7-10 – 7-13). However, 
due to the wide variability within each group no statistical significance was 
detected by two-way ANOVA analysis. The exception was the LPS positive 
control, in which levels of secreted TNF were higher (p < 0.05) than in all other 
groups at all timepoints from 6 hours onwards. 
Despite the lack of statistical significance, some broad trends could be 
observed within the data. Both gamma irradiated and E Beam-treated nerves 
appeared to induce a spike in TNF secretion at the 12 hour timepoint which 
was not observed in wells containing nerves treated with PAA or SCCO2. All 
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sterilisation methods appeared to induce an increase in TNF secretion up until 
the endpoint of the experiment at 48 hours.  
E Beam appeared to induce higher expression levels of all cytokine at some or 
all of the timepoints, relative to all of the other sterilisation groups, with 
significant differences observed in IL-1β expression at the 24 hour timepoint (p 
< 0.05). However, the margin of difference was relatively small and, due to the 
wide intra-group variability, no other significant differences were identified.   
In contrast to the steady increase in TNF secretion over time from cells 
cultured on sterilised nerves was very different from that of cells cultured in the 
presence of LPS. TNF secretion increased steeply to the 6 hour timepoint in 
response to LPS treatment, peaked at 24 hours and then decreased by 
approximately 50 % by the final 48 hour timepoint. LPS stimulation caused a 
steady rise in the secretion of IL-1β and IL-6 throughout the measured 
timepoints, with higher expression levels relative to the sterilisation treatment 
groups (p<0.05). An initial spike in IL-10 secretion (p<0.05) was seen after 6 
hours of LPS stimulation, relative to the sterilisation treatment groups. No 
differences in IL-10 secretion were seen at later timepoints. 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 239 - 
 
 
 
 
 
 
 
 
  
Figure 7-9   Changes in cell population on sterilised nerve segments over 
48 hours in culture 
Change in RAW 264.7 cell number over 48 hours after seeding onto 
decellularised nerve sterilised with PAA, gamma radiation, E Beam or SCCO2. 
RAW 264.7 cells seeded onto segments of unsterilised decellularised nerve and 
cultured in media containing 200 ng.ml-1 LPS were included as a positive 
control. At each timepoint, cell number was interpolated from measured values 
of percentage alamarBlue reduction. Data shown as means, n = 6 for each 
timepoint. Statistical analysis was by two-way ANOVA (p<0.05). 
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A 
B 
Figure 7-10  Changes in TNF concentration over 48 hours in culture  
(A) Standard curve of TNF concentration against absorbance at 450 nm and 
(B) changes in TNF secretion by RAW 264.7 cells seeded onto decellularised 
nerve sterilised with PAA, gamma radiation, E Beam or SCCO2. Cytokine levels 
were measured 0, 6, 12, 24 and 48 hours, and normalised to cell number. RAW 
264.7 cells seeded onto segments of unsterilised decellularised nerve and 
cultured in medium containing 200 ng.ml-1 LPS were included as a positive 
control. Data shown as means, n = 6 for each timepoint. Statistical analysis was 
by two-way ANOVA (p<0.05).  
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B 
Figure 7-11 Changes in IL-1β concentration over 48 hours in culture  
(A) Standard curve of IL-1β concentration against absorbance at 450 nm and 
(B) changes in IL-1β secretion by RAW 264.7 cells seeded onto decellularised 
nerve sterilised with PAA, gamma radiation, E Beam or SCCO2. Cytokine levels 
were measured at timepoints of 0, 6, 12, 24 and 48 hours, and normalised to 
cell number. RAW 264.7 cells seeded onto segments of unsterilised 
decellularised nerve and cultured in medium containing 200 ng.ml-1 LPS were 
included as a positive control. Data shown as means, n = 6 for each timepoint. 
Statistical analysis was by two-way ANOVA (p<0.05). 
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B 
Figure 7-12 Changes in IL-6 concentration over 48 hours in culture  
(A) Standard curve of IL-6 concentration against absorbance at 450 nm and (B) 
changes in IL-6 secretion by RAW 264.7 cells seeded onto decellularised nerve 
sterilised with PAA, gamma radiation, E Beam or SCCO2. Cytokine levels were 
measured at timepoints of 0, 6, 12, 24 and 48 hours, and normalised to cell 
number. RAW 264.7 cells seeded onto segments of unsterilised decellularised 
nerve and cultured in medium containing 200 ng.ml-1 LPS were included as a 
positive control. Data shown as means, n = 6 for each timepoint. Statistical 
analysis was by two-way ANOVA (p<0.05). 
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Figure 7-13 Changes in IL-10 concentration over 48 hours in culture  
(A) Standard curve of IL-10 concentration against absorbance at 450 nm and 
(B) changes in IL-10 secretion by RAW 264.7 cells seeded onto decellularised 
nerve sterilised with PAA, gamma radiation, E Beam or SCCO2. Cytokine levels 
were measured at timepoints of 0, 6, 12, 24 and 48 hours, and normalised to 
cell number. RAW 264.7 cells seeded onto segments of unsterilised 
decellularised nerve and cultured in medium containing 200 ng.ml-1 LPS were 
included as a positive control. Data shown as means, n = 6 for each timepoint. 
Statistical analysis was by two-way ANOVA (p<0.05). 
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7.5 Discussion 
Sterilisation did not appear to negatively affect the cytocompatibility of 
decellularised nerves. No evidence of a strong pro-inflammatory response (in 
comparison to that elicited by incubation in media containing LPS) was seen 
when a murine macrophage cell line was seeded onto segments of sterilised 
nerve.  
Decellularised nerves treated with either PAA, gamma radiation, E Beam or 
SCCO2 did not appear to negatively impact the growth or morphology of L929 
fibroblasts and BHK epithelial cells. These two distinct cell types were selected 
in line with the protocol used being based on that stipulated in ISO standard 
10993-5 (2009); variants on this type of cytotoxicity testing are often applied to 
medical devices as a basic first test of biocompatibility [299, 301, 326, 406]. 
These findings correlate with those of previous studies investigating sterilised 
allogeneic or xenogeneic tissue grafts. Cytocompatibility was retained when 
porcine superflexor tendons were decellularised using a variant of the patented 
Leeds protocol and sterilised with PAA, gamma radiation or E Beam [336]. In 
vitro culture studies did not reveal evidence of cytotoxicity in powdered 
allogeneic bone or allogeneic amniotic membrane sterilised with SCCO2 [428, 
429]. Furthermore, SCCO2 sterilisation did not prevent a decellularised lung 
matrix from supporting seeded populations of A549 human epithelial-like cells 
and rat microvascular lung endothelial cells in vitro [243]. The observed 
cytocompatibility can be considered a positive prognostic indicator for the ability 
of the sterilised nerves to support a viable cell population post-implantation 
[406].    
The likely innate immune response to the sterilised nerves was characterised in 
vitro through seeding of the murine macrophage cell line RAW 264.7 onto 
sterilised nerve segments and quantification of subsequent cytokine secretion. 
The experiment was designed as an in vitro screen, with the aim of identifying if 
treatment of the decellularised nerves with any of the sterilisation methods 
caused the induction of a strong pro-inflammatory response (i.e. seeded cells 
polarised towards an M1-like phenotype, as would be stimulated by exposure to 
a potent stimulant such as LPS). 
- 245 - 
A sustained M1 phenotypic response, characterised by the secretion of pro-
inflammatory cytokines including TNFα, IL-1β, IL-6 and IL-12, is associated with 
an inferior prognosis for graft integration due to impaired cell infiltration, reduced 
ECM remodelling and the formation of a fibrotic tissue capsule surrounding the 
implanted graft [134]. Stimulation of RAW 264.7 cells with the Gram negative 
bacterial cell membrane component LPS appeared to induce such a phenotypic 
response, with the secretion of high levels of TNFα, peaking at 24 hours, and 
gradually increasing levels of IL-1β and IL-6 over the full experimental duration 
of 48 hours.  
Nerve segments from the sterilisation treatment groups did not appear to induce 
high levels of pro-inflammatory cytokine secretion, compared with those seen 
when seeded nerve segements were incubated incubated with media 
containing LPS. There was some difference in response according to the type 
of method used, with an initial rise in TNFα secretion apparent from cells 
cultured on tissue segments treated with ionising radiations (gamma radiation 
and E Beam) but not segments treated with sterilisation methods utilising 
oxidising agents (PAA, SCCO2 with PAA and H2O2). However, this trend was 
not statistically significant and levels of TNFα secretion in all groups appeared 
to converge at later timepoints. Therefore, the findings presented here do not 
provide evidence that sterilisation with ionising radiation increases the 
probability of a sustained pro-inflammatory response (and therefore inferior 
integration) post-implantation. However, the results presented here should be 
considered with the caveat that they do not fully preclude the potential induction 
of some degree of pro-inflammatory response upon implantation in vivo, and 
similarly do not prove that such a response would not be clinically significant 
and have consequent implications for successful graft integration (and therefore 
eventual functional restoration). This is due to the relative potency of LPS as a 
stimulator of the pro-inflammatory response in cellular components of the innate 
immune system (or cell lines derived from such components, e.g. the 
macrophage-like RAW 264.7 cell line used in the present study) [430]. LPS was 
chosen as a positive control in this study due to its proven ability to stimulate a 
pro-inflammatory response, and due to the relative lack of an appropriate 
alternative: for example, synthetic alternatives (such as collagen-based biogels) 
were considered unlikely to definitively elicit a pro-inflammatory response [431].  
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Limited evidence is available in the literature regarding the interaction of 
macrophages with sterilised (either decellularised or unprocessed) tissue grafts 
in vitro and the potential implications for the in vivo host response. When 
radiation sterilisation of tissue grafts is carried out under hydrated conditions, as 
in the present study, hydroxyl radicals are generated [1]. These radicals may 
interact with ECM components and induce the formation of novel inter and intra-
molecular crosslinks [1, 368]. A 2010 study assessed the effects of crosslinked 
decellularised porcine dermal grafts on the secretion of the pro-inflammatory 
cytokines IL-1β, IL-6 and IL-8 by human peripheral blood monocytes [432]. Two 
chemically-crosslinked grafts, Permacol™ (decellualirsed porcine dermis 
sterilised with gamma radiation) and CollaMend™ (decellularised porcine 
dermis sterilised with ethylene oxide), induced several fold greater levels of 
cytokine secretion compared to both the non-crosslinked Strattice™ 
(decellularised porcine dermis sterilised with low-dose E Beam) and cells 
stimulated with an LPS positive control at a concentration of 100 ng.ml-1. The 
crosslinking of the grafts, which was mediated through treatment with 1-ethyl-3-
(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and hexamethylene 
di-isocyanate (HMDI) for CollaMend™ and Permacol™ respectively (rather than 
terminal sterilisation processes used), was carried out to improve the 
mechanical properties of the grafts and ensure the retention of ECM structure 
following implantation [433]. A similar pro-inflammatory macrophage response 
to crosslinked decellularised grafts has been observed in vivo. A carbodiimide-
crosslinked decellularised porcine SIS graft (CuffPatch™) induced a M1-style 
macrophage response following implantation into a rat, characterised by a 
heavy infiltration of macrophages positive for the M1-associated surface 
markers CD80+ and CCR7+, chronic inflammation up to the final 16 week 
timepoint and limited evidence of ECM remodelling or integration with the 
surrounding tissue [421]. In contrast, the analogous non-crosslinked Restore™ 
graft appeared to induce infiltrating macrophages to polarise towards a CD163-
positive M2 phenotype with evidence of cell infiltration, ECM remodelling and 
graft integration. There is a possiblity that residual chemical crosslinking agents 
and/or cellular debris may have been present in the grafts, and if so may have 
influenced cellular interactions with the tissue. Notwithstanding this potential 
study limitation, ECM-crosslinking mediated through chemical agents appeared 
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to induce polarisation of macrophages towards a pro-inflammatory M1 
phenotype; it is conceivable that radiation-mediated ECM crosslinking could 
induce a similar response.  
In the present study, TNFα secretion after 48 hours appeared consistently 
elevated across all groups compared to the initial values (measurements taken 
at 0 hour timepoint). Despite the differences in the profile and magnitude of 
TNFα secretion between the test groups and the LPS positive control, and the 
fact that the rise in TNFα secretion at 48 hours was a pattern seen in all 
sterilisation treatment groups, this may nonetheless have indicated some 
degree of polarisation towards an M1 phenotype, with the reduced magnitude of 
cytokine secretion compared with LPS being due to differences in the relative 
potency of the stimuli. A similar pattern was seen for the cytokines IL-1β and (to 
a lesser extent) IL-6, with the exception of E Beam-treated nerve which induced 
a significant rise in IL-1β secretion peaking at the 24 hour timepoint. However, 
considering that the observed increases were relatively transient compared to 
the LPS control, it may be that the available evidence is indicative of a lower 
likelihood of severe chronic adverse macrophage response in vivo (at least in 
the context of the magnitude of response which would be expected upon 
exposure of the same cell type to pathogenic material, e.g. LPS). However, 
limited inference can be drawn from these data towards the wider immune 
response.  
Emerging evidence from attempts to modulate the polarisation of macrophages 
in tissue engineering applications suggests that the initial secretion of pro-
inflammatory cytokines and polarisation of the macrophage population towards 
an M1 phenotype may play a beneficial role following implantation of a graft 
material, enabling further recruitment of macrophages from circulation, debris 
clearance through phagocytosis and stimulating angiogenesis [434]. A transient 
increase in the secretion of cytokines such as TNFα following graft implantation 
could therefore favour the induction of such processes. A later transition of the 
macrophage population towards a predominantly M2 phenotype enables 
optimal ECM remodelling and integration of the graft. 
In addition to the possible induction of a strong and sustained pro-inflammatory 
response leading to graft rejection, the role of macrophages should also be 
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considered in the context of tissue-specific injury response processes. In 
peripheral nerve, the resident population of macrophages adopt some 
phenotypic characteristics of the M1 classification in the period immediately 
following injury, acting synergistically with Schwann cells to mediate the 
clearance of cell debris by phagocytosis in a process which is stimulated by 
factors including TNFα, IL-1β and IL-6 [32, 435]. Signalling from Schwann cells 
and resident macrophage stimulates the recruitment and activation of 
macrophages from circulation to the site of injury [436]. This occurs around two 
– seven days after injury, and is mediated through the secretion of a range of 
factors including chemokines such as monocyte chemoattractant protein-1 and 
cytokines such as TNFα, IL-1β and IL-6. TNFα secreted by macrophages 
stimulates the maintenance of a dedifferentiated phenotype in Schwann cells, in 
addition to inhibiting their proliferation, during the initial phases of Wallerian 
degeneration [437].  
As Wallerian degeneration progresses from the myelin clearance phase 
towards axonal regeneration, signalling from Schwann cells induces the 
macrophage population to adopt a primarily M2 phenotype (mediated through 
an as yet unidentified ligand, though gene knockout studies suggest the 
expression of the responsible ligand(s) may be associated with a pathway 
requiring the c-Jun transcription factor component) [438]. Macrophages are 
thought to have a key regulatory role in the ongoing process of 
neuroregeneration, though the extent of, and mechanisms responsible for, this 
modulatory capacity have not been fully elucidated [439]. Macrophage-secreted 
cytokines such as TNFα upregulate Schwann cell production of enzymes such 
as matrix metalloprotease-1 (MMP-1) mediating ECM remodelling and, together 
with the later secretion of ECM components including laminin and fibronectin 
sub-units, the formation of novel endoneurial basement membrane [106].  
Macrophages are also thought to stimulate axonal growth through the release of 
neurotrophic factors including IL-6, IGF-1 and PDGF [111, 439].  
The recruitment and activation of a large macrophage population from the 
circulation following peripheral nerve injury, and the growing body of evidence 
attributing cytokine signalling from these cells to the regulation of debris 
clearance and neuroregeneration, means that any changes in cytokine 
secretion patterns as a result of interaction with an implanted scaffold have the 
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potential to modulate the regenerative process. The initial rise in TNFα and IL-
1β implied in some groups within the present study is relatively transient 
compared to the sustained secretion of such cytokines by the Schwann cells 
and macrophages which would already be present in the injury site prior to 
implantation. Furthermore, a small and transient increase in the secretion of 
cytokines such as TNFα, IL-1β or IL-6 into such a microenvironment would be 
unlikely to impede neuroregeneration given the implicated roles of these 
cytokines in the modulation of Schwann cell phenotype, macrophage 
recruitment, phagocytosis of debris, ECM remodelling and axonal outgrowth.  
RAW 264.7 cells were chosen for use in this study due to their well-
characterised properties as an adherent macrophage cell line with consistent 
phenotypic responses (demonstrated up to 50 passages) and rapid growth 
capabilities [440]. RAW 264.7 cells have been used for the in vitro assessment 
of a diverse range of biomaterials; examples include magnesium-doped titanium 
implant surfaces for orthopaedic applications, polyethylene glycol-based 
hydrogels and polydimethylsiloxane implants encapsulated in a collagen and 
hyaluronic acid film [441-443]. A further aspect of the rationale for conducting 
an in vitro screen of macrophage response using a cell line was to eliminate 
potentially unnecessary use of animals in accordance with the principles of the 
3R’s. Flow cytometric characterisation has revealed the composition of the 
murine peritoneal cell population to be approximately 50 – 60 % B cells, 30 % 
macrophages and 5 – 10 % T cells, with an expected total yield of 5 – 10 million 
cells [444]. Given that a total of 150 x 106 cells were required for the main 
experiment (in addition to those required for optimisation), the acquisition of the 
required primary murine macrophages via peritoneal lavage would have 
required the sacrifice of approximately 50 – 100 mice (10 – 20 per group).  
The initial seeded cell population on the nerve segments varied widely, both 
between groups and between individual samples within groups. An 
experimental limitation which may have contributed to the variance in initial cell 
population is the requirement for individual groups to be seeded on separate 
days. The time required to passage and count cell populations from several 
T175 flasks, seed 30 individual samples of decellularised nerve, transfer the 
samples to the final culture plates and conduct the 0 hour data collection was a 
limiting factor preventing simultaneous seeding. The cells in each group were 
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therefore sourced from separate populations (i.e. passaged on separate days, 
cultured in separate flasks with different batches of media etc). The inconsistent 
efficiency of the seeding methodology used in the present study, together with 
differences in the size and surface topography of the tissue segments, may also 
have contributed to the inter and intra-group variability in seeded cell 
population. Some inter-group inconsistency in terms of initial macrophage 
population has been seen in RAW 264.7 cells seeded onto a range of polymeric 
fibres and in primary murine peritoneal macrophages seeded onto alkyl-
aminated polymeric hydrogels [445, 446].   
A further explanation for the variation in initial cell population may be the relative 
availability of ECM motifs. Decellularised nerves sterilised with PAA, gamma 
radiation and SCCO2 were found to have an greater susceptibility to 
collagenase compared to E Beam-treated nerves. If a higher susceptibility to 
collagenase digestion is reflective of an ECM structure with a more specific 
enzymatic cleavage sites exposed, it is likely that a greater proportion of cell 
attachment motifs would also be exposed. This would account for the greater 
seeding efficiency seen, especially in PAA and SCCO2-treated nerves. A similar 
pattern was seen in a study of two different decellularised human dermal 
matrices, FlexHD® Pliable and BellaDerm® [426]. The susceptibility of 
BellaDerm® to digestion with collagenase was approximately 25 % lower than 
that of FlexHD® Pliable. This corresponded to increased levels of cell 
attachment on FlexHD® Pliable compared to BellaDerm® after seeding with 
human dermal fibroblasts, especially in in the initial 48 hour period, and a more 
even pattern of cell attachment across both the dermal and epidermal faces of 
the graft. This finding may have implications for cell attachment and infiltration 
into the decellularised nerves in the present study, with the caveat that the in 
vitro cell surface seeding with a macrophage cell line is not representative of 
cell infiltration in an in vivo environment post-implantation. The growth and 
attachment of key cell types into the decellularised nerves, such as Schwann 
cells and neurons is likely to be influenced by other factors such as the retention 
of endoneurial tubule structure and key basement membrane components (e.g. 
fibronectin, laminin).   
The biocompatibility and immunoreactivity of the decellularised nerves did not 
appear to have been negatively impacted by any of the sterilisation methods, 
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within the context and inherent limitations of the experimental designs utilised. 
Ultimately, in vivo implantation of the sterilised decellularised nerves within an 
animal model (e.g. rat sciatic defect model) would be required to more 
definitively define the likely host immune response; such an experiment would 
enable a fuller characterisation of the complex integrated immune response to 
which the sterilised nerves would be exposed, and as such would enable fuller 
consideration of the likely effects of tissue integration and the resulting 
implications for the support of site-specific cell growth and eventual functional 
restoration. Based on these results, greater emphasis during this initital study 
should be placed upon other factors, such as retention of basement membrane 
components and mechanical properties, when considering the optimal 
sterilisation method for use with the decellularised nerves.  
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8 Effects of long-term storage on the properties of 
decellularised nerves sterilised with PAA, gamma radiation 
or E Beam 
8.1 Introduction 
The required shelf life of a decellularised tissue graft (i.e. from the end of the 
decellularisation process to implantation) is unpredictable. The ability to 
maintain stability of the functional properties of a graft, including structure and 
composition of the ECM, biocompatibility and mechanical properties, over a 
long-term period of storage is therefore advantageous. The ability to store 
decellularised tissue grafts in ambient conditions (i.e. without the requirement 
for highly-controlled storage conditions such as refrigeration or 
cryopreservation) is also desirable, reducing costs associated with 
transportation and storage and decreasing the risk of graft degradation in the 
event that such conditions are not achieved.  
There is limited evidence in the literature regarding the effects of storage on the 
properties of decellularised tissue grafts. Physical and chemical treatments 
mediating the decellularisation of tissues are known to disrupt ECM structure, 
both in terms of the whole tissue histoarchitecture and at the level of inter- and 
intramolecular bonds and interactions [17, 309, 447, 448]. It is conceivable that 
such alterations may decrease the stability of the ECM and therefore increase 
the likelihood of further degradation over time whilst in storage. A 2012 study 
demonstrated negative changes to the histoarchitecture, a reduction in collagen 
fibril integrity, an approximate 50 % increase in susceptibility to collagenase 
digestion and an approximate 50 % reduction in the Young’s Modulus and 
tensile strength of decellularised human tracheas after 12 months of storage 
[449].  
A further factor which may influence the preservation of decellularised tissue 
grafts over a long-term storage period is sterilisation. The elimination of 
microorganisms is essential to reduce the risk of infection post-implantation, 
and prevents ECM degradation by bacterial collagenase enzymes [450]. 
However, aside from a few focussed studies (e.g. examining the effects of 
storage on the viscoelastic properties of decellularised tendons sterilised with 
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PAA, gamma radiation or E Beam), there are very limited data regarding the 
effects of storage on sterilised decellularised tissues [451]. Treatment with 
ionising radiation or oxidising agents may induce changes to the structure of 
ECM components at a molecular level, through mechanisms such as cross-
linking, chain scission and oxidative damage [1, 242]. For example mass 
spectrometric analysis of decellularised murine lungs treated with PAA 
demonstrated a higher proportion of solubilised ECM components compared 
with non-sterilised decellularised tissue; this was likely due to partial 
denaturation as a result of oxidative damage [242]. Such alterations could make 
ECM components more susceptible to further degradation over time, with 
potential implications for graft integration and the ability to support functional 
restoration.  
Assessment of the effects of long-term storage on sterilised decellularised 
peripheral nerves is crucial due to the potential induction of efficacy-altering 
changes with increasing age of the tissue. Good retention of key functional 
properties during the storage period would be advantageous when considering 
use in the clinical environment.  
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8.2 Aims and Objectives 
Aim 
The aim of this chapter was to determine the effects of 12 months storage at 
room temperature on the biological and biomechanical properties and 
biochemical composition of decellularised nerves sterilised with PAA, gamma 
radiation or E Beam.  
 
Objectives 
i. To treat decellularised peripheral nerves with PAA solution, gamma 
radiation, E Beam and store for 12 months. 
ii. To determine effect of storage on the biocompatibility of the aged 
sterilised nerves. 
iii. To determine the effects of storage on sterilised peripheral nerve ECM 
structure through staining of histological sections with H & E and Sirius 
Red & Miller’s. 
iv. To determine the effects of storage on the distribution of collagen type 
IV, laminin and fibronectin within the ECM of sterilised nerves through 
antibody labelling. 
v. To determine the effects of storage on the mechanical properties of  
sterilised nerves through uniaxial tensile testing. 
vi. To determine the effects of storage on the biochemical composition of 
sterilised nerves, through quantification of collagen and denatured 
collagen. 
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8.3 Materials and Methods 
All results were compared to the previously acquired dataset for freshly 
produced sterilised nerves (meaning that data acquisition experiments were 
conducted separately for the 0 month and 12 month storage groups).  
8.3.1 Sterilisation and storage of decellularised nerves 
Three groups of porcine peripheral nerves (n = 30) were dissected and 
decellularised as described in sections 2.9 and 2.10. One group each was 
sterilised by treatment with 0.1 % (v/v) PAA, gamma radiation and E Beam, as 
described in section 2.10.3.  
The sterilised nerves were stored in bijous containing 5 ml PBS, further sealed 
with parafilm, at room temperature (15 – 25 °C) for a period of 12 months. Long-
term storage of decellularised nerves treated with SCCO2 was not possible 
during the study period due to time constraints.   
8.3.2 Contact cytotoxicity 
The cytotoxicity of the aged nerves (n = 6 per group) was assessed by contact 
culture with two distinct cell lines, as described in section 2.12.  
8.3.3 Histological analysis 
Processing and sectioning of tissue was carried out as described in section 
2.11. Staining of sections (n = 3 per group) with H & E and Sirius Red was 
carried out as described in section 2.11.  
8.3.4 Antibody labelling for collagen IV, laminin and fibronectin  
Processing and sectioning of tissue was carried out as described in section 
2.11. Labelling of sections with specific antibodies for collagen IV, laminin and 
fibronectin (n = 3 per group) was carried out as described in section 2.11.8. 
8.3.5 Uniaxial tensile testing 
Samples of aged sterilised nerve (n = 6 per group) were subject to uniaxial 
tensile testing, as described in section 2.13. 
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8.3.6 Quantification of collagen and denatured collagen content 
The amount of collagen (n = 6 per group) and denatured collagen (n = 6 per 
group)  in the sterilised nerves was quantified as described in sections 2.14.4 
and 2.14.5.  
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8.4 Results 
8.4.1 Contact cytotoxicity testing of aged sterilised nerves 
The biocompatibility of the sterilised nerves after 12 months was assessed by 
contact culture studies with two distinct cell lines, L929 and BHK (Figure 8-1 
and ). As previously described in section 2.12.4, cyanoacrylate contact 
adhesive was used as a positive control and a commercially available surgical 
closure strip (Steri-Strip) as a negative control. 
No evidence of cytotoxicity was observed in either cell line when cultured with 
sterilised nerves stored for 12 months. Both cell lines were observed to grow up 
to and in contact with the samples, maintaining a consistent morphology. 
The rounded appearance characteristic of the dead cells cultured in wells with 
the cyanoacrylate positive control was not observed in cells cultured with nerves 
from any of the treatment groups (data not shown). 
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Figure 8-1 Representative images of Giemsa-stained L929 cells cultured 
for 48 hours with decellularised nerves 
L929 cells cultured with: decellularised nerves treated with PAA and stored for 
(A) 0 months and (B) 12 months, treated with gamma radiation stored for (C) 0 
months and (D) 12 months, and treated with E Beam stored for (E) 0 months 
and (F) 12 months. Cells were fixed with NBF and stained with Giemsa 
following 48 h in culture. Position of tissue segments indicated by arrows. 
Images were acquired under Köhler illumination using a x10 objective, scale 
bars = 100 µm.  
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Figure 8-2 Representative images of Giemsa-stained BHK cells 
cultured for 48 hours with decellularised nerves 
BHK cells cultured with: decellularised nerves treated with PAA and stored 
for (A) 0 months and (B) 12 months, treated with gamma radiation stored 
for (C) 0 months and (D) 12 months, and treated with E Beam stored for 
(E) 0 months and (F) 12 months. Cells were fixed with NBF and stained 
with Giemsa following 48 h in culture. Position of tissue segments indicated 
by arrows. Images were acquired under Köhler illumination using a x10 
objective, scale bars = 100 µm.  
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8.4.2 Histological analysis of changes to ECM structure 
H & E staining was used to enable assessment of the effects of the 12 month 
storage period on the histoarchitecture of the sterilised nerves (Figure 8-3). No 
differences were apparent between samples stored for 0 and 12 months, with 
structural disruption only seen in the epineurium and endoneurium of PAA-
treated nerves. The extent and/or severity of this disruption did not appear to 
have increased during the storage period. All major ECM structures 
(endoneurium, perineurium and epineurium) appeared well conserved following 
12 months storage of nerves treated with gamma radiation or E Beam. The 
eosin staining intensity appeared to be different between the two timepoints, 
possibly due to the stains being carried independently for each (and therefore 
being processed using different batches of reagent).  
Sirius Red was used to define the distribution and structure of collagen in the 
stored sterilised nerves (Figure 8-4). Some changes to the collagen structures 
were observed in the epineurium of PAA-treated nerves after 12 months 
storage, with the fibrils appearing less closely associated and organised. No 
obvious differences were observed between nerves treated with gamma 
radiation or E Beam when stored for 0 or 12 months.  
Increased spacing was observed between the perineurium and endoneurium in 
Figure 8-3 F. This is likely representative of an artefact introduced during 
sectioning. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 262 - 
  
Figure 8-3 Representative images of sections stained with H & E 
Decellularised nerves treated with PAA and stored for (A) 0 months and (B) 12 
months, treated with gamma radiation and stored for (C) 0 months and (D) 12 
months, and treated with E Beam and stored for (E) 0 months and (F) 12 
months. There was some evidence of disruption to stored decellularised nerves 
treated PAA, predominantly located in the epineurium (EPI; indicated by 
arrows). The perineurium (PE) and endoneurium (EN) are also indicated. 
Images were acquired under Köhler illumination using a x10 objective, scale 
bars = 100 µm. 
 
A B 
C D 
E F 
0 months 12 months 
EN 
 
EN 
 
EN 
 
EN 
 
EN 
 
EN 
 
EPI 
 
EPI 
 
EPI 
 
EPI 
 
EPI 
 
EPI 
 
PE 
 
PE 
 PE 
 
PE 
 
PE 
 
PE 
 
100 µm 100 µm 
100 µm 100 µm 
100 µm 100 µm 
- 263 - 
A B 
C D 
E F 
0 months 12 months 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8-4 Representative images of sections stained with Sirius 
Red/Miller’s Elastin  
Decellularised nerves treated with PAA and stored for (A) 0 months and (B) 12 
months, treated with gamma radiation and stored for (C) 0 months and (D) 12 
months, and treated with E Beam and stored for (E) 0 months and (F) 12 
months. Sections were viewed under polarised light conditions. Some evidence 
of structural changes was evident, particularly to the endoneurium (indicated by 
arrows). Images were acquired under Polarised light conditions and using a x10 
objective, scale bars = 100 µm. 
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8.4.3 Antibody labelling for collagen IV, laminin and fibronectin  
Sections of sterilised nerve from different groups were labelled with specific 
antibodies to demonstrate the effects of a 12 month storage period on the 
distribution of collagen IV, laminin and fibronectin.  
There was no difference in the distribution of labelling for collagen IV in 
nerves sterilised with gamma radiation and E Beam after 12 months of 
storage ( 
Figure 8-5). However, there was a slight reduction in the intensity of labelling. 
No positive labelling for collagen IV was seen in decellularised nerves treated 
with PAA after either 0 or 12 months of storage.. 
No change to either the distribution or intensity of labelling for laminin was 
observed in the perineurium and endoneurium of nerves treated with gamma 
radiation and E Beam after 12 months of storage (Figure 8-6). However, while 
the distribution of labelling in PAA-treated samples appeared to be unchanged, 
a slight reduction in intensity was evident after 12 months of storage.  
Labelling for fibronectin was almost completely absent in PAA-treated samples 
after 12 months of storage, and appeared to be reduced in intensity in E Beam-
treated samples (Figure 8-7).  
Increased spacing was observed between the perineurium and endoneurium in 
some images, including Figure 8-5 F, Figure 8-6 E, Figure 8-6 F, and Figure 8-7 
E. This is likely representative of artefacts introduced during sectioning. 
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Figure 8-5  Representative images of sections labelled with monoclonal 
antibodies against collagen IV (previous page) 
Decellularised nerves treated with PAA and stored for (A) 0 months and (B) 12 
months, treated with gamma radiation and stored for (C) 0 months and (D) 12 
months, and treated with E Beam and stored for (E) 0 months and (F) 12 
months. A porcine artery positive control (G) and an isotype control (H) were 
included. Images were acquired under Köhler illumination using a x10 objective, 
scale bars = 100 µm. 
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Figure 8-6 Representative images of sections labelled with monoclonal 
antibodies against laminin 
Decellularised nerves treated with PAA and stored for (A) 0 months and (B) 12 
months, treated with gamma radiation and stored for (C) 0 months and (D) 12 
months, and treated with E Beam and stored for (E) 0 months and (F) 12 
months, immunohistochemically labelled for the presence of laminin. A porcine 
artery positive control (G) and an isotype control (H) were included. Images 
were acquired under Köhler illumination using a x10 objective, scale bars = 100 
µm. 
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Figure 8-7 Representative images of sections labelled with a monoclonal 
antibody against fibronectin and counterstained with DAPI 
Decellularised nerves treated with PAA and stored for (A) 0 months and (B) 12 
months, treated with gamma radiation and stored for (C) 0 months and (D) 12 
months, and treated with E Beam and stored for (E) 0 months and (F) 12 
months, immunofluorescently labelled for the presence of fibronectin. A porcine 
artery positive control (G) and an isotype control (H) were included. The 
endoneurium (EN) and perineurium (PE, arrow) are labelled on the first image 
for reference. Images were acquired at a wavelength of 488 nm using a x10 
objective, scale bars = 100 µm. 
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8.4.4 Uniaxial tensile testing 
Samples of aged sterilised nerve were subject to uniaxial tensile testing to 
determine the effects of 12 months of storage on the material properties. 
The UTS, maximum load at failure, Young’s Modulus, stiffness, and energy to 
break values for sterilised nerves were not significantly different after 12 months 
of storage (Figure 8-8, Figure 8-9, and Figure 8-10).  
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B 
Figure 8-8 UTS and maximum load at failure of aged sterilised peripheral 
nerves 
(A) UTS and (B) maximum load at failure of peripheral nerves treated with PAA, 
gamma radiation and E Beam and stored for 0 or 12 months. Data shown as 
mean +/- 95 % confidence interval, n = 6. Statistical analysis was by two-way 
ANOVA.  
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Figure 8-9 Young’s Modulus and Stiffness of aged sterilised peripheral 
nerves. 
(A) Young’s Modulus and (B) Stiffness of peripheral nerves treated with PAA, 
gamma radiation and E Beam and stored for 0 or 12 months. Data shown as 
mean +/- 95 % confidence interval, n = 6. Statistical analysis was by two-way 
ANOVA.  
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Figure 8-10 Energy to break values for aged sterilised peripheral nerves 
Energy to break values for peripheral nerves treated with PAA, gamma radiation 
and E Beam and stored for 0 or 12 months. Data shown as mean +/- 95 % 
confidence interval, n = 6. Statistical analysis was by two-way ANOVA. 
  
- 275 - 
8.4.5 Quantification of collagen and denatured collagen content 
No significant differences were found in the collagen content or denatured 
collagen content of sterilised nerves after 12 months of storage (Figure 8-11). 
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Figure 8-11 Collagen and denatured collagen content of aged sterilised 
porcine peripheral nerves 
(A) Collagen content and (B) denatured collagen content of peripheral nerves 
treated with PAA, gamma radiation and E Beam and stored for 0 or 12 months. 
Data shown as mean +/- 95 % confidence interval, n = 6. Statistical analysis 
was by two-way ANOVA.  
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8.5 Discussion 
The biocompatibility, structure, and mechanical properties of the decellularised 
nerves treated with PAA, gamma radiation and E Beam appeared to be well 
retained after 12 months of storage at room temperature.  
Previous studies into the effects of long-term storage on decellularised tissues 
(including human trachea, murine lung and rabbit oesophagi) have employed 
antibiotic and antimycotic compounds, in combination with controlled 
temperature environments (maintained at 4 °C or cryopreserved in protectant 
medium and stored in liquid nitrogen), to ensure preservation [242, 449, 452]. 
Terminal sterilisation may negate the requirement for such storage conditions 
(although such conditions have been employed as a further protective measure 
e.g. for decellularised human dermis and frozen cellular human bone allografts 
sterilised with gamma radiation); the data from the present study demonstrate 
retention of functional properties in sterilised nerves stored in an unmodified 
PBS solution and at room temperature [453, 454].  
In the present study graft deterioration was limited to some disorder in the 
collagenous structures of the epineurium and possible alterations to the 
distribution of basement membrane components, particularly in PAA-treated 
samples. It is possible that treatment of decellularised nerves with gamma 
radiation or E Beam may mediate inter and intra-molecular crosslinking of 
collagens in the ECM, providing ultrastructural stability and preventing 
degradation; however, due to the inherent difficulties in storing non-sterilised 
tissue for long periods of time, no negative control comparator group was 
available against which to evaluate this possibility [228, 336]. 
In contrast, oxidative degradation and/or solubilisation of ECM components may 
have contributed to the changes seen in PAA-treated samples [242]. Bonenfant 
et al (2013) observed an increase in solubilised ECM components, including 
laminin, fibronectin and collagen IV, in decellularised murine lungs treated with 
PAA compared to freshly decellularised samples. The reduction in labelling 
intensity for laminin and fibronectin observed here may be the result of a similar 
process. It is possible that in the initial period following PAA-mediated oxidative 
degradation of the basement membrane, laminin and fibronectin remained 
localised to the perineurium and endoneurium. This would account for the 
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positive labelling seen in the samples which were fixed and processed 
immediately after PAA treatment.  
There are two possible explanations for the different results seen in PAA-
treated samples after 12 months storage. If the oxidative damage has primarily 
resulted in solubilisation of laminin and fibronectin, the affected proteins may 
have gradually diffused away from the basement membrane regions and 
therefore caused a weaker signal to be detected upon labelling. Alternatively, 
destabilisation of the inter- and intra-molecular bonds of laminin and fibronectin 
sub-units may have led to conformational alterations and/or changes to surface 
chemistry, altering the target epitope of the specific antibodies used in the study 
and reducing the level of antibody binding. As the interaction of Schwann cells 
and neurons with these proteins is thought to facilitate processes including cell 
attachment, migration and myelination, removal or alteration of laminin and 
fibronectin from the endoneurial basement membrane may slow or inhibit the 
process of reinnervation and restoration of function post-implantation.  
The slight increase in disorder within the collagen structures of PAA-treated 
nerves after 12 months of storage was not accompanied by a corresponding 
reduction in the mechanical properties. This finding differs from the 
observations of several previous studies. The UTS and Young’s Modulus of 
decellularised rabbit oesophagi were reduced by approximately 60 % and  50 % 
respectively after storage for 6 months at 4 °C in the presence of antibiotics and 
antimycotics. A proportionally smaller reduction in Young’s Modulus 
(approximately 30 %) was seen in decellularised oesphagi which were 
cryopreserved in protectant medium and stored in liquid nitrogen. Histological 
staining revealed much greater deterioration of collagen structures within the 
decellularised oesophagi stored at 4 °C compared to cryopreserved oesophagi. 
Similar changes to collagen structures and corresponding degradation of 
mechanical properties was seen in decellularised human tracheas stored for 12 
months at 4 °C in the presence of antibiotic and antimycotic compounds [449]. 
In both cases, the changes were considered to be sufficiently extensive that 
implantation of the decellularised material after the given storage period could 
not be recommended. A possible reason underlying such differences compared 
with the present study may be the different decellularisation protocols used; the 
oesophagi and the tracheas were decellularised through cycles of treatment 
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with 4 % (v/v) sodium deoxycholate and DNase-I. The oesophagi and tracheas 
were treated for a total of three and 25 cycles, respectively. This may have led 
to greater degradation of collagen structures relative to the decellularised 
nerves, therefore resulting in a correspondingly greater impacts on mechanical 
properties. Unlike the tracheas, the decellularised oesophagi were not subject 
to sterility testing before or after the storage period; therefore, degradation of 
the ECM by secreted bacterial enymes (e.g. collagenases) cannot be 
discounted as a possible mechanism of scaffold degradation.  
The changes to collagen structures seen in the present study were primarily 
limited to the epineurium. However, given that the perineurium surrounding 
each fascicle is thought to be the primary contributing structure to the tensile 
strength of peripheral nerves, it is unlikely that the observed changes would 
significantly alter the mechanical forces experienced by infiltrating cells in vivo.  
Studies examining the effect of long-term storage on the properties of terminally 
sterilised decellularised tissue grafts are limited. A 2016 study investigated the 
effects of a 12 months storage on decellularised procine superflexor tendons 
sterilised with either PAA, gamma radiation or E Beam [451]. Similarly to the 
findings of the present study, no significant alterations were detected to 
biocompatibility, histological structure, mechanical properties and biochemical 
composition after the storage period.  
Notwithstanding the apparent slight changes to the endoneurial and perineurial 
basement membranes and the organisation of collagen in the epineurium of 
PAA-treated nerves, storage for 12 months and without extensive control of 
environmental conditions did not appear to negatively impact upon key 
functional properties. 
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9 Discussion 
9.1 General Discussion 
There is a need for a novel graft material to promote and support functional 
regeneration across peripheral nerve defects; this is underlined by the inherent 
limitations of the current clinical options. NGCs may facilitate neuroregeneration 
over smaller defects, but efficacy appears to be limited in defects greater than a 
critical value of length (approximately 3 cm) [7]. Furthermore, while autografting 
is the current gold standard method, autograft repair of larger defects 
necessitates the harvest of increasing quantities of material from designated 
donor sites (e.g. the sural nerve), resulting in greater levels of donor site 
morbidity being incurred [50].  
A previously developed decellularisation process for porcine peripheral nerves 
may provide a promising alternative graft material for peripheral nerve repair. 
Tissue grafts derived from xenogeneic sources present many of the advantages 
of unprocessed autografts, providing a scaffold material with a native-like ECM 
structure, cell attachment motifs / chemotrophic cues and biomechanical 
properties [17, 134]. Whilst allogeneic tissues present the same advantages, 
porcine tissue (as a xenogeneic material sourced from relatively young animals) 
provides the additional advantage of ensuring a consistent supply of high quality 
tissue without the inherent inter-donor variability associated with the human 
donor tissue [58]. The use of non-autograft material to repair peripheral nerve 
defects also removes the need to harvest graft material from the patient 
(thereby preventing the associated donor-site morbidity). Decellularised porcine 
peripheral nerves have been demonstrated to support site-specific cell growth 
during preliminary in vivo and in vitro studies [18, 139].  
In order to reduce the risk of an FBRI following implantation, medical devices 
must be terminally sterilised using a method which meets the conditions for 
bioburden reduction stipulated in BS-EN 556-1 [334]. Therefore, the 
identification a suitable terminal sterilisation method is required for 
decellularised tissues (e.g. decellularised nerves) to be safely employed in the 
clinical environment. A range of sterilisation processes, including heat-mediated 
methods (e.g. steam), chemical methods (e.g. ethylene oxide, PAA, H2O2) and 
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ionising radiations (e.g. gamma radiation, E Beam), have been developed for 
use with medical devices. However, the relative sensitivity of tissue components 
(e.g. proteins such as collagen) to factors such as excessive heat, oxidative 
damage and ionising radiations results in an increased risk of incurring damage 
from such methods compared to devices comprising metals and/or polymers 
[141].   
Therefore, the overarching aim of the present study was to identify a 
sterilisation method (or methods) suitable for use with a previously developed 
decellularised porcine peripheral nerve graft. Towards this aim, a hypothesis 
was generated stating that “a terminal sterilisation process, novel or 
established, can be used to treat decellularised porcine peripheral nerves 
without compromising biological and/or physical properties”. The identification of 
such a method would represent an important step in the translation of the 
decellularised nerves towards an “off-the-shelf” clinical product with preserved 
functional properties, minimal risk of graft-related infection post-implantation 
and the capacity to withstand long-term storage (ideally without the requirement 
for highly-controlled environmental conditions).  
Prior to evaluating the effects of candidate sterilisation methods, the previously 
described decellularisation process was optimised in an attempt to reduce the 
length of time required for processing the nerves whilst maintaining the 
preservation of ECM histioarchitecture achieved with the original process [18].  
The principle reason for carrying out decellularisation of potentially highly-
immunogenic xenogeneic (and allogeneic) tissues is to reduce the potential for 
the induction of an adverse host response following implantation, enabling such 
materials to be considered for use in clinical procedures [37]. Therefore, 
ensuring a consistent reduction in the quantities of potentially immunogenic 
materials (e.g. cells and nucleic acids) while preserving key functional 
properties of the peripheral nerve tissue remained the primary consideration 
during the optimisation process [132]. The peripheral nerve decellularisation 
process was shortened through the elimination of a proportion of the hypotonic 
buffer and PBS wash steps (implying a reduction in the cost and resources 
required for graft production). Further optimisation resulted in a reduction of the 
agitation speed applied to the nerves, from 240 rpm to 120 rpm, in order to 
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minimise the structural damage to the ECM induced by mechanical forces 
during decellularisation. Structural damage to nerves processed at 240 rpm was 
most evident in the endoneurium; as in autografts, the structure of the 
endoneurium is thought to be particularly important for the guidance and 
protection of regenerating axons following implantation into a defect site [7, 135, 
137]. Evaluation of the nerves decellularised using the final process indicated a 
high level of retention of ECM structures compared with native tissue. The 
basement membrane components laminin, fibronectin and collagen IV, also 
appeared to be retained; furthermore, the biochemical composition and 
biomechanical properties were not significantly different to unprocessed porcine 
nerve samples, indicating the preservation of a native-like ECM scaffold. Based 
on these results, this decellularisation process was then utilised throughout the 
remainder of the study.  
For all prospective medical devices, including xenogeneic tissue grafts such as 
the decellularised porcine peripheral nerves described in this thesis, the 
identification of a suitable terminal sterilisation process is required prior to 
consideration for clinical use [334]. The scope of the present study was to 
evaluate the effects of sterilisation methods on the biological and physical 
properties of the decellularised nerves, rather than validating sterilisation 
efficacy (i.e. bioburden reduction). Sterilisation methods have been shown to 
degrade ECM components and structure through mechanisms such as cross-
linking, chain scission, oxidation and heat-mediated damage [335]. The 
properties of the ECM which are most affected differ according to the 
mechanism of action of the given sterilisation method, any associated 
processes required (e.g. lyophiisation) and the specific tissue properties. For 
example, some hard tissues such as bone (which may undergo lyophilisation 
without degradation of structural or mechanical properties) have been 
lyophilised and sterilised with ethylene oxide without negatively impacting 
clinical efficacy [187]. However, soft tissues such as arteries and dermis have 
been shown to be susceptible to lyophilisation-induced structural disruption, and 
therefore the use of ionising radiation (under wet-state conditions) or oxidising 
agents in solution may be more applicable [1, 338, 455]. For example, 
decellularised human dermis products sterilised with either gamma radiation 
(kGy) or 0.1% PAA in solution are currently in clinical use [454, 456, 457]. The 
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choice of a sterilisation method for a graft should therefore be guided by 
assessment of the specific tissue in question; in particular, evaluation of which 
biological and/or physical properties are considered most important to retain 
may be crucial for ultimate function of the graft. 
As with dermis, peripheral nerve is a soft tissue. Peripheral nerve tissue is likely 
to be susceptible to physical alterations to the histioarchitecture due to the 
complex and delicate nature of the ECM structures which comprise the majority 
of the tissue (particularly the endoneurium) [18, 58]. Several tissue properties 
were identified as potentially crucial for the optimal function of decellularised 
nerves in vivo. These included the structure and basement membrane 
composition of the endoneurium, which provides chemotrophic and physical 
guidance to infiltrating Schwann cells and neurons, the structure of the 
perineurium (an important determinant of peripheral nerve mechanical 
properties) and the retention of a native-like Young’s Modulus to ensure 
regenerating neurons residing within the graft are not subject to excessive 
tensile mechanical forces [8, 73]. 
Currently, two decellularised nerve grafts (both derived from human tissue) 
have undergone clinical testing (a human decellularised nerve graft evaluated in 
a multicentre study China) or are licensed for clinical use (Avance® nerve graft, 
licensed in the USA) [71, 458, 459]. Both are sterilised with gamma radiation at 
a dose level of 25 kGy; however, it is unclear why this method was selected, 
and limited data are available regarding the effects of the sterilisation process in 
isolation on the properties of the decellularised nerve tissue. Gamma 
sterilisation has been commonly used historically for the sterilisation of both 
unprocessed allografts and decellularised allo/xenografts; examples include 
decellularised human dermis, allogeneic bone grafts, and allogeneic amniotic 
membrane [395, 456, 460-462]. However, the potential negative effects of 
processing with gamma radiation are also well documented; as one example, 
gamma irradiation (12 kGy) was demonstrated to induce disruption to the fine 
ECM structure, and a reduction in the ultimate tensile strength, of a 
decellularised human dermal graft [6]. Whilst the specific conditions used (e.g. 
dose level, whether the tissue is dehydrated prior to irradiation) are increasingly 
recognised as important determinants of the effects of gamma irradiation on 
tissue, the screening of a range of sterilisation methods (functioning through 
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differing mechanisms, and therefore presenting differing advantages and 
disadvantages) was considered to be the best approach for the identification of 
an optimal method for the decellularised porcine peripheral nerves in the 
present study [335, 451].  
PAA solution, gamma radiation, E Beam and SCCO2 (with an additive solution 
comprising 1.5 – 18.5 % [v/v] PAA) and 4.5 – 6 % [v/v] H2O2) were initially 
selected as candidate sterilisation methods due to their proven efficacy in terms 
of bioburden reduction, demonstrated either through the existence of a relevant 
standard (e.g. ISO 11137 for ionising radiations), or via prior data indicating that 
a sterility level equivalent to that stipulated in BS EN 556-1 can be achieved 
through the application of a given method [216, 463-465]. In addition, there is 
an established evidence base for the use of PAA (e.g. decelllarised human 
dermis), gamma radiation (e.g. allogeneic amniotic membrane, decellularised 
human dermis, decellularised porcine superflexor tendon), and E Beam (e.g. 
decellularised porcine superflexor tendon, human flexor digitorum superficialis 
tendon) indicating possible compatibility with soft tissue grafts [231, 335, 336, 
395, 454, 456, 466]. While the application of SCCO2 for tissue graft sterilisation 
is relatively recent compared to the more established methods of PAA, gamma 
and E Beam, previous studies have demonstrated effective reduction of 
bacterial endospore and viral populations can be achieved when SCCO2 is used 
in conjunction with an oxidising agent (which also enables bioburden reduction 
to be achieved under more moderate environmental conditions in terms of 
temperature and pressure) [3, 216, 467]. The ability to carry out processing 
under moderate environmental conditions is especially advantageous when 
considering a sterilisation method for use with medical devices composed of 
biological materials (e.g. collagens) rather than polymers or metals, which may 
be comparatively more sensitive to extremes of temperature and pressure 
[170]. Retention of tissue ECM structure, mechanical properties and 
biocompatibility have been observed when decellularised rat lungs and porcine 
heart valves were treated using SCCO2 in conjunction with a low volume of 
additive solution containing PAA and H2O2; these promising results provided 
evidence justifying the inclusion of SCCO2 processing in the present study [19, 
243]. 
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Ethylene oxide was considered for inclusion as a candidate sterilisation method 
due to its efficacy (in terms of bioburden reduction) and previous history of use 
in tissue banking, particularly with bone allografts [187]. However, prior 
dehydration of ECM-based grafts is required for the safe and effective use of 
ethylene oxide. Dehydration enables sufficient diffusion of the reagent 
throughout the graft and also ensures effective post-processing elimination 
(through aeration) of the toxic breakdown products ethylene glycol and ethylene 
chlorohydrin [468]. Despite attempts to reduce the formation of large ice crystals 
during the process, lyophilisation appeared to induce widespread structural 
disruption to the endoneurial tubules of the decellularised nerves. Desiccation at 
ambient temperature, through the use of silica beads in a sealed glass 
chamber, enabled preservation of decellularised nerve ECM structure. 
However, the internal structure of the nerves did not appear to fully rehydrate 
even after a seven day incubation period in PBS, and furthermore uniaxial 
tensile testing revealed an increased Young’s Modulus. Such mechanical 
changes may have negative implications for neuronal growth and signal 
transduction, as tissue with an increased Young’s Modulus would not deform to 
the same extent as native tissue under a given load; therefore, the surrounding 
nerve tissue would be required to deform further at peak strain levels to 
compensate. Elevated local levels of strain would increase the probability of 
tensile stress experienced by the neurons resident within the nerve exceeding 
normal physiological levels; this could lead to increased local expression and 
wider distribution of transmembrane voltage-gated sodium channels, potentially 
impeding the conduction speed of action potentials [382]. Furthermore, if the 
observed increase in tissue stiffness is mirrored at a microscale-level, this 
would have negative implications for the promotion of neuronal growth. For 
example, an in vitro study of chick dorsal root ganglia cultured with collagen 
gels of increasing stiffness suggested that there is an inverse relationship 
between substrate stiffness and the growth of extending axons [366]. The 
relatively high fat content of the epineurium, and the hydrophobicity of the 
constituent lipid molecules, were considered the most likely mechanism limiting 
the diffusion of water molecules into the proteinaceous ECM structures of the 
perineurium and endoneurium. Meyer et al demonstrated that porcine adipose 
tissue had a lower rehydration capacity than muscle, cartilage, skin, tendon or 
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lung, only achieving 80 % (w/w) of its original mass after 60 minutes of 
rehydration [347]. Due to the failure to identify a non-destructive dehydration 
process, and the documented negative impacts of toxic residues on tissue graft 
integration (relative to the other methods considered in this study; see section 
1.8.4), ethylene oxide was considered to be unsuitable for use with the 
decellularised nerves [188, 191].  
In the present study, the effects of individual sterilisation methods on the 
properties of decellularised nerve ECM appeared to be strongly related to 
whether the method utilised ionising radiation (e.g. gamma radiation, E Beam) 
or oxidising agents (PAA in solution, PAA / H2O2 additive solution for SCCO2 
treatment). Qualitative assessment through histological examination and 
antibody labelling revealed only limited changes to the ECM of decellularised 
nerves treated with ionising radiation, whereas treatment with oxidising agents 
resulted in some disruption to ECM structures (primarily to the endoneurium but 
also in the epineurium) and an observed decrease in the localisation and 
intensity of antibody labelling for key basement membrane components.  
The distinction between the effects of radiation-based methods and those 
utilising oxidising agents was further apparent when the physical properties of 
the sterilised nerves were evaluated. Treatment with both PAA and SCCO2 
caused an increase in the susceptibility of decellularised nerves to digestion 
with collagenase, whilst gamma radiation and E Beam reduced the transition 
temperature of collagen within the nerves. Changes in susceptibility to 
collagenase digestion could have implications for the degree (and rate) of ECM 
remodelling post-implantation, and therefore could potentially affect the 
retention of ECM structure in vivo. One example of such a difference was 
demonstrated through a comparison study of non-crosslinked deceullarised 
porcine dermis (Strattice®) compared with a crosslinked alternative 
(Permacol®), both of which were implanted into porcine abdominal wall defects; 
notwithstanding the small sample sizes used (n=8 per group), proportionally 
more ECM remodelling and neovascularisation was observed after one month 
in defects repaired with the non-crosslinked Strattice®, which was previously 
demonstrated as being significantly more susceptible to collagenase digestion 
[401]. These results suggest that, within the context of the specific defect/graft 
combination investigated, a greater susceptibility to collagenase digestion may 
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aid graft integration to the surrounding tissue; however, it should be noted that a 
reduction in collagenase susceptibility mediated through chemical crosslinking 
may be a greater relative impediment to tissue graft integration than retention of 
a level of collagenase susceptibility which is not significantly different to that of 
native/non-sterilised decellularised tissue, as was seen with decellularised 
nerves sterilised with either gamma radiation or E Beam in the present study. 
Furthermore, the degree to which peripheral nerve ECM is remodelled during 
neuroregeneration, and therefore the implications for the support and promotion 
of processes such as Schwann cell attachment and migration, axonal regrowth 
and (ultimately) distal target reinnervation, is unclear. It has been postulated 
that retention of the ECM histoarchitecture is favourable for the promotion of 
neuroregeneration by peripheral nerve grafts, providing physical and 
chemotrophic guidance to infiltrating Schwann cells and regenerating axons [18, 
58]. Based on this hypothesis, modifications to graft materials potentially 
enabling ECM remodelling to occur at an increased rate could result in a more 
rapid loss of the distinct ECM structures within regions such as the 
endoneurium; therefore, such alterations may not be favourable to the support 
of axonal regrowth in peripheral nerve defects. Furthermore, when considering 
the measured growth rate of human axons (approximately 1 mm/day) 
regenerating neurons would require the guiding endoneurial tubule structures to 
be maintained for at least 30 days, which would favour the retention of a native-
like resistance to enzymatic digestion (and therefore the rate of ECM 
remodelling to occur in parallel with the growth of the extending axons) [403].  
PAA treatment reduced the UTS of the decellularised nerves, whilst SCCO2 
treatment caused an increase in UTS and Young’s Modulus. A reduction in UTS 
could lead to physical failure of the graft if subject to high tensile forces in situ, 
potentially increasing the chance of re-injury; however, the levels of stress 
required for this to occur would likely be high enough as to induce injury in 
axons irrespective of such changes to the mechanical properties of a graft 
material. However, an increased Young’s Modulus could (especially if such 
changes were mirrored at the microscale ECM level) have negative implications 
for the support of neuronal growth, as well as potentially mediating localised 
disruption of signal transduction to propagating action potentials [366, 382]. 
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Such alterations to tissue mechanical properties are therefore likely to have a 
negative impact upon the function of a decellularised peripheral nerve graft. 
Possible mechanisms underlying the differential effects to ECM-based grafts of 
ionising radiations and oxidative agents have previously been described. 
Irradiation of collagenous tissues (e.g. human bone, decellularised human 
dermis, porcine tendon) have been observed to cause changes to structural and 
mechanical properties [6, 220, 336, 390, 451]. Such changes are thought to be 
indicative of scission of the collagen polypeptide backbone and/or the formation 
of novel inter-molecular crosslinks, the occurrence of which has been 
demonstrated with purified and irradiated collagen in vitro [1, 172, 228, 230, 
390]. When tissues are irradiated in a wet state (i.e. in the presence of water 
molecules), as in the present study, crosslinking is favoured due to interactions 
of amino acid side chains with free radicals formed through radiolysis of water 
molecules [1]. However, a reduction in measured transition temperature was 
observed in nerves treated with either gamma radiation or E Beam; this may be 
indicative of disruption of intramolecular hydrogen bonds caused by hydroxyl 
radicals formed during irradiation [1, 228]. While the reduced transition 
temperature seen in decellularised nerves treated with gamma radiation or E 
Beam in the present study suggests some chain scission has taken place, the 
maintained/reduced collagenase susceptibility and retention of ECM structure 
and mechanical properties in irradiated nerves may be indicative of the 
formation of novel inter-molecular crosslinks. This proposed scenario is 
reinforced by the observed results of previous studies: structural damage and 
compromised material properties have been documented following dry-state 
irradiation of allograft human bone and decellularised human dermis, while 
(similarly to the findings of the present study), wet-state irradiation of 
decellularised porcine superflexor tendon did not appear to induce negative 
effects to these properties [179, 336, 393]. Therefore, the observed changes to 
transition temperature are unlikely to imply reductions to the gross parameters 
of the decellularised nerves (such as ECM structure or tensile mechanical 
properties); indeed, the stiffness of the decellularised nerves was found to 
increase following gamma radiation, and the histioarchitecture appeared to be 
well preserved [172]. Whilst the specific implications of such molecular-scale 
changes for the biological properties of the decellularised nerves are not clear, it 
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should be noted that allogeneic tissue grafts irradiated under similar conditions 
(and therefore likely to have undergone similar molecular scale alterations to 
collagen bonding patterns; e.g. amniotic membrane and bone) have been 
demonstrated to be efficacious in clinical practice, with no notable safety 
concerns [394, 395].  
Previous studies have demonstrated evidence of oxidative damage to ECM 
components in decellularised tissue grafts sterilised with PAA. Fourier transform 
infrared spectroscopy (FTIR) revealed an increase in –OH groups and C=O 
groups and a decrease in C-H groups in decellularised porcine 
temporomandibular discs sterilised with 0.2 % (v/v) PAA in 4 % (v/v) ethanol 
solution, compared to native samples or those sterilised with gamma radiation 
(13 kGy) [179]. This was accompanied by an approximate 30 % increase in 
surface free energy and a reduction in the contact angle of distilled water from 
65 ° to 40 ° (indicative of increased hydrophilicity); furthermore, samples treated 
with the PAA/ethanol solution supported a greater population of seeded human 
umbilical cord Warton’s jelly matrix cells compared with gamma irradiated or 
ethylene oxide-treated samples. Mass spectrometric analysis of decellularised 
murine lung samples revealed an increase in residual basement membrane 
sub-units (e.g. laminin sub-units alpha-5 and beta-1, collagen IV alpha-1, 2 and 
3) after sterilisation with 0.2 % (v/v) PAA in 4 % (v/v) ethanol solution, indicative 
of increased solubilisation of these molecules (and hence increased likelihood 
of detection through the mass spectrometry protocol employed in the study) 
[242]. It is possible that similar mechanisms are responsible for the structural 
and chemical alterations seen in decellularised nerve ECM after treatment of 
the decellularised nerves with either 0.1 % (v/v) PAA solution or SCCO2 (with 
the NovaKill™ additive solution).  
A further decrease in the signal intensity of antibody labelling for laminin, 
fibronectin and collagen IV was seen in the perineurium and endoneurium of 
PAA-treated nerves after 12 months storage at room temperature compared 
with those fixed immediately after production (0 months), which was considered 
as likely to be indicative of further degradation to these components (e.g. 
changes to the surface chemistry and/or localisation/solubilisation). Such 
changes were not observed in the endoneurium/perineurium of either gamma 
irradiated or E Beam-treated nerves stored under the same conditions. ECM 
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degradation has previously been observed in decellularised rat lungs sterilised 
with 0.1 % (v/v) PAA solution, with further degradation apparent after a 6 month 
storage period [243].  As with the non-aged PAA-treated samples, the 
mechanisms underlying such changes have not been fully elucidated, but could 
include oxidative degradation, solubilisation of the ECM components, and/or 
destabilisation of the inter-/intramolecular bonds of laminin and fibronectin sub-
units, either in isolation or combination [179, 242].  
It is possible that the observed changes to antibody labelling detailed above, 
and the proposed mechanisms underlying such changes, could have 
implications for the ability of the decelluarised nerves to support of 
neuroregeneration. Both laminin and fibronectin function as chemoattractants 
for Schwann cells and facilitate the direct binding of regenerating axons to the 
ECM; this is underlined by the fact that the expression of both molecules is 
upregulated in Schwann cells following injury [361]. The 2, 4 and 1 laminin 
sub-chains (contained within the isoforms laminin 2 and laminin 8) and the “V 
region” of fibronectin have been implicated as particularly crucial for mediating 
the aforementioned cell-matrix interactions [42, 61]. The reduction in intensity of 
specific antibody labelling for fibronectin, and the loss of localisation for laminin 
labelling, observed in decellularised nerves treated with SCCO2 (plus the 
NovaKill™ additive solution) implies a greater level of basement membrane 
degradation compared with that seen in nerves treated with 0.1 % (v/v) PAA 
solution. If, through the possible mechanisms detailed above, treatment with 
one/both of these sterilisation methods has caused changes to the localisation, 
surface chemistry and/or conformation of key binding sites within laminins 
and/or fibronectin in the basement membrane, it follows that neuroregenerative 
processes thought to be dependent on these molecules, such as Schwann cell 
growth and migration, ECM remodelling, and axon attachment, may be 
impeded. In addition the proposed mechanisms underlying the apparent 
changes to these components could lead to fragments of solubilised 
laminin/fibronectin molecules (or associated fragments) to be recognised as 
DAMPs; this could induce the activation of the innate immune system and 
thereby potentially compromise graft integration into the surrounding tissue 
[132, 133]. However, it is possible that the specific target epitopes of the 
antibodies used to label fibronectin and laminin have been altered by oxidative 
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reactions but key cell attachment motifs for Schwann cells and axons have not; 
in this scenario, the ability of the decellularised nerves to effectively promote 
neuroregeneration may not have been compromised by treatment with PAA or 
SCCO2.  
There is some evidence that, beyond its primary function as a scaffold to 
support other basement membrane components, collagen IV also facilitates 
cell-matrix interactions [321]. Axons (through α1β1 integrin) and Schwann cells 
(through integrins α1β1 and α2β1 and G-protein coupled receptor GPR126) 
sourced from rats have both been demonstrated to interact with collagen IV in 
vitro [362-364]. Downstream signalling from GPR126, mediated though cAMP, 
induces rat Schwann cells to differentiate and adopt pro-myelinating 
characteristics, whereas altering the conformation of GPR126 through a genetic 
knockout animal model prevented the expression of myelin basic protein [365]. 
If a similar pathway exists in human Schwann cells, it is plausible that 
alterations to collagen IV which prevent antibody binding (such as those seen in 
nerves treated with oxidising agents in the present study) may also disrupt cell-
matrix interactions such as that mediated by GPR126.  
Data acquired within this study indicated that whilst decellularised nerves 
sterilised with gamma radiation and E Beam retained localised labelling for 
collagen IV, laminin and fibronectin, the most complete preservation of these 
basement membrane components was achieved when SCCO2 sterilisation was 
carried out under submerged conditions (rather than the standard process, in 
which the tissue is only submerged in PBS post-processing). With the exception 
of a study evaluating the effects of SCCO2 sterilisation on decellularised rat 
lungs, which demonstrated retention of laminin after processing, there is limited 
evidence in the literature regarding the effects of SCCO2 treatment on 
basement membrane components [243]. When considered in isolation, the 
results suggest that ECM-based scaffolds treated with SCCO2 under 
submerged conditions may provide a superior substrate for the growth and 
migration of infiltrating cells compared to scaffolds sterilised with gamma 
radiation or E Beam. However, due to the relative novelty of the submerged 
process and practical limitations in terms of the production of decellularised 
nerves, a smaller group of samples was allocated to this treatment group. This 
restricted the feasible extent of characterisation to histological examination of 
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ECM structure and antibody labelling for selected basement membrane 
components. SCCO2 processing under standard conditions had a negative 
effect on the mechanical properties of the decellularised nerves, mirroring 
alterations seen previously in SCCO2-processed decellularised rat lungs and 
porcine heart valves [19, 243]. The preliminary data presented suggests that 
sterilisation with SCCO2 under submerged conditions should be considered with 
other tissue grafts for which preservation of basement membrane structure and 
composition would be considered a positive functional prognostic indicator. 
Examples could include the endothelial basement membrane in vascular 
tissues and the epithelial basement membrane in gastrointestinal submucosa 
and dermis.   
Histological examination indicated that treatment with PAA and SCCO2 resulted 
in some disruption to the tubular structures of the endoneurium, which could 
negatively impact upon directional guidance and physical support to individual 
regenerating neurons [18, 138]. The importance of retaining an undamaged 
endoneurium for the support of neuroregenerative processes was highlighted by 
a comparative in vivo study of a synthetic guidance conduit composed of 
collagen type I (NeuraGen®) and a decellularised nerve graft produced using 
the patented AxoGen, Inc process and sterilised by gamma radiation; both 
grafts were implanted into a rat sciatic defect model [138]. The decellularised 
nerves were shown to retain endoneurial tubule structure and basement 
membrane laminin localisation, whereas the conduit did not incorporate laminin 
and provided no topographical guidance structures. The conduit and 
decellularised nerve were implanted into a rat sciatic nerve defect and left in situ 
for 22 weeks. While both scaffolds were inferior to the use of an isograft, 
decellularised nerves supported the growth of approximately 20-fold more 
axons into peripheral nerve tissue distal to the site of injury, indicating superior 
guidance and promotion of axonal growth compared to the conduit. A separate 
study showed that implantation of a previous iteration of the decellularised 
porcine nerves used in the present study, sterilised with 0.1 % (v/v) PAA 
solution, enabled the growth of axons across a rat sciatic defect over 11 weeks; 
however, an autograft control supported an average regrowth length of 14 mm 
compared to only 8.5 mm in the decellularised graft [139]. In light of these 
findings, retention of the physical structure and basement membrane 
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composition of the endoneurium was considered a key prognostic indicator for 
the function of sterilised nerves in the present study. The superior preservation 
of endoneurial structure and composition mediated by treatment of 
decellularised nerves with E Beam or gamma radiation may therefore enable 
greater reinnervation of target effectors post-implantation and, ultimately, 
restoration of function. 
None of the sterilisation methods adversely affected the biocompatibility of the 
decellularised nerves during in vitro contact assays, or caused the induction of 
detectable sustained pro-inflammatory response when seeded with a murine 
macrophage cell line. Despite this evidence supporting the cytocompatibility and 
relatively low immunoreactivity of the sterilised nerves, the lack of an in vitro 
and/or in vivo experiment investigating the ability of the decellularised nerves to 
support the growth of site-specific cells (e.g. neurons and Schwann cells) 
represents a limitation of this thesis. It is not clear how the observed changes to 
the basement membrane, endoneurial structure and mechanical properties may 
influence the interaction of cells with the ECM. In peripheral nerve, laminin and 
fibronectin provide cell attachment motifs which mediate the infiltration and 
growth of Schwann cells and neurons, while the β-sheet structures of collagen 
IV act as a supporting scaffold and are provide key cell attachment motifs [380]. 
As the use of oxidising agents appeared to degrade the target epitopes of the 
antibodies specific for these ECM components in the present study, it is 
possible that the attachment of cells could be altered or disrupted in a similar 
manner.  
However, previous in vitro studies evaluating cell attachment in other tissue 
types sterilised with PAA or SCCO2 suggest that cell attachment may not be 
affected by the process of sterilisation. Decellularised porcine 
temporomandibular discs sterilised with 0.2 % (v/v) PAA in 4 % (v/v) ethanol 
were shown by independent studies to support greater levels of cell attachment 
compared with gamma irradiated (13 kGy) samples [179]. The authors 
postulated that the high observed levels of cell adhesion in PAA-treated 
samples compared with gamma irradiated (dry state) was due to oxidative 
changes resulting in the addition of hydroxyl groups and carboxyl groups to the 
amino acids within the tissue. These were linked to a study by Keselowsky et al, 
which examined the relative affinity of specific integrins for specifc chemical 
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groups and the implications for cell binding; hydroxyl groups and carboxylic acid 
groups were found to facilitate the highest levels of integrin adhesion (for α5β1 
and αVβ3 integrins, respectively). Hydroxyl groups, followed by carboxylic acid 
groups, also mediated the highest level of adhesion from seeded M3CTC-E1 
cells [469]. Matuska et al further speculated upon the importance of the relative 
location of oxidative damage to ECM components; FTIR analysis revealed that 
this was predominantly in aliphatic side chains. The authors suggested that, 
considering the non-aliphatic composition of the common cell attachment motif 
RGD (arginine-glycine-aspartic acid), such changes would be less likely to 
negatively impact cellular interaction with the ECM.  
It is possible that the mechanisms detailed above may at least partially underlie 
the similar patterns of cell attachment observed in the present study, when 
sterilised nerves were seeded with the RAW 264.7 murine macrophage cell line. 
PAA and SCCO2-treated nerves appeared to support greater initial attachment 
of macrophages compared to E Beam-treated samples. However, as this only 
represented surface attachment of a non-specific cell type, only very limited 
inference can be made towards the attachment of neurons or Schwann cells to 
the endoneurial basement membrane. Histological evidence in a study of 
decellularised murine lung matrices appeared to show that PAA-treated tissue 
supported a greater viable population of C10 epithelial cells compared to 
gamma irradiated tissue, whilst the opposite was true for mesenchymal stem 
cells [242]. This appears to be indicative of differences in the functional 
susceptibility of cell attachment motifs to radiation-induced or oxidative damage 
mechanisms. Alterations to patterns of attachment and support as a result of 
treatment with a given sterilisation method may therefore be specific to 
individual cell types, and the likely response of site-specific cells (e.g. Schwann 
cells, neurons) to the basement membrane of nerves treated with different 
sterilisation methods remains unknown.  
The safety and efficacy of two decellularised human nerve grafts, developed by 
He et al and AxoGen, Inc (Avance® nerve graft) respectively, has been tested 
in small scale clinical studies, and have either recently completed or are 
currently undergoing larger multicentre trials . Both grafts are terminally 
sterilised with gamma radiation (25 kGy) [137, 310, 458, 459]. The results of 
initial trials indicated that both grafts were safe and did not elicit an adverse host 
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immune response. Initial clinical trials evaluating efficacy revealed that (at least 
partial) functional restoration was achieved in 65.3 % (defect length 1 – 5 cm, 
72 repair procedures) and 87.3 % (defect length 0.5 – 3 cm, 132 repair 
procedures) for the grafts developed by He et al and AxoGen, Inc respectively. 
These initial data suggest that sterilisation with ionising radiation does not 
impair functional properties of decellularised nerves; however, data from larger 
scale trials comparing the clinical applicability of decellularised nerves to the 
current direct suturing (coaptation) or autografting procedures would enable 
more definitive conclusions to be drawn. These in vivo results are encouraging, 
as the findings of the present study appeared to be in line with the previous in 
vitro results observed for the human nerve grafts developed by He et al and 
Axogen, Inc; treatment of the decellularised porcine nerves with ionising 
radiation appeared to enable good preservation of functional properties 
considered important to the provision of a pro-neuroregenerative environment 
(e.g.  ECM structure and composition, particularly in the endoneurium) 
compared with other tested sterilisation methods (0.1% PAA in solution and 
SCCo2 treatment under standard conditions). However, in the present study 
gamma radiation induced some slight differences in terms of mechanical 
properties (significantly increased stiffness) and the intensity of basement 
membrane component labelling compared with non-sterilised decellularised 
nerves, suggesting that, if utilising ionising radiation, sterilisation with E Beam 
rather than gamma radiation may result in a superior graft material. 
9.2 Future work 
The present study demonstrated alterations to decellularised nerve ECM across 
a range of parameters as a result of sterilisation. Observed results indicative of 
alterations to the properties of ECM components included decreased intensity 
of labelling for basement membrane components, and increase or decrease 
(depending on the specific sterilisation method) in collagenase susceptibility, 
collagen denaturation temperature and  mechanical properties. Elucidating the 
precise nature of these changes and the underlying mechanisms responsible 
may enable prediction of the likely implications for graft efficacy.   
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Confirmation of oxidative damage to/solubilisation of ECM components 
following treatment with PAA or SCCO2 could be achieved through analysis of 
sterilised nerve samples with mass spectrometry and FTIR, as previously 
described by Bonenfant et al and Matuska et al respectively [179, 242]. FTIR 
would enable significant changes in the abundance of –OH, C-H and C=O 
groups, associated with oxidation of the ECM components, to be quantified. 
Mass spectrometric identification of residual ECM proteins was attempted within 
thus study, in order to understand if the observed changes in antibody labelling 
intensity for basement membrane components corresponded to changes in the 
abundance of the proteins in the matrix. However, despite the use of a cryomill 
to increase the speed of processing and the repeated optimisation of a tryptic 
digest protocol for use with peripheral nerve samples (based on that provided 
by Bonenfant et al) the detected protein fragments always represented an 
incomplete fraction of the known ECM constituents. For example, despite 
representing approximately 90 % of ECM mass in peripheral nerve tryptic digest 
fragments from collagen type I were only identified in 30 % of samples 
processed according to the final protocol. A possible reason for the apparent 
incomplete digestion and/or lack of recovery of fragments may be the high fat 
content of peripheral nerve, at approximately 50 % of the dry mass. The use of 
a defatting protocol may therefore increase the efficiency of ECM protein 
digestion, and allow the detection of a more complete spectra and enable the 
quantification of relative changes to the abundance of specific protein sub-units 
(e.g. the alpha chains of collagen IV) compared to native or non-sterilised 
decellularised nerves. However, defatting protocols for tissue utilise solvents 
such as acetone or ethanol [17, 470]. These compounds are known to mediate 
crosslinking and precipitation of collagens and are likely to induce alterations to 
other ECM components. Alterations to the ECM incurred by defatting with 
solvents could therefore alter the protein fragment spectra obtained after tryptic 
digest and prevent the determination of changes mediated solely by the 
sterilisation methods. 
Treatment of decellularised tissue with ionising radiation under hydrated 
conditions favours the formation of novel crosslinks within and between 
collagen molecules over chain scission [276]. Increased crosslinking could be 
responsible for the raised stiffness and decreased collagenase susceptibility 
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seen in gamma irradiated and E Beam treated nerves respectively. 
Quantification of crosslinks within decellularised nerve ECM and 
characterisation of the higher order structure of the collagen would provide 
further evidence supporting these theories. Quantification of crosslinks could be 
achieved through an assay using ninhydrin, which enables the proportion of free 
amino groups per given mass of tissue to be determined by the measurement of 
absorbance at 570 nm [471]. This assay has previously been used to determine 
the degree of crosslinking in decellularised porcine articular cartilage and 
decellularised porcine myocardium [472, 473]. In the articular cartilage study, 
which compared the use of different synthetic crosslinking compounds (e.g. 
glutaraldehyde, genipin, epigallocatechin gallate [EGCG]) to stabilise ECM 
structure, it was found that the approximate 33 % lower level of crosslinking in 
EGCG-treated samples compared to other groups corresponded with an 
approximate 33 % greater mass of tissue lost during collagenase susceptibility 
testing. Quantification of crosslinking in the the sterilised nerves could reveal 
similar patterns and provide additional evidence supporting the reason for the 
superior retention of mechanical properties and resistance to collagenase 
digestion of decellularised nerves treated with E Beam. The overlap and 
spacing between two aligned tropocollagen molecules in a fibril, known as a D-
period, is 67 nm in length in the native collagen type I [378]. Crosslinking of 
collagen in human corneas with glutaraldehyde resulted in a shortening of the 
D-period length to 61 nm, with both the length of the overlap and the gap 
between tropocollagen molecules decreasing. It is possible that crosslinking 
mediated by ionising radiation could induce a similar effect, and therefore 
measurement of the D-period could provide further evidence of this effect. The 
D-period of collagen type I in native, decellularised and sterilised nerves could 
be visualised using either transmission electron microscopy or atomic force 
microscopy, and the D-period length deduced from the images.  
A further aspect of peripheral nerve biomechanics which is relevant in the 
context of tissue regeneration (and therefore should be considered when 
evaluating the potential utility of a potential graft material such as decellularised 
nerves) is viscoelasticity. Peripheral nerve is recognised as a viscoelastic tissue 
[474-476], and while the effects of alterations to the viscoelastic properties on 
cellular function have not yet been fully characterised, it is likely that significant 
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deviation from native-like properties in this regard could have an effect on the 
function of key peripheral nerve effector cells (e.g. the viscosity of peripheral 
nerve tissue from diabetic individuals is reduced; this has been identified as a 
factor which may contribute to diabetic-associated neuropathic pathologies) 
[477]. The viscoelastic properties of the sterilised decellularised peripheral 
nerves should therefore be characterised; this could be achieved through 
dynamic mechanical analysis (DMA) [478]. DMA involves the application of 
stress (or strain) to a sample in an oscillating sinusoidal pattern; the 
corresponding strain (stress) is measured, and the resulting data can be used to 
calculate several parameters with relevance to tissue function. These include 
the storage modulus and the loss modulus, which are representative of the 
relative contributions of the elastic solid phase (stored/recoverable strain 
energy) and viscous fluid phase (energy dissipating during the sinusoidal 
application of stress/strain, primarily as heat) contributions to the dynamic 
modulus. The dynamic modulus is also known as the complex modulus, and 
describes as the ratio of stress to strain under the oscillatory [or “vibratory”] 
conditions). Previous studies conducted into the viscoelastic properties of 
another soft tissue, tendon, have postulated that observed differences to 
dynamic mechanical properties are primarily conferred by the crimp pattern of, 
and crosslinking associated with, the collagen fibres in the tissue [479-481]. As 
noted previously, collagen crosslinking may be altered by the sterilisation 
processes used in the present study (and collagen crimp patterns can be 
altered by changes to intramolecular crosslinking), and this process in turn may 
underlie some of the observed alterations to mechanical properties. Significant 
variation was observed in the tensile mechanical data obtained during the 
present study. Therefore, in addition to investigating sterilisation-induced 
changes to collagen structure through crosslink quantification and D-period 
measurement, it is possible that subjecting the sterilised decellularised nerves 
to DMA analysis could yield more definitive data regarding the changes to 
mechanical properties of the sterilised deceullarised nerves.   
It may be possible to mitigate the negative effects of treatment with ionising 
radiations through altering the regime of dose application. The same overall 
dose can be achieved through the application of a series of smaller doses, in a 
process known as dose fractionation [482]. For example, gamma radiation in 
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the present study was applied in a single dose of 25 kGY; this could be applied 
instead in ten individual doses of 2.5 kGy. The use of dose fractionation 
mediates the same level of sterility assurance but has been demonstrated to 
reduce adverse effects to the mechanical properties of a human bone-tendon-
bone allograft sterilised with 34 kGy E Beam [483]. The application of a 
fractionated dose regimen may reduce the magnitude of alterations to the 
physical properties of decellularised nerves seen following treatment of 
decellularised nerves with gamma radiation. However, consideration of a 
tailored (non-standard 25 kGy dose) regimen such as fractionation as a 
treatment methodology would require sole use of a gamma irradiator/electron 
accelerator, which may incur increases in processing costs.  
While the epineurium is not thought to be a major contributor to the tensile 
mechanical properties of peripheral nerves, the heterogeneous mixture of 
collagenous and adipose tissue is thought to modulate the impact of 
compressive forces on the axonal cell bodies and Schwann cells located within 
the fascicles. Excessive compression over both acute (e.g. blunt trauma) or 
chronic (e.g. Saturday night palsy, carpal tunnel syndrome) timescales can 
impair signal conduction function and, although normally only considered a 
Grade I injury on the Seddon and Sunderland classification scale, may induce 
full Wallerian regeneration in severe instances [48]. In the present study, the 
physical properties of the nerves were only tested though the application of 
tensile strain on a longitudinal axis. The compressive properties, particularly the 
compressive modulus and stiffness, should be evaluated to determine the 
extent of any degradation of such properties, which could lead to an increase in 
compressive forces experienced by axons growing within the nerves and a 
corresponding reduction in functional restoration.  
A promising retention of basement membrane labelling intensity and 
histioarchitectural structure was seen in decellularised nerves treated with 
SCCO2 under submerged conditions, implying a reduced level of oxidative 
damage to ECM components. The effects of this SCCO2  treatment under these 
conditions on the mechanical and physical properties, biocompatibility and 
biochemical composition of the decellularised nerves should be fully 
characterised. If improved preservation (in comparison to treatment with SCCO2 
under standard conditions) of such parameters is observed, and the treated 
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nerves can be stored for 12 months without undergoing adverse alterations, 
treatment with SCCO2 under submerged conditions may be considered together 
with E-Beam as a candidate method for the sterilisation of decellularised 
nerves.  
In order to be considered for clinical trials in humans, the safety and efficacy of 
the sterilised nerves should first be demonstrated in both in vitro and in vivo 
model systems [484]. An in vitro screen designed to interrogate the possible 
host immune response to the sterilised nerves has been described in this 
thesis. A similar in vitro screening process, involving seeding with Schwann 
cells and neurons, would be an appropriate first step when investigating the 
potential for the sterilised nerve segments to support neuroregeneration. 
Conducting such an experiment prior to in vivo implantation studies would 
enable quantification of differences in metabolic activity, axonal extension, the 
expression of cell surface markers (e.g. Schwann cell markers enabling 
differentiation of myelinating or non-myelinating phenotypes, such as myelin 
basic protein) and the composition of the protein secretome (particularly relative 
levels of neuroregeneration-associated cytokines [such as NGF, LIF, BDNF and 
FGF] and ECM components [including fibronectin, laminin and collagens]), via 
quantitative mass spectrometry, and qualitative histological analysis to identify 
the degree of ECM remodelling, within a controlled environment [48, 111, 485, 
486].  
Considering the potentially low in vitro growth rate of regenerating axonal 
stumps, a future in vitro study would ideally incorporate co-culture of Schwann 
cells and neurons for a period of 28 days or longer to elucidate the likely ability 
of the sterilise nerves to support and promote neuroregeneration [487]. The 
choice of appropriate cells for the seeding process would be crucial for the 
validity of such an experiment. The use of rat dorsal root ganglia cells (DRGs) 
as a source of primary peripheral neurons would be preferable to currently 
available neuronal cell lines, such as PC12 and NG108-15, which are derived 
from CNS sources [60, 485]. If rat DRGs were used as a source of neurons, the 
Schwann cells used in the experiment should also be sourced from a rat to 
ensure compatibility of paracrine signalling molecules. Rat Schwann cells could 
be obtained from a primary source or via a cell line [488]. Primary cells derived 
from explanted tissue would be preferable to cell lines in terms of phenotypic 
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characteristics; however, complications could be induced due to batch-to-batch 
variation of cell characteristics and the difficulty of isolating a sufficiently 
homogeneous population (with minimal fibroblastic contamination). 
Immortalised cell lines, such as RN22, S16 or RT4-D6P2T, may provide a more 
consistent response and have been shown to retain key phenotypic 
characteristics [488].  
Following in vitro screening, the sterilisation treatment groups which appear to 
support the survival and growth of Schwann cells and neurons would be 
considered for in vivo testing in a surgically-created defect. This would enable 
the concurrent investigation of Schwann cell and neuronal growth and the host 
immune response (including the innate and adaptive immune system). 
Implantation into a rat model, typically in a sciatic nerve defect, is a common 
first step used to assess the efficacy of peripheral nerve repair devices [489]. 
The implanted nerve segment would be retained in the defect site for at least 
three months. Control groups of animals should be included, with the defect 
either repaired via an autograft procedure, to represent current clinical practice, 
or not repaired at all (or repaired with a simple NGC providing no physical or 
chemotrophic cues) [340, 490-492]. Appropriate quantitative outcome measures 
would include axonal extension, analysis of the relative numbers of different cell 
types (e.g. Schwann cells, macrophages, perineurial cells etc), tests of 
muscular function and conduction speed, and analysis of the mechanical 
properties of excised grafts [137, 383, 485, 489]. Qualitative measures could 
include the antibody labelling for cell surface markers to determine phenotype 
(e.g. Schwann cell markers enabling differentiation of myelinating or non-
myelinating phenotypes, such as myelin basic protein), histological anlaysis to 
determine the degree of remodelling within the decellularised nerves 
(particularly at the interface between the decellularised graft and the native 
nerve, antibody labelling to analyse the deposition of specific ECM components 
of interest (e.g. laminin, fibronectin and collagen IV), and histological/antibody 
labelling-mediated analsysis of the extent and nature of the host immune 
response to the graft (e.g. is the phenotype of the macrophage population 
present predominantly M1 or M2, is there evidence of fibrosis and 
encapsulation). 
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Any sterilisation treatment groups which displayed favourable results in a small 
animal model should then be tested in a large animal model; historically, such 
models have not been employed frequently in the testing of peripheral nerve 
repair methods and, as such, an optimal large animal model has not been 
identified [489]. The principal reasons underlying this are thought to be based 
on the relatively high costs associated with conducting   long-term studies in 
large animals compared to a similar study in a rat or mouse, as well as the 
inherent increased complexity of surgical procedures and functional tests. As 
the decellularised nerves are derived from porcine tissue, it may be more 
representative to use an ovine model rather than porcine model (as a same 
species graft does not mirror the intended cross-species application) [493-495]. 
An ovine median nerve model has previously been used to assess the efficacy 
of Corglaes Wrap (similar in design to an NGC, but sized and sealed during the 
surgical procedure [494]. The outcome measures used would be the same as in 
the small animal model, and a control groups would be included in which the 
defects are either not repaired or repaired via autografting. The defect size 
should be sufficient to demonstrate the efficacy of the decellularised peripheral 
nerves over larger defects (i.e. those greater than approximately 3 cm in 
length), given that applications within defects of a larger size may be a crucial 
niche in which decellularised nerves present advantages (in terms of providing 
directional physical and chemotrophic cues) for the promotion of 
neuroregeneration compared with synthetic NGCs.  
9.3 Conclusions 
Decellularised porcine peripheral nerves represent a potential nerve graft 
material, which may enable promotion of regeneration in a similar manner to an 
autograft whilst eliminating the need for a second site of surgery and providing a 
much greater volume and size range (diameter, length) of available tissue for 
the repair of larger defects [496]. The main aim of this study was to identify a 
terminal sterilisation method which would be suitable for use with decellularised 
porcine peripheral nerves; such a method would minimally impact upon the 
ECM structure, biochemical composition, biomechanical properties and 
biocompatibility of the decellularised nerves. Treatment with 0.1 % (v/v) PAA 
solution was not considered to be suitable for the sterilisation of decellularised 
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nerves due to the observed alterations to the ECM structure and basement 
membrane components of the decellularised nerves (specifically disruption to 
the structure of the endoneurium and reductions in the intensity of antibody 
labelling for basement membrane components, particularly collagen IV). 
Furthermore, the severity of basement membrane component alteration in the 
PAA-treated nerves appeared to have increased after 12 months of storage, 
and treatment with PAA solution presents an additional problem due to the fact 
that, as it requires an aseptic transfer procedure post-processing, it does not 
represent a truly terminal sterilisation method. As SCCO2 treatment under 
standard conditions appeared to induce similar negative effects to the 
histioarchitecture whilst additionally causing significant alterations to tensile 
mechanical properties, it was also not considered to be a suitable method of 
sterilisation. Subjecting the decellularised nerves to SCCO2 processing under 
submerged conditions appeared to protect against the occurence of such 
effects; high levels of structural preservation were observed histologically, and 
antibody labelling for the basement membrane components collagen IV, laminin 
and fibronectin retained intensity and remained highly localised to the 
endoneurium and perineurium. 
Treatment with gamma radiation and E Beam appeared to mediate retention of 
the ECM structure of the decellularised nerves, and changes to the localisation 
and intensity of labelling for basement membrane components were minimal 
compared with those observed following treatment with PAA solution or SCCO2 
under standard conditions. However, treatment with gamma radiation appeared 
to cause an increase in the stiffness of the nerves.  
Contact culture experiments did not yield evidence of cytotoxicity following any 
of the sterilisation methods; furthermore, the sterilised nerves did not induce 
any significant changes in the secretion of pro-inflammatory cytokines by a 
murine macrophage cell line.  
In summary, whilst the results obtained during this study indicate E Beam to be 
the most promising sterilisation method for decellularised nerves with respect to 
the current dataset, preliminary results indicated that SCCO2 processing under 
submerged conditions may have the potential to enable retention of a superior 
substrate for neuronal cell growth.  
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Appendix A: Equipment and Materials 
Supplementary Table 1: Chemicals and Reagents 
 
 
 
Chemical/Reagent Company 
Acetic Acid, glacial (17:4 mM) Thermo Fisher Scientific Ltd. 
AlamarBlue® Thermo Fisher Scietific Ltd. 
Aprotinin (50 ml; 10,000 KIU.ml-1) Mayfair House 
Bovine Serum Albumin - 
Benzonase nuclease hc, purity >99% 
(250 U.µl-1) 
Merck 
 
Calcium acetate 97+ % (Dried) Thermo Fisher Scientific Ltd. 
Chloramine T Sigma-Aldrich 
Citric acid Sigma-Aldrich 
Cyanoacrylate contact adhesive: 
Scotch® Super Glue Liquid 
3M UK PLC 
Dako fluorescence mounting medium  Agilent 
DAPI (4',6-diamidino-2-phenylindole 
dihydrochloride) 
Sigma-Aldrich 
Dimethylene blue Sigma-Aldrich 
DMSO   - 
DNAse I (10,000 U/ml) - 
DNeasy kit  Qiagen 
Dulbecco's minimal essential medium  Sigma 
PBS (without Ca/Mg, suitable for 
cell culture) 
Sigma 
 
Distyrene Plasticiser Xylene (DPX) mountant Sigma-Aldrich 
EDTA (disodium ethylenediaminetetraacetic acid) Thermo Fisher Scientific Ltd. 
Ehrlich’s Reagent  
Eosin Y  Merck Millipore 
Eppendorf thermomixer  Eppendorf 
Ethanol 190 % proof  Sigma-Aldrich   
Foetal bovine serum 
Sera Lab 
 
Gentamycin sulphate Sigma-Aldrich 
Giemsa stain  - 
Glasgow's minimal essential media  Sigma 
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Chemical/Reagent Company 
Haematoxylin (Mayer's) Atom Scientific 
Hydrochloric acid (6 M)  Fisher Scientific 
Hydroxylamine hydrochloride Sigma-Aldrich 
Iron (III) chloride Sigma-Aldrich 
Isopropanol  - 
L-glutamine (200 mM)  Sigma 
Magnesium chloride hexahydrate Thermo Fisher Scientific Ltd. 
Molecular grade water  Sigma-Aldrich 
Neutral Buffered Formalin (10 % v/v)  Biostains Ready Reagents 
Oxalic acid Sigma-Aldrich 
Papain Sigma-Aldrich 
Paraffin wax Raymond A Lamb Ltd 
PBS tablets (Dulbecco's `A' PBS 
tablets, without Ca/Mg) 
 
Oxoid 
Penicillin (5000 U/ml)/streptomycin (5 
mg/ml) 
Sigma 
Peracetic Acid, 32 % (v/v) 
Sigma-Aldrich 
 
Polymyxin B Sigma-Aldrich 
Potassium permanganate Sigma-Aldrich 
RNAse A (100 U/ml)  - 
RNase A (17,000 U)  
Qiagen 
 
Roswell Park Memorial Institute Media Sigma 
Scott's tap water 
- 
 
SDS (sodium dodecyl sulphate) Thermo Fisher Scientific Ltd. 
Sirius Red Sigma-Aldrich 
SLS pH Buffer Coloured Red pH4 Scientific Laboratory Supplies 
SLS pH Buffer Coloured Yellow pH7  Scientific Laboratory Supplies 
SLS pH Buffer Coloured Blue pH10  Scientific Laboratory Supplies 
Sodium acetate Sigma Aldrich 
Sodium chloride (NaCl) Thermo Fisher Scientic Ltd. 
Sodium di-orthophosphate 
 
Sigma-Aldrich 
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Chemical/Reagent Company 
Sodium hydroxide (NaOH) Scientific Laboratory Supplies 
Trichloroacetic acid Sigma-Aldrich 
Tris (trizma base) Sigma-Aldrich 
Trypan blue solution, 0.4 % (v/v) 
Sigma 
 
Trypsin-EDTA solution Sigma 
Tryptone phosphate broth Sigma 
Vancomycin hydrochloride Sigma-Aldrich 
Virkon R Rely+OnTM DuPont 
Water, nuclease-free (R0582) Fermentas 
Weigert’s Haematoxylin Sigma-Aldrich 
Xylene Biostains Ready Reagents 
Zinc acetate 99.9 % Sigma-Aldrich 
Zinc chloride Fluka 
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Supplementary Table 2: Equipment 
Equipment Company 
Accumax Pipette Controller  Fine Care Biosystems 
Airone 1800R Fume hood Safelab Systems Ltd 
Bunsen burner - 
Camera, Olympus 450D Camera, Olympus 450D 
Camera stand Manfrotto 
CellB Microscope Software, v3.2 Olympus 
Centrifuge, Harrier 15/80 Sanyo 
Centrifuge, Evolution RC Sorvall 
Dissection kit Dissection kit 
DSC Q2000 TA Instruments 
FastPetteTM V2 Pipette Controller Labnet International, Inc. 
Finnpipette Pipettes (0.2 {2 µl, 2 {20 µl, 
20 {200 µl & 200 {1000 µl) 
Scientific Laboratory Supplies 
Forceps, blue plastic Spencer Wells Fisher Scientific Ltd 
Freezer, cell culture - 
Glass troughs E105 Raymond A Lamb 
Haemacytometer, Neubauer Improved - 
Heraeus Hera Safe Class II biosafety 
cabinet 
Thermo Electron Corporation, USA 
Heraeus Incubator Jencons PLC 
Histology cassettes CMB-160-030R Thermo Fisher Scientific Ltd. 
Histology moulds E10.8/4161 Raymond A Lamb 
Histology water bath MH8515 Barnstead Electrothermal 
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Equipment Company 
Hotplate Stirrer heat-stir CB162 
Stuart Scientific 
Hotplate E18/31 
Raymond A Lamb 
Hot wax oven E18/31 
Raymond A Lamb 
Incubator, cell culture 
- 
Instron 3365 
Instron  
 
Jenway 3510 pH Meter 
Jenway Ltd 
Lancer 810 LX undercounter 
glassware 
Washer 
Lancer UK Ltd 
Magnetic flea 
- 
 
Microcentaur centrifuge MSE 
Microscope, inverted: Olympus CK40 Olympus 
Microtome, Leica RM2255 Leica 
Modulyo Freeze Drier Thermo Savant 
Mr Frosty - 
Nanodrop ND-1000 
spectrophotometer 
Labtech 
Olympus BX51 Microscope Olympus 
Pipe fittings - 
PIPETMAN ® 
Pipettes (0.2{2 µl, 2{20 
µl, 20{200 µl & 200{1000 µl) 
Gilson, Inc. 
 
Precision Balance GR-200 A&D Instruments Ltd 
Purelab OptionWater Purification 
System 
ELGA 
Refrigerator, cell culture - 
Ruler, 150 mm, stainless steel Fisher Scientific Ltd 
Ruler, 300 mm, stainless steel  Fisher Scientific Ltd 
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Equipment Company 
Slide holder E102 Raymond A Lamb 
Spatulas - 
Table shaker KS 130 IKA 
Table shaker PSU 10i Grant 
Table shaker POS 300 Grant 
Tissue Processor TP1020 Leica 
Water bath - 
Triplered SG Series Compact Triple Red 
Wax dispenser E66 Raymond A Lamb 
Whiteley Fume hood Whiteley 
Whirli mixer CM-1 vortexer Thermo Fisher Scientific 
Zeiss AX10 Microscope Carl Zeiss 
Zeiss HXP 10 Carl Zeiss 
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Supplementary Table 3: Glassware 
 
 
 
 
 
 
 
  
Glass/Plasticware Company 
Beaker, 3 L Scientific Laboratory Supplies 
Duran bottles (0.25 l, 0:5 l, 1 l and 2 l) Scientific Laboratory Supplies 
Funnel, small with long neck Scientific Laboratory Supplies 
Funnel, medium with short neck Scientific Laboratory Supplies 
Jar, polypropylene, wide neck with lid, 
1 l 
Thermo Scientific Nalgene 
Measuring cylinders (50 mm, 100 mm, 
250mm and 1000mm) 
Scientific Laboratory Supplies 
 
Mr Frosty - 
Petri Dish, glass, large (200 mm) Smith Scientific Ltd 
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Supplementary Table 4: Consumables 
 
 
Consumable Company 
Autoclave tape SLS1612 Scientific Laboratory Supplies 
Bijous (sterile, 5 ml) - 
Cell scraper ThermoFisher 
Coverslips, glass, E105 Scientific Laboratory Supplies 
Cryovials, 1 ml 
- 
 
Eppendorfs Eppendorf 
Foil - 
Histology cassettes - 
Measuring dishes Scientific Laboratory Supplies 
Microtube I, 1.5 ml, loop cap, Simport VWR International 
Minisart syringe filters, 0.2 µm pore size Sartorius Stedim UK Ltd. 
Needles, Neolus Hypodermic Terumo-Thin 
25G 16 mm (NN-2516R) 
 
Terumo UK Ltd. 
Parafilm - 
Pipettes, Pasteur - 
Pipette Tips, TipOne® (10 µl, 20 µl, 200 µl, 
1000 µl) 
STARLAB 
Serological Pipettes, sterile (5 ml, 10 ml, 25 
ml) 
Starstedty AG & Co. 
Scalpel blades, No. 22, non-sterile Swann-Morton Limited 
Scalpel blades, No. 22, sterile Swann-Morton Limited 
Sterilin pots (150 ml and 250 ml) - 
Superfrost slides Scientific Laboratory Supplies 
Superfrost plus slides MIC3040 Scientific Laboratory Supplies 
Syringes (1 ml, 2.5 ml, 5 ml, 10 ml) Terumo UK Ltd. 
Tissue culture flasks (T25, T75, T175) Thermo Fisher Scientific 
Tissue culture 6-well plates Thermo Fisher Scientific 
Universal containers (20 ml) - 
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Supplementary Table 5: Antibodies 
Antibody 
type 
Antigen Isotype Supplier Code 
Primary Laminin 
Monoclonal 
Rabbit IgG1 
Sigma Aldrich L929 
Primary 
Fibronectin 
 
Polyclonal 
rabbit IgG 
Dako A0245 
Primary Collagen type IV 
Mouse 
monoclonal 
IgG1 
Dako M0785 
Isotype 
control 
Mouse IgG1 - Dako X0931 
Isotype 
control 
Rabbit polyclonal 
IgG 
- Genetex GTX35035 
Secondary 
Goat anti-rabbit 
IgG AlexaFluor 
488 
- Invitrogen 
A11070 
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Supplementary Table 6: Cell Lines 
 Cell line Source 
BHK 21 (epithelial) European Collection of Authenticated Cell Cultures 
L929 European Collection of Authenticated Cell Cultures 
RAW 264.7 European Collection of Authenticated Cell Cultures 
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